<SEC-DOCUMENT>0001022079-22-000074.txt : 20220422
<SEC-HEADER>0001022079-22-000074.hdr.sgml : 20220422
<ACCEPTANCE-DATETIME>20220422161507
ACCESSION NUMBER:		0001022079-22-000074
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		60
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220422
DATE AS OF CHANGE:		20220422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		22845683

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dgx-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:c431f6d8-b8fc-477a-8446-6094ac02b3b7,g:484b9920-d5d4-4a3b-8e7d-6a5d9f5837a8,d:345527f5748848cea641eb9c408bf6be--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dgx="http://questdiagnostics.com/20220331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV8xLTEtMS0xLTQ1MDg1_c2a64094-cdd6-4587-b003-48c8bfa58a35">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV8yLTEtMS0xLTQ1MDg1_36553b5a-8480-4ffd-bc1d-0133c89db2ee">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV8zLTEtMS0xLTQ1MDg1_79fca51c-e367-48d6-8d3b-3c2f6a8e0426">2022</ix:nonNumeric><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV80LTEtMS0xLTQ1MDg1_b8871140-27cf-459b-ab0b-09664a2df11b">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV81LTEtMS0xLTQ1MDg1_615cf3be-8b50-42fc-9851-6a8a9661d2d4">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2dc8d4dcbed40af97db1fac37505ee9_I20220414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a67828d80741189c9e71a1926cad84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib939a88f4c11457d8f94ab3011660e90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387e21b64a5248cc90a14d9bcadffd40_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52d9091e753f4cdfaae8f68bbc2ea33f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a0f83bf88134568bde41c150af0ba41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30bff75e183e4fc391898fd34f86863b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d41353be3a04b738b4f4bc36e5d3820_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93d7d0509f14b08b2b9728096cbb3e7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd6c865cfcc5493cb1940ce9b692bd7a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic760c160bf9646bba4102bda5ef94b44_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57bcad1774d541d9ac66fc0077491325_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1bfa6a5fb1046dca736f71283a88051_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib36d5ba191104fe89f537554035b8907_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffea91bc8dcb4e06aadf8f63905ab017_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e3eda6f95ed4a74b1f90e8c5bd28859_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680491199aa14f2682953e743b93f967_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea0f667d8e834262a48cda2044511f1a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i481f1360cd724a9f8b74bd582e93a71e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i866848e13a4f4ec1bd85c404788b9111_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie178ff96837c4706a3f4b587cccefe07_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifacdb2eb293b429f930747ce81b4dd81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a484208ca0d41ddb217b0144453f3f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f11b90b6d564754b9b5bd0732625a2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i464858952d21412f9213fc378aaab1ac_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2686a6f90fac460b9d020e72884a3fe2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icddb6cb2943147b2b89e52fe7b46911b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i140c25a605a24f3f911883de7c499016_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61fd4bfc4644f119456da0f99198313_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bb36dc1a5204d5a8e9b530e2659be72_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c0f7fb2e84b44339afb9b2e820d731c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fd9349805414371ba05699141101f35_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a9c2b4a76640dfb7f274a43fe1b5eb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida954a9978a1447886fc0195a622b9a4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1ff8668cba4e6684c42088da1bfa77_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i884e9caa9b5c413394c2637a54593f5e_I20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i870e097aa1664c7f8acdc911a05478f0_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdd1512ec1684818af722553ac20625e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d66988d2a014b72871550db7d08daf0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic936b9e915e24f4d821896ad2218ef1f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27a72f75399841a68c34e11399b140b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e3f4eba1f614cb197c151b25af12da1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied8ed8c262d24d46a2c201ca154c4272_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic598741bcee9497b94ab1430b0c70994_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcb19055dda64f259d36cb98695b26b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e2a68bb24914f12aeee3a6a2f421c55_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47b7a4e4c1d74dffbfc1eda1b01dc524_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dgx:MeasurementInputComparableCompanyRevenueVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if5267cce41ca40a1842a5b25f34596c8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4641ff4492b5431787af20a7c361b215_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c1e1a831dc645f884fd63f68dafc0eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fa858bac8ab409c945714c4cfc92476_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06ff7b7bc1e443609656c518c6eb5ae7_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5303d7e238e424da44bd18e24d4586b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ca82d7b06e45028a679da518e76e9b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a068e932f834d0fbed8af834b0682fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc15825d3594bf5b2196f75b4ee733a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id71bba1de51f4a99b9449c6f849555cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8340eece4f647c8a754867732e5a6f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f08c600ea6544d49b1b2a1a8014d75d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b6174ae321c4e74944b97981d1b2ae3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bc34a35184c4ce7a3e425dbd8fd8062_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ce3a63acc1249caaa4588f7c259007a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a36c4164bf4b33be691b9ef663be7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59659f457ca94d118fef31ba6ba41012_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97ad39521e69481f9a20580c7230cd21_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaa2c3e268834b25b750134c958ab08c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c37e4e3f1a4370a83bb9c770279e61_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b580343931c4d66b78cda2fd05abe6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ec31233f0e4dad9da135008aa5f080_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i254bf5959746494883fdd89b5852102b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf58f44b38cb4bb8837626b15f8ab005_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia613c80a290b4a8eb01c818fb05d0800_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9547ae76ad524df1be143291c3dc3dc8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99220d08c6b942a2b4ba862f3c64bf42_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42df8753f0440b391d7bee60af61213_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29b9b62572e64aaeb2ee5d852bb0ac6f_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i551c518ca51d4c9c9055dcba49fc4c81_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dgx:TriggeringEventAxis">dgx:AmendedRealEstateLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic10d96a9520947408f8b1fbb71092e38_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id00a1c2aa7e8495ab6e23f05811ff14c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a79d7e1b5247eca266100ab948eb9f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01801313bd9d425a81cb897b8cba44d0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="i3b1004fab47841e394d81b95440cd37a_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe7c88a31514a2893220839bc498be1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1824dfa71e45bab55dc851db327252_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c68974c9ae14e999016cc1e131cfde0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67a7e4d1308249418b99f41ff7f71e1c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i406d4d3cc39844eb98b58ddc6a62338d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic37254f6ff664132a27df6fb73d9bc34_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0262431589c64d5988860f60c34228e6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c63e12f82864bd19c390ad2281a65b9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4be0056c2d4457d87c5fadf557e6aa3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8822bce97a2b4af293f8ceb8f7512c0c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06dddf077b184e02aeb6d79159ca7906_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8517e8d9b8ac4e6daf93a2e50dccb9da_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357b7ece8680488e8499ff07ec4d5141_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9f3a4d5ffd34af588f97c9b3c569245_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i554bdadf4c5d454fbfe277f057fbf835_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0122ad278dc483e8e5ca7f6dbcfebaa_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6e73eb975d144a494494df1d9ae3f91_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i391bf57712c046ac8a065213c2be01ca_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2618e94f78ff4be6a974f3d7437c9209_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b2b3bb914b24a5fb505052ab070ca0e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic31416e26495484dbfd0cc01ec4b8a6a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15e3cb2bbf8749a79b1c1e421d2c139e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c1aad07e73c4da6b04fcd621739200e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425a3e05cbb94ca5a14e66f99fada19f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149bfab7a1c24f29b4792c319f8ef948_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cd4daa713554f92aef54d2f74630a39_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70a9907567b640a289999fae84223794_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f9da75efe04d6daab9a677cd6e4633_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia292ad0369a643b9828d88492775c95c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01cb765ce9e44733bd6b1826d67c2ff7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i170456437f45486e9e310a25b9ca855a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a550c5ebbc248d0b9bce68cfbfe1a1b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2160658eb534668abfaded3ccde2376_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2a0ec3fce9b4f089434858787b2e801_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2135620d30a34a64941ea2b56bd5a164_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i951aac53e0e940dcb3d7a633466939f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65b4fed4ceae4b3cab7b60c00ca07f58_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c1bc5bdc9442598a7e0cbe2845150b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b80ff0f7b2446d5abc033b9fca38b60_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i933ce909814a47798eadf9de833f81dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7cf4826791442d82f7d57441fce080_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1679f660fe4a49e7a6124528bc22afb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c3b5952b744911ba36a0b36600e646_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ad59c542884b95abd5a3ffaad7ec7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i345527f5748848cea641eb9c408bf6be_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI1_33accfe4-f3f2-44dc-9aad-38e7acaeac47">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI2_6ee5d1ef-4a96-4d69-a657-1a8e4beceaba">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV84MjQ2MzM3MjEwMjcy_7e280708-630b-422e-9e8d-f7a3bf3bb292">March 31, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI3_4fce5d5c-3040-4d61-96c4-f6774df1e3aa">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from          to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI4_84380149-36ad-451b-a00e-5d6315f59f95">001-12215</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI5_e0b08b20-6246-4646-87c7-c0f2bc3cf786">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:519.00pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18wLTAtMS0xLTQ1MDg1_3671cfba-ae40-442b-a604-399247a16c35">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18wLTUtMS0xLTQ1MDg1_76891609-047a-4822-9d75-0438f6edc15c">16-1387862</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18yLTAtMS0xLTQ1MDg1_762af191-4889-439d-a0a7-13630416d2ff">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18zLTAtMS0xLTQ1MDg1_6526ed5a-925d-4c30-802c-1ace71fbcd36">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18zLTEtMS0xLTQ1MDg1_1b8c3063-8752-40d1-82b1-ebc261842317">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18zLTItMS0xLTQ1MDg1_37cc3e3f-ce0d-4ff5-ba69-89c69d980218">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN180LTAtMS0xLTQ1MDg1_660f00a0-6157-4a79-bac7-be2545d871c7">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN180LTEtMS0xLTQ1MDg1_046fb434-4579-4a16-931f-12033e09e5d0">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.055%"><tr><td style="width:1.0%"></td><td style="width:30.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6YjlkODgzNmUwMzQ3NDNhMGJkZjAwZjdmNDk3NGNjNWUvdGFibGVyYW5nZTpiOWQ4ODM2ZTAzNDc0M2EwYmRmMDBmN2Y0OTc0Y2M1ZV8xLTAtMS0xLTQ1MDg1_e67761f7-e8bc-41df-8725-05179f1b45fb">Common Stock, $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6YjlkODgzNmUwMzQ3NDNhMGJkZjAwZjdmNDk3NGNjNWUvdGFibGVyYW5nZTpiOWQ4ODM2ZTAzNDc0M2EwYmRmMDBmN2Y0OTc0Y2M1ZV8xLTEtMS0xLTQ1MDg1_8360a5d2-1180-419d-97f2-65b703d9ac20">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6YjlkODgzNmUwMzQ3NDNhMGJkZjAwZjdmNDk3NGNjNWUvdGFibGVyYW5nZTpiOWQ4ODM2ZTAzNDc0M2EwYmRmMDBmN2Y0OTc0Y2M1ZV8xLTItMS0xLTQ1MDg1_c5b8a023-d83b-4536-8bec-043b6fc7e6c5">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTIy_b9394394-3a7d-4809-a567-534d08066275">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTIz_9803761f-c762-4f3c-ad4e-cc7f8100d7b4">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.166%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6Nzk5NzU3MWY4OGNiNDQ2ZGFmYmQxY2Y0N2NkYjM0ZmIvdGFibGVyYW5nZTo3OTk3NTcxZjg4Y2I0NDZkYWZiZDFjZjQ3Y2RiMzRmYl8wLTAtMS0xLTQ1MDg1_383e0983-af43-431a-b231-279d76eb1c05">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6Nzk5NzU3MWY4OGNiNDQ2ZGFmYmQxY2Y0N2NkYjM0ZmIvdGFibGVyYW5nZTo3OTk3NTcxZjg4Y2I0NDZkYWZiZDFjZjQ3Y2RiMzRmYl8xLTMtMS0xLTQ1MDg1_ad02571a-eb0d-442b-957f-93ee29315165">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6Nzk5NzU3MWY4OGNiNDQ2ZGFmYmQxY2Y0N2NkYjM0ZmIvdGFibGVyYW5nZTo3OTk3NTcxZjg4Y2I0NDZkYWZiZDFjZjQ3Y2RiMzRmYl8yLTMtMS0xLTQ1MDg1_91910dfd-be9d-44d9-a84b-371babce8aed">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI0_dadad0d7-7b6e-4976-aee9-5dc30f2eab7c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;14, 2022, there were outstanding <ix:nonFraction unitRef="shares" contextRef="ic2dc8d4dcbed40af97db1fac37505ee9_I20220414" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xODYz_8f8f29ea-5c8f-4575-a6b7-351050083982">117,365,028</ix:nonFraction>  shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1. Financial Statements (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Index to unaudited consolidated financial statements filed as part of this report:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_13">Consolidated Statements of Operations for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_16">Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_19">Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_22">Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_25">Consolidated Statements of Stockholders&#8217; Equity for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_28">Notes to Consolidated Financial Statements</a> (unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_76">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_76">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_91">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_76">See Item 2. &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_91">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_94">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_94">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_94">32</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2022 AND 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_13"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:77.855%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMi01LTEtMS00NTA4NQ_4a068ce4-1042-47ff-b864-fa2cdc220c4e">2,611</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMi03LTEtMS00NTA4NQ_adb82e78-aa06-4d83-96b0-468ad1ac51d7">2,720</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNS01LTEtMS00NTA4NQ_bf924a53-4d11-4aee-a06a-51390b7971e2">1,646</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNS03LTEtMS00NTA4NQ_ac3694a4-2179-42ba-b95b-88a68486ec74">1,626</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNi01LTEtMS00NTA4NQ_8c7d2f21-1970-4f0e-8ff6-af5ffe3bc9ed">425</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNi03LTEtMS00NTA4NQ_af89c0ab-531f-490f-866b-5b4073cd2569">407</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNy01LTEtMS00NTA4NQ_4b2d7487-3170-4b92-89d6-8fd44593db20">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNy03LTEtMS00NTA4NQ_0a386b12-7e06-4877-9f95-569b66fbdd90">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTAtNS0xLTEtNDUwODU_c19bb904-070f-44d7-929c-62442fc084da">2,098</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTAtNy0xLTEtNDUwODU_7fbb653c-5b0b-44b8-8ee0-4df9962cc67a">2,060</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTItNS0xLTEtNDUwODU_31064a01-9169-46e1-b6b8-0d175d576afa">513</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTItNy0xLTEtNDUwODU_d53ae8f3-cb89-4e56-9aef-f4ea4a3dce8e">660</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTUtNS0xLTEtNDUwODU_6c0145e2-4c33-4b67-a80b-04fffa68265b">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTUtNy0xLTEtNDUwODU_290865fb-1f2e-48e3-9d50-41856f720135">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTYtNS0xLTEtNDUwODU_1a273971-dff3-44ea-bbbc-4369e03ef2e3">24</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTYtNy0xLTEtNDUwODU_08bb8688-da99-4a18-8e1c-51193a39391a">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTctNS0xLTEtNDUwODU_7c0dc35b-7736-421e-bd1c-e25ea09f363a">61</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTctNy0xLTEtNDUwODU_fe3d8ff2-4e3d-4988-acdf-13e93a7481e4">34</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTktNS0xLTEtNDUwODU_f7a169a1-d52b-4566-8aa5-ece629c44f7f">452</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTktNy0xLTEtNDUwODU_e24a0d1c-d02f-4dbb-88b0-d9552ca074e1">626</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjAtNS0xLTEtNDUwODU_e2fb4455-2f7c-4708-9da8-f8814813e150">110</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjAtNy0xLTEtNDUwODU_f3f7b257-d451-4850-a307-f9880cad52e7">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjEtNS0xLTEtNDUwODU_73c943dd-0fd2-449c-a7e1-f320cc5df30e">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjEtNy0xLTEtNDUwODU_13126ed9-f8e8-48df-8001-637de22bf1b5">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjQtNS0xLTEtNDUwODU_df0ba1d5-121a-4f27-a2bc-012df953f6d5">373</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjQtNy0xLTEtNDUwODU_7c77420e-457f-429d-b4c2-c6f5360588cb">490</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjUtNS0xLTEtNDUwODU_233006f2-fe72-4ebe-944b-24c5e6a84fc3">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjUtNy0xLTEtNDUwODU_2a0de432-db73-4bc2-86ad-caf0327f2a86">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjYtNS0xLTEtNDUwODU_33d788c6-929c-4290-8f35-513393dba18b">355</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjYtNy0xLTEtNDUwODU_64e7effd-baf4-44f1-a795-b36069d54937">469</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMzYtNS0xLTEtNDUwODU_e7bdd92f-07a2-4766-a48b-de08a0420353">2.97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMzYtNy0xLTEtNDUwODU_d7f26672-f4f0-468a-a59d-c0cad197442a">3.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDEtNS0xLTEtNDUwODU_ee41b1ff-f4cb-452a-9e59-6a5bbc0a53fc">2.92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDEtNy0xLTEtNDUwODU_4b799806-8ed0-4128-be56-069490043477">3.46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDQtNS0xLTEtNDUwODU_4eea8766-5b49-426b-80d5-ea8ad0d48316">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDQtNy0xLTEtNDUwODU_aaa301be-baa9-4030-9604-4905282853ec">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDYtNS0xLTEtNDUwODU_475e5896-ac4a-46ad-8112-f39f1ba8efab">121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDYtNy0xLTEtNDUwODU_836b9335-f5e2-4d21-abad-acf0cb9bae92">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2022 AND 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:77.073%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMi01LTEtMS00NTA4NQ_df0ba1d5-121a-4f27-a2bc-012df953f6d5">373</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMi03LTEtMS00NTA4NQ_7c77420e-457f-429d-b4c2-c6f5360588cb">490</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNS01LTEtMS00NTA4NQ_37f1875d-1509-4b05-ae5b-dd12d611274d">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNS03LTEtMS00NTA4NQ_86846e89-bc86-4cfa-9131-f4841711d493">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in available-for-sale debt securities, net of taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNi01LTEtMS00NTA4NQ_ab776ae1-d1a1-4335-85ea-9e532eee81a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNi03LTEtMS00NTA4NQ_f9fb019a-1653-488a-8769-53a36cfe49d7">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfOS01LTEtMS00NTA4NQ_20770d43-afdf-4d97-a956-6fd014d4f02a">2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfOS03LTEtMS00NTA4NQ_649dbd03-dcf7-4261-8a17-f79033935f64">10</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTEtNS0xLTEtNDUwODU_1089f3c3-431c-490d-89af-3433f722de6e">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTEtNy0xLTEtNDUwODU_4c8caf16-3b18-4b0f-bbd9-762cf61787ae">480</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTItNS0xLTEtNDUwODU_5c2bd5da-71bf-4b38-a936-5e6c81b49ae3">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTItNy0xLTEtNDUwODU_887e7721-60bd-49d0-9fab-4bf767e8e4e7">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTMtNS0xLTEtNDUwODU_645762fd-382f-40e6-a219-b8e4c8dcadc4">353</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTMtNy0xLTEtNDUwODU_9e152628-5f84-4d38-9140-c24f237536f3">459</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_19"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARCH&#160;31, 2022 AND DECEMBER&#160;31, 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMy0xLTEtMS00NTA4NQ_98bec17f-2c80-499e-a944-7ddae25c44d1">712</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMy0zLTEtMS00NTA4NQ_d6d8c31f-b108-44e6-956d-cfc04698dd61">872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0wLTEtMS00NTA4NS90ZXh0cmVnaW9uOjA4Mzk1OTFmMGQxYjRiMWI5MzRjNTVlNGExNTVjNzE1XzYz_f5f78746-5950-4942-9122-d1cf034391b5">30</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0wLTEtMS00NTA4NS90ZXh0cmVnaW9uOjA4Mzk1OTFmMGQxYjRiMWI5MzRjNTVlNGExNTVjNzE1Xzcw_ee019ee2-fc1e-4b32-b829-b7429e071774">31</ix:nonFraction> as of March&#160;31, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0xLTEtMS00NTA4NQ_6aad901a-5e16-4c5e-8ac9-6bbe3abef882">1,371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0zLTEtMS00NTA4NQ_839d8c0b-edc3-4f83-ae45-762fdce94d3e">1,438</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNS0xLTEtMS00NTA4NQ_f5fddac9-9be8-4fc2-84ab-04bb819573a7">197</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNS0zLTEtMS00NTA4NQ_498ff8e4-7388-44ea-8a53-0863ad707493">208</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNi0xLTEtMS00NTA4NQ_c0f3328d-6d05-42ae-890c-22a2734e2942">195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNi0zLTEtMS00NTA4NQ_96b4a779-074b-49a7-89cf-e82bd6a820c2">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOC0xLTEtMS00NTA4NQ_30c7779a-03ba-442c-bdc1-bf942e3bfcfa">2,475</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOC0zLTEtMS00NTA4NQ_a9e0f911-bd19-44d1-91ac-f98a32d8b39a">2,741</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOS0xLTEtMS00NTA4NQ_a6587642-0d83-4268-8924-e4ec2ed5587b">1,668</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOS0zLTEtMS00NTA4NQ_b79265f4-2560-4c30-8634-5809e9805694">1,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTAtMS0xLTEtNDUwODU_e4f1a285-9366-43c7-80be-44887015b967">620</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTAtMy0xLTEtNDUwODU_a2374933-f104-4f23-8d00-74536b577a46">597</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTEtMS0xLTEtNDUwODU_95da02f4-feb9-43cb-9cd5-9d9279414770">7,197</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTEtMy0xLTEtNDUwODU_279da6e6-d32e-44d6-9349-309a693276a5">7,095</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTItMS0xLTEtNDUwODU_2cd21dbb-d53d-4d81-88ba-cdfc44fac116">1,172</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTItMy0xLTEtNDUwODU_251d5f8d-ab8b-4725-93ae-fa1efb72db9c">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTMtMS0xLTEtNDUwODU_8744dbe3-37d3-476c-a191-0d0137984024">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTMtMy0xLTEtNDUwODU_50b991fa-b948-4e24-9b4b-688dabdde8eb">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTQtMS0xLTEtNDUwODU_09d01510-8272-4702-b691-8066db56d7ac">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTQtMy0xLTEtNDUwODU_88753373-7848-4b2f-bdc9-2902f4e6db01">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTYtMS0xLTEtNDUwODU_4fdee1b3-9963-4198-8871-d424130a27de">13,442</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTYtMy0xLTEtNDUwODU_f5dfd89a-49aa-42c2-abae-1d416d988a09">13,611</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjAtMS0xLTEtNDUwODU_d1d98f06-aae9-4fca-8bb5-80000602cc0a">1,544</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjAtMy0xLTEtNDUwODU_d3404641-77a7-4587-90ee-94b7c7593516">1,600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjEtMS0xLTEtNDUwODU_a9972dbe-76f6-416e-b413-1c95a680c71e">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjEtMy0xLTEtNDUwODU_84b46af5-3571-4233-b183-3660575327bd">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjItMS0xLTEtNDUwODU_ae12f260-5aa3-466d-897a-231606ebba9a">154</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjItMy0xLTEtNDUwODU_92ded2c0-d6ff-4a25-815c-a1928e62ebe0">151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjQtMS0xLTEtNDUwODU_655ccd84-10a7-4357-aad2-6f855145012a">1,700</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjQtMy0xLTEtNDUwODU_a029914e-ec3e-4e92-bbb3-0dd17309d015">1,753</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjUtMS0xLTEtNDUwODU_33ec3eb8-05f0-4634-91db-fbe1e908fe60">3,985</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjUtMy0xLTEtNDUwODU_e0061fb4-0e55-479f-bece-e1c81fa434e5">4,010</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjYtMS0xLTEtNDUwODU_591ab7bf-236e-495d-9b6f-de0293c727ce">522</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjYtMy0xLTEtNDUwODU_7365a477-a572-4b49-b0d8-f9dd166873e7">494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjctMS0xLTEtNDUwODU_7d3eadb9-1238-41cf-ba17-7b0ada4b8ea7">742</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjctMy0xLTEtNDUwODU_73885057-b05c-4dc2-8f5e-ceb48fcc62bf">792</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjktMS0xLTEtNDUwODU_ca851a6a-2089-4a0b-9df6-aa452f057fc2"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjktMy0xLTEtNDUwODU_5fabb530-e194-4715-858d-28d823b1650b"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzAtMS0xLTEtNDUwODU_6386405b-e0d6-4870-b236-499353bdfcb9">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzAtMy0xLTEtNDUwODU_7f6fd3cd-1011-4830-802f-6eee1898f295">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8yOA_98e928b5-a586-42c9-afe5-c3dc7bee05f2"><ix:nonFraction unitRef="usdPerShare" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8yOA_b267389b-75b5-41b0-9937-227eec5418d6">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl80Mg_38c7b8c1-5e38-4a34-87ea-849a8dfed567"><ix:nonFraction unitRef="shares" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl80Mg_9a35bff7-5c29-4e72-8bcf-339b6a50c9d1">600</ix:nonFraction></ix:nonFraction> shares authorized as of both March 31, 2022 and December 31, 2021; <ix:nonFraction unitRef="shares" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8xMTY_2656bcd8-bb88-4fe7-bbae-4e5ddab92531"><ix:nonFraction unitRef="shares" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8xMTY_33b599cc-8870-42e3-8566-e902c05917e0">162</ix:nonFraction></ix:nonFraction> shares issued as of both March 31, 2022 and December 31, 2021</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMS0xLTEtNDUwODU_5ea36b79-84da-4584-934b-c96e2d43eb85">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMy0xLTEtNDUwODU_039b44a7-33aa-43d5-b040-3d43e8ff1b25">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzQtMS0xLTEtNDUwODU_50d768df-f2d2-4c87-af17-7d445639dda0">2,226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzQtMy0xLTEtNDUwODU_0b90f3c4-7ec5-45cb-afd4-3385b1abf7b3">2,260</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzUtMS0xLTEtNDUwODU_e8cec2e0-69d2-402d-a4c2-38281c15f19e">7,926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzUtMy0xLTEtNDUwODU_fcd14887-acbb-4a70-849f-7290603205a5">7,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzYtMS0xLTEtNDUwODU_b3e27e76-cb72-4a75-a4f6-fbb5262c1855">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzYtMy0xLTEtNDUwODU_a1d4f71f-46b5-4566-b999-2608b64d3c60">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjo2YTQ0ZTAyZDYyZWM0YWFmYmYzNTk0YjVjMzU0NDc1M18yOQ_62997032-0fc6-41c4-8f12-1fce3d0b2b8a">45</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjo2YTQ0ZTAyZDYyZWM0YWFmYmYzNTk0YjVjMzU0NDc1M18zNg_f80a0ffc-3a44-4b2e-b4a9-6eacb30df425">43</ix:nonFraction> shares as of March&#160;31, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMS0xLTEtNDUwODU_a84df10a-6641-4190-9bab-1173cbf2b3c0">3,761</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMy0xLTEtNDUwODU_7e8d016a-e37b-440a-9efa-f52db4e939e8">3,453</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzgtMS0xLTEtNDUwODU_22efadb2-b0f5-4fac-93bf-2da59065e43d">6,377</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzgtMy0xLTEtNDUwODU_cb327d1d-4345-4688-8a18-20fdd88d39b1">6,444</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzktMS0xLTEtNDUwODU_866e2d51-7512-49bc-a910-e0b0b7e1f6ce">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzktMy0xLTEtNDUwODU_7225cfd0-5db8-4101-8194-ce7cff375f02">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDAtMS0xLTEtNDUwODU_a00ba80d-9b67-4bf0-a40d-746ff80deeef">6,415</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDAtMy0xLTEtNDUwODU_5bfc60e1-a914-4683-b3ec-006dedd02f58">6,483</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDEtMS0xLTEtNDUwODU_f1ffa8f9-7670-416c-bbd6-c68d037327e0">13,442</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDEtMy0xLTEtNDUwODU_dde6d203-cedb-4ac7-9295-36e8a09efbd8">13,611</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2022 AND 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions) </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMy0xLTEtMS00NTA4NQ_df0ba1d5-121a-4f27-a2bc-012df953f6d5">373</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMy0zLTEtMS00NTA4NQ_7c77420e-457f-429d-b4c2-c6f5360588cb">490</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNS0xLTEtMS00NTA4NQ_9c02013f-7a68-4b77-a0e8-1601621e7705">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNS0zLTEtMS00NTA4NQ_a0e88d81-eb63-41f5-8442-3fff5c773e4d">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNi0xLTEtMS00NTA4NQ_d031348a-c75a-493e-81b0-66f6bd61b70a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNi0zLTEtMS00NTA4NQ_58b7b034-c9bd-491d-a8da-20e5525dc8c7">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNy0xLTEtMS00NTA4NQ_46e000ce-875d-4bf2-aa6c-c9077cabdfe5">43</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNy0zLTEtMS00NTA4NQ_31c08ada-c6af-476a-8472-3d8b5114a9c2">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfOC0xLTEtMS00NTA4NQ_0b8a187e-14e2-4b6e-8d48-66ffdfa0b4c4">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfOC0zLTEtMS00NTA4NQ_1f8a835f-abb5-4f28-bee3-099c8c023a7c">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTEtMS0xLTEtNDUwODU_1f126cda-b5d3-430f-8583-adc0bbfba74c">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTEtMy0xLTEtNDUwODU_333ca86b-4d9f-499a-858b-5c032f3f8927">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTMtMS0xLTEtNDUwODU_21127bea-c1d1-4442-a598-a3fa090bebca">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTMtMy0xLTEtNDUwODU_21559f03-4a1f-4547-9e37-f745511c1873">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTQtMS0xLTEtNDUwODU_496a4d9f-6b07-46db-b29d-4493b9c90d0a">165</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTQtMy0xLTEtNDUwODU_5bc6d1c7-ca90-441c-8ef8-b43f53b60f15">164</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTUtMS0xLTEtNDUwODU_4fc0fc80-30fa-45fe-adb2-b4fc96faebf9">95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTUtMy0xLTEtNDUwODU_5a1a91a3-37a1-4c65-9968-2580069f2b5f">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTctMS0xLTEtNDUwODU_4ba62d2c-db14-476b-bb71-bd69bc91182c">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTctMy0xLTEtNDUwODU_4b6c5a6a-f3c3-471e-8dbd-777239a19c1b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTgtMS0xLTEtNDUwODU_aaa42016-bbb7-427f-bd1c-a3a9fe62f277">480</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTgtMy0xLTEtNDUwODU_c86a36de-1df3-423c-98dc-451290c22edd">731</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjEtMS0xLTEtNDUwODU_f26611e9-ea1e-4dad-94b3-18e958d01fde">105</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjEtMy0xLTEtNDUwODU_22d373fa-406e-4f90-b581-6aa6804e27d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjQtMS0xLTEtNDUwODU_ce3e6538-a1e4-44dd-b0ea-937a24500cf3">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjQtMy0xLTEtNDUwODU_4be1d902-b1ba-42fa-a2f3-3945646398dc">86</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in investments and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjctMS0xLTEtNDUwODU_a345bf79-6fce-45c3-831c-1f318accc484">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjctMy0xLTEtNDUwODU_804ef472-df44-48e7-b205-dd3bfb0230f3">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjgtMS0xLTEtNDUwODU_60f1be2b-fa52-4dab-bceb-9f4efe5d9f10">169</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjgtMy0xLTEtNDUwODU_f751c9bb-91df-41f5-acee-bd658544bd8d">93</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzItMS0xLTEtNDUwODU_47af3c62-efd7-4545-8bbc-c23b4b54bac1">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzItMy0xLTEtNDUwODU_0879204d-817b-426a-b069-28331fe15cf3">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzMtMS0xLTEtNDUwODU_00cd785d-33d8-44c3-acf8-b37070bfe99f">373</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzMtMy0xLTEtNDUwODU_14c2ebe0-0d05-41fb-b44e-4918a4af9bb9">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzQtMS0xLTEtNDUwODU_e3ef6753-669a-4390-a8ff-645917f4df6f">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzQtMy0xLTEtNDUwODU_826834ae-1fed-42c1-96a1-a948e422474e">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzUtMS0xLTEtNDUwODU_075ae360-c3d5-4cbd-b4b2-7212a22e1119">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzUtMy0xLTEtNDUwODU_9b5ef5d5-290c-40b3-83ee-155eb0887c9b">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzYtMS0xLTEtNDUwODU_774c65de-abde-4e2a-b099-fe61ddce6835">74</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzYtMy0xLTEtNDUwODU_ef54eea7-0f7c-4193-b28e-f7a4eb4ef360">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzctMS0xLTEtNDUwODU_4cd00dad-870e-45cd-bea6-3ea44a69b9b0">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzctMy0xLTEtNDUwODU_46903dc4-bf74-451c-b137-4ce9fc82763b">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDAtMS0xLTEtNDUwODU_579017c6-bd00-4ce0-aa0d-b771e6b4d356">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDAtMy0xLTEtNDUwODU_62282c26-741e-4e40-b106-2974a1a27822">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDEtMS0xLTEtNDUwODU_4e210fe3-6934-4ea1-b637-c15ccb13cda4">471</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDEtMy0xLTEtNDUwODU_414274d7-0725-4a85-bc0b-70e24ddf00c8">566</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDMtMS0xLTEtNDUwODU_0155645f-816b-468a-b2df-8f43402d40f0">160</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDMtMy0xLTEtNDUwODU_9d98fbee-618a-409b-8408-e58328ee6e4d">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDUtMS0xLTEtNDUwODU_3137d606-c9d9-4030-8556-427585f75522">872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a67828d80741189c9e71a1926cad84_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDUtMy0xLTEtNDUwODU_4bb4445b-6cf1-40f0-893d-b8a248699851">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDYtMS0xLTEtNDUwODU_7dd468cc-b358-4c22-a82c-b29d4616e4f7">712</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDYtMy0xLTEtNDUwODU_6222d583-86c4-4362-a407-6524730d215b">1,230</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2022 AND 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib939a88f4c11457d8f94ab3011660e90_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMS0xLTEtNDUwODU_797d91d4-9b17-49f7-b297-8612c1e6109f">119</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib939a88f4c11457d8f94ab3011660e90_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMy0xLTEtNDUwODU_a6c9cd18-2baf-4074-83bd-88e3c714394d">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i387e21b64a5248cc90a14d9bcadffd40_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctNS0xLTEtNDUwODU_d4f37289-eeef-4bde-875b-d0f72163f7f2">2,260</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d9091e753f4cdfaae8f68bbc2ea33f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctNy0xLTEtNDUwODU_9ba3aec6-0098-4dfb-87c6-9a552572fb95">7,649</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a0f83bf88134568bde41c150af0ba41_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctOS0xLTEtNDUwODU_965e6ba8-61d4-40af-865e-7c08c55ee6f1">14</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30bff75e183e4fc391898fd34f86863b_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTEtMS0xLTQ1MDg1_0c950184-182b-46bc-90cd-1037da63f90c">3,453</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d41353be3a04b738b4f4bc36e5d3820_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTMtMS0xLTQ1MDg1_c5c298ba-ad21-4b28-8cc9-6344b1fa81ad">39</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTUtMS0xLTQ1MDg1_3e37742c-b64b-4cb7-b50d-ba213ff7323b">6,483</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTgtMS0xLTQ1MDg1_64d34a02-155b-4753-8ea3-f75703a9f0d3">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia93d7d0509f14b08b2b9728096cbb3e7_D20220101-20220331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtNy0xLTEtNDUwODU_40ee5f54-7269-4fb9-afdf-f7065c697b68">355</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6c865cfcc5493cb1940ce9b692bd7a_D20220101-20220331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtMTMtMS0xLTQ1MDg1_aaac184e-3326-410b-838b-4017e497de58">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtMTUtMS0xLTQ1MDg1_e524c631-aa62-4755-b330-159affe7b379">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtMTgtMS0xLTQ1MDg1_07ed1047-56a8-46a5-b0bf-e18560681723">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic760c160bf9646bba4102bda5ef94b44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTktOS0xLTEtNDUwODU_695f2fb3-02c9-4c28-bf66-ab3f8003c5aa">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTktMTUtMS0xLTQ1MDg1_d8a6b9a7-f107-4979-9af5-5806ae8ff238">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia93d7d0509f14b08b2b9728096cbb3e7_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjAtNy0xLTEtNDUwODU_c01fe405-ccbb-4220-9ffa-e03d7cd30a12">78</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjAtMTUtMS0xLTQ1MDg1_ea5dd237-ae36-4185-bfca-79404744dc76">78</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd6c865cfcc5493cb1940ce9b692bd7a_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjEtMTMtMS0xLTQ1MDg1_c043c3b8-eb77-4cbe-ad1e-96d0dc1d192b">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjEtMTUtMS0xLTQ1MDg1_56f14fc7-a216-481c-9a4f-6407983eb5e8">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjEtMTgtMS0xLTQ1MDg1_b001aa21-0827-404a-b0a8-439d4f3ab8a0">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57bcad1774d541d9ac66fc0077491325_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItMS0xLTEtNDUwODU_d467946e-cc74-4a75-a5f5-2da355eae480">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItNS0xLTEtNDUwODU_ab126913-4923-4d08-823e-fa8625cebbd2">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItMTEtMS0xLTQ1MDg1_f6251027-1c0e-4dc7-9787-0014f5a13572">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItMTUtMS0xLTQ1MDg1_832c61a2-a9fb-4c46-abd8-efb097bbdc18">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjMtNS0xLTEtNDUwODU_ab393bc4-30ca-44d7-b162-19594b05e52b">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjMtMTUtMS0xLTQ1MDg1_a330c9a3-c956-4ab1-a4ce-80170b9a263f">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjQtNS0xLTEtNDUwODU_8b9bedd9-c499-4f59-b71f-3fcbdd92391b">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjQtMTEtMS0xLTQ1MDg1_d5066383-08ae-4f8f-bf64-492ee2b68a4b">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjQtMTUtMS0xLTQ1MDg1_ce68f013-d504-4205-8bdd-c5b8ca2e0f4d">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjUtNS0xLTEtNDUwODU_b4e2bb22-43f4-412c-add2-fdea6e8a255e">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjUtMTEtMS0xLTQ1MDg1_19c44656-8c6d-48c7-9d74-3867ce1e33d5">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjUtMTUtMS0xLTQ1MDg1_d6483263-bf7e-4150-8ac4-1ad3977d55b1">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i57bcad1774d541d9ac66fc0077491325_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjYtMS0xLTEtNDUwODU_3a0fea7b-7b31-43dd-9fc5-d2212a7b518e">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjYtMTEtMS0xLTQ1MDg1_adc52811-8ecf-4be5-bb44-d1fd25051f79">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjYtMTUtMS0xLTQ1MDg1_713c47b2-34a5-4afc-a2b7-120fa32b967b">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1bfa6a5fb1046dca736f71283a88051_I20220331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMS0xLTEtNDUwODU_c9967f70-dc15-40b6-8ad4-6039cf40cf76">117</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bfa6a5fb1046dca736f71283a88051_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMy0xLTEtNDUwODU_63eea5a9-c4d4-4eb2-9a97-3be3ac82ccd8">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36d5ba191104fe89f537554035b8907_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtNS0xLTEtNDUwODU_abc76ea0-e4e4-445a-8060-1c9e62a61b08">2,226</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffea91bc8dcb4e06aadf8f63905ab017_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtNy0xLTEtNDUwODU_ae268977-d4ad-43bc-8707-8e2214d9057d">7,926</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e3eda6f95ed4a74b1f90e8c5bd28859_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtOS0xLTEtNDUwODU_7bf64cc5-e12f-42c6-a31e-e2343f029780">16</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i680491199aa14f2682953e743b93f967_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTEtMS0xLTQ1MDg1_a12ced3d-c72f-42b2-aaef-8860fccc2fa1">3,761</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea0f667d8e834262a48cda2044511f1a_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTMtMS0xLTQ1MDg1_d39a28b3-f8b1-4f19-9552-d9c478fa9108">38</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTUtMS0xLTQ1MDg1_3288286d-771f-47c7-b241-dc40df6d4ba5">6,415</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTgtMS0xLTQ1MDg1_7c82d902-2aa8-4bf2-b08b-376ff6d92d3e">78</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.025%"><tr><td style="width:1.0%"></td><td style="width:28.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i481f1360cd724a9f8b74bd582e93a71e_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMS0xLTEtNDUwODU_ed654926-360d-457c-9f7a-52cbaad5ecd2">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481f1360cd724a9f8b74bd582e93a71e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMy0xLTEtNDUwODU_b749ff7b-0d57-45a0-96d2-b1bf71023231">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866848e13a4f4ec1bd85c404788b9111_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtNS0xLTEtNDUwODU_d4ec6894-be93-40f4-804f-eb39482b385d">2,841</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie178ff96837c4706a3f4b587cccefe07_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtNy0xLTEtNDUwODU_8a548145-caea-4af4-8349-62fbc28e2c35">9,303</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifacdb2eb293b429f930747ce81b4dd81_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtOS0xLTEtNDUwODU_a7412b0b-1046-43f9-8fad-c00468356815">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a484208ca0d41ddb217b0144453f3f2_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTEtMS0xLTQ1MDg1_0b7c0a1b-7390-42e8-88d5-9f99ee3d2dcc">5,366</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f11b90b6d564754b9b5bd0732625a2b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTMtMS0xLTQ1MDg1_66ec6383-89de-4f1d-ac72-78c0fc763e3b">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a67828d80741189c9e71a1926cad84_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTUtMS0xLTQ1MDg1_e6a17255-b197-46f6-a07b-aeb836b686f3">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a67828d80741189c9e71a1926cad84_I20201231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTgtMS0xLTQ1MDg1_9eae1637-9da6-4ca4-b0ab-22df8c8a327e">82</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i464858952d21412f9213fc378aaab1ac_D20210101-20210331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctNy0xLTEtNDUwODU_7e9fbd51-2b7e-44c0-a85f-ca6b821a6356">469</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2686a6f90fac460b9d020e72884a3fe2_D20210101-20210331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctMTMtMS0xLTQ1MDg1_8ff29d1b-45b8-49e7-87b9-02521c28c3e5">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctMTUtMS0xLTQ1MDg1_eb4f2b05-beeb-493c-9cdb-f49f67cab817">486</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctMTgtMS0xLTQ1MDg1_ea0dde50-98cd-4ae9-9205-8c1cf334f09b">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icddb6cb2943147b2b89e52fe7b46911b_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTgtOS0xLTEtNDUwODU_b225156d-a57c-48ae-a048-284d0575ab02">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTgtMTUtMS0xLTQ1MDg1_1025c509-1f63-4125-b4d5-3c0f620564ba">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i464858952d21412f9213fc378aaab1ac_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTktNy0xLTEtNDUwODU_fe62e50f-9b80-4684-99d6-8911f23076d2">82</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTktMTUtMS0xLTQ1MDg1_1357f94c-f683-4810-bb42-6ccca783e94e">82</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2686a6f90fac460b9d020e72884a3fe2_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjAtMTMtMS0xLTQ1MDg1_4e55bc66-3a07-4678-ac20-e352f9a138cb">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjAtMTUtMS0xLTQ1MDg1_e36a5ca4-4513-4ee6-bcd9-a9d7caf635bc">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjAtMTgtMS0xLTQ1MDg1_013d8ea1-972f-42d0-8ebc-b17a479fb613">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjEtNS0xLTEtNDUwODU_5f1a76e1-9d5c-4217-8632-6e58db1cfc3d">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjEtMTEtMS0xLTQ1MDg1_521db9c4-ef7c-4ed0-9e5d-df7fdb8b7cda">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjEtMTUtMS0xLTQ1MDg1_c17ce449-ff0d-4bad-94fa-ce644d9aee72">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjItNS0xLTEtNDUwODU_3a64e927-28ac-4a02-95bf-1fbf6c1aa83e">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjItMTUtMS0xLTQ1MDg1_dce74170-9e8b-4459-a140-56324c16968e">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id61fd4bfc4644f119456da0f99198313_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtMS0xLTEtNDUwODU_e80e0f97-86c2-4502-bc50-58abe920c00f">1</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtNS0xLTEtNDUwODU_b0791fed-b026-4ded-b0e4-de93ef783f71">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtMTEtMS0xLTQ1MDg1_c55d9b24-3e8f-42d7-9df7-c6edbf4b8789">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtMTUtMS0xLTQ1MDg1_317167bd-2cf5-45b0-b852-559906b8cd0e">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjQtNS0xLTEtNDUwODU_0b163910-1867-4e84-8661-760c0be749f0">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjQtMTEtMS0xLTQ3MjU5_bcf48bd8-555a-4560-addf-8bbbd0a11930">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjQtMTUtMS0xLTQ1MDg1_8956564a-19a0-4d57-ae70-c65059f50329">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id61fd4bfc4644f119456da0f99198313_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjUtMS0xLTEtNDUwODU_89b118a7-db06-4752-b4e7-b49d3a05d71e">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjUtMTEtMS0xLTQ1MDg1_52b22775-7cda-404a-b3c7-2a156397bedb">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjUtMTUtMS0xLTQ1MDg1_37adb0f2-a71f-4492-a42e-f667249d8c94">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2bb36dc1a5204d5a8e9b530e2659be72_I20210331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMS0xLTEtNDUwODU_bf1a71a4-8c94-42de-a3ca-7842c8241f90">131</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb36dc1a5204d5a8e9b530e2659be72_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMy0xLTEtNDUwODU_c2d3e9f7-a89f-4f00-a3a1-fab17241bb05">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0f7fb2e84b44339afb9b2e820d731c_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtNS0xLTEtNDUwODU_69be6397-f019-485d-b37f-74920ae4bc72">2,824</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fd9349805414371ba05699141101f35_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtNy0xLTEtNDUwODU_666083f5-d31a-4f71-92d4-4ddcf816f510">9,690</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a9c2b4a76640dfb7f274a43fe1b5eb_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtOS0xLTEtNDUwODU_9e3f4caa-d6b4-4194-ac88-1b682f042e50">31</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida954a9978a1447886fc0195a622b9a4_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTEtMS0xLTQ1MDg1_d817ca7d-269e-4200-8806-72a010ef19ea">5,740</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida1ff8668cba4e6684c42088da1bfa77_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTMtMS0xLTQ1MDg1_cea8b795-39fb-4ea2-abf5-305ca9d164bc">45</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTUtMS0xLTQ1MDg1_892a7e0f-b860-48b8-b0d2-e3e1f509ca1b">6,790</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTgtMS0xLTQ1MDg1_6fa9d363-6c91-4d5e-9dc4-d3ec99635baf">79</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_28"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zMS9mcmFnOmNkMzVhZWZkOGVjNTRhNjc5OTdmNmNmZmUwOTQ0OTRjL3RleHRyZWdpb246Y2QzNWFlZmQ4ZWM1NGE2Nzk5N2Y2Y2ZmZTA5NDQ5NGNfMTcwMw_50aa7bea-d22f-4692-985b-67a9ef092583" continuedAt="ic87969ff8c9e435da46b5b98e7b11d56" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="ic87969ff8c9e435da46b5b98e7b11d56" continuedAt="ida16bcd4d64a4a84b8fdade870da65c4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ida16bcd4d64a4a84b8fdade870da65c4">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM0MQ_61557ea7-e07d-4ec6-b864-dc4d1ebb3b59" continuedAt="ief437e7917574245b72875d83f2b93ea" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div style="text-indent:29.25pt"><span><br/></span></div><ix:continuation id="ief437e7917574245b72875d83f2b93ea" continuedAt="i2a589c03a3ab464688422c48c938885c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM1NA_c75b708f-ec08-4e9f-9091-a4aaa5f11a15" escape="true">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of significant demand for COVID-19 testing.  As a result, operating results for the three months ended March&#160;31, 2022 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM1NQ_a897e138-92d1-4291-b0d9-72dc3dcb6e1d" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM0Ng_028c0eeb-5d7c-4053-ac98-d17ae1affbab" continuedAt="i0894cc5829cb4a27af4e325edc3e734f" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2a589c03a3ab464688422c48c938885c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0894cc5829cb4a27af4e325edc3e734f">dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDMzNg_c5ef46b6-56b8-4dd8-9865-916867b1903b" escape="true">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RleHRyZWdpb246OTI3YTA4OWZkODY0NGNjYWIxNTRjNGFiNDg4ZTNmNWNfODc5_f6fee789-1eb8-4b72-a44c-361580773319" continuedAt="ia1c183c295554678839dca3f3e4a96d2" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia1c183c295554678839dca3f3e4a96d2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RleHRyZWdpb246OTI3YTA4OWZkODY0NGNjYWIxNTRjNGFiNDg4ZTNmNWNfODgz_fc4e3520-a54b-4c84-b7f7-9371adbafdd4" continuedAt="i6f58915c6a794369b9de1cdf064c69ce" escape="true">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i6f58915c6a794369b9de1cdf064c69ce"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:77.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfNy01LTEtMS00NTA4NQ_1cd8faaa-92b3-4088-8152-c6dc9aa8d255">355</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfNy03LTEtMS00NTA4NQ_5e28949f-4b1b-468d-b310-9d90336caf16">469</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOC01LTEtMS00NTA4NQ_db818d3c-264a-40e7-adb6-c935d239465a">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOC03LTEtMS00NTA4NQ_834cad5b-d650-4457-b233-c0a95f49fb95">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOS01LTEtMS00NTA4NQ_83191a5d-b512-4e0e-bd23-2036239b292c">354</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOS03LTEtMS00NTA4NQ_5423752d-f37b-4de3-8aec-8a6ec802d71c">468</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTEtNS0xLTEtNDUwODU_4eea8766-5b49-426b-80d5-ea8ad0d48316">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTEtNy0xLTEtNDUwODU_aaa301be-baa9-4030-9604-4905282853ec">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTMtNS0xLTEtNDUwODU_2cba3c9b-e5ed-4516-868d-ff7db3187664">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTMtNy0xLTEtNDUwODU_5090a94f-61bd-4faf-af4c-70d7dba82f90">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTQtNS0xLTEtNDUwODU_475e5896-ac4a-46ad-8112-f39f1ba8efab">121</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTQtNy0xLTEtNDUwODU_836b9335-f5e2-4d21-abad-acf0cb9bae92">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTctNS0xLTEtNDUwODU_e2b10e1f-e2c1-4b41-848c-b67a7fea4cf5">2.97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTctNy0xLTEtNDUwODU_1d866f94-bb0c-44a2-af6a-87b8314edfdf">3.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMjItNS0xLTEtNDUwODU_298ea881-3450-4699-bc39-8438bd6300ce">2.92</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMjItNy0xLTEtNDUwODU_ece92274-e260-4672-b0cc-86a08436c22b">3.46</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RleHRyZWdpb246OTI3YTA4OWZkODY0NGNjYWIxNTRjNGFiNDg4ZTNmNWNfODg2_39611a6e-2eef-4dc6-b898-149568d683bc" continuedAt="ia5ace6669b224b18a5f9d3f31239e13f" escape="true">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ia5ace6669b224b18a5f9d3f31239e13f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:77.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjkwNDQwMTFkNTg1YjQxN2FhMjk5MmZhMmRiNWMxMGQzL3RhYmxlcmFuZ2U6OTA0NDAxMWQ1ODViNDE3YWEyOTkyZmEyZGI1YzEwZDNfMi01LTEtMS00NTA4NQ_4c0d7b6a-9bba-418d-b9ed-63d432593406">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjkwNDQwMTFkNTg1YjQxN2FhMjk5MmZhMmRiNWMxMGQzL3RhYmxlcmFuZ2U6OTA0NDAxMWQ1ODViNDE3YWEyOTkyZmEyZGI1YzEwZDNfMi03LTEtMS00NTA4NQ_a04f259a-3f67-4b35-89fe-2b3f822cd70c">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_40"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfMTYyMQ_ef3caf0f-45f2-4175-aa7e-87a381777371" continuedAt="i2431e47771f24ad1ae333fb5ae1a301d" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2431e47771f24ad1ae333fb5ae1a301d" continuedAt="i0b17c9901d9441a5bbbc53609b1a46a2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1ODkyMw_31142bed-50bd-4432-a154-7f529099abbc">123</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNTQ5NzU1ODE0NTQ5MA_45d3771e-b0cb-4bde-a994-f921860f3265">4</ix:nonFraction>&#160;million cash acquired, which consisted of cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTExNQ_3d79d5e0-4dba-4fb9-a51d-23e8549da135">105</ix:nonFraction>&#160;million and contingent consideration initially estimated at $<ix:nonFraction unitRef="usd" contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1ODkzNw_92f3199e-d245-4c10-a2d3-4e7f13779624">18</ix:nonFraction>&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $<ix:nonFraction unitRef="usd" contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNzE0NjgyNTU4NzI4Mw_c20bc7bc-3031-4e33-b3c5-468a3802b10b">96</ix:nonFraction>&#160;million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNTQ5NzU1ODE0NTgxNg_7f7530f4-59bb-4f79-9714-e8c6c456ad01">78</ix:nonFraction>&#160;million is tax-deductible), $<ix:nonFraction unitRef="usd" contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1ODk3Mw_37e28cff-d055-4a79-84cd-11f576871810">30</ix:nonFraction>&#160;million of intangible assets,  $<ix:nonFraction unitRef="usd" contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTAwOQ_d21f1a15-0d94-459e-afed-7d6fb936aa82">5</ix:nonFraction>&#160;million of operating lease right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTAyMQ_412d42c6-586d-4188-8f31-d8549ca00094">5</ix:nonFraction>&#160;million of operating lease liabilities and $(<ix:nonFraction unitRef="usd" contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201" decimals="-6" sign="-" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNTQ5NzU1ODE0NTcwOQ_69cac492-0d68-4841-af73-1b7bb29a90f9">3</ix:nonFraction>)&#160;million of working capital. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="i870e097aa1664c7f8acdc911a05478f0_D20220201-20220201" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTA0OA_8c95cea8-4ee8-4db3-b2a2-68fa2c43d4ba">15</ix:nonNumeric> years.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 11.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On December 13, 2021, the Company completed the acquisition of assets of Labtech Diagnostics, LLC ("Labtech"), an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, and recorded the assets acquired and liabilities assumed based on a preliminary purchase price allocation. During the three months ended March 31, 2022, the Company revised its purchase price allocation and recorded a $<ix:nonFraction unitRef="usd" contextRef="ifdd1512ec1684818af722553ac20625e_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk2MjYzOA_4d3242c0-17c1-4938-a0cc-4b17fb1295dd">7</ix:nonFraction>&#160;million increase to goodwill, a $<ix:nonFraction unitRef="usd" contextRef="i5d66988d2a014b72871550db7d08daf0_D20220101-20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk2MjY2Mw_67b04256-30df-431e-9bc0-654c34d192a3">3</ix:nonFraction>&#160;million increase to customer-related intangible assets and a $<ix:nonFraction unitRef="usd" contextRef="ifdd1512ec1684818af722553ac20625e_D20220101-20220331" decimals="-6" name="dgx:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk2MjY4OQ_4b1cba9d-01c8-4577-b1be-2f4905bdf489">10</ix:nonFraction>&#160;million increase to the estimated contingent consideration liability.  These adjustments did not have a material impact on the Company's consolidated results of operations. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0b17c9901d9441a5bbbc53609b1a46a2">&#160;&#160;&#160;&#160;For details regarding the Company's 2021 acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_46"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjE2Ng_eb80e6a8-f09a-4bef-818d-1cd740da00f8" continuedAt="i97cceb7674fa4eaaa7fe1d5e31ad2a1d" escape="true">FAIR VALUE MEASUREMENTS  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i97cceb7674fa4eaaa7fe1d5e31ad2a1d" continuedAt="i65c5b00ac8934eb8b328967fa30830ad"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjE1Ng_b5b5d4ce-c91a-4b97-98da-1820dc0c6524" continuedAt="i2cb685a9e5ef4ae58dd08ccaec5199e1" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><ix:continuation id="i2cb685a9e5ef4ae58dd08ccaec5199e1"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi0xLTEtMS00NTA4NQ_01570880-d6d5-45ac-8e30-2bbf61af3f0d">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi0zLTEtMS00NTA4NQ_39fb3430-6a80-4a71-a34e-3f29ff05affe">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi01LTEtMS00NTA4NQ_fcb0cb7f-ec46-433d-9c0d-e1777b77ce44">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi03LTEtMS00NTA4NQ_8c22a391-1975-452e-92de-46dba2c869e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy0xLTEtMS00NTA4NQ_b92401ca-3420-43f1-a49a-0875d0ceefae">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy0zLTEtMS00NTA4NQ_ac2d3e0e-68d8-4a1b-b0d6-a1ececc854bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy01LTEtMS00NTA4NQ_45d55a1e-47e7-41d7-b3cb-69e2ab802a5a">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy03LTEtMS00NTA4NQ_5248bda9-812e-40dd-9735-0a7dffb40dc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC0xLTEtMS00NTA4NQ_a320462f-ef95-4be7-a95a-d8d3d29cefb6">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC0zLTEtMS00NTA4NQ_2eb990eb-f383-48ec-8074-db9bbccacd13">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC01LTEtMS00NTA4NQ_7226001d-3d75-43e9-b537-14eeb73dd4d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC03LTEtMS00NTA4NQ_0ddb6829-17f4-4e9a-9b1d-59ab39d20bc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS0xLTEtMS00NTA4NQ_93dfcd01-1985-4b42-8441-722a3f8332bc">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS0zLTEtMS00NTA4NQ_5673896e-e6f8-4889-9e41-77668504bf77">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS01LTEtMS00NTA4NQ_2f0dfe03-2735-4fda-bf9c-ffabbbf39635">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS03LTEtMS00NTA4NQ_dd9fb3d4-9989-43c9-9098-efba7eaa758c">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItMS0xLTEtNDUwODU_f5f29bad-c93a-451a-90f9-c5d760bb61bc">158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItMy0xLTEtNDUwODU_029ebb44-9fe7-476e-b35d-b59b19d8cfe3">103</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItNS0xLTEtNDUwODU_9a0f8377-87e1-448a-96c8-6976c6a865e6">54</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItNy0xLTEtNDUwODU_eb2a3c2c-bd0f-4bd3-9731-812f9994870d">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtMS0xLTEtNDUwODU_b88859cf-23f8-408d-8209-ea7b2a11898c">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtMy0xLTEtNDUwODU_6c712446-39fb-4c0f-81d1-22debead4c42">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtNS0xLTEtNDUwODU_8c329f14-3d95-4077-b4ed-0b03275b4ad2">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtNy0xLTEtNDUwODU_5cd4e3aa-7982-4567-b05c-6ba657c4be59">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtMS0xLTEtNDUwODU_59876ccb-b04a-402c-b2f1-f75e169ce024">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtMy0xLTEtNDUwODU_bde1c08d-d575-45ed-9c7a-29c1463bd505">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtNS0xLTEtNDUwODU_036b114e-dfc7-4b2f-b4a0-6e214acd44b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtNy0xLTEtNDUwODU_65fd694c-f3b0-44c4-afd4-d90748d29705">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtMS0xLTEtNDUwODU_1a61392e-ed86-4040-b653-1bf9182ea08d">169</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtMy0xLTEtNDUwODU_f6ebbce1-a5f6-48aa-aadc-f7b4e724e3c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtNS0xLTEtNDUwODU_f4b8cf6c-68b3-4429-8ef8-38d10cdf2f55">136</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtNy0xLTEtNDUwODU_922fe093-dcd2-4dfd-b4fd-5b61b70dd7c1">33</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjItMS0xLTEtNDUwODU_0e34e08b-8f2a-46b9-bb14-ad3bd12cde9e">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a72f75399841a68c34e11399b140b9_I20220331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjItMy0xLTEtNDUwODU_1b86b7e3-fb2b-4164-8f48-d6262b9f5c4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjItNy0xLTEtNDUwODU_b4ca20c9-799e-4762-b1ba-05ca7fb66cf4">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy0xLTEtMS00NTA4NQ_9f8f9a56-431b-445c-9a9e-edbc43822875">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy0zLTEtMS00NTA4NQ_036d1694-9676-4727-998b-2c52b40c3890">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy01LTEtMS00NTA4NQ_448305d6-4cd1-4955-b67e-a68fe38cb45f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy03LTEtMS00NTA4NQ_d039cfd8-0887-4217-b9d5-40fe3b7e39df">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC0xLTEtMS00NTA4NQ_5e7b1c87-6671-4e79-90d9-b4a3f6e32751">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC0zLTEtMS00NTA4NQ_d84c4a44-7e93-4a6a-9c2f-aba70e3232f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC01LTEtMS00NTA4NQ_03c13fde-eca7-4bf9-a338-6918a1c989de">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC03LTEtMS00NTA4NQ_f5680246-5da1-47f6-8302-b7cea2bb00a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0xLTEtMS00NzQyMg_24c22667-3e71-431f-af2e-754e3ec23036">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0zLTEtMS00NzQyMg_1de74ecc-1aac-4d25-b21b-4763169adb2f">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS01LTEtMS00NzQyMg_7b41cf1a-12f8-435a-b555-d27ee41d9062">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS03LTEtMS00NzQyMg_83791045-7e97-4c83-8943-cfba9cd8d99c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0xLTEtMS00NTA4NQ_37c19246-312c-43c1-8a55-9f1a659f9e26">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0zLTEtMS00NTA4NQ_79723b55-d0fd-4fa0-b766-02aad474fb8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS01LTEtMS00NTA4NQ_178a386d-652a-4f29-822b-c2b8f4383ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS03LTEtMS00NTA4NQ_3013cbc0-54f3-4f37-810f-e304bb217a51">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtMS0xLTEtNDUwODU_b646f376-6f00-464b-970f-7b7df022c553">179</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtMy0xLTEtNDUwODU_1c044ad6-dd32-4be9-81b6-af5aa0b46908">121</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtNS0xLTEtNDUwODU_632ccb0f-92a6-4eca-8d05-f63c5728e3b6">57</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtNy0xLTEtNDUwODU_6851ad08-4640-42c0-8186-89f775684bac">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtMS0xLTEtNDUwODU_1f872c47-768b-4046-a495-00dcbc16c21d">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtMy0xLTEtNDUwODU_49ceccf0-8136-4ac4-ae70-c93dca9fe53b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtNS0xLTEtNDUwODU_c0eb0140-51cf-4fb6-b059-8d3ba49f4e47">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtNy0xLTEtNDUwODU_2c275517-837d-44f3-96c8-e0041344c63b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtMS0xLTEtNDUwODU_5b87e09c-4113-4b44-8ecd-9a9cfeb19604">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtMy0xLTEtNDUwODU_b2d0ce96-ae52-4645-8e28-a68cab332ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtNS0xLTEtNDUwODU_4d07b470-ae96-4956-9ac6-9aa006ee6dad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtNy0xLTEtNDUwODU_d06bbe34-6fc4-466b-9418-64bd99bb7bcb">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktMS0xLTEtNDUwODU_3c267f4a-8cf3-4357-a567-58d221fefec9">148</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktMy0xLTEtNDUwODU_9140c4e2-f799-4acd-9ec9-960f0c6d856b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktNS0xLTEtNDUwODU_dfe3ed35-3f5c-4009-865e-c8f0aa3f1722">143</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktNy0xLTEtNDUwODU_feb196ba-52ca-486a-8553-bbfb08d0b77d">5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMjEtMS0xLTEtNDUwODU_303a6705-0bb9-4e12-9834-b0cce218fbdc">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMjEtMy0xLTEtNDUwODU_37f83399-e534-427b-b159-0b391d850d96">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMjEtNy0xLTEtNDUwODU_a4fa9a26-2aa2-4c94-9dc2-380fd7c1d466">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i65c5b00ac8934eb8b328967fa30830ad" continuedAt="ie3361f7cdc52468a8530974e0e1057c9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Such equity investments are classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the acquisitions of Pack Health and Labtech, the Company has contingent consideration obligations, with a potential maximum aggregate payment of $<ix:nonFraction unitRef="usd" contextRef="idcb19055dda64f259d36cb98695b26b1_I20220331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDU4NQ_ecf6b0be-d24c-4008-901e-b327d415ef83">40</ix:nonFraction>&#160;million, that are to be paid based on the achievement of certain testing volume or revenue benchmarks.  As of March&#160;31, 2022, the fair value of these contingent consideration liabilities totaled $<ix:nonFraction unitRef="usd" contextRef="i2e2a68bb24914f12aeee3a6a2f421c55_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfMTY0OTI2NzQ1NTYzMw_e08b76d9-879c-417b-a4d2-68a90d32d9ae">33</ix:nonFraction> million.  These contingent consideration liabilities are measured at fair value using either an option-pricing method or a Monte Carlo method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume or revenue and other market inputs, including comparable company revenue volatility (<ix:nonFraction unitRef="number" contextRef="i47b7a4e4c1d74dffbfc1eda1b01dc524_I20220331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDM4MA_06356c83-fa57-496f-8929-f4022512dff2">7.5</ix:nonFraction>%) and a discount rate (ranging from <ix:nonFraction unitRef="number" contextRef="if5267cce41ca40a1842a5b25f34596c8_I20220331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDQxNA_07c6ed90-e04b-4d8d-bbad-f4566e879e11">2.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4641ff4492b5431787af20a7c361b215_I20220331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDQyMA_ef656efb-5bc6-4c24-86f0-878e99a53b72">3.0</ix:nonFraction>%).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding the Company's acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 4 to the interim unaudited consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfODI0NjMzNzIyNTc4Mg_fe3d55ea-5a6e-48a2-aafb-bdba63bb27ce" continuedAt="i6a3dfa958bea46b895209566fdaa09ea" escape="true">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i6a3dfa958bea46b895209566fdaa09ea"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1e1a831dc645f884fd63f68dafc0eb_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjkyY2Y4M2ZhNjU2ZTQ3OWVhY2ZiNDhiYzk0NGZhYTZlL3RhYmxlcmFuZ2U6OTJjZjgzZmE2NTZlNDc5ZWFjZmI0OGJjOTQ0ZmFhNmVfMi0xLTEtMS00NzYwMA_d1773486-29fb-4b5b-92a0-cb06c0420699">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa858bac8ab409c945714c4cfc92476_D20220101-20220331" decimals="-6" name="dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjkyY2Y4M2ZhNjU2ZTQ3OWVhY2ZiNDhiYzk0NGZhYTZlL3RhYmxlcmFuZ2U6OTJjZjgzZmE2NTZlNDc5ZWFjZmI0OGJjOTQ0ZmFhNmVfMy0xLTEtMS00NzYwMA_b9775d4e-233a-413e-959d-f87ccdcf3cda">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2a68bb24914f12aeee3a6a2f421c55_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjkyY2Y4M2ZhNjU2ZTQ3OWVhY2ZiNDhiYzk0NGZhYTZlL3RhYmxlcmFuZ2U6OTJjZjgzZmE2NTZlNDc5ZWFjZmI0OGJjOTQ0ZmFhNmVfOS0xLTEtMS00NzYwMA_e08b76d9-879c-417b-a4d2-68a90d32d9ae">33</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i06ff7b7bc1e443609656c518c6eb5ae7_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNDI4OQ_3a9adaba-de71-4a21-9f22-4338f46f640c">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2022, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ie3361f7cdc52468a8530974e0e1057c9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of March&#160;31, 2022 and December&#160;31, 2021, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfMTA5OTUxMTYzNjk1NQ_8f359804-d838-434f-814d-5cd4fbb33374">4.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNTc5Ng_9ada7f2a-c6ac-440e-ba22-bc958dc51fb5">4.4</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTI0NQ_4ab76518-1d18-4c73-a9a4-8154ae93a2ed" continuedAt="i18dd8a9803d44bb0be233d76c9707c36" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i18dd8a9803d44bb0be233d76c9707c36" continuedAt="i2114cbeb852e4b9bb33634b34e495de8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTI1MA_fd9b7f4a-5d95-40dd-a924-dc16b5b838bf" continuedAt="if7e919a5304a48d8b530c4c0de7eec37" escape="true">The changes in goodwill for the three months ended March&#160;31, 2022 and for the year ended December&#160;31, 2021 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="if7e919a5304a48d8b530c4c0de7eec37"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:57.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMS0xLTEtMS00NTA4NQ_896be123-7a60-4d1d-8786-1c8c518680a7">7,095</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a67828d80741189c9e71a1926cad84_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMS0zLTEtMS00NTA4NQ_e4249cd5-f5dc-4063-9c4d-6b4882f7d8b1">6,873</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMi0xLTEtMS00NTA4NQ_eccf06d2-f9db-413f-8c85-fc671842250b">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5303d7e238e424da44bd18e24d4586b_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMi0zLTEtMS00NTA4NQ_bc142af9-3543-4424-93cc-b32f4b913e7f">228</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMy0xLTEtMS00NTA4NQ_809b1f87-ccdd-4d66-8c7d-784a4e158ad9">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5303d7e238e424da44bd18e24d4586b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMy0zLTEtMS00NTA4NQ_e075df2a-f3e5-4e22-911a-9689f86ab58f">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfNy0xLTEtMS00NTA4NQ_1b497a72-357e-4cda-ad75-0b036764a616">7,197</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfNy0zLTEtMS00NTA4NQ_6b8898f3-2856-4f15-8efb-65d94d6980d5">7,095</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of March&#160;31, 2022 and December&#160;31, 2021 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, goodwill acquired was principally associated with the acquisition of Pack Health, and adjustments to goodwill primarily related to an adjustment of the purchase price allocation for Labtech (see Note 4), partially offset by foreign currency translation. For the year ended December&#160;31, 2021, goodwill acquired was principally associated with the acquisitions of the assets of the outreach laboratory services business of Mercy Health and the assets of Labtech (see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K), and adjustments to goodwill related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTIzMw_b8e34e6d-b50b-4ed5-86c0-d4f14107fd13" continuedAt="iaa09ddcc58fa4bfa8f5aa8c5488646de" escape="true">Intangible assets as of March&#160;31, 2022 and December&#160;31, 2021 consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="iaa09ddcc58fa4bfa8f5aa8c5488646de"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.727%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5ca82d7b06e45028a679da518e76e9b_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0xLTEtMS00NTA4NQ_4706d592-58f6-4bdf-ab74-cb142c2f7e3f">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0zLTEtMS00NTA4NQ_1e712245-272f-4618-bfee-01e9f9d63b9c">1,609</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy01LTEtMS00NTA4NQ_c52925cc-30ca-4256-8c85-21e7c15ee46c">749</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy03LTEtMS00NTA4NQ_2e3a38dc-ac03-47f5-b328-202f1a9b8220">860</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a068e932f834d0fbed8af834b0682fc_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy05LTEtMS00NTA4NQ_02dba096-6104-4138-99f0-d0876703d8a9">1,581</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a068e932f834d0fbed8af834b0682fc_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0xMS0xLTEtNDUwODU_ba3528af-6d23-450d-871b-398bdd4f5b10">726</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a068e932f834d0fbed8af834b0682fc_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0xMy0xLTEtNDUwODU_e26b222e-3a28-44ec-b1c2-259b4ba04086">855</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icbc15825d3594bf5b2196f75b4ee733a_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0xLTEtMS00NTA4NQ_c3a789e5-84c9-4ec4-82bd-65b75c916085">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id71bba1de51f4a99b9449c6f849555cd_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0zLTEtMS00NTA4NQ_b4afdd10-87fd-4b24-bf07-e4f8e285e156">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id71bba1de51f4a99b9449c6f849555cd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC01LTEtMS00NTA4NQ_85155d37-247a-4c70-a8ad-f90621695e9c">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id71bba1de51f4a99b9449c6f849555cd_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC03LTEtMS00NTA4NQ_bbc34e2a-510f-4f9d-b2bc-0a13fbe300ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8340eece4f647c8a754867732e5a6f0_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC05LTEtMS00NTA4NQ_4cc25eb6-6601-43df-8589-467c0e64ede1">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8340eece4f647c8a754867732e5a6f0_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0xMS0xLTEtNDUwODU_3d6b6239-e9d8-491c-8f35-083db328fde9">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8340eece4f647c8a754867732e5a6f0_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0xMy0xLTEtNDUwODU_1ae8c944-78ef-4fbb-acec-d033b9f9a8ff">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3f08c600ea6544d49b1b2a1a8014d75d_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0xLTEtMS00NTA4NQ_d1134445-12b5-408a-b961-886002090035">14</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0zLTEtMS00NTA4NQ_9cbd50b9-8b11-40cc-9623-f001f54612e7">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS01LTEtMS00NTA4NQ_11178b2b-da1f-44c4-b755-e72158273cc8">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS03LTEtMS00NTA4NQ_8cceab98-2e01-476d-a1e4-f045d4222135">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b6174ae321c4e74944b97981d1b2ae3_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS05LTEtMS00NTA4NQ_bb1c8e0b-f107-4bba-b840-8bed5f0ab64f">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b6174ae321c4e74944b97981d1b2ae3_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0xMS0xLTEtNDUwODU_417b3cd8-c3d1-4f2f-a5e1-63c0dc657c51">74</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b6174ae321c4e74944b97981d1b2ae3_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0xMy0xLTEtNDUwODU_8d7a4ace-d525-45db-8847-94334fc4f6d1">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bc34a35184c4ce7a3e425dbd8fd8062_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0xLTEtMS00NTA4NQ_0457bb20-5e55-4692-a0c5-69d6272e608e">6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce3a63acc1249caaa4588f7c259007a_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0zLTEtMS00NTA4NQ_f347d44e-dfcc-4c06-a74b-40638c70dbec">114</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ce3a63acc1249caaa4588f7c259007a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi01LTEtMS00NTA4NQ_842abe28-4173-4516-bb89-1b3b44b111ad">102</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce3a63acc1249caaa4588f7c259007a_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi03LTEtMS00NTA4NQ_5c58c7d2-26d3-44ad-9256-b17afcb29253">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a36c4164bf4b33be691b9ef663be7b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi05LTEtMS00NTA4NQ_2d3ac538-0928-40ca-8f60-1086e1e0a143">109</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a36c4164bf4b33be691b9ef663be7b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0xMS0xLTEtNDUwODU_45c43cd0-3d2b-475a-b9bf-da69c648a808">101</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a36c4164bf4b33be691b9ef663be7b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0xMy0xLTEtNDUwODU_556ebbe1-6b4d-4f34-bbfd-905f52dee48b">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59659f457ca94d118fef31ba6ba41012_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0xLTEtMS00NTA4NQ_6406cfd1-2c6e-4833-981b-08f70fb822be">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97ad39521e69481f9a20580c7230cd21_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0zLTEtMS00NTA4NQ_8c587ad0-f066-457f-bee0-f1cbe3abad8c">1,866</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97ad39521e69481f9a20580c7230cd21_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy01LTEtMS00NTA4NQ_42053c39-2d6a-4cd0-8c5f-b6dc57d041be">930</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97ad39521e69481f9a20580c7230cd21_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy03LTEtMS00NTA4NQ_5a2a8763-0bfe-462f-bb80-8210dabbcb3a">936</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaa2c3e268834b25b750134c958ab08c_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy05LTEtMS00NTA4NQ_9bd6cf35-c030-454b-a467-6e30caa7404a">1,834</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaa2c3e268834b25b750134c958ab08c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0xMS0xLTEtNDUwODU_abdc14e8-d79f-4e44-a4b7-28e0107630d9">903</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaa2c3e268834b25b750134c958ab08c_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0xMy0xLTEtNDUwODU_53020913-2899-49fb-abc3-f61377502208">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c37e4e3f1a4370a83bb9c770279e61_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtMy0xLTEtNDUwODU_81b608f8-eddb-4404-860e-8ed7307d451a">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c37e4e3f1a4370a83bb9c770279e61_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtNy0xLTEtNDUwODU_a6e75eca-2319-40ef-8e49-e7731734a07e">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b580343931c4d66b78cda2fd05abe6a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtOS0xLTEtNDUwODU_2a12a261-0ab5-4332-8779-732016592f54">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b580343931c4d66b78cda2fd05abe6a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtMTMtMS0xLTQ1MDg1_5a6670fa-3b0a-4ae5-94da-3bc254ee182e">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ec31233f0e4dad9da135008aa5f080_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItMy0xLTEtNDUwODU_23dab266-cd35-4492-b4cd-8b5a28aca0df">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ec31233f0e4dad9da135008aa5f080_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItNy0xLTEtNDUwODU_97c2be32-2641-4799-abe3-e0e1fcb96e22">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254bf5959746494883fdd89b5852102b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItOS0xLTEtNDUwODU_dfd9d6a8-8c12-4be9-8b48-eee89d08cc75">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254bf5959746494883fdd89b5852102b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItMTMtMS0xLTQ1MDg1_b090e95b-e097-4a3d-8644-7419d90ee9c7">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtMy0xLTEtNDUwODU_15647984-dab9-4567-bb04-509722194013">2,102</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtNS0xLTEtNDUwODU_d1241d13-ef68-4b24-8500-bb7abf9122c8">930</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtNy0xLTEtNDUwODU_a3c09c89-4e2b-4db3-b5a0-336bfeee4435">1,172</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtOS0xLTEtNDUwODU_0afd1551-7681-4d66-bf4e-b275c6145f90">2,070</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtMTEtMS0xLTQ1MDg1_e0cbf0c8-619d-49cb-87af-dab0b1e1d5a7">903</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtMTMtMS0xLTQ1MDg1_19cd2ac0-8251-4925-8bf0-a837a121348c">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2114cbeb852e4b9bb33634b34e495de8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTI0MQ_d8e13822-f820-490d-a7f7-0227ce9b4453" continuedAt="ibdf3c0dcd7d6451b976999e925cf2a1f" escape="true">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2022 is as follows:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><ix:continuation id="ibdf3c0dcd7d6451b976999e925cf2a1f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"></td><td style="width:72.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfMS0xLTEtMS00NTA4NQ_8cd804e7-0f98-420c-8c6a-3f10ab5618e3">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfMi0xLTEtMS00NTA4NQ_d11aa008-1781-4ef1-89bf-ea2ff621b4d8">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfMy0xLTEtMS00NTA4NQ_38e7f68f-3786-433e-86d6-230fe1514f57">102</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNC0xLTEtMS00NTA4NQ_be24022d-606a-441a-bac9-e2cf1afdadc8">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNS0xLTEtMS00NTA4NQ_232c81de-e2af-430a-b1cf-11592dfa90da">95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNi0xLTEtMS00NTA4NQ_328d5fd7-bf09-4dc0-b249-6b10fda8bb43">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNy0xLTEtMS00NTA4NQ_f9640a0b-d4ba-40b7-b8e6-335cde699deb">367</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfOC0xLTEtMS00NTA4NQ_e24a54a7-77dc-405a-ac54-c6ff515574b5">936</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RleHRyZWdpb246YWJlOGY1OTY1YzIyNDJkMjlkMWFmYjlkZGFiYzc1N2FfMzQ1Mw_cd1378f2-a0ab-48e0-9075-710eff6acfba" continuedAt="i88ddc08fcbe348ffb7ecef1802b6289d" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i88ddc08fcbe348ffb7ecef1802b6289d" continuedAt="iada48fb57e5e4031868077913c6bcc88"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RleHRyZWdpb246YWJlOGY1OTY1YzIyNDJkMjlkMWFmYjlkZGFiYzc1N2FfMzQ4MQ_c18a065e-37ae-4637-9129-321136eafe97" continuedAt="i2acb348027ac4f5cb7aa6bec2b6275a5" escape="true">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2acb348027ac4f5cb7aa6bec2b6275a5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RleHRyZWdpb246YWJlOGY1OTY1YzIyNDJkMjlkMWFmYjlkZGFiYzc1N2FfMzQ2Mw_09ec8385-2c19-47e4-a28b-0c08215194ca" continuedAt="i7b3adf2be0154e12a54b7d797ac6a04d" escape="true">As of March&#160;31, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iada48fb57e5e4031868077913c6bcc88" continuedAt="idad1da0291d5402383703badef892352"><ix:continuation id="i7b3adf2be0154e12a54b7d797ac6a04d"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf58f44b38cb4bb8837626b15f8ab005_I20220331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RhYmxlOmI4OTEzZDg3YTRiMTRkNTNhZmU4NmM4NTU2MDgxNmVjL3RhYmxlcmFuZ2U6Yjg5MTNkODdhNGIxNGQ1M2FmZTg2Yzg1NTYwODE2ZWNfMi01LTEtMS00NTA4NQ_240b9a79-8d28-4ba1-960a-975f96cd92fc">35</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia613c80a290b4a8eb01c818fb05d0800_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RhYmxlOmI4OTEzZDg3YTRiMTRkNTNhZmU4NmM4NTU2MDgxNmVjL3RhYmxlcmFuZ2U6Yjg5MTNkODdhNGIxNGQ1M2FmZTg2Yzg1NTYwODE2ZWNfMi05LTEtMS00NTA4NQ_0de2448a-69d6-49cf-83c4-b13bcc3c401d">38</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="idad1da0291d5402383703badef892352" continuedAt="ic76f4c3b622440839bfeedec181c508c">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic76f4c3b622440839bfeedec181c508c">A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</ix:continuation>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNTU5MA_ce22414f-49df-4e32-8ccb-3c1f2d438968" continuedAt="i9728d43d5c1d4e56ba9e14484b885561" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="i9728d43d5c1d4e56ba9e14484b885561" continuedAt="i85951c4687064b7eaa32b006402839a9"><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 7); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022 and 2021, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2022, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTQ5OA_2b2b1368-c054-423e-bc4a-d4a48d59ca4e">0.66</ix:nonFraction> per common share.  During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9547ae76ad524df1be143291c3dc3dc8_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_1ec5918c-8672-415c-b1db-a23b969c7800"><ix:nonFraction unitRef="usdPerShare" contextRef="i99220d08c6b942a2b4ba862f3c64bf42_D20211001-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_42687315-fde3-417d-921f-ad18a5afac3b"><ix:nonFraction unitRef="usdPerShare" contextRef="ia42df8753f0440b391d7bee60af61213_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_56211d06-7d26-4461-8303-8d014e3c3763"><ix:nonFraction unitRef="usdPerShare" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_988f51c3-f6cf-4a16-87f2-0924f5cd1842">0.62</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2022, the Company's Board of Directors increased the size of its share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="i29b9b62572e64aaeb2ee5d852bb0ac6f_D20220201-20220201" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTgxMg_0eabb765-1a4e-4609-9600-0b893ee275b4">1</ix:nonFraction>&#160;billion. As of March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTA5OTUxMTYzNjIwMA_ac2b1385-a632-4353-b2ad-f36b85011ba5">1.3</ix:nonFraction> billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMjA1NQ_a6efa34e-b352-4c2c-ac16-b83840918d3d">2.6</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMjEwMA_3fc34292-1476-49b3-89dc-1e1c0ec694a5">350</ix:nonFraction>&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMzYxMw_b78781de-f235-43bd-81e4-0a30edfcfd42">3.4</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMzY0Nw_548f7fc0-f79a-49d7-8f5b-07dcf09ca0b6">410</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i85951c4687064b7eaa32b006402839a9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022 and 2021, the Company reissued <ix:nonFraction unitRef="shares" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNDEzNw_5e69aa4e-bf5d-42e6-93cf-e8e048cece48">0.5</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNDE1MQ_72c9d4a0-a697-478e-9c74-1e89ea98f8c5">0.6</ix:nonFraction> million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i06ff7b7bc1e443609656c518c6eb5ae7_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNDg2MA_3a9adaba-de71-4a21-9f22-4338f46f640c">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2022 and December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 5.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_58"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RleHRyZWdpb246ZmU5OGIzZjNjNjM2NDE3Njg5NjE1NzljNTYwZGQwOGNfMTM2Nw_922fce88-048b-4e4d-9ed1-242df5fa01c1" continuedAt="i912eab0829284029a0a57f3f096ab914" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i912eab0829284029a0a57f3f096ab914"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RleHRyZWdpb246ZmU5OGIzZjNjNjM2NDE3Njg5NjE1NzljNTYwZGQwOGNfMTM3MA_1be55af2-d1cd-4826-a85d-7f7f3e1d7ca5" continuedAt="ic251ddb5245940efa701d29f695c7b36" escape="true">Supplemental cash flow and other data for the three months ended March&#160;31, 2022 and 2021 was as follows:</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic251ddb5245940efa701d29f695c7b36" continuedAt="i9f2cb0301db9430c8ee58fe3a9af240a"> </ix:continuation></span></div><div style="margin-top:5pt"><ix:continuation id="i9f2cb0301db9430c8ee58fe3a9af240a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:78.042%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.959%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMi01LTEtMS00NTA4NQ_244d2770-20ec-4434-af4c-ad86455997d6">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMi03LTEtMS00NTA4NQ_6083e47d-455a-49e4-a09f-c2394076d95c">74</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMy01LTEtMS00NTA4NQ_4b2d7487-3170-4b92-89d6-8fd44593db20">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMy03LTEtMS00NTA4NQ_c3c060e7-fbd9-44a7-bf8b-16ffec71ac25">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNC01LTEtMS00NTA4NQ_f912700c-50ce-4d80-8279-787277afc0d0">106</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNC03LTEtMS00NTA4NQ_ca771cd1-449b-424b-b8c9-ae13fe099464">101</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNi01LTEtMS00NTA4NQ_aec9d36e-5a8e-4381-a191-66cee90d6a1f">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNi03LTEtMS00NTA4NQ_a62449f2-041e-4440-b17e-5a3ecad18b17">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNy01LTEtMS00NTA4NQ_23418b9d-ec58-4fe0-812e-37199bfa6d96">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNy03LTEtMS00NTA4NQ_961b0e46-6e97-4627-9098-3a36b27bbd9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfOC01LTEtMS00NTA4NQ_8ab5fc5d-b647-4b2d-bd90-61ce48f7fd0e">37</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfOC03LTEtMS00NTA4NQ_77debe91-42e1-48eb-b183-107bd1b4ab99">38</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTAtNS0xLTEtNDUwODU_292c8dd7-f8a6-42a6-a1b6-a11f1ba059c4">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTAtNy0xLTEtNDUwODU_d276a40d-f308-4270-9395-54365325d141">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTEtNS0xLTEtNDUwODU_227ce3a6-6196-4187-aa3d-4097f9a9b1e6">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTEtNy0xLTEtNDUwODU_e6deaa59-281e-4b9c-bf90-2e4431831e93">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTMtNS0xLTEtNDUwODU_604acf5c-c1ad-4297-973e-4097eaa3b27a">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTMtNy0xLTEtNDUwODU_0bc37e3d-6d5c-4416-b7bd-5243b354b834">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTUtNS0xLTEtNDUwODU_f4a6c272-c308-4c38-8355-10fa0b2b2a56">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTUtNy0xLTEtNDUwODU_9ee8e8ed-2b61-4e8f-b8c1-64f30ea83235">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTgtNS0xLTEtNDUwODU_74ccb7c1-9303-4c1d-a141-487772b16851">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTktNS0xLTEtNDUwODU_21d7eda2-0c43-4afd-866e-1bcbb769914d">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:LiabilitiesAssumed1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTktNy0xLTEtNDUwODU_56f633f3-79c5-4e49-b160-6b290f9eaadd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjAtNS0xLTEtNDUwODU_7030e63c-6f01-42bb-9a4f-3e432484d8da">127</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjEtNS0xLTEtNDUwODU_ed5fdd0d-2a2e-4e83-897d-c37c4ce26bd7">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjEtNy0xLTEtNDUwODU_ee6006ac-bf81-40ec-b80c-37fba1dc848c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjItNS0xLTEtNDUwODU_0e09eaa2-68b3-4b99-a8d5-888eda903db7">109</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjItNy0xLTEtNDUwODU_be7db6cf-748b-40cc-9608-c6b0d82428c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjMtNS0xLTEtNDUwODU_d5b915e5-2ffb-4031-9773-d4f39f3ce826">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjMtNy0xLTEtNDUwODU_d2cedb18-6823-41ae-be7b-9e87b5b102b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjQtNS0xLTEtNDUwODU_4b5ca169-b3a4-4ecd-bc29-f091bae4b3ef">105</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMzEtNS0xLTEtNDUwODU_54300f80-8640-4f20-9efe-ca7a937be664">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMzEtNy0xLTEtNDUwODU_e0edf689-f116-463d-aa0b-6c7e8b91fb59">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March 31, 2022, the Company amended a real estate lease and, based on the updated terms, the classification of the lease changed from a finance lease to an operating lease.  As a result, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i551c518ca51d4c9c9055dcba49fc4c81_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RleHRyZWdpb246ZmU5OGIzZjNjNjM2NDE3Njg5NjE1NzljNTYwZGQwOGNfNjA0NzMxMzk1NTc3NA_4493e809-41f2-42b9-b7d9-e24108f7f24b">31</ix:nonFraction>&#160;million operating lease right-of-use asset.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i345527f5748848cea641eb9c408bf6be_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODQ1Nw_9c5a1e2f-346d-4dc8-a334-e9d69ae6a733" continuedAt="idd74eea2aa964823866a2ae6ce48c3b1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="idd74eea2aa964823866a2ae6ce48c3b1" continuedAt="i705ad9c3e619457ebfd087a8fe063f1b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="ic10d96a9520947408f8b1fbb71092e38_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTEx_ebb74ba2-0f7d-490e-b302-e82b5c9eb27f">100</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="id00a1c2aa7e8495ab6e23f05811ff14c_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTI0_be46b273-9379-451e-b2d1-809c60598105">600</ix:nonFraction>&#160;million secured receivables credit facility and $<ix:nonFraction unitRef="usd" contextRef="ic6a79d7e1b5247eca266100ab948eb9f_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTY3_b760ed80-e042-4d36-bfb7-21861e53fbc8">150</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i01801313bd9d425a81cb897b8cba44d0_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTgw_c77097d7-213e-4a84-922c-1ee46d117cb0">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i705ad9c3e619457ebfd087a8fe063f1b" continuedAt="i75d3e985586c4bbf95c286a06f509639"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $<ix:nonFraction unitRef="usd" contextRef="id00a1c2aa7e8495ab6e23f05811ff14c_I20220331" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMzgz_3d8866d2-58cf-40fb-be8f-e599a5d44f9a">70</ix:nonFraction> million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2022, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="i25a67828d80741189c9e71a1926cad84_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTcyNw_0f98aa3b-07de-4b33-ac9f-f9f24c43fb19">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="i3b1004fab47841e394d81b95440cd37a_I20201031" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMjI3NQ_1314bedf-5679-4a12-9d15-b858c9fe3117">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, in 2019 the Company was notified that the Office for Civil Rights of the U.S. Department of Health and Human Services ("OCR") and numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  On April 6, 2022, OCR informed the Company that it closed its review.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i75d3e985586c4bbf95c286a06f509639" continuedAt="i8acfec36d33e4c178d3fb95c39932fa9"><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ReproSource Fertility Diagnostics, Inc.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#8220;ReproSource&#8221;), a subsidiary of the Company, is subject to <ix:nonFraction unitRef="claim" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODI0NjMzNzIyNjkyMQ_a8a29f7a-cedb-41e8-b665-523158e23b16">two</ix:nonFraction> putative class action lawsuits: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bickham v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for Massachusetts) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for Nevada). The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#8217; private information. ReproSource has moved to dismiss both complaints and to transfer the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint to the U.S. District Court for Massachusetts.  In addition, the Company has been notified that certain federal and state governmental authorities, including OCR and attorney general offices from three states, are investigating or otherwise seeking information and/or documents related to the incident.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2022, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="iefe7c88a31514a2893220839bc498be1_I20220331" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfNzE2OA_58c89698-c8b9-4a92-a852-63be972ada65">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1e1824dfa71e45bab55dc851db327252_I20211231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfNzE3NQ_b07eaf16-e1c9-4717-9ab1-8b2383e9e050">4</ix:nonFraction> million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><ix:continuation id="i8acfec36d33e4c178d3fb95c39932fa9" continuedAt="i4f6aea3f592f45f8ac3192df8d034801"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4f6aea3f592f45f8ac3192df8d034801">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODI4Mw_0f4d65cb-d56e-40a8-be67-677739771748">158</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODI5MA_c43a26dd-49de-495a-9cc5-91adc25dd01a">159</ix:nonFraction> million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfMjQxNw_071d0bd5-8798-4106-be3d-e743ffe3cb59" continuedAt="i2037a6d11ac6426889e6edceb3c2a497" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2037a6d11ac6426889e6edceb3c2a497" continuedAt="i31f8d25acb604d9fb298c037a1c791d9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i7c68974c9ae14e999016cc1e131cfde0_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfODA2_1240f7e0-b29f-474c-abed-21497cbaf769"><ix:nonFraction unitRef="number" contextRef="i67a7e4d1308249418b99f41ff7f71e1c_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfODA2_6879de7e-4c6d-4058-b10d-0a4713ae94d6">95</ix:nonFraction></ix:nonFraction>% of net revenues in 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2022, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfMjQwNw_89aa431f-b7fb-4a25-b496-d81e011857c1" continuedAt="i7bf388d42df746a999957055d35fd7ed" escape="true">The following table is a summary of segment information for the three months ended March&#160;31, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i31f8d25acb604d9fb298c037a1c791d9"><div style="margin-top:5pt;text-align:center"><ix:continuation id="i7bf388d42df746a999957055d35fd7ed"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:77.792%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMy01LTEtMS00NTA4NQ_cc08e4f6-94e0-46cf-8157-1c6762e8dbf7">2,541</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMy03LTEtMS00NTA4NQ_7642847b-e533-403f-8a57-ac75316dc72f">2,643</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i406d4d3cc39844eb98b58ddc6a62338d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNC01LTEtMS00NTA4NQ_82fcde73-5e80-4c32-800b-d53a54c4e8af">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic37254f6ff664132a27df6fb73d9bc34_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNC03LTEtMS00NTA4NQ_76f23564-89d1-4d5a-bbf0-54c96bf18889">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNS01LTEtMS00NTA4NQ_cbd9bcc5-ba40-4192-a353-16b4e8ea578e">2,611</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNS03LTEtMS00NTA4NQ_a8e3935e-3672-467f-bf4e-c3703a6d1897">2,720</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOC01LTEtMS00NTA4NQ_9c532beb-8c1a-4575-a0a4-dcf189bb24f9">562</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOC03LTEtMS00NTA4NQ_79007064-293a-4b8d-882a-7191e91188bd">712</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i406d4d3cc39844eb98b58ddc6a62338d_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOS01LTEtMS00NTA4NQ_1ddbd216-5e43-49d4-957b-767ba8b85786">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic37254f6ff664132a27df6fb73d9bc34_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOS03LTEtMS00NTA4NQ_96811512-c6e8-4d27-9ff2-a79c4a6b6791">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0262431589c64d5988860f60c34228e6_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTAtNS0xLTEtNDUwODU_2e95848f-3eac-40b9-9fc6-c975491aeeb2">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c63e12f82864bd19c390ad2281a65b9_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTAtNy0xLTEtNDUwODU_1830ad3c-20ef-4ff7-ace1-0cdd4376eec1">61</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTEtNS0xLTEtNDUwODU_8509a5b8-7bde-4277-83bb-0aa5fbddeb06">513</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTEtNy0xLTEtNDUwODU_d6ef4b19-ccc7-4171-bdac-476e4fb1e08e">660</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTItNS0xLTEtNDUwODU_7c0dc35b-7736-421e-bd1c-e25ea09f363a">61</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTItNy0xLTEtNDUwODU_fe3d8ff2-4e3d-4988-acdf-13e93a7481e4">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTMtNS0xLTEtNDUwODU_f7a169a1-d52b-4566-8aa5-ece629c44f7f">452</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTMtNy0xLTEtNDUwODU_e24a0d1c-d02f-4dbb-88b0-d9552ca074e1">626</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTQtNS0xLTEtNDUwODU_e2fb4455-2f7c-4708-9da8-f8814813e150">110</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTQtNy0xLTEtNDUwODU_f3f7b257-d451-4850-a307-f9880cad52e7">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTUtNS0xLTEtNDUwODU_73c943dd-0fd2-449c-a7e1-f320cc5df30e">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTUtNy0xLTEtNDUwODU_13126ed9-f8e8-48df-8001-637de22bf1b5">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTgtNS0xLTEtNDUwODU_df0ba1d5-121a-4f27-a2bc-012df953f6d5">373</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTgtNy0xLTEtNDUwODU_7c77420e-457f-429d-b4c2-c6f5360588cb">490</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTktNS0xLTEtNDUwODU_233006f2-fe72-4ebe-944b-24c5e6a84fc3">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTktNy0xLTEtNDUwODU_2a0de432-db73-4bc2-86ad-caf0327f2a86">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMjAtNS0xLTEtNDUwODU_33d788c6-929c-4290-8f35-513393dba18b">355</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMjAtNy0xLTEtNDUwODU_64e7effd-baf4-44f1-a795-b36069d54937">469</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfMjQwOQ_c81c6c80-ed9c-4037-8144-3959d958b48d" continuedAt="i6bb43c2dd3f04e81a544ddafa320f695" escape="true">Net revenues by major service were as follows:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i6bb43c2dd3f04e81a544ddafa320f695"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:77.792%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4be0056c2d4457d87c5fadf557e6aa3_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfMy01LTEtMS00NTA4NQ_f8e7b679-d113-41db-942f-a8e63c470e3e">1,066</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8822bce97a2b4af293f8ceb8f7512c0c_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfMy03LTEtMS00NTA4NQ_ebaa9bef-77d4-426e-9d15-9aa77482dfe9">1,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dddf077b184e02aeb6d79159ca7906_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNC01LTEtMS00NTA4NQ_00612ea8-a5bc-4091-a0a9-a6869699a897">599</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8517e8d9b8ac4e6daf93a2e50dccb9da_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNC03LTEtMS00NTA4NQ_9874f6b9-95cf-4b43-870d-6bb2a9d2b277">828</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357b7ece8680488e8499ff07ec4d5141_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNS01LTEtMS00NTA4NQ_ef472941-6f23-4457-b2e7-ec54d194ff90">739</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f3a4d5ffd34af588f97c9b3c569245_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNS03LTEtMS00NTA4NQ_e798b542-dd17-4177-b672-1e2e1deb0589">653</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i554bdadf4c5d454fbfe277f057fbf835_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNi01LTEtMS00NTA4NQ_7707b27f-869d-4592-b587-e46eb83ee93a">137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0122ad278dc483e8e5ca7f6dbcfebaa_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNi03LTEtMS00NTA4NQ_56488527-fda1-45c0-b1eb-9192f5f01b86">130</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e73eb975d144a494494df1d9ae3f91_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNy01LTEtMS00NTA4NQ_b800aa9e-3116-4d2e-9a8b-0af179cc7572">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i391bf57712c046ac8a065213c2be01ca_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNy03LTEtMS00NTA4NQ_9d4a66b0-5d33-4e23-8252-9dd156b56e5c">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfOC01LTEtMS00NTA4NQ_43870c99-da30-4f32-b26b-367ffe1991d1">2,611</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfOC03LTEtMS00NTA4NQ_59291475-2edd-4fca-a1b7-7f7648628590">2,720</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfMTU1Mg_5c5cb636-2ee8-4c5c-84c1-3ad9f007f8b0" continuedAt="i3fbc93b2388a46f1befa65a1f255c7dd" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3fbc93b2388a46f1befa65a1f255c7dd" continuedAt="i85ebf4b5b1b047c0a77884ca211c6b89"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over <ix:nonFraction unitRef="number" contextRef="i67a7e4d1308249418b99f41ff7f71e1c_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfOTk_40ef7773-7642-4275-8175-16d3a1105f2c"><ix:nonFraction unitRef="number" contextRef="i7c68974c9ae14e999016cc1e131cfde0_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfOTk_a6216764-4e6e-4784-9eec-13d3d526a9c3">95</ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total net revenues for the three months ended March&#160;31, 2022 and 2021 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i85ebf4b5b1b047c0a77884ca211c6b89" continuedAt="i2d01a0640f704dab95edc758ad75075b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue and Net Accounts Receivable by Customer Type</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfMTU1MA_f874e123-acf8-44d7-bc5a-c82b3fc248df" continuedAt="if840234529e0496b9a95e6832ff82c2f" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><ix:continuation id="if840234529e0496b9a95e6832ff82c2f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2618e94f78ff4be6a974f3d7437c9209_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMy01LTEtMS00NTA4NQ_a4ad1af7-909a-4927-8a18-3363c524748f">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b2b3bb914b24a5fb505052ab070ca0e_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMy03LTEtMS00NTA4NQ_2567b853-40b7-455f-99b2-734d54532aa7">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic31416e26495484dbfd0cc01ec4b8a6a_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNC01LTEtMS00NTA4NQ_5960ac6a-5974-4965-ad8e-38e5b1a9f98a">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15e3cb2bbf8749a79b1c1e421d2c139e_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNC03LTEtMS00NTA4NQ_bc32215c-e54b-46a6-8257-d71d6bbb25b6">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c1aad07e73c4da6b04fcd621739200e_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNS01LTEtMS00NTA4NQ_9b492891-54f0-4415-85cf-a4248d100ff8">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i425a3e05cbb94ca5a14e66f99fada19f_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNS03LTEtMS00NTA4NQ_3875c47d-7a14-47ba-9115-386c32d1d921">40</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i149bfab7a1c24f29b4792c319f8ef948_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNi01LTEtMS00NTA4NQ_4b9c9638-5b58-476d-b226-baa8250c9330">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cd4daa713554f92aef54d2f74630a39_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNi03LTEtMS00NTA4NQ_9f3d7516-bc12-4800-bf33-07d71a285586">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70a9907567b640a289999fae84223794_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNy01LTEtMS00NTA4NQ_62c79379-0bbc-45cf-907b-f2043eaf6d2f">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84f9da75efe04d6daab9a677cd6e4633_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNy03LTEtMS00NTA4NQ_0c9b4af1-7179-464e-a77f-b8f3360f86ba">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia292ad0369a643b9828d88492775c95c_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOC01LTEtMS00NTA4NQ_1b3bd4ef-6e7a-43ab-8a18-34999cfac5b8">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01cb765ce9e44733bd6b1826d67c2ff7_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOC03LTEtMS00NTA4NQ_73d61929-f4f6-4cd4-ab04-dcee97a24c15">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOS01LTEtMS00NTA4NQ_62fe90a6-c611-4128-aecd-0db735edf63f">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOS03LTEtMS00NTA4NQ_6aafcc7a-3970-4c90-be1c-43825866a483">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i170456437f45486e9e310a25b9ca855a_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTAtNS0xLTEtNDUwODU_0f4036c2-4c5e-4559-a90a-ac1ac86b084a">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a550c5ebbc248d0b9bce68cfbfe1a1b_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTAtNy0xLTEtNDUwODU_eac9d235-908b-4569-96ae-5c91b0ff7bad">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTEtNS0xLTEtNDUwODU_3d3abf3d-0611-4b4e-9689-624f384ea5b8">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTEtNy0xLTEtNDUwODU_e0c3bfd7-5ba6-40b9-acb3-038fabfb2017">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfMTU1Mw_1ce8d51a-374b-4dfe-a0da-356c57379b8a" continuedAt="i6ba5f09739a2489e8e549255d5f0c603" escape="true">The approximate percentage of net accounts receivable by type of customer was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:5pt;text-align:center"><ix:continuation id="i2d01a0640f704dab95edc758ad75075b"><ix:continuation id="i6ba5f09739a2489e8e549255d5f0c603"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2160658eb534668abfaded3ccde2376_I20220331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMi0xLTEtMS00NTA4NQ_b7970ef4-61cd-4037-ae83-ffdd470388df">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2a0ec3fce9b4f089434858787b2e801_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMi0zLTEtMS00NTA4NQ_eeb1d142-b2f7-4dea-94b2-46cc11dddba6">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2135620d30a34a64941ea2b56bd5a164_I20220331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMy0xLTEtMS00NTA4NQ_9b4d9376-ece0-4727-8b15-9117f9ea0554">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i951aac53e0e940dcb3d7a633466939f8_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMy0zLTEtMS00NTA4NQ_fabfdc74-ed01-4c10-b4eb-59904896f264">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65b4fed4ceae4b3cab7b60c00ca07f58_I20220331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNC0xLTEtMS00NTA4NQ_35e8b93f-6c1d-4f83-bc4a-170fc190e990">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0c1bc5bdc9442598a7e0cbe2845150b_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNC0zLTEtMS00NTA4NQ_7588ca9e-0eae-44fd-8848-c20c254fb624">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b80ff0f7b2446d5abc033b9fca38b60_I20220331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNS0xLTEtMS00NTA4NQ_05075c3f-9c88-4dff-bbf2-912ea2c09626">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i933ce909814a47798eadf9de833f81dd_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNS0zLTEtMS00NTA4NQ_fe7fd68a-510c-49b1-a4dc-333975c7ad7c">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e7cf4826791442d82f7d57441fce080_I20220331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNi0xLTEtMS00NTA4NQ_d3cba155-bf93-49cc-8afd-b6a9bb07fd3f">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1679f660fe4a49e7a6124528bc22afb7_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNi0zLTEtMS00NTA4NQ_d2fd6944-6e54-4573-a1cc-a5d333e0b0fd">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28c3b5952b744911ba36a0b36600e646_I20220331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNy0xLTEtMS00NTA4NQ_68fc696e-c5aa-408d-a4f5-9110ddde6324">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2ad59c542884b95abd5a3ffaad7ec7d_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNy0zLTEtMS00NTA4NQ_b3cffa0c-1057-44b3-b162-49257e003eb0">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfOC0xLTEtMS00NTA4NQ_6f7b5c79-fa0e-4f2b-9ad9-15e4442eda0b">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfOC0zLTEtMS00NTA4NQ_69132eea-ff7d-4790-b16e-e108ab298949">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition. Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s).  Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e., unit price), test mix, payer mix, and the number of tests per requisition. Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix.  Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter Highlights</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:60.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,611</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,720</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base business revenues (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,012</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,892</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$599</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$828</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,541</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,643</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.2)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$77</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$355</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$469</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.92</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.46</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$480</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$731</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Excludes COVID-19 testing.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact that the COVID-19 pandemic had on our DIS revenues, including requisition volume and revenue per requisition are discussed further below under "Impact of COVID-19" and "Results of Operations".</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further discussion of the year-over-year changes for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021, see "Results of Operations" below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID - 19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a novel strain of coronavirus (COVID-19) continues to impact the economy of the United States and other countries around the world, we are committed to being a part of the coordinated public and private sector response to this unprecedented challenge. We have made substantial investments to expand and maintain the amount of COVID-19 testing available to the country. We have been effectively managing challenges in the global supply chain; and, at this point, we have sufficient supplies to conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Due to the COVID-19 pandemic, we have experienced significant volatility, including periods of material decline compared to prior year periods in testing volume in our base business (which excludes COVID-19 testing) and periods of significant demand for COVID-19 testing services, with demand generally fluctuating in line with changes in the prevalence of the virus and related variants.  Additionally, compared to historical levels, our revenue per requisition has been positively impacted by COVID-19 molecular testing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2022, the U.S. Health Resources and Services Administration ("HRSA") informed providers that, after March 22, 2022, it would stop accepting claims for testing and treatment for uninsured individuals under the HRSA COVID-19 Uninsured Program and that claims submitted prior to that date would be subject to eligibility and availability of funds.  For the three months ended March 31, 2022, revenue for testing of uninsured individuals under the HRSA COVID-19 Uninsured Program represented approximately 12% of our COVID-19 testing revenue.  As of March&#160;31, 2022, less than 5% of our net accounts receivable was associated with claims for reimbursement for COVID-19 testing of uninsured individuals.  Although we believe that our estimates for contractual allowances and patient price concessions are appropriate, actual results could differ from those estimates. For further details on revenue and receivables, see Note 12 to the interim unaudited consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Pack Health, LLC ("Pack Health")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 1, 2022, we completed the acquisition of Pack Health, a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $123&#160;million, net of $4&#160;million cash acquired, which consisted of cash consideration of $105&#160;million and contingent consideration initially estimated at $18&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 4 to the interim unaudited consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Invigorate Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to achieve savings and productivity improvements of approximately 3% of our costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization and automation; and optimization initiatives in our lab network and patient service center network.  We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, we incurred $11&#160;million of pre-tax charges under our Invigorate program primarily consisting of systems conversion and integration costs, all of which result in cash expenditures. Additional restructuring charges may be incurred in future periods as we identify additional opportunities to achieve further savings and productivity improvements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There have been no significant changes to our critical accounting policies from those disclosed in our 2021 Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of new accounting standards, if any, is discussed in Note 2 to the interim unaudited consolidated financial statements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impact of recent accounting pronouncements not yet effective on our consolidated financial statements, if any, is also discussed in Note 2 to the interim unaudited consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables set forth certain results of operations data for the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:59.107%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share attributable to Quest Diagnostics' common stockholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.54)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not Meaningful</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended March&#160;31, 2022 were affected by certain items that on a net basis decreased diluted earnings per share by $0.30 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $27 million or $0.16 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $16 million in other (expense) income, net, or $0.10 per diluted share, representing net losses associated with changes in the carrying value of our strategic investments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $12 million ($3 million in cost of services and $9 million in selling, general and administrative expenses), or $0.07 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $2 million in selling, general and administrative, or $0.01 per diluted share, primarily representing costs associated with donations, contributions and other financial support through Quest for Health Equity (our initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities); partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $5 million, or $0.04 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, diluted earnings per share benefited from the impact of share repurchases, including under accelerated share repurchase agreements entered into in April 2021 to repurchase $1.5 billion of our common stock, on our weighted average shares outstanding as compared to the prior year period.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended March 31, 2021 were affected by certain items that on a net basis decreased diluted earnings per share by $0.30 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $29 million ($27 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes) or $0.16 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $17 million ($7 million in cost of services and $10&#160;million in selling, general and administrative expenses), or $0.10 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax non-cash impairment to the carrying value of an equity method investment of $8&#160;million, or $0.04 per diluted share, recorded in equity in earnings of equity method investees, net of taxes; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $4 million in cost of services, or $0.03 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including incremental costs incurred primarily to protect the health and safety of our employees and customers; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $4 million, or $0.03 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the three months ended March&#160;31, 2022 decreased by 4.0% compared to the prior year period. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the three months ended March&#160;31, 2022 decreased by 3.9% compared to the prior year period.  For the three months ended March&#160;31, 2022:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The decrease in revenue compared to the prior year period was driven by a decrease in COVID-19 testing, partially offset by growth in the base business (which excludes COVID-19 testing) and the impact of recent acquisitions.  For the three months ended March&#160;31, 2022, recent acquisitions contributed approximately 1.3% to DIS revenues.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 7.0% compared to the prior year period, as our base business continued to recover from the impact of the COVID-19 pandemic.  </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 1.3% compared to the prior year period driven by growth in the base business, and the impact of recent acquisitions, which contributed approximately 1.3% to DIS volume, partially offset by a decrease in COVID-19 testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) was up 6.2% compared to the prior year period due to the continued recovery from the impact of the COVID-19 pandemic.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition decreased by 5.2% compared to prior year period driven in large part by the decrease in COVID-19 molecular testing and unit price pressure of less than 1%.         </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DS revenues for the three months ended March&#160;31, 2022 decreased by 8.9% compared to the prior year period primarily due to lower revenues associated with our risk assessment services offered to the life insurance industry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.  For the three months ended March&#160;31, 2022, cost of services increased by $20 million compared to the prior year period.  The increase was primarily driven by higher compensation and benefits costs (primarily related to wage increases), higher collection expense associated with COVID-19 testing volumes that come in through non-traditional channels, and additional costs associated with our acquisitions.  These increases were partially offset by lower supplies expense associated with reduced COVID-19 testing volumes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consist principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support as well as administrative facility costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $18 million for the three months ended March&#160;31, 2022, compared to the prior year period, primarily driven by additional costs associated with investments in our strategic growth initiatives and higher compensation and benefits costs (including headcount and wage increases), partially offset by $12 million of lower costs associated with changes in the value of our deferred compensation obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in the value of our deferred compensation obligations is largely offset by changes in the value of the associated investments, which are recorded in other (expense) income, net.  For further details regarding our deferred compensation plans, see Note 17 to the audited consolidated financial statements included in our 2021 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Amortization Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, amortization expense was flat compared to the prior year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest expense, net for the three months ended March&#160;31, 2022 was primarily consistent with the prior year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other (Expense) Income, Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other (expense) income, net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, other (expense) income, net included $16&#160;million of losses associated with changes in the carrying value of our strategic investments and $8&#160;million of losses associated with investments in our deferred compensation plans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, other (expense) income, net included $4&#160;million of gains associated with investments in our deferred compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Income Tax Expense </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the three months ended March&#160;31, 2022 and 2021 was $110 million and $153 million, respectively.  The decrease in income tax expense for the three months ended March&#160;31, 2022 compared to the prior year period was primarily driven by a decrease in income before income taxes and equity in earnings of equity method investees.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes increased for the three months ended March&#160;31, 2022 by $14 million compared to the prior year period primarily due to demand for COVID-19 testing services and recovery in the base business of our diagnostic information services joint venture combined with lower equity earnings in the prior year period due to a non-cash impairment to the carrying value of an equity method investment of $8&#160;million, partially offset by $7 million of lower equity earnings in the current year period as a result of the April 2021 sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">       </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i345527f5748848cea641eb9c408bf6be_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2022 and December&#160;31, 2021, the fair value of our debt was estimated at approximately $4.1 billion and $4.4 billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of March&#160;31, 2022 and December&#160;31, 2021, the estimated fair value exceeded the carrying value of the debt by $65&#160;million and $403&#160;million, respectively.  A hypothetical 10% increase in interest rates (representing 35 basis points as of March&#160;31, 2022 and 23 basis points as of December&#160;31, 2021) would potentially reduce the estimated fair value of our debt by approximately $108&#160;million and $89&#160;million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates.  Interest on our secured receivables credit facility is based on either commercial paper rates for highly rated issuers, or London Interbank Offered Rate ("LIBOR"), plus a spread.  As of March&#160;31, 2022, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings. As such, our borrowing cost under this credit arrangement is subject to fluctuations in interest rates and changes in our public debt ratings.  As of March&#160;31, 2022, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.725% to 0.80%; and for our senior unsecured revolving credit facility, LIBOR plus 1.00%.  As of March&#160;31, 2022, there were no borrowings outstanding under either our $600&#160;million secured receivables credit facility or our $750&#160;million senior unsecured revolving credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change our annual interest expense. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt, see Note 13 to the audited consolidated financial statements included in our 2021 Annual Report on Form 10-K.  For details regarding our financial instruments and hedging activities, see Note 7 to the interim unaudited consolidated financial statements and Note 15 to the audited consolidated financial statements included in our 2021 Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in our consolidated balance sheet with changes in fair value recorded in current earnings in our consolidated statement of operations.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  We regularly evaluate equity investments that do not have readily determinable fair values to determine if there are any indicators that the investments are impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $4&#160;million as of March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  As of March&#160;31, 2022, a 10% change in the fair values of our equity investments with readily determinable fair values would have impacted our consolidated income before income taxes and equity in earnings of equity method investees by $3&#160;million.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified, as our ability to realize returns on investments depends on, among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our March&#160;31, 2022 financial statements, we considered whether the carrying values of our investments were impaired and concluded that no such impairment existed. </span></div><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments with original maturities, at the time of acquisition, of three months or less.  Cash and cash equivalents as of March&#160;31, 2022 totaled $712 million, compared to $872 million as of December&#160;31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2022, approximately 6% of our $712 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the three months ended March&#160;31, 2022 and 2021 was $480 million and $731 million, respectively.  The $251 million decrease in net cash provided by operating activities for the three months ended March&#160;31, 2022, compared to the prior year period was primarily a result of lower operating income in 2022 as compared to 2021, and the timing of movements in our working capital accounts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding ("DSO"), a measure of billing and collection efficiency, was 49 days as of March&#160;31, 2022, 48 days as of December&#160;31, 2021 and 46 days as of March&#160;31, 2021.  Recent changes in our DSO are partially due to fluctuations in our monthly revenue due to the impact of the COVID-19 pandemic.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in investing activities for the three months ended March&#160;31, 2022 and 2021 was $169 million and $93 million, respectively.  This $76 million increase in cash used in investing activities for the three months ended March&#160;31, 2022, compared to the prior year period was primarily a result of a $105 million increase in cash paid for business acquisitions, net of cash acquired, partially offset by a $23 million decrease in capital expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the three months ended March&#160;31, 2022 and 2021 was $471 million and $566 million, respectively.  This $95 million decrease in cash used in financing activities for the three months ended March&#160;31, 2022, compared to the prior year period was primarily a result of: </span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $60 million change in bank overdrafts, which are generally settled in cash the following day; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $37 million decrease in repurchases of our common stock.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During both the three months ended March&#160;31, 2022 and 2021, there were no borrowings or repayments under our secured receivables credit facility or senior unsecured revolving credit facility.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2022, our Board of Directors declared a quarterly cash dividend of $0.66 per common share.  During each of the four quarters of 2021, our Board of Directors declared a quarterly cash dividend of $0.62 per common share. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2022, our Board of Directors increased the size of our share repurchase program by $1&#160;billion.  As of March&#160;31, 2022, $1.3 billion remained available under our share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, we repurchased 2.6 million shares of our common stock for $350 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, we repurchased 3.4 million shares of our common stock for $410 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of a diagnostic information services joint venture and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is approximately 5% of our consolidated income before income taxes and equity in earnings of equity method investees.  We have no material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our March&#160;31, 2022 financial statements, we considered whether the carrying values of our equity method investments were impaired and concluded that no such impairment existed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $400&#160;million during 2022 for capital expenditures, to support and grow our existing operations, principally related to investments in information technology, laboratory equipment and facilities, including laboratory automations and footprint optimization; and in our advanced diagnostics and consumer growth strategies.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2022, we had $1.3 billion of borrowing capacity available under our existing credit facilities, including $530&#160;million available under our secured receivables credit facility and $750 million available under our senior unsecured revolving credit facility.  There were no borrowings under these credit facilities as of March&#160;31, 2022.   In support of our risk management program, $70&#160;million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2022.  The secured receivables credit facility includes a $250 million loan commitment which matures in October 2022, and a $250 million loan commitment and a $100 million letter of credit facility which mature in October 2023.  The senior unsecured revolving credit facility matures in November 2026. For further details regarding our credit facilities, see Note 13 to the audited consolidated financial statements in our 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness.  As of March&#160;31, 2022, we were in compliance with all such applicable financial covenants.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have assessed the impact of the cessation of LIBOR and have identified and evaluated financial instruments and other contracts that refer to LIBOR. Our underlying exposure to LIBOR includes our existing credit facilities (see discussion above) under which we had no outstanding borrowings as of March 31, 2022. We expect to be able to transition all LIBOR based instruments and contracts to an alternative reference rate on or before the cessation of LIBOR and we do not believe that the cessation of LIBOR, or its replacement with an alternative reference rate or rates, will have a material impact on us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities for the foreseeable future.  However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_88"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements.  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221;  These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements.  Risks and uncertainties that may affect our future results include, but are not limited to, impacts of the COVID-19 pandemic and measures taken in response, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in our most recently filed Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; &#8220;Cautionary Factors that May Affect Future Results&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of those reports.</span></div><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2022, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_97"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART II - OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i345527f5748848cea641eb9c408bf6be_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 10 to the interim unaudited consolidated financial statements for information regarding the status of legal proceedings involving the Company.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_106"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the first quarter of 2022.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.435%"><tr><td style="width:1.0%"></td><td style="width:43.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.170%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022 &#8211; January 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2022 &#8211; February 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051,997&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051,997&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,907&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022 &#8211; March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525,773&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525,773&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">In February 2022, our Board of Directors increased the size of our share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="i29b9b62572e64aaeb2ee5d852bb0ac6f_D20220201-20220201" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMDYvZnJhZzo0MDYxYTQ0OWVhN2Q0OTRmYjI1ZjJkZWNjMTc1OTlmZi90ZXh0cmVnaW9uOjQwNjFhNDQ5ZWE3ZDQ5NGZiMjVmMmRlY2MxNzU5OWZmXzE2NDkyNjc0NDM3MjQ_0eabb765-1a4e-4609-9600-0b893ee275b4">1</ix:nonFraction>&#160;billion.  Since the share repurchase program&#8217;s inception in May 2003, our Board of Directors has authorized $12 billion of share repurchases of our common stock through March&#160;31, 2022.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company&#8217;s Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted stock units and performance share units.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Exhibits </span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibits:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312022ex22.htm">Subsidiary Guarantors</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312022ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312022ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312022ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312022ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document  - dgx-20220331.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20220331_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20220331_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20220331_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20220331_pre.xml</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i345527f5748848cea641eb9c408bf6be_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i345527f5748848cea641eb9c408bf6be_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;22, 2022 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.087%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div id="i345527f5748848cea641eb9c408bf6be_115"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>2
<FILENAME>dgx03312022ex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iffc0270b4c354f498c83f67e0a8f811c_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit 22</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Subsidiary Guarantors of Securities</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of April&#160;22, 2022, the following subsidiaries of Quest Diagnostics Incorporated provided, subject to the terms of such senior notes, unconditional and irrevocable guarantees to the senior notes listed below that were issued by Quest Diagnostics Incorporated pursuant to an offering registered under the Securities Act of 1933, as amended&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:27.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Securities</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuer</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsidiary Guarantor</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Organization</font></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="29" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.95% Senior Notes due 2037</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.75% Senior Notes due 2040</font></div></td><td colspan="3" rowspan="29" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">American Medical Laboratories, Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Consolidated Labs, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Hospital Services Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Kentucky, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kentucky</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath New York, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Texas, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Athena Diagnostics, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Pathology Services, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oklahoma</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pennsylvania</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide of NJ, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New Jersey</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kailash B. Sharma, M.D., Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Missouri</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne of Ohio, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ocmulgee Medical Pathology Association, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Clinical Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Holdings Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nevada</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Investments LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Connecticut</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illinois</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Massachusetts</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Virginia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics of Pennsylvania Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Specialty Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unilab Corporation</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>dgx03312022ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1214fcecaf7f429c87d6aea20448a37b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen H. Rusckowski, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;22, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.134%"><tr><td style="width:1.0%"></td><td style="width:11.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>dgx03312022ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icee81d64953b44ecb7c6b9c8fb565f3a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark J. Guinan, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;22, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.140%"><tr><td style="width:1.0%"></td><td style="width:14.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>dgx03312022ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1aadbc2655b54ab2a48a2260dfca70f1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended March&#160;31, 2022 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 22, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>dgx03312022ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iafcbd571030047f88811113a14135ee4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended March&#160;31, 2022 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 22, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>dgx-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c431f6d8-b8fc-477a-8446-6094ac02b3b7,g:484b9920-d5d4-4a3b-8e7d-6a5d9f5837a8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20220331" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>2104103 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables">
        <link:definition>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails">
        <link:definition>2406401 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>2107104 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2109105 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2310302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2411403 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2412404 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails">
        <link:definition>2413405 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails">
        <link:definition>2414406 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2115106 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSGoodwillDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
        <link:definition>2417407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSSchedulesDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
        <link:definition>2418408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2119107 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>2421409 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2122108 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
        <link:definition>2423410 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA">
        <link:definition>2124109 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables">
        <link:definition>2325305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails">
        <link:definition>2426411 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
        <link:definition>2427412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2128110 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2429413 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>2130111 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2331306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>2432414 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION">
        <link:definition>2133112 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables">
        <link:definition>2334307 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2435415 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAmountAuthorized" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" abstract="true" name="PackHealthLLCAndLabtechDiagnosticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" abstract="false" name="ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataTable" abstract="true" name="SupplementalCashFlowAndOtherDataTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" abstract="false" name="EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AmendedRealEstateLeaseMember" abstract="true" name="AmendedRealEstateLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DescriptionOfBusinessAbstract" abstract="true" name="DescriptionOfBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataLineItems" abstract="true" name="SupplementalCashFlowAndOtherDataLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_TriggeringEventAxis" abstract="true" name="TriggeringEventAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_PackHealthLLCMember" abstract="true" name="PackHealthLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_Mergerconsiderationpaidpayablenet" abstract="false" name="Mergerconsiderationpaidpayablenet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" abstract="false" name="ScheduleOfRevenuesByMajorServiceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" abstract="true" name="ExcludesgeneralandprofessionalliabilityclaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LabtechDiagnosticsLLCMember" abstract="true" name="LabtechDiagnosticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TriggeringEventDomain" abstract="true" name="TriggeringEventDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_PatientsMember" abstract="true" name="PatientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TotalAmortizingIntangibleAssetsMember" abstract="true" name="TotalAmortizingIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_RoutineClinicalTestingAndOtherServicesMember" abstract="true" name="RoutineClinicalTestingAndOtherServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" abstract="true" name="MeasurementInputComparableCompanyRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>dgx-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c431f6d8-b8fc-477a-8446-6094ac02b3b7,g:484b9920-d5d4-4a3b-8e7d-6a5d9f5837a8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9a6653db-eb65-456e-a40f-5aac05ad3fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_2fa01180-6dd0-4294-aee5-fc4389cae997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a6653db-eb65-456e-a40f-5aac05ad3fcd" xlink:to="loc_us-gaap_CostsAndExpenses_2fa01180-6dd0-4294-aee5-fc4389cae997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77ea6039-b137-4b9e-8372-2caffd2fecae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a6653db-eb65-456e-a40f-5aac05ad3fcd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77ea6039-b137-4b9e-8372-2caffd2fecae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f2af2f3a-b16f-4d51-9eec-aebe81560a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a75be0ae-8ac0-45e6-beec-9be596b06ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f2af2f3a-b16f-4d51-9eec-aebe81560a8c" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a75be0ae-8ac0-45e6-beec-9be596b06ae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_40e7bc73-3af9-46f2-8d18-c09e673370c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f2af2f3a-b16f-4d51-9eec-aebe81560a8c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_40e7bc73-3af9-46f2-8d18-c09e673370c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ad4a5b4e-65d6-4414-a710-a73917f06afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7f71f804-b729-49a2-88a0-ebbd541965cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ad4a5b4e-65d6-4414-a710-a73917f06afc" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7f71f804-b729-49a2-88a0-ebbd541965cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_897174d5-2bbb-46b2-9de0-e58bb265e733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ad4a5b4e-65d6-4414-a710-a73917f06afc" xlink:to="loc_us-gaap_OperatingIncomeLoss_897174d5-2bbb-46b2-9de0-e58bb265e733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c5299917-7675-4997-8c35-84d987b466a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_133d31da-868f-4b22-ba9b-95bae23425de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c5299917-7675-4997-8c35-84d987b466a3" xlink:to="loc_us-gaap_ProfitLoss_133d31da-868f-4b22-ba9b-95bae23425de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_884e990b-c2fe-45ff-8d82-9cfd18a24075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c5299917-7675-4997-8c35-84d987b466a3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_884e990b-c2fe-45ff-8d82-9cfd18a24075" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ca755d6-d10f-4174-affd-3e614accdabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_20d5f84d-79bc-4ac7-b8fe-8669de4a0802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6ca755d6-d10f-4174-affd-3e614accdabf" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_20d5f84d-79bc-4ac7-b8fe-8669de4a0802" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a421271a-dece-4494-a8f4-e14f1f434ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6ca755d6-d10f-4174-affd-3e614accdabf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a421271a-dece-4494-a8f4-e14f1f434ce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8ed5d414-bf21-4a3b-8f97-4c73bece6647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6ca755d6-d10f-4174-affd-3e614accdabf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8ed5d414-bf21-4a3b-8f97-4c73bece6647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_2744cfb1-360b-4278-b52c-d35473597c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_024bfa3a-81d9-4a6d-9c6e-d3bc21951c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2744cfb1-360b-4278-b52c-d35473597c02" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_024bfa3a-81d9-4a6d-9c6e-d3bc21951c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_4265006d-5493-4ba7-93c0-807cd73d7ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2744cfb1-360b-4278-b52c-d35473597c02" xlink:to="loc_us-gaap_CostOfRevenue_4265006d-5493-4ba7-93c0-807cd73d7ef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e94e5a00-2e32-4c9a-879f-508fe26fe480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2744cfb1-360b-4278-b52c-d35473597c02" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e94e5a00-2e32-4c9a-879f-508fe26fe480" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c0a4e447-5ebd-4026-8649-14257c6bcbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5598211-750d-400e-a2bc-0bb230f14765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c0a4e447-5ebd-4026-8649-14257c6bcbb9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5598211-750d-400e-a2bc-0bb230f14765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1ca05b79-28b7-4c4a-893b-229291d4886b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c0a4e447-5ebd-4026-8649-14257c6bcbb9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1ca05b79-28b7-4c4a-893b-229291d4886b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42fa6686-2a33-417d-a0c4-a480099ca532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2bf186ad-7f39-4c1d-ab8f-a011e9c53e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42fa6686-2a33-417d-a0c4-a480099ca532" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2bf186ad-7f39-4c1d-ab8f-a011e9c53e60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2f03c0e2-8e41-4100-81f4-2c0f9e6aa5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42fa6686-2a33-417d-a0c4-a480099ca532" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2f03c0e2-8e41-4100-81f4-2c0f9e6aa5e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1378a6c-33ea-485d-b202-8d42bf665e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf45bb10-2fdc-424d-b9e0-51ee84aab024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1378a6c-33ea-485d-b202-8d42bf665e59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf45bb10-2fdc-424d-b9e0-51ee84aab024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_813c012a-7c96-4c97-96a9-d717b301e2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1378a6c-33ea-485d-b202-8d42bf665e59" xlink:to="loc_us-gaap_ProfitLoss_813c012a-7c96-4c97-96a9-d717b301e2b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f53a615a-1196-4a65-a7f8-0fb8fe670730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_18bf5a73-17f8-4a08-af59-d2b550a5677d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f53a615a-1196-4a65-a7f8-0fb8fe670730" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_18bf5a73-17f8-4a08-af59-d2b550a5677d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c025f566-c4c0-441c-acd6-1917a0e32e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f53a615a-1196-4a65-a7f8-0fb8fe670730" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c025f566-c4c0-441c-acd6-1917a0e32e07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_35e246b4-09b9-4b8b-a200-191ba0e72c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f53a615a-1196-4a65-a7f8-0fb8fe670730" xlink:to="loc_us-gaap_LongTermDebtCurrent_35e246b4-09b9-4b8b-a200-191ba0e72c26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8db069e7-a8eb-421d-9d8b-f3ec9cdad7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:to="loc_us-gaap_LiabilitiesCurrent_8db069e7-a8eb-421d-9d8b-f3ec9cdad7c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b8507f1e-a7a8-49bc-a3e3-5a74ff145c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b8507f1e-a7a8-49bc-a3e3-5a74ff145c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_846e3a28-fd7a-415a-8a21-4f58111ce6de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_846e3a28-fd7a-415a-8a21-4f58111ce6de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cb62061a-3f46-43ad-bbcf-74fed39543d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cb62061a-3f46-43ad-bbcf-74fed39543d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_fc1c5fc8-5704-4e61-bd98-3e2bf3fbe5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_fc1c5fc8-5704-4e61-bd98-3e2bf3fbe5e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ec2e63d1-938d-433e-ad01-7d86599b8cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ec2e63d1-938d-433e-ad01-7d86599b8cc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3e2498b4-2959-4e7c-894d-0b43f74be838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ee1a20b-0276-40b3-886f-a09c3fa2e816" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3e2498b4-2959-4e7c-894d-0b43f74be838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_acbc3a0d-645a-40a6-863c-ca5a0e817e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:to="loc_us-gaap_AssetsCurrent_acbc3a0d-645a-40a6-863c-ca5a0e817e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5312ec9b-8fb1-462b-a599-667723b3b228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5312ec9b-8fb1-462b-a599-667723b3b228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9fb5ebef-8dc2-4cc4-9cf2-6d6788999f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9fb5ebef-8dc2-4cc4-9cf2-6d6788999f39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ada7b980-bd85-4d91-bce9-abb4f0518e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:to="loc_us-gaap_Goodwill_ada7b980-bd85-4d91-bce9-abb4f0518e22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7f56ce7c-fb3d-45d6-a569-d3e9c3698dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7f56ce7c-fb3d-45d6-a569-d3e9c3698dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_9858bebf-81e4-4c30-a61e-12fa14fc693f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:to="loc_us-gaap_EquityMethodInvestments_9858bebf-81e4-4c30-a61e-12fa14fc693f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_89c56b23-8274-445b-b5cb-ac52b19f3532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9c0ee739-652f-4cda-892b-fcc02bad8419" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_89c56b23-8274-445b-b5cb-ac52b19f3532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7cbebc15-c248-49e5-a94f-c942a0b98cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4d570bb-5c39-40a2-8b01-dc41221bbbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7cbebc15-c248-49e5-a94f-c942a0b98cb2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4d570bb-5c39-40a2-8b01-dc41221bbbb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_15d06cb0-e488-4ccd-870a-e0a1d122b4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7cbebc15-c248-49e5-a94f-c942a0b98cb2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_15d06cb0-e488-4ccd-870a-e0a1d122b4a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_19cc59aa-d111-49df-8d35-73292b52de92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7cbebc15-c248-49e5-a94f-c942a0b98cb2" xlink:to="loc_us-gaap_InventoryNet_19cc59aa-d111-49df-8d35-73292b52de92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ade837a0-56f1-4694-bb9b-360d1aeacf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7cbebc15-c248-49e5-a94f-c942a0b98cb2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ade837a0-56f1-4694-bb9b-360d1aeacf9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3918784a-69f7-4548-a0fe-dc20837eb75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3a78216c-8e6a-44bc-9152-2362895153a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3918784a-69f7-4548-a0fe-dc20837eb75b" xlink:to="loc_us-gaap_StockholdersEquity_3a78216c-8e6a-44bc-9152-2362895153a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ab451e9e-013f-4b9a-9a1e-9de8fc784fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3918784a-69f7-4548-a0fe-dc20837eb75b" xlink:to="loc_us-gaap_MinorityInterest_ab451e9e-013f-4b9a-9a1e-9de8fc784fa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_728ec965-9f40-4c3d-a3f8-3630037b065f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_353431b0-be37-4dc6-8467-1613e484477d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_728ec965-9f40-4c3d-a3f8-3630037b065f" xlink:to="loc_us-gaap_CommonStockValue_353431b0-be37-4dc6-8467-1613e484477d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6572305a-e1f0-4a89-bd81-1ecbeb2f8f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_728ec965-9f40-4c3d-a3f8-3630037b065f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6572305a-e1f0-4a89-bd81-1ecbeb2f8f5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9023dc76-9515-4611-a8a8-591fd620d358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_728ec965-9f40-4c3d-a3f8-3630037b065f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9023dc76-9515-4611-a8a8-591fd620d358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf2aa4cc-b4a4-4a5f-837e-8a54cd5a6db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_728ec965-9f40-4c3d-a3f8-3630037b065f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf2aa4cc-b4a4-4a5f-837e-8a54cd5a6db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_781cc67c-5990-46f1-a5c6-7dac702de2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_728ec965-9f40-4c3d-a3f8-3630037b065f" xlink:to="loc_us-gaap_TreasuryStockValue_781cc67c-5990-46f1-a5c6-7dac702de2a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8f840234-1119-45d7-b7bf-41dd4278a6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c064ab73-43b5-4ecb-9457-38371c1a73c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8f840234-1119-45d7-b7bf-41dd4278a6f2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c064ab73-43b5-4ecb-9457-38371c1a73c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4114a678-1c9d-48b1-8d27-e4f5f4b2b695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8f840234-1119-45d7-b7bf-41dd4278a6f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4114a678-1c9d-48b1-8d27-e4f5f4b2b695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8caeed96-3a7c-4dc9-a56d-a2734770d0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8f840234-1119-45d7-b7bf-41dd4278a6f2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8caeed96-3a7c-4dc9-a56d-a2734770d0e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_7bf51f58-b50b-434f-865f-8ad48aac7a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:to="loc_us-gaap_RepaymentsOfDebt_7bf51f58-b50b-434f-865f-8ad48aac7a05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_98fd0dd8-8dd0-44fe-93c0-4ae5230b85e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_98fd0dd8-8dd0-44fe-93c0-4ae5230b85e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ff55ff42-b776-4642-9360-03dc0d82d4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ff55ff42-b776-4642-9360-03dc0d82d4d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5fbb0fd7-234e-4fcd-a717-ab8133367eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5fbb0fd7-234e-4fcd-a717-ab8133367eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_cd481948-99cd-4f61-9a9f-d4a6608b958a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_cd481948-99cd-4f61-9a9f-d4a6608b958a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_c8cefbcb-85c1-48a4-a1bd-801de9b0380a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_c8cefbcb-85c1-48a4-a1bd-801de9b0380a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5a3de22d-da09-4f29-9d85-9d3be53872e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb2830a4-3aeb-4d0a-b1fe-5973f0d60420" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5a3de22d-da09-4f29-9d85-9d3be53872e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1f896d7-47ce-4f35-ae5b-3869e955f8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34b9fccb-a830-4212-8089-86d4349bb197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1f896d7-47ce-4f35-ae5b-3869e955f8b0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34b9fccb-a830-4212-8089-86d4349bb197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c3299eee-7bdb-41e2-a14d-38a0db8bda62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1f896d7-47ce-4f35-ae5b-3869e955f8b0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c3299eee-7bdb-41e2-a14d-38a0db8bda62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecc00c6d-3e48-45ff-8c99-3684d55d66e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1f896d7-47ce-4f35-ae5b-3869e955f8b0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecc00c6d-3e48-45ff-8c99-3684d55d66e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_005af441-87fa-47d2-9fda-390336b5f796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_ProfitLoss_005af441-87fa-47d2-9fda-390336b5f796" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_866fec59-20e8-44f7-a59f-adeb43081d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_866fec59-20e8-44f7-a59f-adeb43081d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_b5f10f08-a351-4585-9f56-36fc561dfbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_b5f10f08-a351-4585-9f56-36fc561dfbf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fba17d45-406b-41fc-8e7e-81b5f586d552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fba17d45-406b-41fc-8e7e-81b5f586d552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ce504395-87da-4a18-9544-9ae9fc7e9d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_ShareBasedCompensation_ce504395-87da-4a18-9544-9ae9fc7e9d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_efba3223-a3f6-4322-a7c6-464260b38b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_efba3223-a3f6-4322-a7c6-464260b38b7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c5efd15f-8ee1-4eb1-a3ba-dc113388e77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c5efd15f-8ee1-4eb1-a3ba-dc113388e77f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6664dede-562b-4d03-90b4-65c0a56aa54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6664dede-562b-4d03-90b4-65c0a56aa54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_13c3e8a3-5111-40f0-a6b6-fad6f2deec82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_13c3e8a3-5111-40f0-a6b6-fad6f2deec82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_483e1252-cd30-445f-8850-c88f83f1134c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21db3168-ed84-4f7b-9712-c6de6dd662a6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_483e1252-cd30-445f-8850-c88f83f1134c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f93f9c92-8fe3-48df-b0f2-14f9aadfaee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_130620a2-0620-4d5a-aafe-e0a47214c6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f93f9c92-8fe3-48df-b0f2-14f9aadfaee9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_130620a2-0620-4d5a-aafe-e0a47214c6d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_41286586-8481-440d-83b5-67ce1165689b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f93f9c92-8fe3-48df-b0f2-14f9aadfaee9" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_41286586-8481-440d-83b5-67ce1165689b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_e06e50d1-ee70-4318-94a6-f1e1e05be61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9704e551-8d1f-4fd5-b950-3f5be1e8c619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_e06e50d1-ee70-4318-94a6-f1e1e05be61b" xlink:to="loc_us-gaap_NetIncomeLoss_9704e551-8d1f-4fd5-b950-3f5be1e8c619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_a9efdcb6-2969-4441-bde4-e9ffffd9e261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_e06e50d1-ee70-4318-94a6-f1e1e05be61b" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_a9efdcb6-2969-4441-bde4-e9ffffd9e261" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_db87e581-cfa2-4ba2-ac59-bd0cc1b21eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_2d980ded-cc38-4f04-8b99-6c83ddb9b259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_db87e581-cfa2-4ba2-ac59-bd0cc1b21eba" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_2d980ded-cc38-4f04-8b99-6c83ddb9b259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_73ced4ff-c241-416f-a933-43ca1254625a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_db87e581-cfa2-4ba2-ac59-bd0cc1b21eba" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_73ced4ff-c241-416f-a933-43ca1254625a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3904f5e2-3e2b-4574-87ba-5a5dc10353bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_d313ef74-a4b9-468e-939a-f2a8e60b97e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_3904f5e2-3e2b-4574-87ba-5a5dc10353bc" xlink:to="loc_us-gaap_TradingSecurities_d313ef74-a4b9-468e-939a-f2a8e60b97e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_715e29ea-c28c-423c-8f7b-d64d713854d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_3904f5e2-3e2b-4574-87ba-5a5dc10353bc" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_715e29ea-c28c-423c-8f7b-d64d713854d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_e0610c9d-827c-40c7-91f7-68e6e6d2bf60" xlink:href="dgx-20220331.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_3904f5e2-3e2b-4574-87ba-5a5dc10353bc" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_e0610c9d-827c-40c7-91f7-68e6e6d2bf60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_497ea57f-fc41-4c06-adfe-acabb1535404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_3904f5e2-3e2b-4574-87ba-5a5dc10353bc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_497ea57f-fc41-4c06-adfe-acabb1535404" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c4e02f17-a5ae-4458-91eb-8a0ec970edeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c4e02f17-a5ae-4458-91eb-8a0ec970edeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4ae534c9-d19e-486c-b219-52a32dc23a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4ae534c9-d19e-486c-b219-52a32dc23a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b0d24e51-1871-4c9e-866e-581e8b5b1dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b0d24e51-1871-4c9e-866e-581e8b5b1dcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f731d6ec-3e5f-4a44-8548-7703427624c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f731d6ec-3e5f-4a44-8548-7703427624c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_e335f694-9194-4f90-80b9-e48d0aa3ed34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_e335f694-9194-4f90-80b9-e48d0aa3ed34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_11c9dc1f-85a4-4843-8958-59aa6007518a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_11c9dc1f-85a4-4843-8958-59aa6007518a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_bed6c796-8fb6-4939-a97e-6155c35be500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f11a71a8-542f-4502-9578-9d350884965e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_bed6c796-8fb6-4939-a97e-6155c35be500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c418b975-4e47-4bc6-bf4d-ed14b375ead0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_95f306c4-2edb-4c6e-b289-d620cc7ad3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c418b975-4e47-4bc6-bf4d-ed14b375ead0" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_95f306c4-2edb-4c6e-b289-d620cc7ad3dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3ba97315-fc4f-4510-a2e9-d1a387a355c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c418b975-4e47-4bc6-bf4d-ed14b375ead0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3ba97315-fc4f-4510-a2e9-d1a387a355c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_fd87c12c-27a3-4b19-9df7-17610ac6ffc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_fb15fd5c-c274-4e47-a249-26360d228a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_fd87c12c-27a3-4b19-9df7-17610ac6ffc2" xlink:to="loc_us-gaap_InterestExpense_fb15fd5c-c274-4e47-a249-26360d228a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_bf1ee971-cd64-4a7c-8bca-057ef40e3487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_fd87c12c-27a3-4b19-9df7-17610ac6ffc2" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_bf1ee971-cd64-4a7c-8bca-057ef40e3487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_cf6367d0-dbfe-46a1-bd28-faa43264fe07" xlink:href="dgx-20220331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_2c9de352-1de0-4007-8771-319eadc5ef6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_cf6367d0-dbfe-46a1-bd28-faa43264fe07" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_2c9de352-1de0-4007-8771-319eadc5ef6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_669da012-ae66-4035-9d0a-5db67a0bc00c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_cf6367d0-dbfe-46a1-bd28-faa43264fe07" xlink:to="loc_us-gaap_LiabilitiesAssumed1_669da012-ae66-4035-9d0a-5db67a0bc00c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_caa0c1d6-fff2-4e57-b8a3-a9c8471c60b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1b5f51ea-efc8-4a43-90ff-ffd4de1967b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_caa0c1d6-fff2-4e57-b8a3-a9c8471c60b4" xlink:to="loc_us-gaap_Depreciation_1b5f51ea-efc8-4a43-90ff-ffd4de1967b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ce6907af-3036-49ad-a9e1-41138045b807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_caa0c1d6-fff2-4e57-b8a3-a9c8471c60b4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ce6907af-3036-49ad-a9e1-41138045b807" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>dgx-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c431f6d8-b8fc-477a-8446-6094ac02b3b7,g:484b9920-d5d4-4a3b-8e7d-6a5d9f5837a8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="idd10ed3dd6b148c8b75730ea85d5fa9f_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6ee5f5a2-98d7-497b-91e7-42a69522d5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6ee5f5a2-98d7-497b-91e7-42a69522d5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1182375c-3481-4743-893d-ac175a05ebf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1182375c-3481-4743-893d-ac175a05ebf1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_2531ffab-3d8e-4a9e-9afe-ccf2021b7d57" xlink:href="dgx-20220331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_2531ffab-3d8e-4a9e-9afe-ccf2021b7d57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2bb0ca09-d2f0-4b53-8454-ed4c96464fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2bb0ca09-d2f0-4b53-8454-ed4c96464fcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_89b2e1d7-f22b-4287-8cc6-4b68d592ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_DividendsCommonStockCash_89b2e1d7-f22b-4287-8cc6-4b68d592ee84" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_af97930f-ea2a-4ef5-8f95-6ac367f70e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_af97930f-ea2a-4ef5-8f95-6ac367f70e85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_92e4cc1c-3b41-4292-b5ce-815de2e001ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_92e4cc1c-3b41-4292-b5ce-815de2e001ec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_416f97f2-022a-4b1d-bd21-a1ba49dfe531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_416f97f2-022a-4b1d-bd21-a1ba49dfe531" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_215e9d20-7d7b-48a7-8a8d-803d166fd7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_215e9d20-7d7b-48a7-8a8d-803d166fd7a6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ea03c05-3919-490d-888b-de6dd19331f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ea03c05-3919-490d-888b-de6dd19331f9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ac31a521-9384-41f3-bcc8-72baffebb732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ac31a521-9384-41f3-bcc8-72baffebb732" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_395b4ea6-2774-4501-a1a4-6800a49f2a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_395b4ea6-2774-4501-a1a4-6800a49f2a43" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8b908e95-7805-4e50-b6cb-307e3dbb3390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8b908e95-7805-4e50-b6cb-307e3dbb3390" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d89aded8-ecc2-4e94-831e-bbcff2312178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d89aded8-ecc2-4e94-831e-bbcff2312178" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b19cf682-3019-44c6-a99e-f7039f0dbafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c0e2628c-29b2-437f-9e2b-520325ccb361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_ac1320f5-4301-4464-aae8-b11b336ec10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_ac1320f5-4301-4464-aae8-b11b336ec10f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_2c3509e3-27a1-4a28-bcf5-08133001e056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_2c3509e3-27a1-4a28-bcf5-08133001e056" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_549919e4-55c0-43ef-8676-c51d1abac88d" xlink:href="dgx-20220331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_549919e4-55c0-43ef-8676-c51d1abac88d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_34fefa79-ff4d-4bfb-9b9a-dc927f2d0e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d3897c9b-e9b8-49b8-8897-f4c756db4e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:to="loc_us-gaap_StatementTable_d3897c9b-e9b8-49b8-8897-f4c756db4e5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fe65ce61-99a1-4150-9b9b-2ce934212fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d3897c9b-e9b8-49b8-8897-f4c756db4e5c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fe65ce61-99a1-4150-9b9b-2ce934212fc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fe65ce61-99a1-4150-9b9b-2ce934212fc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fe65ce61-99a1-4150-9b9b-2ce934212fc2" xlink:to="loc_us-gaap_EquityComponentDomain_fe65ce61-99a1-4150-9b9b-2ce934212fc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fe65ce61-99a1-4150-9b9b-2ce934212fc2" xlink:to="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ed7bb2c3-0b71-40b9-8ff1-80610f1a1a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_CommonStockMember_ed7bb2c3-0b71-40b9-8ff1-80610f1a1a6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bf583b88-3c32-4a01-aacb-b6ecb92209f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bf583b88-3c32-4a01-aacb-b6ecb92209f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9bd14d9a-81ae-46b2-aceb-c107dd2e5665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_RetainedEarningsMember_9bd14d9a-81ae-46b2-aceb-c107dd2e5665" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f066383f-021b-42c1-9224-136c9766060c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f066383f-021b-42c1-9224-136c9766060c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c77ddfcf-5e22-48d8-af43-7a68b9679b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_TreasuryStockMember_c77ddfcf-5e22-48d8-af43-7a68b9679b62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b1d7133d-a2a8-4594-85b9-5ac5c2068eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b1d7133d-a2a8-4594-85b9-5ac5c2068eff" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="i71e2fdc933e349d0b83edfe413cad1fa_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5dfb2d04-31fc-4ac6-9598-0eb16ad7791b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5dfb2d04-31fc-4ac6-9598-0eb16ad7791b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_3d97bdc4-7754-4122-b64b-746e0df94546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_3d97bdc4-7754-4122-b64b-746e0df94546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_00177627-1fb2-40fa-9b43-a3a94d7ba3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_00177627-1fb2-40fa-9b43-a3a94d7ba3f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30d25146-7cc8-4d25-ae42-236d43c3e888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30d25146-7cc8-4d25-ae42-236d43c3e888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7ac9805b-c63d-49e7-b6c8-e3355b70b79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_Goodwill_7ac9805b-c63d-49e7-b6c8-e3355b70b79d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_60238a9a-f6bd-40fe-b556-7ed9689959c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_60238a9a-f6bd-40fe-b556-7ed9689959c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02c639ab-39a2-43c2-93f3-91ba08c55a14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02c639ab-39a2-43c2-93f3-91ba08c55a14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a33880fa-b028-4e2f-8b46-f57d0c48675d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a33880fa-b028-4e2f-8b46-f57d0c48675d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_46d32c55-2ec3-4d5c-81fa-194fc9efc9be" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_46d32c55-2ec3-4d5c-81fa-194fc9efc9be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_7a8a8736-c987-449a-9f1d-2890283d2454" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_7a8a8736-c987-449a-9f1d-2890283d2454" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_feef624b-5f1e-4c0b-a7f3-599229ba75c1" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_feef624b-5f1e-4c0b-a7f3-599229ba75c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_06e8063d-a896-41e2-bf38-bcb1a45f9d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_06e8063d-a896-41e2-bf38-bcb1a45f9d31" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_f6bdf21d-6869-4a32-bb45-a6d2395c52bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_f6bdf21d-6869-4a32-bb45-a6d2395c52bb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_68e916c8-238f-49a2-a0c8-3dcced92fa44" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_68e916c8-238f-49a2-a0c8-3dcced92fa44" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember_91181102-139d-4d6e-95f9-b898774e8aee" xlink:href="dgx-20220331.xsd#dgx_PackHealthLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:to="loc_dgx_PackHealthLLCMember_91181102-139d-4d6e-95f9-b898774e8aee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_3f984d22-a713-40cb-ab62-71610cb2d9af" xlink:href="dgx-20220331.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_3f984d22-a713-40cb-ab62-71610cb2d9af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1576d1a0-c43f-4523-8176-0b7c8eb31b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1576d1a0-c43f-4523-8176-0b7c8eb31b10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1576d1a0-c43f-4523-8176-0b7c8eb31b10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1576d1a0-c43f-4523-8176-0b7c8eb31b10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1576d1a0-c43f-4523-8176-0b7c8eb31b10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c855ae5-b2fb-4290-9cb9-41d6a1a71023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1576d1a0-c43f-4523-8176-0b7c8eb31b10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c855ae5-b2fb-4290-9cb9-41d6a1a71023" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f0e6801c-50b4-498c-abee-50769b4fccd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c855ae5-b2fb-4290-9cb9-41d6a1a71023" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f0e6801c-50b4-498c-abee-50769b4fccd9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i4e2f736aad5d49f597a6dac65605386e_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_9f873afd-65c6-44b7-9ff8-6d646bc1b407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_TradingSecurities_9f873afd-65c6-44b7-9ff8-6d646bc1b407" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_16e57505-0485-4de6-8218-647bd12ed348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_16e57505-0485-4de6-8218-647bd12ed348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_8ce6ad51-87ec-413f-bedf-30ca4d52218c" xlink:href="dgx-20220331.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_8ce6ad51-87ec-413f-bedf-30ca4d52218c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9ef6c6ad-3306-48f2-95a1-734a78388984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9ef6c6ad-3306-48f2-95a1-734a78388984" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1ca91096-f0bb-4414-9017-e2929e51c59b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1ca91096-f0bb-4414-9017-e2929e51c59b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1e03629e-0786-4aba-969d-50c3cfc8272d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1e03629e-0786-4aba-969d-50c3cfc8272d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fb810f88-6f62-48f8-89c3-abb12ad7b95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fb810f88-6f62-48f8-89c3-abb12ad7b95f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_a2b458eb-7403-49eb-afe7-70f6d7b0303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_a2b458eb-7403-49eb-afe7-70f6d7b0303b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_7e4d3567-dea7-4922-96a3-93f785b49d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_7e4d3567-dea7-4922-96a3-93f785b49d64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bf0cf66-8a79-4b78-beb1-c7e0e53243c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bf0cf66-8a79-4b78-beb1-c7e0e53243c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6ed15e33-6921-499f-9f3c-6e31d339c38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bf0cf66-8a79-4b78-beb1-c7e0e53243c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6ed15e33-6921-499f-9f3c-6e31d339c38d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_102a309f-0d4f-420b-aab9-8c3c74fa8f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_102a309f-0d4f-420b-aab9-8c3c74fa8f83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_102a309f-0d4f-420b-aab9-8c3c74fa8f83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_102a309f-0d4f-420b-aab9-8c3c74fa8f83" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_102a309f-0d4f-420b-aab9-8c3c74fa8f83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_102a309f-0d4f-420b-aab9-8c3c74fa8f83" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_90a8ce1a-f89f-44d2-92e1-8092195f842b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_90a8ce1a-f89f-44d2-92e1-8092195f842b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_57b95af9-e94b-443e-8aef-a8ce6cce4e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_57b95af9-e94b-443e-8aef-a8ce6cce4e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_06d94262-196b-46ce-8a63-a42693b3effd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_06d94262-196b-46ce-8a63-a42693b3effd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="ic3e51e3efe394a76857a0f515bd732f5_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9eaf9258-3ce1-49d3-9a41-3b49c935db72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9eaf9258-3ce1-49d3-9a41-3b49c935db72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3f86357f-7384-4df3-a20c-0a239101198e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3f86357f-7384-4df3-a20c-0a239101198e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e7d40610-0806-44f6-a853-83bf1874cda9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:to="loc_srt_OwnershipAxis_e7d40610-0806-44f6-a853-83bf1874cda9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e7d40610-0806-44f6-a853-83bf1874cda9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_e7d40610-0806-44f6-a853-83bf1874cda9" xlink:to="loc_srt_OwnershipDomain_e7d40610-0806-44f6-a853-83bf1874cda9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_fd14af3c-3585-4f85-a053-4d5764aff82e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_e7d40610-0806-44f6-a853-83bf1874cda9" xlink:to="loc_srt_OwnershipDomain_fd14af3c-3585-4f85-a053-4d5764aff82e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_475c39c3-2d57-4677-adc8-08fe48b22389" xlink:href="dgx-20220331.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_fd14af3c-3585-4f85-a053-4d5764aff82e" xlink:to="loc_dgx_UMassJointVentureMember_475c39c3-2d57-4677-adc8-08fe48b22389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c5c49ac5-e532-4270-9a15-6d09faba205b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c5c49ac5-e532-4270-9a15-6d09faba205b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c5c49ac5-e532-4270-9a15-6d09faba205b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c5c49ac5-e532-4270-9a15-6d09faba205b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c5c49ac5-e532-4270-9a15-6d09faba205b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abcfa4e-36a5-4104-8428-09718aedbc88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c5c49ac5-e532-4270-9a15-6d09faba205b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abcfa4e-36a5-4104-8428-09718aedbc88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_823df78e-17f3-4c26-b6bf-8db3a6a96994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abcfa4e-36a5-4104-8428-09718aedbc88" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_823df78e-17f3-4c26-b6bf-8db3a6a96994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8f1a760b-ae30-4072-b19b-b8842805d96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8f1a760b-ae30-4072-b19b-b8842805d96e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_80160045-9a67-4856-aff0-0d707bed94a6" xlink:href="dgx-20220331.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8f1a760b-ae30-4072-b19b-b8842805d96e" xlink:to="loc_dgx_ContingentConsiderationMember_80160045-9a67-4856-aff0-0d707bed94a6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="extended" id="i033594b4a4404bd6a93e598206f36947_FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_98d80cd6-da61-4e96-a54a-f1533f9d8a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_98d80cd6-da61-4e96-a54a-f1533f9d8a00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a6521c09-7637-4e80-bd2a-de5e9e8c2533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a6521c09-7637-4e80-bd2a-de5e9e8c2533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_064f57b5-6a04-4dd9-aaad-4b13d4c62d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_064f57b5-6a04-4dd9-aaad-4b13d4c62d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_064f57b5-6a04-4dd9-aaad-4b13d4c62d35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_064f57b5-6a04-4dd9-aaad-4b13d4c62d35" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_064f57b5-6a04-4dd9-aaad-4b13d4c62d35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e738347a-0cb8-408b-8bb3-04178e6c5f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_064f57b5-6a04-4dd9-aaad-4b13d4c62d35" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e738347a-0cb8-408b-8bb3-04178e6c5f35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_465c6c13-5ccd-4f5c-b532-0bdb1b3b1b20" xlink:href="dgx-20220331.xsd#dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e738347a-0cb8-408b-8bb3-04178e6c5f35" xlink:to="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_465c6c13-5ccd-4f5c-b532-0bdb1b3b1b20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_b0d1c212-e479-472b-ad64-5967da96f063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_b0d1c212-e479-472b-ad64-5967da96f063" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b0d1c212-e479-472b-ad64-5967da96f063_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b0d1c212-e479-472b-ad64-5967da96f063" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b0d1c212-e479-472b-ad64-5967da96f063_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b0d1c212-e479-472b-ad64-5967da96f063" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_f256df87-72d7-44a4-84b4-0aa29652915b" xlink:href="dgx-20220331.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:to="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_f256df87-72d7-44a4-84b4-0aa29652915b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_4b7cc713-cfab-4d53-98e6-b4f1e5468678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_4b7cc713-cfab-4d53-98e6-b4f1e5468678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_493a5b62-d98b-4f9c-a94c-0c7aa237d443" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:to="loc_srt_RangeAxis_493a5b62-d98b-4f9c-a94c-0c7aa237d443" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_493a5b62-d98b-4f9c-a94c-0c7aa237d443_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_493a5b62-d98b-4f9c-a94c-0c7aa237d443" xlink:to="loc_srt_RangeMember_493a5b62-d98b-4f9c-a94c-0c7aa237d443_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_493a5b62-d98b-4f9c-a94c-0c7aa237d443" xlink:to="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8afc2074-fd65-43e8-9262-c773e0292c49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:to="loc_srt_MinimumMember_8afc2074-fd65-43e8-9262-c773e0292c49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30c44ca7-b4a9-4ecb-9e45-13e3ee0b9011" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:to="loc_srt_MaximumMember_30c44ca7-b4a9-4ecb-9e45-13e3ee0b9011" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="extended" id="i20d571c4e7154cdb80fb807af8eac68d_FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_305629bb-3e7a-4874-828e-f41b37595ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_305629bb-3e7a-4874-828e-f41b37595ac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_730fd5e2-ae59-4e9a-b84d-3d5092670d0f" xlink:href="dgx-20220331.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:to="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_730fd5e2-ae59-4e9a-b84d-3d5092670d0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_455fea2f-819c-4988-b9b8-b2b74681edca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_923d1ea0-116b-44b2-9157-66ba7734d820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_923d1ea0-116b-44b2-9157-66ba7734d820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_923d1ea0-116b-44b2-9157-66ba7734d820_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_923d1ea0-116b-44b2-9157-66ba7734d820" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_923d1ea0-116b-44b2-9157-66ba7734d820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b282536-26e9-4581-913e-bfca89661243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_923d1ea0-116b-44b2-9157-66ba7734d820" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b282536-26e9-4581-913e-bfca89661243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_131d724e-7530-4c40-b196-63b381cbc5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b282536-26e9-4581-913e-bfca89661243" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_131d724e-7530-4c40-b196-63b381cbc5fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_66320660-706b-4949-9f00-d5274cb37641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_66320660-706b-4949-9f00-d5274cb37641" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_66320660-706b-4949-9f00-d5274cb37641_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_66320660-706b-4949-9f00-d5274cb37641" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_66320660-706b-4949-9f00-d5274cb37641_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7ccfcc54-a8ec-4fe5-9ad6-dea18e669e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_66320660-706b-4949-9f00-d5274cb37641" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7ccfcc54-a8ec-4fe5-9ad6-dea18e669e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_98e77ebf-c6c9-4c11-8257-70cfb0f5cb64" xlink:href="dgx-20220331.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7ccfcc54-a8ec-4fe5-9ad6-dea18e669e07" xlink:to="loc_dgx_ContingentConsiderationMember_98e77ebf-c6c9-4c11-8257-70cfb0f5cb64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended" id="if7e2ba543a9e451b86c5be4b49e1c70c_GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:href="dgx-20220331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3046f3ea-0f12-4bdc-ae48-bc625d3784af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3046f3ea-0f12-4bdc-ae48-bc625d3784af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_276da3f7-1496-4bc3-95f1-e7f1670902aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_276da3f7-1496-4bc3-95f1-e7f1670902aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f3fcdd9d-4417-4d71-81d3-e6dfa988fd18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f3fcdd9d-4417-4d71-81d3-e6dfa988fd18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ab71f914-6a82-4e0d-a204-2590f7f41840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ab71f914-6a82-4e0d-a204-2590f7f41840" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6e2cec31-8d94-4c7e-86f6-0fee569568fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6e2cec31-8d94-4c7e-86f6-0fee569568fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8bf7dffe-a1c5-4887-9202-a5fbec782184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8bf7dffe-a1c5-4887-9202-a5fbec782184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6fb3b03a-f07e-4b16-aab8-fd95b8eb11f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6fb3b03a-f07e-4b16-aab8-fd95b8eb11f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_243fc5d6-cc07-4f64-9039-a3095ab277c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_243fc5d6-cc07-4f64-9039-a3095ab277c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_454e23c5-c354-4299-a34b-02579165f440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_454e23c5-c354-4299-a34b-02579165f440" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1168faa-754f-4c9b-be45-148a2875d3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1168faa-754f-4c9b-be45-148a2875d3a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4cec162b-4b40-49d8-8559-57d7dcb32ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4cec162b-4b40-49d8-8559-57d7dcb32ad1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a97b021e-5215-4c6a-9e0f-b7b1697eeec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a97b021e-5215-4c6a-9e0f-b7b1697eeec2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_79c035d9-a905-42a6-ae9d-9755c803fb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_79c035d9-a905-42a6-ae9d-9755c803fb92" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:href="dgx-20220331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_448125e0-c031-456a-b2ad-9525ecf2a23c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_448125e0-c031-456a-b2ad-9525ecf2a23c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_448125e0-c031-456a-b2ad-9525ecf2a23c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_448125e0-c031-456a-b2ad-9525ecf2a23c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_448125e0-c031-456a-b2ad-9525ecf2a23c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_448125e0-c031-456a-b2ad-9525ecf2a23c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cc81db3e-a1d1-46ee-afaf-637c2fc58b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cc81db3e-a1d1-46ee-afaf-637c2fc58b72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_1332e825-c1b4-4d40-95d5-85591c3c7cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_1332e825-c1b4-4d40-95d5-85591c3c7cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_b22a9777-acea-43b9-bf80-0a95009bac9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_b22a9777-acea-43b9-bf80-0a95009bac9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_df73d89d-c695-49aa-837d-179943e0196b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_df73d89d-c695-49aa-837d-179943e0196b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_8c0e4832-411c-4f0b-8526-59cf0eeb3800" xlink:href="dgx-20220331.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_8c0e4832-411c-4f0b-8526-59cf0eeb3800" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_40cd61fb-d38d-4379-95e5-7ca1c74306f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_40cd61fb-d38d-4379-95e5-7ca1c74306f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_40cd61fb-d38d-4379-95e5-7ca1c74306f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_40cd61fb-d38d-4379-95e5-7ca1c74306f9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_40cd61fb-d38d-4379-95e5-7ca1c74306f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_40cd61fb-d38d-4379-95e5-7ca1c74306f9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_aa95ba3f-d14d-4a4a-8f15-d85a01a1fffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:to="loc_us-gaap_TradeNamesMember_aa95ba3f-d14d-4a4a-8f15-d85a01a1fffa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4eedbad9-3f82-40a7-92c1-87faa7c01123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4eedbad9-3f82-40a7-92c1-87faa7c01123" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="iae653f89947c4b13a6694cf8a5601f04_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b488f1ea-a40b-4561-9356-7b41b80f575a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_99271b94-442a-4fb3-ac69-712df68c8a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b488f1ea-a40b-4561-9356-7b41b80f575a" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_99271b94-442a-4fb3-ac69-712df68c8a43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b488f1ea-a40b-4561-9356-7b41b80f575a" xlink:to="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_92caefd3-2682-4ecd-9d87-0b0d0242f82c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_92caefd3-2682-4ecd-9d87-0b0d0242f82c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_92caefd3-2682-4ecd-9d87-0b0d0242f82c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_92caefd3-2682-4ecd-9d87-0b0d0242f82c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_92caefd3-2682-4ecd-9d87-0b0d0242f82c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0e4fbd33-85ad-4453-a151-00dca8d5c36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_92caefd3-2682-4ecd-9d87-0b0d0242f82c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0e4fbd33-85ad-4453-a151-00dca8d5c36d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_10daf63f-60e5-4e71-99b1-398a3089e68d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0e4fbd33-85ad-4453-a151-00dca8d5c36d" xlink:to="loc_us-gaap_LongTermDebtMember_10daf63f-60e5-4e71-99b1-398a3089e68d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8d2d75d0-1928-4a35-bf4c-866579524d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8d2d75d0-1928-4a35-bf4c-866579524d0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8d2d75d0-1928-4a35-bf4c-866579524d0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8d2d75d0-1928-4a35-bf4c-866579524d0b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8d2d75d0-1928-4a35-bf4c-866579524d0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2bb8264b-4bf3-4b34-b8e4-c125e834380c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8d2d75d0-1928-4a35-bf4c-866579524d0b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2bb8264b-4bf3-4b34-b8e4-c125e834380c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c8c95f13-8256-4d4f-8678-7a3a4fc5049b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2bb8264b-4bf3-4b34-b8e4-c125e834380c" xlink:to="loc_us-gaap_FairValueHedgingMember_c8c95f13-8256-4d4f-8678-7a3a4fc5049b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended" id="i93ca782a3e4e4daf8bddf700bd866d2c_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:href="dgx-20220331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e799ed32-f4e8-43d9-9859-37fe932a1341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e799ed32-f4e8-43d9-9859-37fe932a1341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_691fa8d6-7d74-4c9a-908e-41d47b22e837" xlink:href="dgx-20220331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_691fa8d6-7d74-4c9a-908e-41d47b22e837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7e27bc57-5b50-4215-b639-0fb8a6f9724b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7e27bc57-5b50-4215-b639-0fb8a6f9724b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_132fce40-9533-4dc9-a812-089e1022e304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_132fce40-9533-4dc9-a812-089e1022e304" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_1a654445-4724-49d1-9c25-c09854307e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_1a654445-4724-49d1-9c25-c09854307e48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_9b8bcb1b-5203-469c-8254-63d989d28733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_9b8bcb1b-5203-469c-8254-63d989d28733" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d0760e65-5351-4fbc-917f-81c58b64c2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d0760e65-5351-4fbc-917f-81c58b64c2e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:href="dgx-20220331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3423d06f-6e2c-439c-8c25-65bffdfdb17e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3423d06f-6e2c-439c-8c25-65bffdfdb17e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3423d06f-6e2c-439c-8c25-65bffdfdb17e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3423d06f-6e2c-439c-8c25-65bffdfdb17e" xlink:to="loc_us-gaap_EquityComponentDomain_3423d06f-6e2c-439c-8c25-65bffdfdb17e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3423d06f-6e2c-439c-8c25-65bffdfdb17e" xlink:to="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_d1c98df7-cb69-435e-b554-c72d50985f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:to="loc_us-gaap_TreasuryStockMember_d1c98df7-cb69-435e-b554-c72d50985f20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d8be2b09-701d-40f4-b306-f1a5dce06e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d8be2b09-701d-40f4-b306-f1a5dce06e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e346c51c-aae1-48fa-b7fe-76a52053e7cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:to="loc_srt_OwnershipAxis_e346c51c-aae1-48fa-b7fe-76a52053e7cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e346c51c-aae1-48fa-b7fe-76a52053e7cd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_e346c51c-aae1-48fa-b7fe-76a52053e7cd" xlink:to="loc_srt_OwnershipDomain_e346c51c-aae1-48fa-b7fe-76a52053e7cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_3ff626f0-694e-45d3-883d-4e4b90624e1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_e346c51c-aae1-48fa-b7fe-76a52053e7cd" xlink:to="loc_srt_OwnershipDomain_3ff626f0-694e-45d3-883d-4e4b90624e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_32b4b1e7-f882-4e93-a652-9001383b0cdc" xlink:href="dgx-20220331.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_3ff626f0-694e-45d3-883d-4e4b90624e1d" xlink:to="loc_dgx_UMassJointVentureMember_32b4b1e7-f882-4e93-a652-9001383b0cdc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended" id="i8db44ebf8dda45a4978db29553033eb5_SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_20faef0c-4fe0-4382-8266-68243fbc7de5" xlink:href="dgx-20220331.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ef344ec5-9cf3-4d83-8023-aba9750c8b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_20faef0c-4fe0-4382-8266-68243fbc7de5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ef344ec5-9cf3-4d83-8023-aba9750c8b45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_5de0e860-cc61-45bd-8218-f0819e9069ac" xlink:href="dgx-20220331.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_20faef0c-4fe0-4382-8266-68243fbc7de5" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_5de0e860-cc61-45bd-8218-f0819e9069ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventAxis_31b5844a-752c-446b-925c-aff447f1b012" xlink:href="dgx-20220331.xsd#dgx_TriggeringEventAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_5de0e860-cc61-45bd-8218-f0819e9069ac" xlink:to="loc_dgx_TriggeringEventAxis_31b5844a-752c-446b-925c-aff447f1b012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain_31b5844a-752c-446b-925c-aff447f1b012_default" xlink:href="dgx-20220331.xsd#dgx_TriggeringEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dgx_TriggeringEventAxis_31b5844a-752c-446b-925c-aff447f1b012" xlink:to="loc_dgx_TriggeringEventDomain_31b5844a-752c-446b-925c-aff447f1b012_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain_47d04395-3099-4c52-b7f1-2b35dd438d8d" xlink:href="dgx-20220331.xsd#dgx_TriggeringEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dgx_TriggeringEventAxis_31b5844a-752c-446b-925c-aff447f1b012" xlink:to="loc_dgx_TriggeringEventDomain_47d04395-3099-4c52-b7f1-2b35dd438d8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmendedRealEstateLeaseMember_23e0c5ce-1bf3-4f69-bc2b-b5966c655d33" xlink:href="dgx-20220331.xsd#dgx_AmendedRealEstateLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_TriggeringEventDomain_47d04395-3099-4c52-b7f1-2b35dd438d8d" xlink:to="loc_dgx_AmendedRealEstateLeaseMember_23e0c5ce-1bf3-4f69-bc2b-b5966c655d33" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="i986ef5f7b50145b087025506ab0f7c9d_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_4b4f97cb-8e08-49ff-8137-d28c50aee8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_4b4f97cb-8e08-49ff-8137-d28c50aee8df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_934d9bbc-5674-45f6-a588-5266bc471e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:to="loc_us-gaap_LitigationReserve_934d9bbc-5674-45f6-a588-5266bc471e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_804d0989-600f-47f8-992e-3d97c768f6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:to="loc_us-gaap_LossContingenciesTable_804d0989-600f-47f8-992e-3d97c768f6b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_804d0989-600f-47f8-992e-3d97c768f6b7" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7913d63f-dd62-486b-bd1c-86a454fab72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7913d63f-dd62-486b-bd1c-86a454fab72f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_4a34d64d-2cd5-4082-9df5-2dd6fd3490af" xlink:href="dgx-20220331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7913d63f-dd62-486b-bd1c-86a454fab72f" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_4a34d64d-2cd5-4082-9df5-2dd6fd3490af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd28ea7b-8d8b-4dd0-8637-0ac80c846b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd28ea7b-8d8b-4dd0-8637-0ac80c846b04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c67df93d-ef29-4979-be26-6262f6ed9d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c67df93d-ef29-4979-be26-6262f6ed9d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:to="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_883333c7-1088-421d-bec8-1057d9e33056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_883333c7-1088-421d-bec8-1057d9e33056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_883333c7-1088-421d-bec8-1057d9e33056_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_883333c7-1088-421d-bec8-1057d9e33056" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_883333c7-1088-421d-bec8-1057d9e33056_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_883333c7-1088-421d-bec8-1057d9e33056" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f716b557-217c-465d-92d7-5e2120471a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:to="loc_us-gaap_SecuredDebtMember_f716b557-217c-465d-92d7-5e2120471a87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f553c023-916e-4b98-bf42-d153e5536dba" xlink:href="dgx-20220331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f553c023-916e-4b98-bf42-d153e5536dba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_03944f41-2f74-4d81-b4cd-dfed4b8fc048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:to="loc_us-gaap_CreditFacilityAxis_03944f41-2f74-4d81-b4cd-dfed4b8fc048" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_03944f41-2f74-4d81-b4cd-dfed4b8fc048_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_03944f41-2f74-4d81-b4cd-dfed4b8fc048" xlink:to="loc_us-gaap_CreditFacilityDomain_03944f41-2f74-4d81-b4cd-dfed4b8fc048_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_49da40d2-6c33-4081-aa04-f9c3517f5c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_03944f41-2f74-4d81-b4cd-dfed4b8fc048" xlink:to="loc_us-gaap_CreditFacilityDomain_49da40d2-6c33-4081-aa04-f9c3517f5c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_f780a266-a7cb-49da-8597-8a988c30cb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_49da40d2-6c33-4081-aa04-f9c3517f5c0f" xlink:to="loc_us-gaap_LetterOfCreditMember_f780a266-a7cb-49da-8597-8a988c30cb7f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="i33e046e509df4f5a88eab58b6ef7edf2_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_dd20d8a9-8260-4f1b-887f-131eaeb5e1cd" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_dgx_PercentageofNetRevenues_dd20d8a9-8260-4f1b-887f-131eaeb5e1cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8de139c-e273-4fa8-aefb-3fd03feb260b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8de139c-e273-4fa8-aefb-3fd03feb260b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a236b46f-97a6-499d-ab9f-28aabf8ac2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_OperatingIncomeLoss_a236b46f-97a6-499d-ab9f-28aabf8ac2a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9c71be83-6731-48d0-aca4-b9d68324fce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9c71be83-6731-48d0-aca4-b9d68324fce7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b8d2653-b3d0-4bd9-ab70-61eba69bc4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b8d2653-b3d0-4bd9-ab70-61eba69bc4cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a7c49fcc-5ada-4f01-ac70-2c3e2f11b51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a7c49fcc-5ada-4f01-ac70-2c3e2f11b51d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83fb89f5-a3f4-4e15-80e7-66642cb0aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83fb89f5-a3f4-4e15-80e7-66642cb0aa56" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3ce01535-5d8b-4403-8b45-ad57b3518efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_ProfitLoss_3ce01535-5d8b-4403-8b45-ad57b3518efa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_93d547fd-9c01-45d9-9649-2bed704a51c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_93d547fd-9c01-45d9-9649-2bed704a51c7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5bf10556-ac90-4650-be5d-562d4e800c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_NetIncomeLoss_5bf10556-ac90-4650-be5d-562d4e800c78" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cac64441-c2a8-4cf7-b34c-f4f023cfd55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cac64441-c2a8-4cf7-b34c-f4f023cfd55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cac64441-c2a8-4cf7-b34c-f4f023cfd55a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cac64441-c2a8-4cf7-b34c-f4f023cfd55a" xlink:to="loc_us-gaap_SegmentDomain_cac64441-c2a8-4cf7-b34c-f4f023cfd55a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cac64441-c2a8-4cf7-b34c-f4f023cfd55a" xlink:to="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_23f75c29-ded1-45cf-8321-35a3dc6b365d" xlink:href="dgx-20220331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_23f75c29-ded1-45cf-8321-35a3dc6b365d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_8629f90d-fcdb-4022-95f1-2faa44015bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_8629f90d-fcdb-4022-95f1-2faa44015bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_6b97bcbd-a6a4-4f5a-86d1-5bf9e291c5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:to="loc_us-gaap_CorporateMember_6b97bcbd-a6a4-4f5a-86d1-5bf9e291c5ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bcca7bd5-e3e3-468f-a916-0480a676c26f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:to="loc_srt_RangeAxis_bcca7bd5-e3e3-468f-a916-0480a676c26f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bcca7bd5-e3e3-468f-a916-0480a676c26f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bcca7bd5-e3e3-468f-a916-0480a676c26f" xlink:to="loc_srt_RangeMember_bcca7bd5-e3e3-468f-a916-0480a676c26f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0592ae12-d43b-457b-8a0d-e25e6020ff0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bcca7bd5-e3e3-468f-a916-0480a676c26f" xlink:to="loc_srt_RangeMember_0592ae12-d43b-457b-8a0d-e25e6020ff0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2c85aea6-2705-443f-a7bf-6717206900fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0592ae12-d43b-457b-8a0d-e25e6020ff0d" xlink:to="loc_srt_MinimumMember_2c85aea6-2705-443f-a7bf-6717206900fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4915e114-415f-48a7-b514-ba3aeda1ffba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:to="loc_srt_ProductOrServiceAxis_4915e114-415f-48a7-b514-ba3aeda1ffba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4915e114-415f-48a7-b514-ba3aeda1ffba_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4915e114-415f-48a7-b514-ba3aeda1ffba" xlink:to="loc_srt_ProductsAndServicesDomain_4915e114-415f-48a7-b514-ba3aeda1ffba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4915e114-415f-48a7-b514-ba3aeda1ffba" xlink:to="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_165d6bec-b1b4-4916-8b7b-ca6ba9c48eb6" xlink:href="dgx-20220331.xsd#dgx_RoutineClinicalTestingAndOtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_165d6bec-b1b4-4916-8b7b-ca6ba9c48eb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_4876c691-ea75-4369-abdf-e7d51a2e715c" xlink:href="dgx-20220331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_COVID19TestingServicesMember_4876c691-ea75-4369-abdf-e7d51a2e715c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_1c8b248f-cf38-4c45-b64b-fc8543d1e590" xlink:href="dgx-20220331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_1c8b248f-cf38-4c45-b64b-fc8543d1e590" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_2baae3e9-365d-46cb-b66f-a4e04c3f9793" xlink:href="dgx-20220331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_2baae3e9-365d-46cb-b66f-a4e04c3f9793" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_55b4fd70-31a7-4922-8bf6-cd068ea460de" xlink:href="dgx-20220331.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_AllotherservicesMember_55b4fd70-31a7-4922-8bf6-cd068ea460de" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="iff4049dcdffe42faa041dac15ef6fe0c_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_dd50affd-5730-4c20-a494-4ba7cf04cbd9" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:to="loc_dgx_PercentageofNetRevenues_dd50affd-5730-4c20-a494-4ba7cf04cbd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_f6f61f5c-c547-4513-9bae-922a9603e6cf" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_f6f61f5c-c547-4513-9bae-922a9603e6cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7dca3647-9e2c-4140-b85a-9d77b69833a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7dca3647-9e2c-4140-b85a-9d77b69833a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7dca3647-9e2c-4140-b85a-9d77b69833a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7dca3647-9e2c-4140-b85a-9d77b69833a0" xlink:to="loc_us-gaap_SegmentDomain_7dca3647-9e2c-4140-b85a-9d77b69833a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7dca3647-9e2c-4140-b85a-9d77b69833a0" xlink:to="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_3721b6ae-682e-4fbc-87bb-e0f5a2ebdaa2" xlink:href="dgx-20220331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_3721b6ae-682e-4fbc-87bb-e0f5a2ebdaa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_eca43f54-fd64-462e-90bc-c370fef3cdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:to="loc_us-gaap_AllOtherSegmentsMember_eca43f54-fd64-462e-90bc-c370fef3cdbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_srt_RangeAxis_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8" xlink:to="loc_srt_RangeMember_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38fed6c8-8345-4476-8b4a-6b3582e10a49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8" xlink:to="loc_srt_RangeMember_38fed6c8-8345-4476-8b4a-6b3582e10a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9b8c8a44-d461-4799-bb28-eae4a1533637" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_38fed6c8-8345-4476-8b4a-6b3582e10a49" xlink:to="loc_srt_MinimumMember_9b8c8a44-d461-4799-bb28-eae4a1533637" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_7ba65155-91a9-4758-9c3e-5ac1c378423a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_us-gaap_SubsegmentsAxis_7ba65155-91a9-4758-9c3e-5ac1c378423a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_7ba65155-91a9-4758-9c3e-5ac1c378423a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_7ba65155-91a9-4758-9c3e-5ac1c378423a" xlink:to="loc_us-gaap_SubsegmentsDomain_7ba65155-91a9-4758-9c3e-5ac1c378423a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_7ba65155-91a9-4758-9c3e-5ac1c378423a" xlink:to="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_5493f1e6-28b8-4858-b4ca-ef4e32ac48b6" xlink:href="dgx-20220331.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_HealthcareInsurersMember_5493f1e6-28b8-4858-b4ca-ef4e32ac48b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_8658beb8-42a2-46f4-93be-cb5cfcb1a615" xlink:href="dgx-20220331.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_GovernmentPayersMember_8658beb8-42a2-46f4-93be-cb5cfcb1a615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_93eb8be6-704c-4a49-b017-fe0935be33b7" xlink:href="dgx-20220331.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_ClientPayersMember_93eb8be6-704c-4a49-b017-fe0935be33b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_fad6e705-3f51-41f6-9979-2dcdafc10115" xlink:href="dgx-20220331.xsd#dgx_PatientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_PatientsMember_fad6e705-3f51-41f6-9979-2dcdafc10115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_46656931-8321-4889-a78e-156a74ce1a56" xlink:href="dgx-20220331.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_DSBusinessesMember_46656931-8321-4889-a78e-156a74ce1a56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_92df0d0f-9b3f-48bc-9500-02dd035e5841" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_srt_ProductOrServiceAxis_92df0d0f-9b3f-48bc-9500-02dd035e5841" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92df0d0f-9b3f-48bc-9500-02dd035e5841_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_92df0d0f-9b3f-48bc-9500-02dd035e5841" xlink:to="loc_srt_ProductsAndServicesDomain_92df0d0f-9b3f-48bc-9500-02dd035e5841_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_92df0d0f-9b3f-48bc-9500-02dd035e5841" xlink:to="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_a95d98bf-4c0a-4f6f-b7ad-4bb13dbb3fec" xlink:href="dgx-20220331.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:to="loc_dgx_FeeforserviceMember_a95d98bf-4c0a-4f6f-b7ad-4bb13dbb3fec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_9a7edff9-e5db-4104-b354-451c0551e8d3" xlink:href="dgx-20220331.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:to="loc_dgx_CapitatedMember_9a7edff9-e5db-4104-b354-451c0551e8d3" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>dgx-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c431f6d8-b8fc-477a-8446-6094ac02b3b7,g:484b9920-d5d4-4a3b-8e7d-6a5d9f5837a8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_79b784e0-4d2b-4455-b6e7-ff840af95fe4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_4d8f6117-3299-4e32-87f6-87b9c7d56c8a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_475c25e9-6cb3-4afd-b7c5-a705bca58d28_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_efe915c1-7259-4b06-8026-71a8435f8eb7_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_19e6b4ba-e256-43f1-b9e8-85909c61c208_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_83f470db-6fbe-4b8c-8614-402d3b747c1e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_96a2ba73-a87a-434f-afdc-418a1f3f39d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_c69406af-e411-4a4d-84d0-c6fb4a072183_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_af1484ff-8904-4f1b-bac2-7c264e137caa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4f86dce9-691d-4817-b6f1-0ae48e81197f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c9aedc7b-168f-4a05-8bec-741fc867aa50_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_75f87d40-57dc-4c4b-b9df-d5e82de95ef0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_821a7ac2-bac5-4100-a82b-5c4a2fdfd089_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9e31ae4b-b331-476d-9224-36697472643f_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_382ce6bb-9667-4ac5-bf84-8eeeba588a57_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_9af9c39d-d891-47c1-8a8b-b4b291570e5e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_2d3c6b08-8ded-4681-90af-873d3d60c139_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_ce5cc9b3-4bca-42f5-aed7-956c378cd858_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_4b2f2034-8073-4938-9921-45e1cb46be82_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b208867f-3dfe-4a69-92f5-f524df5ff438_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_a3776f9d-fb5f-4f51-87d9-ea89c94bf3c9_terseLabel_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_label_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_documentation_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:href="dgx-20220331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:to="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_716e52f3-c7ad-49d5-9f17-eeb7ac9a7b0b_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20220331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_9152255a-5491-4a7e-a519-52667325429a_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_c631b6d0-8d3f-4c50-bc07-1ccea7d50e74_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1439f3d6-3595-4fff-b7ab-71c4ded68867_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_21d8f196-2ebd-4376-ac1c-773bf816d90d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_b31d9dfa-c90f-436d-ae92-13a8cc09b489_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_36da4574-3909-4b3e-a843-a23a98f0067b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a457f288-2ced-4f3f-9618-1723953eb414_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_c9d0b55b-b009-47d5-a559-dcbc5621c943_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b09aac80-5118-4acf-a156-dbecd218f3b8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_300218bd-c5cb-4f2a-9387-babc57a2eae1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f704321a-1be5-417a-9a0e-1d8416596942_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_74c3c6c3-c50a-4546-a735-9240f7f8fa90_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_839c691a-c25f-4d3f-bbb7-0373103aaa44_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_5051c1a5-629e-41d4-bb20-0fc2da73bb79_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e2e6f502-2b96-444a-8b62-203ed9adb366_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_8a9c071d-4aac-45a5-885a-2c46cdc8f67f_terseLabel_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:href="dgx-20220331.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:to="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_356a1d70-8f1b-4e2a-8aa3-cc6569f8f6e2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_d4c7c535-35d6-468b-a5ec-01f5d8af6667_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_bad33f23-8599-4ca5-945c-4cf87260874c_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_989f9f9c-22fd-4b8e-b9f6-1692f2a64bd5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_73fa180d-9642-4bf5-9ba3-1488c733308f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9eb869e4-dcdf-451a-b44b-efb325ff5a51_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_791f018f-55ca-4699-a40d-b7cec5499378_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ba747e5e-196a-4135-ae27-f3a4388d7672_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_188a344c-30e6-40a7-b400-8a97ca526b0f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2278e6fe-8238-42f7-b85c-8e15be31c0fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_819effba-f900-4ac3-b240-2a7b8306373c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $30 and $31 as of March&#160;31, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b1b4af7f-01bd-44d7-a3a6-103165972ebd_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_21f20160-279a-49a5-b951-3eadc53fde97_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, purchase adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_53d72b78-ad58-4b61-9b76-1af4b8c7b8bf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ce051bd0-5da2-4220-8612-870507bbd87c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e1f1af60-6d08-4832-8b6b-0454f4b2698b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8f4ee7a2-a9e9-496f-9a68-986ae7ea9687_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ab6f7556-624b-41bf-98d6-4beaa65146db_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_12f6e46e-e319-43fe-b7d7-43f004d55fc3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_a1db1e5b-28b9-46cf-a3ad-92c44557105d_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20220331.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_83658961-d45b-4a48-b7ad-a5ff446708c8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4d6e85af-c669-4ebb-a9f6-4e4508b3b385_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Reporting Information by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_3a38f10c-3248-47a7-ab71-660025179dd1_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20220331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_3be992a5-6300-4342-b80e-8dd705ba8bc9_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_e9a43a2e-ee48-4a63-99c9-96ae7efeffca_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b7d09de7-a59c-498c-804f-be042e02b46b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8fdc0d74-222d-4f34-9b26-7a867d80c258_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization remaining available</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_8c5738a6-2e78-4244-99df-f1686570e351_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Other</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_42cc671d-e05d-4a33-98c0-799bf0553859_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a75b5de5-6628-4b0c-9dcf-e5a62de80461_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_f979bfed-14d2-4de5-bc62-d7313c787967_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_82ec7e2d-5d20-46bc-ab53-16baf4799bc2_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_baeb5bf2-796c-4bad-b245-b3c3910d8d44_terseLabel_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpatentedTechnologyMember" xlink:to="lab_us-gaap_UnpatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_1774ff11-f3de-48c1-87f0-d67424f79934_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_6df8507d-0c44-4a76-a0be-e1be23e46d41_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_0b4ef1c6-0d02-42b2-8df7-591ee6c9954b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_c4324247-54da-46f6-8e57-6fcb9b1fe486_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_daf28527-d141-4dba-8c16-e1ae54d8c886_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_2e551663-8d5c-4b5a-bc8e-317b5506a411_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c9c2ebc3-0373-470f-ae6e-302ce1a54c00_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_64801057-4d7a-44d3-b54f-ebe750cf8d0b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PackHealthLLCMember_2b61e067-b4cb-4fe9-9a59-c305dd44a602_terseLabel_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC</link:label>
    <link:label id="lab_dgx_PackHealthLLCMember_label_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC [Member]</link:label>
    <link:label id="lab_dgx_PackHealthLLCMember_documentation_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember" xlink:href="dgx-20220331.xsd#dgx_PackHealthLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PackHealthLLCMember" xlink:to="lab_dgx_PackHealthLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ffdfc199-eb8a-4336-af16-09c14f408594_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_80c43d11-d7b9-4c53-8048-b9dd6c4fa14e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_fc0ffa83-e2ab-4075-abe1-9ad205d3d6fb_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_c38cff70-3b2b-4bcb-9f2a-6d935326da59_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_72f9723a-7c9d-4504-ba1f-2946d75885b4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_12a1380e-718a-4702-b3da-10556279599c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_dc5d983e-4b45-4d4f-8fdd-a603b9484144_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_04303389-ac2a-4974-b1b3-0e2573baa503_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_addae182-275f-47b5-88a0-caed233ec6a8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_42dae1b8-8bda-4dd8-a415-7a55838c080d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_324952e8-d0a9-450a-87e4-34724fe7bf96_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_aaf25fb6-3725-45c5-98c1-521c348ca2ee_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_587d34ca-cc46-418d-a0a1-5b9637dd1b84_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_41bb2c7c-5690-49d9-8b43-ca43b4832998_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20220331.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_e6a072f4-a442-444c-ab42-63d31985a596_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ed451026-f6b4-44a2-afec-313c775430b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Consideration Payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a4512d5d-ac71-4f33-ac12-a21087d1aac2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_137d16ed-5c4b-44d5-8d1e-74b498cb6a4f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_164bb8a8-ab7f-4613-b728-2d087c1aecbb_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_3f30a6b6-8857-45e9-9cce-e68d51395cba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_55283db3-b533-4fd7-9078-0f11464bb17c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4acfeb3b-ceae-45e2-8cc9-d48c5872b8ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5469d47c-b147-423d-9738-2aa3945df796_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e0e6969c-7ea7-4fb8-ae97-80d179b6cc96_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ccc03fc4-6042-4b31-a110-405711a49094_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_cb6a2ea3-bded-4245-a93d-1744fb50018c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_4bcdf44a-4891-421c-a69f-45f6c0ded32b_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20220331.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_7bcb13dd-e0f0-41d3-9caf-2f3a18119500_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_bf60c943-ccd7-4aa7-9127-0bc3006ec77e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7c52184f-8fad-4964-a11b-7c81dd20bedb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5911a23a-cc37-4ffb-bbf2-aaaf9f7bdabc_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_6798e95f-793e-4cfd-9f3c-a38cff0f8b66_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:href="dgx-20220331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_17b5d487-d695-4dd4-a181-a6f09d3e2ee6_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4a8c708a-037d-498e-9630-729fd8eba0a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e244b27-b7d1-45be-9565-4b9839e6c26d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7cf6d570-1c27-4e5a-8ddc-5c9c44135f8c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4cf3d5f-f67a-48e2-8dc7-e00a1232429c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9568e160-d56e-4226-be16-2dd704b625c2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5cdc2a9c-90f2-49e7-beb9-4644814835b7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d2e6d27e-b51c-44f9-b8b3-bace3c7c5d53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_baa2986d-ef26-4f76-a87f-5d47c3007b34_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TriggeringEventAxis_ad8c93ad-1142-4141-bb96-fa079513ccdf_terseLabel_en-US" xlink:label="lab_dgx_TriggeringEventAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Axis]</link:label>
    <link:label id="lab_dgx_TriggeringEventAxis_label_en-US" xlink:label="lab_dgx_TriggeringEventAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Axis]</link:label>
    <link:label id="lab_dgx_TriggeringEventAxis_documentation_en-US" xlink:label="lab_dgx_TriggeringEventAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventAxis" xlink:href="dgx-20220331.xsd#dgx_TriggeringEventAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TriggeringEventAxis" xlink:to="lab_dgx_TriggeringEventAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0347fb64-392f-407e-a712-aa8834d3cdcc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_85e284ee-b5a7-4435-bee8-b1c6370e501e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic(in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_0790598a-6b7d-475e-a50d-040817a275d4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_15a1eed5-9a36-4e81-800a-9c40c485020a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action lawsuits</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c18f4065-2373-41c5-99e3-2243ec8e8f8f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_96173cd5-a2c7-4e0e-8c83-a0276618fc08_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0348e78b-ef52-48f6-8742-534e0a60bf7e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_14f470c2-aa25-4fc6-bd57-52bc8145d1c4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f1264b10-9e9c-4f9d-a9a7-0a3e2c3d1e0d_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_b212d888-2c41-4476-91bb-15b43f84729d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c37f3f8c-a6a5-48c9-aff6-aee34ad25c8a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_f323c149-ef83-4b72-b334-cf03918835e1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_c069cff3-d561-40bd-abff-213922cf7b36_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_022da2f7-aa43-47fe-a9b7-5e7a31c00a42_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_59f85118-9327-417d-8d7e-e820700841c1_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_afc03296-a30f-4e23-b3f0-bc17513b2ef4_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, March 31, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_c955a209-f345-4401-9aa6-d8ab92f42762_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20220331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_15128fee-1102-42ae-b6be-024872f9fee9_terseLabel_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comparable Company Revenue Volatility</link:label>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_label_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Comparable Company Revenue Volatility [Member]</link:label>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_documentation_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Comparable Company Revenue Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:href="dgx-20220331.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:to="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_6a344cc5-ce02-40a6-b0e3-f578c0ed3c54_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:href="dgx-20220331.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:to="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c4da7592-86c0-4a93-b76e-70255b5ef9a4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_c786e026-5dd6-46d4-9c4f-00ee59418a3a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f1bc0616-2eec-49ad-9545-1ad02c1adf54_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0a034f27-706a-49c9-8c3e-2b70d86df12a_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_315ed2c4-df3a-41bd-ada8-efcd1a9ea7ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_a74963c2-6aa9-4201-9e27-0e94ec58f290_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d08ab55c-ddfd-4989-aba1-c73253a555d6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_3cfef6db-bbdd-40ad-8b83-a46d3d12d7f0_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TriggeringEventDomain_87515834-f4ab-4f39-bcc4-fa3dc9ea0281_terseLabel_en-US" xlink:label="lab_dgx_TriggeringEventDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Domain]</link:label>
    <link:label id="lab_dgx_TriggeringEventDomain_label_en-US" xlink:label="lab_dgx_TriggeringEventDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Domain]</link:label>
    <link:label id="lab_dgx_TriggeringEventDomain_documentation_en-US" xlink:label="lab_dgx_TriggeringEventDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain" xlink:href="dgx-20220331.xsd#dgx_TriggeringEventDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TriggeringEventDomain" xlink:to="lab_dgx_TriggeringEventDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_7e18266c-81ca-4774-9f6d-5360a2ee2f45_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d45acd22-810b-423c-9ce2-df5570135f5b_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_3ec356a2-e689-46a0-a0c5-172a37e0ebed_terseLabel_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration payable</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_label_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_documentation_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:href="dgx-20220331.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:to="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_05de8dd3-56f5-48da-a427-626b926513cb_terseLabel_en-US" xlink:label="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC and Labtech Diagnostics, LLC</link:label>
    <link:label id="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_label_en-US" xlink:label="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC and Labtech Diagnostics, LLC [Member]</link:label>
    <link:label id="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_documentation_en-US" xlink:label="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC and Labtech Diagnostics, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:href="dgx-20220331.xsd#dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:to="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_8b6079ab-db44-4a92-bd82-63db906dd44f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2e849719-2842-4240-a6cb-2c8e3c4f1590_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aad5a0ce-f11b-4aae-a9c7-828a9cf633e9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7ed4f587-3cbd-4f72-b50d-9b58fa28a35e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_58c87419-ab59-4352-bf12-1b9ecd83522b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_4a9d087d-4f80-407b-9449-5f0903386b2e_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20220331.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_81510e2f-9e43-49e1-9229-406430f8ace7_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20220331.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_b606cf5b-7ec3-4eb0-9880-5133b722d136_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20d80204-2414-4558-b290-aa2abe45548a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_908c4d37-0bd6-47fe-a302-d1dd89acf019_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_37c2fcc1-66a3-43a2-a484-66e2991a6e02_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_020febee-f202-43d7-819b-8f37fceefbaf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_cc77270f-5ea4-4306-9cf0-6fc3747efa05_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_b2d0a731-f944-4b58-abfb-c2f03da398c7_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_2fde6d30-c119-4bbb-a775-7fab3100cfac_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_bd073409-cb0d-4477-b25e-4827348bf7a8_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b68bdf0-1d8d-493c-9d51-bd5e22acd9e3_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4cc57ee9-0ead-4d7e-99c2-64a39976e3b6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_763eae07-d5a7-48d6-9fb8-f9a8375502ee_terseLabel_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_label_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_documentation_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:href="dgx-20220331.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:to="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_04b6e741-f51b-4eda-a4a1-e9505fcc9275_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_216c7f12-9347-4c81-8f81-3eb7eced7b2c_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to the estimated contingent consideration liability</link:label>
    <link:label id="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill and Intangible Assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:to="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_ea462da4-0bbd-4eff-835f-c1199705b5ad_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate activities</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_159e1195-fbcd-441c-95c9-bdc8663af6e3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_9b2bfb1d-c2ff-4975-9b63-ade03fc07502_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_816318e9-90e2-48ea-bbd6-c07542b63ec2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_c695703d-f721-4a68-afd8-ad35563d4f78_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_29cc4b59-88c5-48ad-827b-5c724b81517b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_37804155-e3fe-4a69-9f66-bb73b27ccab6_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8d121026-64fb-4751-a904-0bb05ebaefcc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_28a89c0b-3221-4132-9eb7-0e87c08f6a51_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_beed1bde-7a88-4894-b775-9118e46de291_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 45 and 43 shares as of March&#160;31, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8e66fd8c-0fbb-44e6-8a3c-67472ca38b0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_15febeca-1f9e-4d7e-a42a-ee5e35a4e0ee_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_d7978084-1e4d-4920-891d-fcec4c8f9a5d_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineClinicalTestingAndOtherServicesMember_ca1b0dff-723e-40a6-89bd-4c1c1235c4eb_terseLabel_en-US" xlink:label="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing and other services</link:label>
    <link:label id="lab_dgx_RoutineClinicalTestingAndOtherServicesMember_label_en-US" xlink:label="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing and other services [Member]</link:label>
    <link:label id="lab_dgx_RoutineClinicalTestingAndOtherServicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing and other services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:href="dgx-20220331.xsd#dgx_RoutineClinicalTestingAndOtherServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:to="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_8610f76f-f284-43c7-95f9-bdf684266017_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_b99caa16-729d-4ca5-bd24-918d12c8d501_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20220331.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_04612648-a5b6-488f-83b5-675a3b066ed1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_52142ad8-59c0-46e8-b363-9849b6bd4a73_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_d164ce54-30d4-4cbc-9def-700a77a1729a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientsMember_c472fdf5-0f07-42c3-a1bb-56aa6307e7bf_terseLabel_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients (including coinsurance and deductible responsibilities)</link:label>
    <link:label id="lab_dgx_PatientsMember_label_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:label id="lab_dgx_PatientsMember_documentation_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember" xlink:href="dgx-20220331.xsd#dgx_PatientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientsMember" xlink:to="lab_dgx_PatientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_3e3b56c8-487e-4014-a6cb-e6489dbbbe62_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_5fcd48dc-3489-4f5e-9a99-879ed1c76433_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_b4b097bd-caf6-47b8-8a64-f24c0ee8299f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2f2ec19a-07c2-4856-b3dd-786f40a2ee20_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_bfba389a-8764-4383-b393-afc0c2ce94fb_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_cf4a8ae5-c8f7-4cdb-af50-eda844910f6f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_e0a91dd3-fbca-43f1-98d3-741ce0967bc2_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20220331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_413b1aec-407c-4e42-b807-d5525d3b1a2a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ea244f88-017d-4125-b29a-92d7f71610d2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_875e855c-e93f-4433-883c-cb57abb476ee_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:href="dgx-20220331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e73e58b6-4f07-4780-b5e2-df484701a0a2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_f17ffec1-ba69-41f2-889b-49dbd99edc12_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f559936b-4503-4b25-b9f1-7476cfbf857a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_79e08dc2-2ee8-4b2c-8d59-ad9702d561b0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_89ea9e2b-b2d8-4a68-bda8-bac6d690b9ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_d11debba-195f-4909-a528-d73a3880e43f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ee8f27f7-83b1-42ba-bf7f-e7675e8e5c36_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_223944b7-bead-48cd-8480-a48f7dc62767_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_657700b7-8ed2-4581-979a-b72f77240ddc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_942a34cd-f96a-4086-a07c-44b7d43915cb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_530dfa82-f71a-4b43-9f30-9c333abba304_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_14cecae0-ec32-4ecc-a790-a78928f4a92c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_c7d1e927-d6b8-4dc2-a4a8-a8e7d547585d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_bd0961ff-93e5-4384-ade9-edbb0d42c56f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5587fbd0-198b-4e5e-88cf-1a0f226958b1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_5205be3e-229a-4671-8143-bff63a7f11b5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, purchase adjustments</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b7b8c2f0-3a85-4084-a858-bc62f614f2a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8c92721e-b627-4345-8ab7-a39071fa9897_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ea74ad5f-5d70-488d-bcb8-29685fc44523_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_46dfec09-7935-4948-8315-8691b7375671_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b55b4049-ceaf-4526-979f-5d8d426748be_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_86379894-adff-43ae-a308-bf4977026ff1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_876675d8-6724-4191-bed3-1415d1d3b38f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in available-for-sale debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_082a46f9-3669-4253-b2c1-b11a778ffc20_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_1c7251cb-15f0-47cd-8300-4851043a1905_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ad5b27a7-26de-4441-a31e-3dde4ec72f2a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_a53315f6-0f22-4141-bb7d-48556acecd3d_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20220331.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_a8da3f9c-8a59-4e02-9d98-7b8c39ce6ea8_terseLabel_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_label_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_documentation_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract" xlink:href="dgx-20220331.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DescriptionOfBusinessAbstract" xlink:to="lab_dgx_DescriptionOfBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c8f237ba-f2f3-4173-b293-4e265e1b6a10_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_b2460432-cd29-418a-9559-1a27060e4997_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2178fc52-132d-4efd-aed1-a4133ed6fba8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f5470c6a-47d7-4062-8c81-43d755113bc9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0e1c2acc-10fc-424f-b0f5-7f3135966264_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_683c8a7d-8a6a-4c22-9d5f-452850ddddff_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a32c5053-e3a5-4adb-abae-b4b71253294f_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related intangibles</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b18dbc66-5e36-4d44-967b-e900649d9594_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_f8f72be8-fa2c-4551-b9e7-ff7b224c2cf0_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20220331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2a892e5c-c42a-4772-9eff-c90ecf3061a2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7eb56126-bdbf-4e9e-b2b4-b25ef3a09a05_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4bd4eb29-b042-4b86-8a36-b2038be562cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_92370d40-b184-4eff-8c00-77f98c0c471b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_c8413be3-863a-4a1a-8f41-2a610b4bd554_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e8643363-f27f-4d80-a71c-01c0f42986a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_57c93f29-c99d-4111-bff0-5818d1e4573d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b08b29f1-85d0-460a-9c47-fc931af360e5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock- shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_66d856d4-aff2-46a9-bef2-ce906f8151b1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7e37dc64-58ce-4eed-9773-5f1ca9b8cba4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6ced8aab-b0e9-47e3-bf9f-168734560cb4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7295719c-73ba-4062-a0d6-d2106675fcd9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ec1ae473-688a-4d21-a896-817285926904_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_d64fcc5d-5577-4ab4-a6d2-1613f86a19ee_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="dgx-20220331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_3bf989b3-df68-4a96-be58-8ba07bd756b3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e599e56a-881b-48a4-a712-c51c8c8098a5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_93ad52f2-e458-48b9-a7f6-bd8761adf719_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_dfd20fbd-b26e-4402-9480-5612e6d02a07_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_cd2d7466-aa15-4b00-a235-66a766984838_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:href="dgx-20220331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_7b812d06-086b-47c0-b561-b952bcdb96da_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20220331.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_1bf8e1d4-1a83-46f3-8d15-57ca557905bb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating income:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_dec58883-c24d-4631-b091-3b22640f5fef_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e9e59da4-5f5f-427e-9915-a860992cbf4a_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_327fcf5d-5e4b-41ce-bc9f-8c1e3b69ef6d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_a0a32f03-2124-4f75-8836-7326c4f3c4d3_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_0911a983-c000-45ec-a4e7-82dff37f09dd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2022 and December 31, 2021; 162 shares issued as of both March 31, 2022 and December 31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5e16d82f-2c6a-4c92-81e1-479a10df0204_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_75d6cdce-23ac-4d3c-a6bd-57006a18e818_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AmendedRealEstateLeaseMember_c09a2127-b8de-48b6-b97b-73d340168494_terseLabel_en-US" xlink:label="lab_dgx_AmendedRealEstateLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Real Estate Lease</link:label>
    <link:label id="lab_dgx_AmendedRealEstateLeaseMember_label_en-US" xlink:label="lab_dgx_AmendedRealEstateLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Real Estate Lease [Member]</link:label>
    <link:label id="lab_dgx_AmendedRealEstateLeaseMember_documentation_en-US" xlink:label="lab_dgx_AmendedRealEstateLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Real Estate Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmendedRealEstateLeaseMember" xlink:href="dgx-20220331.xsd#dgx_AmendedRealEstateLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AmendedRealEstateLeaseMember" xlink:to="lab_dgx_AmendedRealEstateLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_8927b163-5c82-4986-b853-6cd4bd110d88_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ad2f2e65-c517-48be-af54-a8bf9a3bd13d_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_6ce6f824-dc80-48c4-99da-2435664d86a1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_3520cc22-39d2-4efe-84a1-91cd1fd7c541_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20220331.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_96c00ffd-3bf4-4b70-994a-145d09669cdd_terseLabel_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, additions and issuances</link:label>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_label_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</link:label>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_documentation_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:href="dgx-20220331.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:to="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_409e4be1-3139-4092-8fac-3e9494534756_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f739acbf-3444-42d6-b52e-b493787447ba_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_705f6631-c8ad-4487-b549-b703614cba11_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_44553610-5220-41c4-b41f-84d2b2fd65f6_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_bf31688b-6afd-46e4-a07d-fc500737b24d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_df5f9b60-d720-4519-b4db-fd0c75eb2347_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_72f5f19c-2ec8-4ec0-9ed5-96ce323619a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_039cfd20-fc16-45a3-b763-d80b8f1ab2e8_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_6b2538ec-6f42-48a2-ab37-3da222e9521a_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_7fbf3bd2-dedf-417e-85c3-c0713c081cc2_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f701ec91-7c7b-4e2b-ae3a-1a77510c0a4a_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_59c2183b-407e-469f-ab2e-d21d02eb5846_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d71bd851-db6d-422a-a59b-391b7ac9cbf8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a61a9aee-46c9-46dd-a338-eee5251df8bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_c7965495-d874-47d3-8c18-222c744bc5a5_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_9a5a4333-2d82-43e1-aeea-f92e6561de6b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_d7640bf6-2225-4a5b-84ff-33ca85158693_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_96c99d2c-a7a6-48e4-90aa-a589a59bc8c7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_e86ff861-8a6f-46fe-8a82-5a7ee60432c7_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:href="dgx-20220331.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:to="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fa63ae5-1096-4f05-8345-6c92fb04dddc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_30caa0a2-87ec-44c8-a399-9a6f63a010c4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_1179f869-e2fc-41d3-a9dc-d98865ab85c4_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bf93af29-11ab-4598-866f-ec784bc95150_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_3bb71437-5f25-4546-a6e5-20874d872621_terseLabel_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC</link:label>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_label_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC [Member]</link:label>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_documentation_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember" xlink:href="dgx-20220331.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LabtechDiagnosticsLLCMember" xlink:to="lab_dgx_LabtechDiagnosticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_945acd21-6b43-48f4-9bcb-2355b9e787e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ff7cd623-5e9b-4e84-9ebb-bb6360bbcace_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6e51b921-487d-48c2-8e05-9f8a7b6972ca_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45c90485-560a-4871-a6be-b2cbdfbf9c03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContingentConsiderationMember_95b36e4e-e609-40c2-beb2-12d0f5d60aa5_terseLabel_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_label_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember" xlink:href="dgx-20220331.xsd#dgx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContingentConsiderationMember" xlink:to="lab_dgx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cde506e7-b2f0-46e0-8573-0abb22fef855_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3cde9605-d088-4d64-97c4-c697b157dacc_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_57de452e-497d-40ae-ac39-57f3da768e70_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_07105024-82a0-406d-8195-a4eec76cbbad_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7e120033-885b-4aad-9c95-a0398a514a47_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_44bd1c30-b48f-42e0-baf7-c284355f1467_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b766c86-b889-42e3-b2db-8f4be073660f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58dd4906-d280-4eb2-a723-e523fe270f97_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_73917f85-e977-4cc4-944f-334697cf3a5b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c57d38a9-0f17-49b0-bb53-2d771bede3fd_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1c3dccc4-b4e8-46d8-8ebd-9ac74b7e23ba_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8be4b9fa-92fc-4450-bd93-b1528b9b206d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_086e71b3-6a44-41f5-9fbb-cb783de8840e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_2fe72e67-c5c3-4a16-adc7-d5fc44990d87_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_5acdd9aa-bd1c-4268-a279-1c1d294f6031_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_42b84a76-a073-405a-a4e0-bc759a8413c6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_12016fdd-493f-4eba-82b6-09f776de2675_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_f3db7e1a-b357-46c7-82de-06eca679a307_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_5c1b4f2a-a88d-415f-83f9-91bf1f781699_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5daec149-51fd-41d5-af06-c5293bbd4478_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_19144bce-457f-4e0e-9971-df6616d0a5bd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_861fc568-da7a-4008-9f99-44710e47ce1c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce024ba7-7e76-434e-a2bb-9e4c7b6f0a75_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7e3b6166-dd93-40ce-9ce2-34a5dd239409_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f5cecd48-6d3c-4df6-adbb-04c23c49dac4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1349a52e-f1e9-4d4d-abb8-fa60314841af_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6ffe4a35-d76c-49f6-8bc4-16f1594f0ed4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d9a42473-3711-4fc0-a9a3-7bf4d4d0fb17_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_af91162d-272b-46c8-88d9-8acda210a6d7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9ffc2001-e61c-4ae0-b8ab-914df88309a7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_31fce71f-2e85-4589-99c8-3c1e262bc807_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_80146d05-b87b-4724-b94c-249a70ab805b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2e66e74-a8bb-4dc6-9145-8c5f5d525be2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7bbf68d5-43c6-4e91-9d0b-af2e71086da0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f8850e5e-9cdd-4179-beb9-9e74135c2060_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_1a4ba4cd-3dc4-47c8-9b74-7d87822339ea_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_00c6996c-f07c-4ced-8620-5ab34c31b1f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_e633b2b0-3a70-452e-ac39-5e02264ad549_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_173fa91c-793a-4275-8cbf-1ae27945ebf8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a22c9b3-00a2-4002-a7c2-20e1c99dc5b4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_ead01767-e031-4c8c-8a6c-9431f7e3f70a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_39b2537b-2148-44d4-a743-96c1eb5654d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_ad88ba4f-ac02-4e47-ab67-d341e4c7c30c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9501eff1-8d37-4106-b071-60167a7a9d1c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_80737cce-ceed-4d6f-8268-3ccf578ae5c9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_ae816edc-15d0-4207-a4a9-e202ed747eb3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a6445416-abed-4770-ba3d-d00914f405e8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_1b0cef79-63c3-4d57-a147-e124af710b4d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_aba84957-5169-400c-8e5f-cf53296004b2_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_3ebc8708-29fb-4dad-8457-2b927b9a40bc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_de8224e4-9fdb-47d1-a56b-beb4d38d796c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_b0c6fdc6-6a7b-4c16-b8be-6d5b5d8ccaac_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20220331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_8ce4f086-f5d0-465b-9600-f37a006111d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9466ceaf-8a76-4a25-84db-bc1053bfbbe8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4657cf62-70f8-4897-b738-56ef9d45b064_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_b06184d9-469f-40b3-ba72-715963d06fa3_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:href="dgx-20220331.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_341a6d01-bd62-4740-8bab-3b2d385db678_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards to be Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_21e03a91-a9f2-40b1-90c0-475431ea822a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in investments and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8b91b462-f1ff-4966-8829-d475a17481ea_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_ecdee1ba-863b-40f4-a9f7-62e50cc32ec8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6f8945cf-43c3-4d49-89fc-72dd18465aca_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_21a7284b-9ca9-47c8-8b6d-40dba4ff5178_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_fd5e066c-f277-48d1-8f4b-9fa9fb120c43_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_92eb08cd-46c9-461e-9cc9-f3a87067e783_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20220331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_86f9cc6a-f4e8-4899-a06c-1aa8f51d05fa_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:href="dgx-20220331.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c8854558-cae5-4db5-bbd3-ce2e5cdeb58b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_175fb58a-2792-4cb9-896b-095c95388878_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9a68fd1b-dd42-4f26-af5f-c79e5e8451f3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_5cf51cea-c96d-4db8-af73-5b94e35e67a2_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_0237022f-fdfd-4684-bba1-10bf770d462d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_6f25462b-8233-40cb-868f-74e397050aad_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_f98fb383-d044-4045-9512-f2d5133d4457_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_830fc556-b2c4-43ba-9e5e-daa3ef14c7f6_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_e1edd3b8-c274-42ab-b839-3ab85822b6e6_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_484f1373-5b6a-4d40-bd0f-be6abe0021f4_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_80b43b03-1602-4d07-9b67-00921c8c7b03_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_309becfd-3f00-45e7-9638-32fd31361c76_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_99cff545-c8fa-437a-8298-3e254092fe31_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c8425f0f-8f2e-4c8b-a9a9-8cd3d2c30859_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6944586b-8a55-40ba-a5e9-545e093e794c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_3c7c91e4-f05c-4198-9704-1dd2fc7e5939_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_075190cf-5b25-44b5-81d2-74def8a7f379_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f0b579d1-4a41-43e1-9bbb-a8e03be9e4fe_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:href="dgx-20220331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2897e88a-fb8d-49ad-8be5-fe1f1b79e5ed_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1fb2ecd1-3a61-4d6e-bff9-de9903fb3a07_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_1bf5857e-4a91-4494-8999-ec364f1b84bc_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20220331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_943bb2b0-97f6-4d63-bc26-c8103d01de44_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_906623d6-378e-4eea-94ed-9fe003d7adde_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_83c41e2c-0022-40a0-b76b-de15b272eaed_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fd6ed726-f161-4fe9-983f-78d32d67083b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_6f1529f4-b832-4d9a-889e-7a1213290d4c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e722ab7-7bd4-4fdc-a507-9efe44f8a097_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>dgx-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c431f6d8-b8fc-477a-8446-6094ac02b3b7,g:484b9920-d5d4-4a3b-8e7d-6a5d9f5837a8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9f607880-fffe-4015-a0c3-310fe22de782" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_DocumentType_9f607880-fffe-4015-a0c3-310fe22de782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ee5c0ff6-d3d1-46ac-9833-9edbae89e422" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_DocumentQuarterlyReport_ee5c0ff6-d3d1-46ac-9833-9edbae89e422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_03bbaae5-aa40-4d51-ac6a-09db1fb1cc3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_DocumentPeriodEndDate_03bbaae5-aa40-4d51-ac6a-09db1fb1cc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_12e35074-1dc6-478f-b9c7-267d03af7b23" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_DocumentTransitionReport_12e35074-1dc6-478f-b9c7-267d03af7b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_558c34c2-6d23-4dcd-bc7e-fa0ce31a2e23" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityFileNumber_558c34c2-6d23-4dcd-bc7e-fa0ce31a2e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_731184a1-56a6-4b7f-82eb-1cdb75dee6b2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityRegistrantName_731184a1-56a6-4b7f-82eb-1cdb75dee6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2f1b1958-5232-45c6-8d27-36730192f0d2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityCentralIndexKey_2f1b1958-5232-45c6-8d27-36730192f0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dca96d98-eb6f-49ee-baba-ce0ea8bcdf0c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_CurrentFiscalYearEndDate_dca96d98-eb6f-49ee-baba-ce0ea8bcdf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d30fc1cc-8117-4cb6-826b-e6f646251619" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_DocumentFiscalYearFocus_d30fc1cc-8117-4cb6-826b-e6f646251619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_504962aa-6250-4ac0-a7ab-c20cd7a49d61" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_DocumentFiscalPeriodFocus_504962aa-6250-4ac0-a7ab-c20cd7a49d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c9e5d517-f843-49c4-bd64-2a65a5bfe6d7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_AmendmentFlag_c9e5d517-f843-49c4-bd64-2a65a5bfe6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d891750d-8788-4eb7-88b3-a7e86905debc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d891750d-8788-4eb7-88b3-a7e86905debc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_36f6173a-e5af-43f0-8171-6e296088a12c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityTaxIdentificationNumber_36f6173a-e5af-43f0-8171-6e296088a12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f87004a9-dc72-44fe-8262-898f4b0be4af" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityAddressAddressLine1_f87004a9-dc72-44fe-8262-898f4b0be4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c6c628c6-043e-4a36-9ec0-f5f66a9fbbc7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityAddressCityOrTown_c6c628c6-043e-4a36-9ec0-f5f66a9fbbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_224213ab-607b-4df6-a867-76a54e8ac610" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityAddressStateOrProvince_224213ab-607b-4df6-a867-76a54e8ac610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_57449523-74f7-4123-be45-d6266944231a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityAddressPostalZipCode_57449523-74f7-4123-be45-d6266944231a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_379c77e7-c3a8-4f39-b2ce-c4efab15dbe7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_CityAreaCode_379c77e7-c3a8-4f39-b2ce-c4efab15dbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_371b2993-b97e-4df6-8750-3549afb60d0c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_LocalPhoneNumber_371b2993-b97e-4df6-8750-3549afb60d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1c605797-afa0-4fc4-bb10-b4c6ea753e17" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_Security12bTitle_1c605797-afa0-4fc4-bb10-b4c6ea753e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d3aeb0c6-0760-4e04-b6a5-5be547f68e8b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_TradingSymbol_d3aeb0c6-0760-4e04-b6a5-5be547f68e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9decfb2b-d436-4b79-899b-c0aee32c63bc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_SecurityExchangeName_9decfb2b-d436-4b79-899b-c0aee32c63bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0037cf6c-7b0f-449d-a81b-5ca9605acd74" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityCurrentReportingStatus_0037cf6c-7b0f-449d-a81b-5ca9605acd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e5601e82-0e67-4327-aa98-feec695bb7d5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityInteractiveDataCurrent_e5601e82-0e67-4327-aa98-feec695bb7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6609120e-289a-4e5e-bdba-bc5670b68e7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityFilerCategory_6609120e-289a-4e5e-bdba-bc5670b68e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_e7875f83-2736-4ccb-b506-8cbadb77505b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntitySmallBusiness_e7875f83-2736-4ccb-b506-8cbadb77505b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c98ef657-28af-420d-b10f-e812dc40ddca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityEmergingGrowthCompany_c98ef657-28af-420d-b10f-e812dc40ddca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_7fec252e-58ea-4fe8-bc37-2612d2cf6671" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityShellCompany_7fec252e-58ea-4fe8-bc37-2612d2cf6671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_25f990b1-524a-47ef-8615-d259d8586d2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1cbc3d5-32b9-4aeb-9719-dab055e31e63" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_25f990b1-524a-47ef-8615-d259d8586d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e0b97e8-f497-484c-b135-c97d853bf85e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e0b97e8-f497-484c-b135-c97d853bf85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_5cc1ecb4-f54b-48a2-8056-1bdb34f0cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_CostOfRevenueAbstract_5cc1ecb4-f54b-48a2-8056-1bdb34f0cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_a261bf2d-613b-4ebe-990b-e2d8a3e81fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_5cc1ecb4-f54b-48a2-8056-1bdb34f0cb04" xlink:to="loc_us-gaap_CostOfRevenue_a261bf2d-613b-4ebe-990b-e2d8a3e81fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ecc4570a-b83a-4c0f-8c5a-f777b7698ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_5cc1ecb4-f54b-48a2-8056-1bdb34f0cb04" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ecc4570a-b83a-4c0f-8c5a-f777b7698ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_113edafe-a413-4ac3-a23d-68fdf9c53bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_5cc1ecb4-f54b-48a2-8056-1bdb34f0cb04" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_113edafe-a413-4ac3-a23d-68fdf9c53bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_bed2eadd-f99b-41c8-a4d0-560535332163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_CostsAndExpenses_bed2eadd-f99b-41c8-a4d0-560535332163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_912fa4ba-7220-4830-b84a-d00a60cc7314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_OperatingIncomeLoss_912fa4ba-7220-4830-b84a-d00a60cc7314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7ea374f5-bd50-4c0e-826d-319c60adc250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7ea374f5-bd50-4c0e-826d-319c60adc250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_9a2727ba-8a07-44c8-b01d-016afef7b786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7ea374f5-bd50-4c0e-826d-319c60adc250" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_9a2727ba-8a07-44c8-b01d-016afef7b786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1dced9f4-5224-4915-aeb5-2c59e1937d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7ea374f5-bd50-4c0e-826d-319c60adc250" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1dced9f4-5224-4915-aeb5-2c59e1937d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_230a8888-c82f-4cd8-bc27-09717e49fbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7ea374f5-bd50-4c0e-826d-319c60adc250" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_230a8888-c82f-4cd8-bc27-09717e49fbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2265cfbe-8bad-4bea-b1e6-aeab017499fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2265cfbe-8bad-4bea-b1e6-aeab017499fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_714f82d3-6b6d-4e11-bf93-b5de32d56bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_714f82d3-6b6d-4e11-bf93-b5de32d56bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e6c0e1bb-4520-42e7-81cb-b5c94433d9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e6c0e1bb-4520-42e7-81cb-b5c94433d9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a9307289-81a3-4e0d-a19d-332936c18e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_ProfitLoss_a9307289-81a3-4e0d-a19d-332936c18e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2025f4cf-2066-4cf8-a121-838d4ea0b4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2025f4cf-2066-4cf8-a121-838d4ea0b4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_43c83f9c-7c4e-4a71-b133-c166b3135c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_NetIncomeLoss_43c83f9c-7c4e-4a71-b133-c166b3135c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e02370c2-edd0-40ba-b78c-91a54d64b4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e02370c2-edd0-40ba-b78c-91a54d64b4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_58568933-70e9-4dd7-915c-f16163268f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e02370c2-edd0-40ba-b78c-91a54d64b4c2" xlink:to="loc_us-gaap_EarningsPerShareBasic_58568933-70e9-4dd7-915c-f16163268f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_803ddb20-1d08-44ba-a380-401fd3f56900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e02370c2-edd0-40ba-b78c-91a54d64b4c2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_803ddb20-1d08-44ba-a380-401fd3f56900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_48bbb14c-3895-4b30-b1dc-4aa9c5b5ce9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7439bda5-4882-4797-b968-35ba2ae468a1" xlink:to="loc_us-gaap_EarningsPerShareAbstract_48bbb14c-3895-4b30-b1dc-4aa9c5b5ce9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a00efff-8546-414b-b83d-77d2b2a815b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_48bbb14c-3895-4b30-b1dc-4aa9c5b5ce9a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a00efff-8546-414b-b83d-77d2b2a815b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a3ec923-9d41-4053-96e0-d5c7e65ddc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_48bbb14c-3895-4b30-b1dc-4aa9c5b5ce9a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a3ec923-9d41-4053-96e0-d5c7e65ddc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f1d879dd-419f-479e-84b1-0d21290e1a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7cce6d5a-fca9-4f81-9e13-5f1a43138baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f1d879dd-419f-479e-84b1-0d21290e1a0c" xlink:to="loc_us-gaap_ProfitLoss_7cce6d5a-fca9-4f81-9e13-5f1a43138baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7eb1109c-6d4b-49d2-96e9-81cc0cd04c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f1d879dd-419f-479e-84b1-0d21290e1a0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7eb1109c-6d4b-49d2-96e9-81cc0cd04c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9bbd6579-2b4e-43af-97cf-6c84bab07fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7eb1109c-6d4b-49d2-96e9-81cc0cd04c2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9bbd6579-2b4e-43af-97cf-6c84bab07fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2c3faf06-62f0-47e2-87fc-0ce5a91adcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7eb1109c-6d4b-49d2-96e9-81cc0cd04c2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2c3faf06-62f0-47e2-87fc-0ce5a91adcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_afb417cb-9c89-4205-ab6c-ecf0c866ecb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7eb1109c-6d4b-49d2-96e9-81cc0cd04c2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_afb417cb-9c89-4205-ab6c-ecf0c866ecb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1167221d-bb14-4d71-b676-8a5f0110e510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f1d879dd-419f-479e-84b1-0d21290e1a0c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1167221d-bb14-4d71-b676-8a5f0110e510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_624e86c4-c04e-4f10-a3cd-1a3a1187cdd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f1d879dd-419f-479e-84b1-0d21290e1a0c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_624e86c4-c04e-4f10-a3cd-1a3a1187cdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_80e4228b-6f7d-4844-b49b-95848762479a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f1d879dd-419f-479e-84b1-0d21290e1a0c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_80e4228b-6f7d-4844-b49b-95848762479a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_57cc5eed-8cd5-445a-8549-1b59bd84aaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57cc5eed-8cd5-445a-8549-1b59bd84aaf0" xlink:to="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf22f4fd-c07b-478e-a82c-09d73f4798c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf22f4fd-c07b-478e-a82c-09d73f4798c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cb85cd16-b3a9-41da-b973-a6f6ed9d0fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cb85cd16-b3a9-41da-b973-a6f6ed9d0fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_99969260-4dff-4eba-bf4e-68855b96bfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_InventoryNet_99969260-4dff-4eba-bf4e-68855b96bfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b5c485e1-b52f-4109-842f-b964c5ee9561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b5c485e1-b52f-4109-842f-b964c5ee9561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e9a29c35-96ee-4ebd-b22e-be84a2537a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_AssetsCurrent_e9a29c35-96ee-4ebd-b22e-be84a2537a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_829ea333-165e-4c98-b40d-17a7bc60c453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_829ea333-165e-4c98-b40d-17a7bc60c453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_701f4837-a546-4e7c-8a23-ad829f6760cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_701f4837-a546-4e7c-8a23-ad829f6760cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_20e7cf19-9644-47aa-b04c-209b890cd54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_Goodwill_20e7cf19-9644-47aa-b04c-209b890cd54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aea0da52-ab4a-493f-b4eb-d4afbca410a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aea0da52-ab4a-493f-b4eb-d4afbca410a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_093cd554-c84a-4d7a-b66b-e7437a081360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_EquityMethodInvestments_093cd554-c84a-4d7a-b66b-e7437a081360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9109c4a2-0a7a-4bcc-afbb-e70d48ce2a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9109c4a2-0a7a-4bcc-afbb-e70d48ce2a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f8b16d1b-ace5-40b7-89ae-d555bc5263f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96e7c322-aa29-4e61-a869-86917f929951" xlink:to="loc_us-gaap_Assets_f8b16d1b-ace5-40b7-89ae-d555bc5263f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57cc5eed-8cd5-445a-8549-1b59bd84aaf0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6b87e8b4-95df-4d17-8eea-71aad4ebd4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6b87e8b4-95df-4d17-8eea-71aad4ebd4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5d9f63f7-210c-411a-8d57-254eafa8d49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_LongTermDebtCurrent_5d9f63f7-210c-411a-8d57-254eafa8d49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e2094950-c850-4b8b-aff1-06aac5c9c0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e2094950-c850-4b8b-aff1-06aac5c9c0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ea336c63-18f3-4fb6-b738-c7f252ae7edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_LiabilitiesCurrent_ea336c63-18f3-4fb6-b738-c7f252ae7edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fb4ee961-d9b9-4ea8-bb47-01de192ce788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fb4ee961-d9b9-4ea8-bb47-01de192ce788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4117a1fc-cb32-4780-aded-3937daa50e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4117a1fc-cb32-4780-aded-3937daa50e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_297c6751-c91a-4b40-b5a1-33754e48af66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_297c6751-c91a-4b40-b5a1-33754e48af66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e75606a3-eed2-438e-a6db-9b0b91498fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e75606a3-eed2-438e-a6db-9b0b91498fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59a8505d-6762-4b6e-828f-0880e91b7e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59a8505d-6762-4b6e-828f-0880e91b7e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8f9c5fef-a653-4ada-82b7-be4d51287c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8f9c5fef-a653-4ada-82b7-be4d51287c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8f9c5fef-a653-4ada-82b7-be4d51287c8a" xlink:to="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_21abf7fc-b167-4695-8735-67f935481ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:to="loc_us-gaap_CommonStockValue_21abf7fc-b167-4695-8735-67f935481ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_08da839b-1011-4078-93e2-16cce4175364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_08da839b-1011-4078-93e2-16cce4175364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62faf784-6b0a-4f14-bf96-af344d0fbff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62faf784-6b0a-4f14-bf96-af344d0fbff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_548aaf83-bce3-44a5-bd3f-053eab368e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_548aaf83-bce3-44a5-bd3f-053eab368e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_44eb8d1b-9582-43a6-98f6-d0f1627cf6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:to="loc_us-gaap_TreasuryStockValue_44eb8d1b-9582-43a6-98f6-d0f1627cf6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b1034059-d01f-47fd-8de9-2a4095f0b768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_59c5fc0b-b9f6-44bc-859c-fac7e34bc9ca" xlink:to="loc_us-gaap_StockholdersEquity_b1034059-d01f-47fd-8de9-2a4095f0b768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3fdd45e7-2dca-44f8-86f4-23b320b21fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8f9c5fef-a653-4ada-82b7-be4d51287c8a" xlink:to="loc_us-gaap_MinorityInterest_3fdd45e7-2dca-44f8-86f4-23b320b21fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3cb2309f-3bbd-4b49-8517-8dc5025bbeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8f9c5fef-a653-4ada-82b7-be4d51287c8a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3cb2309f-3bbd-4b49-8517-8dc5025bbeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8a1d8cee-3adf-4f29-b93b-d4fd2fd6f45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_281e08b3-42d7-431b-ad21-29fdf9c3f011" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8a1d8cee-3adf-4f29-b93b-d4fd2fd6f45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_02c8c542-f521-46fc-b1de-36577b46094c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b79a8825-cafd-4c98-bfad-66c0d82d4181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02c8c542-f521-46fc-b1de-36577b46094c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b79a8825-cafd-4c98-bfad-66c0d82d4181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c457925f-ba4c-425d-a29f-cb432ea4c1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02c8c542-f521-46fc-b1de-36577b46094c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c457925f-ba4c-425d-a29f-cb432ea4c1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a1075e10-2ca5-405b-a6e7-1ea56f99f754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02c8c542-f521-46fc-b1de-36577b46094c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a1075e10-2ca5-405b-a6e7-1ea56f99f754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2e91505e-9f4f-48fa-ac40-63654438d207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02c8c542-f521-46fc-b1de-36577b46094c" xlink:to="loc_us-gaap_CommonStockSharesIssued_2e91505e-9f4f-48fa-ac40-63654438d207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_892926a9-5086-4d3e-884c-4e79e2cc1926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02c8c542-f521-46fc-b1de-36577b46094c" xlink:to="loc_us-gaap_TreasuryStockShares_892926a9-5086-4d3e-884c-4e79e2cc1926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c77e555a-7302-4ef0-9229-d1b13e2f6937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c77e555a-7302-4ef0-9229-d1b13e2f6937" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da815186-2de4-4053-bb8f-663042cd40c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da815186-2de4-4053-bb8f-663042cd40c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_49e315de-31ec-4975-9cb8-0c001b67821b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da815186-2de4-4053-bb8f-663042cd40c5" xlink:to="loc_us-gaap_ProfitLoss_49e315de-31ec-4975-9cb8-0c001b67821b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d622b9e-35bc-4324-a032-98e559bc07c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da815186-2de4-4053-bb8f-663042cd40c5" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d622b9e-35bc-4324-a032-98e559bc07c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_26f59f97-f0c7-4a52-95d9-72c58d31b8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d622b9e-35bc-4324-a032-98e559bc07c0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_26f59f97-f0c7-4a52-95d9-72c58d31b8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_5da3887c-5732-49aa-b820-edd61a382b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d622b9e-35bc-4324-a032-98e559bc07c0" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_5da3887c-5732-49aa-b820-edd61a382b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5a047fc8-6b2e-46cf-b3ee-50ceb74d9add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d622b9e-35bc-4324-a032-98e559bc07c0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5a047fc8-6b2e-46cf-b3ee-50ceb74d9add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_603a00cc-1109-4d99-a346-a40e55cf3233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d622b9e-35bc-4324-a032-98e559bc07c0" xlink:to="loc_us-gaap_ShareBasedCompensation_603a00cc-1109-4d99-a346-a40e55cf3233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_3b857d5e-dce7-48b3-a748-c697ee90cfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d622b9e-35bc-4324-a032-98e559bc07c0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_3b857d5e-dce7-48b3-a748-c697ee90cfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eba65732-c3b9-4cfe-8f8d-1d30789d2c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da815186-2de4-4053-bb8f-663042cd40c5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eba65732-c3b9-4cfe-8f8d-1d30789d2c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fdee16e6-ac12-4522-94d5-4ec168a6afde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eba65732-c3b9-4cfe-8f8d-1d30789d2c88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fdee16e6-ac12-4522-94d5-4ec168a6afde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23cd4224-e83c-4e26-9bea-5c55551aba25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eba65732-c3b9-4cfe-8f8d-1d30789d2c88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23cd4224-e83c-4e26-9bea-5c55551aba25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_660041ec-1efe-4f20-9f06-2079c9846539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eba65732-c3b9-4cfe-8f8d-1d30789d2c88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_660041ec-1efe-4f20-9f06-2079c9846539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0d2985a7-d8e7-47d6-b705-b06430b79a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eba65732-c3b9-4cfe-8f8d-1d30789d2c88" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0d2985a7-d8e7-47d6-b705-b06430b79a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8283a60-2815-4736-b9c8-568c57961833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da815186-2de4-4053-bb8f-663042cd40c5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8283a60-2815-4736-b9c8-568c57961833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_63453887-abf4-4cd7-b560-2ddd79c381ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_63453887-abf4-4cd7-b560-2ddd79c381ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6518e2e8-4584-4a69-a651-9ab7063e3de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_63453887-abf4-4cd7-b560-2ddd79c381ea" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6518e2e8-4584-4a69-a651-9ab7063e3de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c776ec32-af6e-4f3c-a2c3-7d897554a3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_63453887-abf4-4cd7-b560-2ddd79c381ea" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c776ec32-af6e-4f3c-a2c3-7d897554a3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b3a62aee-65c5-4a5b-8ce7-17620c9bfefc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_63453887-abf4-4cd7-b560-2ddd79c381ea" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b3a62aee-65c5-4a5b-8ce7-17620c9bfefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7b179b15-12c2-4933-9489-a517522962be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_63453887-abf4-4cd7-b560-2ddd79c381ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7b179b15-12c2-4933-9489-a517522962be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_2ce71c71-7b8d-4759-a60e-0ede9c4e1ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_RepaymentsOfDebt_2ce71c71-7b8d-4759-a60e-0ede9c4e1ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4ed5c2c5-765a-406f-b3ae-00fb1847502b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4ed5c2c5-765a-406f-b3ae-00fb1847502b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_bc32dbfd-74c6-4cc3-9409-a7bd53d6d119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_bc32dbfd-74c6-4cc3-9409-a7bd53d6d119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2f344b19-679f-44af-8be0-1369d163fcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2f344b19-679f-44af-8be0-1369d163fcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_35b4fa39-bfd6-4b7a-af85-c2c0a276c631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_35b4fa39-bfd6-4b7a-af85-c2c0a276c631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_4705ccee-21c6-4b66-a246-dd9d67150d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_4705ccee-21c6-4b66-a246-dd9d67150d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bbd1303c-ead9-48e3-9263-67a8fdd51be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bbd1303c-ead9-48e3-9263-67a8fdd51be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0477a506-4773-44f2-88cc-950e60432456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8a0d0c3-0523-40f8-bcd7-593a5a4add5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0477a506-4773-44f2-88cc-950e60432456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d9b742d1-4549-4e3f-a879-7c7ce9392096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d9b742d1-4549-4e3f-a879-7c7ce9392096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_072423e9-959c-4919-b821-0ec6bee3114b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_072423e9-959c-4919-b821-0ec6bee3114b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_77fe6525-173a-410f-9cfa-a1e5631dda9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_7ee81889-7d64-4214-8e9c-c39a952f0d8b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_77fe6525-173a-410f-9cfa-a1e5631dda9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20220331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_67392815-e779-4f23-a684-da37d3835f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d3897c9b-e9b8-49b8-8897-f4c756db4e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_67392815-e779-4f23-a684-da37d3835f69" xlink:to="loc_us-gaap_StatementTable_d3897c9b-e9b8-49b8-8897-f4c756db4e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fe65ce61-99a1-4150-9b9b-2ce934212fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d3897c9b-e9b8-49b8-8897-f4c756db4e5c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fe65ce61-99a1-4150-9b9b-2ce934212fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fe65ce61-99a1-4150-9b9b-2ce934212fc2" xlink:to="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ed7bb2c3-0b71-40b9-8ff1-80610f1a1a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_CommonStockMember_ed7bb2c3-0b71-40b9-8ff1-80610f1a1a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bf583b88-3c32-4a01-aacb-b6ecb92209f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bf583b88-3c32-4a01-aacb-b6ecb92209f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9bd14d9a-81ae-46b2-aceb-c107dd2e5665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_RetainedEarningsMember_9bd14d9a-81ae-46b2-aceb-c107dd2e5665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f066383f-021b-42c1-9224-136c9766060c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f066383f-021b-42c1-9224-136c9766060c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c77ddfcf-5e22-48d8-af43-7a68b9679b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_TreasuryStockMember_c77ddfcf-5e22-48d8-af43-7a68b9679b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b1d7133d-a2a8-4594-85b9-5ac5c2068eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d54a379f-73b4-4711-88cf-5ba6694f7b5e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b1d7133d-a2a8-4594-85b9-5ac5c2068eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d3897c9b-e9b8-49b8-8897-f4c756db4e5c" xlink:to="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6ee5f5a2-98d7-497b-91e7-42a69522d5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6ee5f5a2-98d7-497b-91e7-42a69522d5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1182375c-3481-4743-893d-ac175a05ebf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1182375c-3481-4743-893d-ac175a05ebf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_2531ffab-3d8e-4a9e-9afe-ccf2021b7d57" xlink:href="dgx-20220331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_2531ffab-3d8e-4a9e-9afe-ccf2021b7d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2bb0ca09-d2f0-4b53-8454-ed4c96464fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2bb0ca09-d2f0-4b53-8454-ed4c96464fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_89b2e1d7-f22b-4287-8cc6-4b68d592ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_DividendsCommonStockCash_89b2e1d7-f22b-4287-8cc6-4b68d592ee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_af97930f-ea2a-4ef5-8f95-6ac367f70e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_af97930f-ea2a-4ef5-8f95-6ac367f70e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_92e4cc1c-3b41-4292-b5ce-815de2e001ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_92e4cc1c-3b41-4292-b5ce-815de2e001ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_416f97f2-022a-4b1d-bd21-a1ba49dfe531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_416f97f2-022a-4b1d-bd21-a1ba49dfe531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_215e9d20-7d7b-48a7-8a8d-803d166fd7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_215e9d20-7d7b-48a7-8a8d-803d166fd7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ea03c05-3919-490d-888b-de6dd19331f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ea03c05-3919-490d-888b-de6dd19331f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ac31a521-9384-41f3-bcc8-72baffebb732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ac31a521-9384-41f3-bcc8-72baffebb732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_395b4ea6-2774-4501-a1a4-6800a49f2a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_395b4ea6-2774-4501-a1a4-6800a49f2a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8b908e95-7805-4e50-b6cb-307e3dbb3390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8b908e95-7805-4e50-b6cb-307e3dbb3390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d89aded8-ecc2-4e94-831e-bbcff2312178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d89aded8-ecc2-4e94-831e-bbcff2312178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b19cf682-3019-44c6-a99e-f7039f0dbafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b19cf682-3019-44c6-a99e-f7039f0dbafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c0e2628c-29b2-437f-9e2b-520325ccb361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97e3e47b-5aba-4fbd-a412-82e97d18515f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c0e2628c-29b2-437f-9e2b-520325ccb361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c634cea-3d68-47c9-a6e8-5adf0ca27f9f" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_ac1320f5-4301-4464-aae8-b11b336ec10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_ac1320f5-4301-4464-aae8-b11b336ec10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_2c3509e3-27a1-4a28-bcf5-08133001e056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_2c3509e3-27a1-4a28-bcf5-08133001e056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_549919e4-55c0-43ef-8676-c51d1abac88d" xlink:href="dgx-20220331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_549919e4-55c0-43ef-8676-c51d1abac88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_34fefa79-ff4d-4bfb-9b9a-dc927f2d0e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_256c1e56-f9ee-423e-9ceb-26335fed46b0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_34fefa79-ff4d-4bfb-9b9a-dc927f2d0e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20220331.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract_e91df9ab-3bb9-4497-85a9-659caeb40f16" xlink:href="dgx-20220331.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_75c416d7-834b-4f0d-910a-fa80d55a41b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_DescriptionOfBusinessAbstract_e91df9ab-3bb9-4497-85a9-659caeb40f16" xlink:to="loc_us-gaap_NatureOfOperations_75c416d7-834b-4f0d-910a-fa80d55a41b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7f69171a-652e-4a6f-bedf-93fd759aaec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4f283da1-cc0b-4ae5-83a9-b46ed59e2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7f69171a-652e-4a6f-bedf-93fd759aaec4" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4f283da1-cc0b-4ae5-83a9-b46ed59e2ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f3d06ebd-d753-43a3-911d-d344d7dcb724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_451f3474-9ea5-4686-9db5-8872628005da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3d06ebd-d753-43a3-911d-d344d7dcb724" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_451f3474-9ea5-4686-9db5-8872628005da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9c83d4d0-f23b-459a-8f28-61230aaa9e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3d06ebd-d753-43a3-911d-d344d7dcb724" xlink:to="loc_us-gaap_UseOfEstimates_9c83d4d0-f23b-459a-8f28-61230aaa9e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_2be848c2-8826-4f93-b5c4-55f984f78a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3d06ebd-d753-43a3-911d-d344d7dcb724" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_2be848c2-8826-4f93-b5c4-55f984f78a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6a473356-8257-4877-a456-2555d128518b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3d06ebd-d753-43a3-911d-d344d7dcb724" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6a473356-8257-4877-a456-2555d128518b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_4a70703c-b6b5-4078-a3d0-a1ae28f08d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3d06ebd-d753-43a3-911d-d344d7dcb724" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_4a70703c-b6b5-4078-a3d0-a1ae28f08d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20220331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_db4f4c45-53fd-481b-b6c8-52cd2e42114a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a201279a-acc5-4554-b35c-d72717fe258b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_db4f4c45-53fd-481b-b6c8-52cd2e42114a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a201279a-acc5-4554-b35c-d72717fe258b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20220331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_310384a0-2e62-4e65-b925-ef1aa95a1a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_58ac0b3f-b2c5-4ab6-9d84-7a65c74b4bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_310384a0-2e62-4e65-b925-ef1aa95a1a98" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_58ac0b3f-b2c5-4ab6-9d84-7a65c74b4bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_6371273b-76ae-4e5a-8825-55ccfefd0836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_310384a0-2e62-4e65-b925-ef1aa95a1a98" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_6371273b-76ae-4e5a-8825-55ccfefd0836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b2dd5eb0-aa90-49fe-bbbf-87d628d7e1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b2dd5eb0-aa90-49fe-bbbf-87d628d7e1e0" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7e094898-ec31-44da-a059-4f9eb7d9ef58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_NetIncomeLoss_7e094898-ec31-44da-a059-4f9eb7d9ef58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_282c46ee-beec-47d1-ad6a-090b7c81a9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_282c46ee-beec-47d1-ad6a-090b7c81a9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_27ef963f-987d-42d9-9320-2798eef14f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_27ef963f-987d-42d9-9320-2798eef14f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_191f9be0-8b55-4b4f-892f-91ce3ddb0be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_191f9be0-8b55-4b4f-892f-91ce3ddb0be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_461e4d60-2f83-4d80-a4d3-5138ed2de2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_461e4d60-2f83-4d80-a4d3-5138ed2de2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a3074051-a9f2-40c4-b19a-f0807a212a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a3074051-a9f2-40c4-b19a-f0807a212a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0ca6b387-dbea-4e46-8fc4-3552516714dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_EarningsPerShareBasic_0ca6b387-dbea-4e46-8fc4-3552516714dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6b513107-7cd9-419c-b317-3038b4761b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cee5b158-f661-4c1e-8be2-80131ef548d6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6b513107-7cd9-419c-b317-3038b4761b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7fb42aa9-551c-4636-bad3-98cf28ab408a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b2dd5eb0-aa90-49fe-bbbf-87d628d7e1e0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7fb42aa9-551c-4636-bad3-98cf28ab408a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20220331.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1110344d-aaa0-4c44-973c-374eb9598982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_34ebfba7-c5ba-4169-a9bf-c921c2b967de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1110344d-aaa0-4c44-973c-374eb9598982" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_34ebfba7-c5ba-4169-a9bf-c921c2b967de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8b2afda0-8b91-4cd3-be14-a3e8b15d449c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8b2afda0-8b91-4cd3-be14-a3e8b15d449c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_06457bf6-10cf-4e3b-aaa5-da6c4dafe6ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember_91181102-139d-4d6e-95f9-b898774e8aee" xlink:href="dgx-20220331.xsd#dgx_PackHealthLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:to="loc_dgx_PackHealthLLCMember_91181102-139d-4d6e-95f9-b898774e8aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_3f984d22-a713-40cb-ab62-71610cb2d9af" xlink:href="dgx-20220331.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6b4a411-55d8-411e-b61c-d7c7fa0a7ade" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_3f984d22-a713-40cb-ab62-71610cb2d9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1576d1a0-c43f-4523-8176-0b7c8eb31b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1576d1a0-c43f-4523-8176-0b7c8eb31b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c855ae5-b2fb-4290-9cb9-41d6a1a71023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1576d1a0-c43f-4523-8176-0b7c8eb31b10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c855ae5-b2fb-4290-9cb9-41d6a1a71023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f0e6801c-50b4-498c-abee-50769b4fccd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c855ae5-b2fb-4290-9cb9-41d6a1a71023" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f0e6801c-50b4-498c-abee-50769b4fccd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f6896c-6206-4f11-8569-43b04b65273b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5dfb2d04-31fc-4ac6-9598-0eb16ad7791b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5dfb2d04-31fc-4ac6-9598-0eb16ad7791b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_3d97bdc4-7754-4122-b64b-746e0df94546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_3d97bdc4-7754-4122-b64b-746e0df94546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_00177627-1fb2-40fa-9b43-a3a94d7ba3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_00177627-1fb2-40fa-9b43-a3a94d7ba3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30d25146-7cc8-4d25-ae42-236d43c3e888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30d25146-7cc8-4d25-ae42-236d43c3e888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7ac9805b-c63d-49e7-b6c8-e3355b70b79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_Goodwill_7ac9805b-c63d-49e7-b6c8-e3355b70b79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_60238a9a-f6bd-40fe-b556-7ed9689959c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_60238a9a-f6bd-40fe-b556-7ed9689959c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02c639ab-39a2-43c2-93f3-91ba08c55a14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02c639ab-39a2-43c2-93f3-91ba08c55a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a33880fa-b028-4e2f-8b46-f57d0c48675d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a33880fa-b028-4e2f-8b46-f57d0c48675d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_46d32c55-2ec3-4d5c-81fa-194fc9efc9be" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_46d32c55-2ec3-4d5c-81fa-194fc9efc9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_7a8a8736-c987-449a-9f1d-2890283d2454" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_7a8a8736-c987-449a-9f1d-2890283d2454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_feef624b-5f1e-4c0b-a7f3-599229ba75c1" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_feef624b-5f1e-4c0b-a7f3-599229ba75c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_06e8063d-a896-41e2-bf38-bcb1a45f9d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_06e8063d-a896-41e2-bf38-bcb1a45f9d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_f6bdf21d-6869-4a32-bb45-a6d2395c52bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_f6bdf21d-6869-4a32-bb45-a6d2395c52bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_68e916c8-238f-49a2-a0c8-3dcced92fa44" xlink:href="dgx-20220331.xsd#dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cf117b62-92f8-4fe4-ae1a-50af16861814" xlink:to="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_68e916c8-238f-49a2-a0c8-3dcced92fa44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4fdd6043-5fcd-4dac-a55a-1fb06380eab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d6b3aa1a-3c6e-4529-9ec7-244bf293c17e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4fdd6043-5fcd-4dac-a55a-1fb06380eab7" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d6b3aa1a-3c6e-4529-9ec7-244bf293c17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_da8d231e-a1d0-495a-a4de-5381fb52ba96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_8a7f8a63-4bd8-481b-89ea-ed52ad3a8793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_da8d231e-a1d0-495a-a4de-5381fb52ba96" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_8a7f8a63-4bd8-481b-89ea-ed52ad3a8793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6e1b8ec9-e1f3-4219-98e1-17726a4ab510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_da8d231e-a1d0-495a-a4de-5381fb52ba96" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6e1b8ec9-e1f3-4219-98e1-17726a4ab510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_63e1b11b-cb60-4c55-b6ad-0eb0b01fec86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_63e1b11b-cb60-4c55-b6ad-0eb0b01fec86" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bf0cf66-8a79-4b78-beb1-c7e0e53243c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ef3de6-ed15-4cd5-9547-2fd8ad12bae5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bf0cf66-8a79-4b78-beb1-c7e0e53243c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6ed15e33-6921-499f-9f3c-6e31d339c38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bf0cf66-8a79-4b78-beb1-c7e0e53243c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6ed15e33-6921-499f-9f3c-6e31d339c38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_102a309f-0d4f-420b-aab9-8c3c74fa8f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_102a309f-0d4f-420b-aab9-8c3c74fa8f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_102a309f-0d4f-420b-aab9-8c3c74fa8f83" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_90a8ce1a-f89f-44d2-92e1-8092195f842b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_90a8ce1a-f89f-44d2-92e1-8092195f842b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_57b95af9-e94b-443e-8aef-a8ce6cce4e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_57b95af9-e94b-443e-8aef-a8ce6cce4e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_06d94262-196b-46ce-8a63-a42693b3effd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab03de7e-a711-4cdd-a5c5-11579b86a6fb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_06d94262-196b-46ce-8a63-a42693b3effd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a1a01cab-7e8b-4033-870b-a5724bb5a840" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_9f873afd-65c6-44b7-9ff8-6d646bc1b407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_TradingSecurities_9f873afd-65c6-44b7-9ff8-6d646bc1b407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_16e57505-0485-4de6-8218-647bd12ed348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_16e57505-0485-4de6-8218-647bd12ed348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_8ce6ad51-87ec-413f-bedf-30ca4d52218c" xlink:href="dgx-20220331.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_8ce6ad51-87ec-413f-bedf-30ca4d52218c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9ef6c6ad-3306-48f2-95a1-734a78388984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9ef6c6ad-3306-48f2-95a1-734a78388984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1ca91096-f0bb-4414-9017-e2929e51c59b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1ca91096-f0bb-4414-9017-e2929e51c59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1e03629e-0786-4aba-969d-50c3cfc8272d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1e03629e-0786-4aba-969d-50c3cfc8272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fb810f88-6f62-48f8-89c3-abb12ad7b95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fb810f88-6f62-48f8-89c3-abb12ad7b95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_a2b458eb-7403-49eb-afe7-70f6d7b0303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_a2b458eb-7403-49eb-afe7-70f6d7b0303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_7e4d3567-dea7-4922-96a3-93f785b49d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4796cc86-0325-4200-ab6f-ff3069135ca2" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_7e4d3567-dea7-4922-96a3-93f785b49d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_caa11f40-e5f3-4524-a1e4-8b891080e146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_caa11f40-e5f3-4524-a1e4-8b891080e146" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e7d40610-0806-44f6-a853-83bf1874cda9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:to="loc_srt_OwnershipAxis_e7d40610-0806-44f6-a853-83bf1874cda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_fd14af3c-3585-4f85-a053-4d5764aff82e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_e7d40610-0806-44f6-a853-83bf1874cda9" xlink:to="loc_srt_OwnershipDomain_fd14af3c-3585-4f85-a053-4d5764aff82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_475c39c3-2d57-4677-adc8-08fe48b22389" xlink:href="dgx-20220331.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_fd14af3c-3585-4f85-a053-4d5764aff82e" xlink:to="loc_dgx_UMassJointVentureMember_475c39c3-2d57-4677-adc8-08fe48b22389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c5c49ac5-e532-4270-9a15-6d09faba205b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c5c49ac5-e532-4270-9a15-6d09faba205b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abcfa4e-36a5-4104-8428-09718aedbc88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c5c49ac5-e532-4270-9a15-6d09faba205b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abcfa4e-36a5-4104-8428-09718aedbc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_823df78e-17f3-4c26-b6bf-8db3a6a96994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abcfa4e-36a5-4104-8428-09718aedbc88" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_823df78e-17f3-4c26-b6bf-8db3a6a96994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8f1a760b-ae30-4072-b19b-b8842805d96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ad51ff7c-bdb3-41db-b9ab-3f9b741217fd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8f1a760b-ae30-4072-b19b-b8842805d96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_80160045-9a67-4856-aff0-0d707bed94a6" xlink:href="dgx-20220331.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8f1a760b-ae30-4072-b19b-b8842805d96e" xlink:to="loc_dgx_ContingentConsiderationMember_80160045-9a67-4856-aff0-0d707bed94a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_577c0751-140d-4c01-89b2-5cc5b02937a2" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9eaf9258-3ce1-49d3-9a41-3b49c935db72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9eaf9258-3ce1-49d3-9a41-3b49c935db72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3f86357f-7384-4df3-a20c-0a239101198e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e9aab470-0352-47ca-b8c8-e8a2696aeccd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3f86357f-7384-4df3-a20c-0a239101198e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5f5c4fa7-83be-45a5-98fe-24a51e243b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_caa11f40-e5f3-4524-a1e4-8b891080e146" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5f5c4fa7-83be-45a5-98fe-24a51e243b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ed2c5f3d-baf9-4643-9194-460ff6335c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed2c5f3d-baf9-4643-9194-460ff6335c8a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_064f57b5-6a04-4dd9-aaad-4b13d4c62d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_064f57b5-6a04-4dd9-aaad-4b13d4c62d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e738347a-0cb8-408b-8bb3-04178e6c5f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_064f57b5-6a04-4dd9-aaad-4b13d4c62d35" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e738347a-0cb8-408b-8bb3-04178e6c5f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_465c6c13-5ccd-4f5c-b532-0bdb1b3b1b20" xlink:href="dgx-20220331.xsd#dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e738347a-0cb8-408b-8bb3-04178e6c5f35" xlink:to="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_465c6c13-5ccd-4f5c-b532-0bdb1b3b1b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_b0d1c212-e479-472b-ad64-5967da96f063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_b0d1c212-e479-472b-ad64-5967da96f063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b0d1c212-e479-472b-ad64-5967da96f063" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_f256df87-72d7-44a4-84b4-0aa29652915b" xlink:href="dgx-20220331.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:to="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_f256df87-72d7-44a4-84b4-0aa29652915b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_4b7cc713-cfab-4d53-98e6-b4f1e5468678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ebf33573-e682-4910-92ea-f9cbc345bf31" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_4b7cc713-cfab-4d53-98e6-b4f1e5468678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_493a5b62-d98b-4f9c-a94c-0c7aa237d443" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:to="loc_srt_RangeAxis_493a5b62-d98b-4f9c-a94c-0c7aa237d443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_493a5b62-d98b-4f9c-a94c-0c7aa237d443" xlink:to="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8afc2074-fd65-43e8-9262-c773e0292c49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:to="loc_srt_MinimumMember_8afc2074-fd65-43e8-9262-c773e0292c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30c44ca7-b4a9-4ecb-9e45-13e3ee0b9011" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0e6b431-b072-46c7-979e-c67addc82527" xlink:to="loc_srt_MaximumMember_30c44ca7-b4a9-4ecb-9e45-13e3ee0b9011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_005c3c88-2ecb-432e-b0cc-80535c1996cf" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_98d80cd6-da61-4e96-a54a-f1533f9d8a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_98d80cd6-da61-4e96-a54a-f1533f9d8a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a6521c09-7637-4e80-bd2a-de5e9e8c2533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ad88895-a976-4dc4-923e-3306cd4cd191" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a6521c09-7637-4e80-bd2a-de5e9e8c2533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_96a3148b-0f82-4f25-a95e-8aeb44818c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_96a3148b-0f82-4f25-a95e-8aeb44818c18" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_923d1ea0-116b-44b2-9157-66ba7734d820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_923d1ea0-116b-44b2-9157-66ba7734d820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b282536-26e9-4581-913e-bfca89661243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_923d1ea0-116b-44b2-9157-66ba7734d820" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b282536-26e9-4581-913e-bfca89661243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_131d724e-7530-4c40-b196-63b381cbc5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b282536-26e9-4581-913e-bfca89661243" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_131d724e-7530-4c40-b196-63b381cbc5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_66320660-706b-4949-9f00-d5274cb37641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_66320660-706b-4949-9f00-d5274cb37641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7ccfcc54-a8ec-4fe5-9ad6-dea18e669e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_66320660-706b-4949-9f00-d5274cb37641" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7ccfcc54-a8ec-4fe5-9ad6-dea18e669e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_98e77ebf-c6c9-4c11-8257-70cfb0f5cb64" xlink:href="dgx-20220331.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7ccfcc54-a8ec-4fe5-9ad6-dea18e669e07" xlink:to="loc_dgx_ContingentConsiderationMember_98e77ebf-c6c9-4c11-8257-70cfb0f5cb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a710b7f1-ba09-4cb7-af83-1608218cb903" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_305629bb-3e7a-4874-828e-f41b37595ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_305629bb-3e7a-4874-828e-f41b37595ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_730fd5e2-ae59-4e9a-b84d-3d5092670d0f" xlink:href="dgx-20220331.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:to="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_730fd5e2-ae59-4e9a-b84d-3d5092670d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_455fea2f-819c-4988-b9b8-b2b74681edca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9091d08f-b3ca-4d2c-b9d9-dbbb45b37842" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_455fea2f-819c-4988-b9b8-b2b74681edca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20220331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_07db275e-4437-45a9-8094-f8f4e8fe44dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_24d75975-cb07-49d7-9ae7-2d0b6ffee9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_07db275e-4437-45a9-8094-f8f4e8fe44dc" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_24d75975-cb07-49d7-9ae7-2d0b6ffee9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20220331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35be5b96-9e2a-4226-ae59-6b1f3bf33fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_33e3c8ef-7441-4d85-932f-6bf64d312ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35be5b96-9e2a-4226-ae59-6b1f3bf33fde" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_33e3c8ef-7441-4d85-932f-6bf64d312ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_57f718cc-20e1-4b7c-9dc6-559dcc398e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35be5b96-9e2a-4226-ae59-6b1f3bf33fde" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_57f718cc-20e1-4b7c-9dc6-559dcc398e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_20220784-ff20-4069-a113-aa9f9e90f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35be5b96-9e2a-4226-ae59-6b1f3bf33fde" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_20220784-ff20-4069-a113-aa9f9e90f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6937d033-1c13-4b8e-98b3-de943b564197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2582e7b6-ef42-4e1b-8c4c-7f022713a18a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6937d033-1c13-4b8e-98b3-de943b564197" xlink:to="loc_us-gaap_GoodwillRollForward_2582e7b6-ef42-4e1b-8c4c-7f022713a18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2264147e-d7ba-40bf-a00f-facc3288cf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2582e7b6-ef42-4e1b-8c4c-7f022713a18a" xlink:to="loc_us-gaap_Goodwill_2264147e-d7ba-40bf-a00f-facc3288cf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_cf586a59-ff72-4309-bbe5-947205138452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2582e7b6-ef42-4e1b-8c4c-7f022713a18a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_cf586a59-ff72-4309-bbe5-947205138452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_03fb7f32-4f3b-453e-910a-62fd51a139eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2582e7b6-ef42-4e1b-8c4c-7f022713a18a" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_03fb7f32-4f3b-453e-910a-62fd51a139eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1ea224d6-765f-4e05-98f9-9fbc20641197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2582e7b6-ef42-4e1b-8c4c-7f022713a18a" xlink:to="loc_us-gaap_Goodwill_1ea224d6-765f-4e05-98f9-9fbc20641197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ef1d0e7c-c8c9-4a94-a5e2-1e76a6be9fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:href="dgx-20220331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ef1d0e7c-c8c9-4a94-a5e2-1e76a6be9fa2" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_448125e0-c031-456a-b2ad-9525ecf2a23c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_448125e0-c031-456a-b2ad-9525ecf2a23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_448125e0-c031-456a-b2ad-9525ecf2a23c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cc81db3e-a1d1-46ee-afaf-637c2fc58b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cc81db3e-a1d1-46ee-afaf-637c2fc58b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_1332e825-c1b4-4d40-95d5-85591c3c7cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_1332e825-c1b4-4d40-95d5-85591c3c7cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_b22a9777-acea-43b9-bf80-0a95009bac9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_b22a9777-acea-43b9-bf80-0a95009bac9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_df73d89d-c695-49aa-837d-179943e0196b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_df73d89d-c695-49aa-837d-179943e0196b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_8c0e4832-411c-4f0b-8526-59cf0eeb3800" xlink:href="dgx-20220331.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c8c7eb9-be5e-48aa-911a-111b76fa442b" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_8c0e4832-411c-4f0b-8526-59cf0eeb3800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_40cd61fb-d38d-4379-95e5-7ca1c74306f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_40cd61fb-d38d-4379-95e5-7ca1c74306f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_40cd61fb-d38d-4379-95e5-7ca1c74306f9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_aa95ba3f-d14d-4a4a-8f15-d85a01a1fffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:to="loc_us-gaap_TradeNamesMember_aa95ba3f-d14d-4a4a-8f15-d85a01a1fffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4eedbad9-3f82-40a7-92c1-87faa7c01123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1af3cc60-3f08-457b-aba7-581e522df74f" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4eedbad9-3f82-40a7-92c1-87faa7c01123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:href="dgx-20220331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_6f10c6f6-e416-4d54-99e1-0a2151eefc69" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3046f3ea-0f12-4bdc-ae48-bc625d3784af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3046f3ea-0f12-4bdc-ae48-bc625d3784af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_276da3f7-1496-4bc3-95f1-e7f1670902aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_276da3f7-1496-4bc3-95f1-e7f1670902aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f3fcdd9d-4417-4d71-81d3-e6dfa988fd18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f3fcdd9d-4417-4d71-81d3-e6dfa988fd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ab71f914-6a82-4e0d-a204-2590f7f41840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ab71f914-6a82-4e0d-a204-2590f7f41840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6e2cec31-8d94-4c7e-86f6-0fee569568fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6e2cec31-8d94-4c7e-86f6-0fee569568fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e416f099-6011-4432-91fc-c81533d4961a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8bf7dffe-a1c5-4887-9202-a5fbec782184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8bf7dffe-a1c5-4887-9202-a5fbec782184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6fb3b03a-f07e-4b16-aab8-fd95b8eb11f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6fb3b03a-f07e-4b16-aab8-fd95b8eb11f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_243fc5d6-cc07-4f64-9039-a3095ab277c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_243fc5d6-cc07-4f64-9039-a3095ab277c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_454e23c5-c354-4299-a34b-02579165f440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_454e23c5-c354-4299-a34b-02579165f440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1168faa-754f-4c9b-be45-148a2875d3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1168faa-754f-4c9b-be45-148a2875d3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4cec162b-4b40-49d8-8559-57d7dcb32ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4cec162b-4b40-49d8-8559-57d7dcb32ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a97b021e-5215-4c6a-9e0f-b7b1697eeec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a97b021e-5215-4c6a-9e0f-b7b1697eeec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_79c035d9-a905-42a6-ae9d-9755c803fb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_20d6a8da-7791-4c11-a6bc-7b09c0440d85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_79c035d9-a905-42a6-ae9d-9755c803fb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20220331.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a530391-4233-4d03-9be6-0aeca457f144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9703e17d-7d37-45fd-a889-487194dc70c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a530391-4233-4d03-9be6-0aeca457f144" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9703e17d-7d37-45fd-a889-487194dc70c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20220331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a3fe6a78-c3e6-4781-97ae-c6c5ec52c00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_c7786f41-1e4d-49c6-b82f-120997e3328f" xlink:href="dgx-20220331.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a3fe6a78-c3e6-4781-97ae-c6c5ec52c00f" xlink:to="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_c7786f41-1e4d-49c6-b82f-120997e3328f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_59baf7d8-153f-41a0-b0cd-7813ebca40dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_59baf7d8-153f-41a0-b0cd-7813ebca40dc" xlink:to="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_92caefd3-2682-4ecd-9d87-0b0d0242f82c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_92caefd3-2682-4ecd-9d87-0b0d0242f82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0e4fbd33-85ad-4453-a151-00dca8d5c36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_92caefd3-2682-4ecd-9d87-0b0d0242f82c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0e4fbd33-85ad-4453-a151-00dca8d5c36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_10daf63f-60e5-4e71-99b1-398a3089e68d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0e4fbd33-85ad-4453-a151-00dca8d5c36d" xlink:to="loc_us-gaap_LongTermDebtMember_10daf63f-60e5-4e71-99b1-398a3089e68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8d2d75d0-1928-4a35-bf4c-866579524d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8d2d75d0-1928-4a35-bf4c-866579524d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2bb8264b-4bf3-4b34-b8e4-c125e834380c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8d2d75d0-1928-4a35-bf4c-866579524d0b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2bb8264b-4bf3-4b34-b8e4-c125e834380c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c8c95f13-8256-4d4f-8678-7a3a4fc5049b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2bb8264b-4bf3-4b34-b8e4-c125e834380c" xlink:to="loc_us-gaap_FairValueHedgingMember_c8c95f13-8256-4d4f-8678-7a3a4fc5049b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b488f1ea-a40b-4561-9356-7b41b80f575a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_303b02a0-0111-4524-b4ae-fba5cdef0008" xlink:to="loc_us-gaap_DerivativeLineItems_b488f1ea-a40b-4561-9356-7b41b80f575a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_99271b94-442a-4fb3-ac69-712df68c8a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b488f1ea-a40b-4561-9356-7b41b80f575a" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_99271b94-442a-4fb3-ac69-712df68c8a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20220331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_22ee260c-f363-4eda-acc5-b13b745b1f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cefa5573-9479-4bd0-ad11-d422a61835b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22ee260c-f363-4eda-acc5-b13b745b1f6a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cefa5573-9479-4bd0-ad11-d422a61835b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6962720f-e6ef-489f-b11f-46546f476ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:href="dgx-20220331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6962720f-e6ef-489f-b11f-46546f476ba2" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3423d06f-6e2c-439c-8c25-65bffdfdb17e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3423d06f-6e2c-439c-8c25-65bffdfdb17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3423d06f-6e2c-439c-8c25-65bffdfdb17e" xlink:to="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_d1c98df7-cb69-435e-b554-c72d50985f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:to="loc_us-gaap_TreasuryStockMember_d1c98df7-cb69-435e-b554-c72d50985f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d8be2b09-701d-40f4-b306-f1a5dce06e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6651db34-637e-4181-9912-20ace8707064" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d8be2b09-701d-40f4-b306-f1a5dce06e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e346c51c-aae1-48fa-b7fe-76a52053e7cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:to="loc_srt_OwnershipAxis_e346c51c-aae1-48fa-b7fe-76a52053e7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_3ff626f0-694e-45d3-883d-4e4b90624e1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_e346c51c-aae1-48fa-b7fe-76a52053e7cd" xlink:to="loc_srt_OwnershipDomain_3ff626f0-694e-45d3-883d-4e4b90624e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_32b4b1e7-f882-4e93-a652-9001383b0cdc" xlink:href="dgx-20220331.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_3ff626f0-694e-45d3-883d-4e4b90624e1d" xlink:to="loc_dgx_UMassJointVentureMember_32b4b1e7-f882-4e93-a652-9001383b0cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:href="dgx-20220331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_467240a2-e823-4cc3-a709-bd36506d08f7" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e799ed32-f4e8-43d9-9859-37fe932a1341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e799ed32-f4e8-43d9-9859-37fe932a1341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_691fa8d6-7d74-4c9a-908e-41d47b22e837" xlink:href="dgx-20220331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_691fa8d6-7d74-4c9a-908e-41d47b22e837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7e27bc57-5b50-4215-b639-0fb8a6f9724b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7e27bc57-5b50-4215-b639-0fb8a6f9724b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_132fce40-9533-4dc9-a812-089e1022e304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_132fce40-9533-4dc9-a812-089e1022e304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_1a654445-4724-49d1-9c25-c09854307e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_1a654445-4724-49d1-9c25-c09854307e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_9b8bcb1b-5203-469c-8254-63d989d28733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_9b8bcb1b-5203-469c-8254-63d989d28733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d0760e65-5351-4fbc-917f-81c58b64c2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fcb5345-595b-4ff1-9796-e2474bee8192" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d0760e65-5351-4fbc-917f-81c58b64c2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_dc1d11e3-28e9-4a78-bf1b-e44b81e945a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_f2f16bcb-f1f5-488a-ba5b-2be7e9f8cba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_dc1d11e3-28e9-4a78-bf1b-e44b81e945a1" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_f2f16bcb-f1f5-488a-ba5b-2be7e9f8cba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_2784c807-2405-4e4a-8935-73f5913115f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_f41663bc-24b1-4d24-aece-342319e9e869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2784c807-2405-4e4a-8935-73f5913115f7" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_f41663bc-24b1-4d24-aece-342319e9e869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6fc95826-d447-45c1-bcfe-6d36355d8e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_Depreciation_6fc95826-d447-45c1-bcfe-6d36355d8e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8a92c187-df08-4aeb-8908-badd65bfbdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8a92c187-df08-4aeb-8908-badd65bfbdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ffae8357-3e78-4aa8-a261-e9f8d53e329f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ffae8357-3e78-4aa8-a261-e9f8d53e329f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6737a5c9-3f78-4efd-8807-c685c45c6eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_InterestExpense_6737a5c9-3f78-4efd-8807-c685c45c6eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_8625cb52-d3ce-4d5a-b050-aafc12b90505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_8625cb52-d3ce-4d5a-b050-aafc12b90505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_67eea325-4be6-4e42-acf2-3355770027fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_67eea325-4be6-4e42-acf2-3355770027fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_beb62d1c-bfcd-4e52-bff2-22a3f46d0630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_InterestPaidNet_beb62d1c-bfcd-4e52-bff2-22a3f46d0630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_af0a2bc3-a319-4310-9177-83944fda69d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_IncomeTaxesPaid_af0a2bc3-a319-4310-9177-83944fda69d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_14bc58a9-eba7-417f-808d-4bcf21fd7e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_14bc58a9-eba7-417f-808d-4bcf21fd7e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_2655e32b-ca1c-45dd-b719-5e6ff46613b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_2655e32b-ca1c-45dd-b719-5e6ff46613b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_d7935211-3111-4fa7-bde9-979144c502b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_d7935211-3111-4fa7-bde9-979144c502b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_9fba57ad-d5e5-40a9-8493-18f9b68c3929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_LiabilitiesAssumed1_9fba57ad-d5e5-40a9-8493-18f9b68c3929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_58cc99be-2587-4547-9714-5398a90610cb" xlink:href="dgx-20220331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_58cc99be-2587-4547-9714-5398a90610cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet_b5cba913-fb48-4cc6-baa7-9d82320ec3e2" xlink:href="dgx-20220331.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_dgx_Mergerconsiderationpaidpayablenet_b5cba913-fb48-4cc6-baa7-9d82320ec3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ba8ad89b-9f6e-4a59-ad4b-9d46b4b2e9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ba8ad89b-9f6e-4a59-ad4b-9d46b4b2e9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_ccce951c-0bcd-4b87-87ea-f5d2c4394944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_ccce951c-0bcd-4b87-87ea-f5d2c4394944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b6b283de-31a5-4250-8473-413b7a6f9988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b6b283de-31a5-4250-8473-413b7a6f9988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_55aa96de-fd7a-4252-8d68-9b5dc1ed2d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_711b8568-8b09-4071-ad54-0a8fd2161994" xlink:to="loc_us-gaap_LeaseCostAbstract_55aa96de-fd7a-4252-8d68-9b5dc1ed2d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a8672913-4e29-460b-b3f8-d594d36b1348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_55aa96de-fd7a-4252-8d68-9b5dc1ed2d87" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a8672913-4e29-460b-b3f8-d594d36b1348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_9dec91c9-0005-496a-a4bc-e037777affe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_5de0e860-cc61-45bd-8218-f0819e9069ac" xlink:href="dgx-20220331.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9dec91c9-0005-496a-a4bc-e037777affe9" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_5de0e860-cc61-45bd-8218-f0819e9069ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventAxis_31b5844a-752c-446b-925c-aff447f1b012" xlink:href="dgx-20220331.xsd#dgx_TriggeringEventAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_5de0e860-cc61-45bd-8218-f0819e9069ac" xlink:to="loc_dgx_TriggeringEventAxis_31b5844a-752c-446b-925c-aff447f1b012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain_47d04395-3099-4c52-b7f1-2b35dd438d8d" xlink:href="dgx-20220331.xsd#dgx_TriggeringEventDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_TriggeringEventAxis_31b5844a-752c-446b-925c-aff447f1b012" xlink:to="loc_dgx_TriggeringEventDomain_47d04395-3099-4c52-b7f1-2b35dd438d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmendedRealEstateLeaseMember_23e0c5ce-1bf3-4f69-bc2b-b5966c655d33" xlink:href="dgx-20220331.xsd#dgx_AmendedRealEstateLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_TriggeringEventDomain_47d04395-3099-4c52-b7f1-2b35dd438d8d" xlink:to="loc_dgx_AmendedRealEstateLeaseMember_23e0c5ce-1bf3-4f69-bc2b-b5966c655d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_20faef0c-4fe0-4382-8266-68243fbc7de5" xlink:href="dgx-20220331.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_5de0e860-cc61-45bd-8218-f0819e9069ac" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_20faef0c-4fe0-4382-8266-68243fbc7de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ef344ec5-9cf3-4d83-8023-aba9750c8b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_20faef0c-4fe0-4382-8266-68243fbc7de5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ef344ec5-9cf3-4d83-8023-aba9750c8b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20220331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a7bd68ea-6cbe-442e-a36a-fbd982c70bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_490f18e6-6ccc-4368-a395-c72b9d16877e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a7bd68ea-6cbe-442e-a36a-fbd982c70bf4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_490f18e6-6ccc-4368-a395-c72b9d16877e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1f9c35a2-e6d7-4460-8ca1-80fec9ff95fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_804d0989-600f-47f8-992e-3d97c768f6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1f9c35a2-e6d7-4460-8ca1-80fec9ff95fb" xlink:to="loc_us-gaap_LossContingenciesTable_804d0989-600f-47f8-992e-3d97c768f6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_804d0989-600f-47f8-992e-3d97c768f6b7" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7913d63f-dd62-486b-bd1c-86a454fab72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f1b9ba87-8143-4114-8d2d-cb9ba8ffeddd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7913d63f-dd62-486b-bd1c-86a454fab72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_4a34d64d-2cd5-4082-9df5-2dd6fd3490af" xlink:href="dgx-20220331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7913d63f-dd62-486b-bd1c-86a454fab72f" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_4a34d64d-2cd5-4082-9df5-2dd6fd3490af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_804d0989-600f-47f8-992e-3d97c768f6b7" xlink:to="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_4b4f97cb-8e08-49ff-8137-d28c50aee8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_4b4f97cb-8e08-49ff-8137-d28c50aee8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_934d9bbc-5674-45f6-a588-5266bc471e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fe7ca59c-ab7d-4eeb-b535-4abc96e42015" xlink:to="loc_us-gaap_LitigationReserve_934d9bbc-5674-45f6-a588-5266bc471e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1f9c35a2-e6d7-4460-8ca1-80fec9ff95fb" xlink:to="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_883333c7-1088-421d-bec8-1057d9e33056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_883333c7-1088-421d-bec8-1057d9e33056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_883333c7-1088-421d-bec8-1057d9e33056" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f716b557-217c-465d-92d7-5e2120471a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:to="loc_us-gaap_SecuredDebtMember_f716b557-217c-465d-92d7-5e2120471a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f553c023-916e-4b98-bf42-d153e5536dba" xlink:href="dgx-20220331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7a53ecd5-f6bd-4e66-be3b-652b55496894" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f553c023-916e-4b98-bf42-d153e5536dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_03944f41-2f74-4d81-b4cd-dfed4b8fc048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:to="loc_us-gaap_CreditFacilityAxis_03944f41-2f74-4d81-b4cd-dfed4b8fc048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_49da40d2-6c33-4081-aa04-f9c3517f5c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_03944f41-2f74-4d81-b4cd-dfed4b8fc048" xlink:to="loc_us-gaap_CreditFacilityDomain_49da40d2-6c33-4081-aa04-f9c3517f5c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_f780a266-a7cb-49da-8597-8a988c30cb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_49da40d2-6c33-4081-aa04-f9c3517f5c0f" xlink:to="loc_us-gaap_LetterOfCreditMember_f780a266-a7cb-49da-8597-8a988c30cb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a742909-ce04-43ac-91a9-fa26785c84c4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd28ea7b-8d8b-4dd0-8637-0ac80c846b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd28ea7b-8d8b-4dd0-8637-0ac80c846b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c67df93d-ef29-4979-be26-6262f6ed9d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5d54d52a-b122-404c-9b09-b07fb154530b" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c67df93d-ef29-4979-be26-6262f6ed9d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_a5c09088-d10e-4008-9e9b-baef06e05a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1f9c35a2-e6d7-4460-8ca1-80fec9ff95fb" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_a5c09088-d10e-4008-9e9b-baef06e05a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20220331.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ed42f7ff-c5df-4a37-ad81-a7b0ff853528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_e79b6c98-f7db-4ea6-971b-734ad1369de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ed42f7ff-c5df-4a37-ad81-a7b0ff853528" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_e79b6c98-f7db-4ea6-971b-734ad1369de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20220331.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6996ed33-2110-4906-b0e6-ff1e2b1958ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_58cc4920-4524-4ba9-bcaf-5affd8e3c635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6996ed33-2110-4906-b0e6-ff1e2b1958ad" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_58cc4920-4524-4ba9-bcaf-5affd8e3c635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_603de15d-8486-4ff6-9505-dafad6926ef1" xlink:href="dgx-20220331.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6996ed33-2110-4906-b0e6-ff1e2b1958ad" xlink:to="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_603de15d-8486-4ff6-9505-dafad6926ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9bbe7ac5-03ab-48f6-b8d5-11f5723e218a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9bbe7ac5-03ab-48f6-b8d5-11f5723e218a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cac64441-c2a8-4cf7-b34c-f4f023cfd55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cac64441-c2a8-4cf7-b34c-f4f023cfd55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cac64441-c2a8-4cf7-b34c-f4f023cfd55a" xlink:to="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_23f75c29-ded1-45cf-8321-35a3dc6b365d" xlink:href="dgx-20220331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_23f75c29-ded1-45cf-8321-35a3dc6b365d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_8629f90d-fcdb-4022-95f1-2faa44015bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_8629f90d-fcdb-4022-95f1-2faa44015bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_6b97bcbd-a6a4-4f5a-86d1-5bf9e291c5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_66defa5a-a309-4989-9227-fa6c47c6ef9f" xlink:to="loc_us-gaap_CorporateMember_6b97bcbd-a6a4-4f5a-86d1-5bf9e291c5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bcca7bd5-e3e3-468f-a916-0480a676c26f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:to="loc_srt_RangeAxis_bcca7bd5-e3e3-468f-a916-0480a676c26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0592ae12-d43b-457b-8a0d-e25e6020ff0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bcca7bd5-e3e3-468f-a916-0480a676c26f" xlink:to="loc_srt_RangeMember_0592ae12-d43b-457b-8a0d-e25e6020ff0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2c85aea6-2705-443f-a7bf-6717206900fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0592ae12-d43b-457b-8a0d-e25e6020ff0d" xlink:to="loc_srt_MinimumMember_2c85aea6-2705-443f-a7bf-6717206900fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4915e114-415f-48a7-b514-ba3aeda1ffba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:to="loc_srt_ProductOrServiceAxis_4915e114-415f-48a7-b514-ba3aeda1ffba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4915e114-415f-48a7-b514-ba3aeda1ffba" xlink:to="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_165d6bec-b1b4-4916-8b7b-ca6ba9c48eb6" xlink:href="dgx-20220331.xsd#dgx_RoutineClinicalTestingAndOtherServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_165d6bec-b1b4-4916-8b7b-ca6ba9c48eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_4876c691-ea75-4369-abdf-e7d51a2e715c" xlink:href="dgx-20220331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_COVID19TestingServicesMember_4876c691-ea75-4369-abdf-e7d51a2e715c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_1c8b248f-cf38-4c45-b64b-fc8543d1e590" xlink:href="dgx-20220331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_1c8b248f-cf38-4c45-b64b-fc8543d1e590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_2baae3e9-365d-46cb-b66f-a4e04c3f9793" xlink:href="dgx-20220331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_2baae3e9-365d-46cb-b66f-a4e04c3f9793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_55b4fd70-31a7-4922-8bf6-cd068ea460de" xlink:href="dgx-20220331.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e3276a82-88fd-4798-aae4-f3dde2769ccd" xlink:to="loc_dgx_AllotherservicesMember_55b4fd70-31a7-4922-8bf6-cd068ea460de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09f7cb5a-0690-4207-ba79-51b95747592b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_dd20d8a9-8260-4f1b-887f-131eaeb5e1cd" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_dgx_PercentageofNetRevenues_dd20d8a9-8260-4f1b-887f-131eaeb5e1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8de139c-e273-4fa8-aefb-3fd03feb260b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8de139c-e273-4fa8-aefb-3fd03feb260b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a236b46f-97a6-499d-ab9f-28aabf8ac2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_OperatingIncomeLoss_a236b46f-97a6-499d-ab9f-28aabf8ac2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9c71be83-6731-48d0-aca4-b9d68324fce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9c71be83-6731-48d0-aca4-b9d68324fce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b8d2653-b3d0-4bd9-ab70-61eba69bc4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b8d2653-b3d0-4bd9-ab70-61eba69bc4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a7c49fcc-5ada-4f01-ac70-2c3e2f11b51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a7c49fcc-5ada-4f01-ac70-2c3e2f11b51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83fb89f5-a3f4-4e15-80e7-66642cb0aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83fb89f5-a3f4-4e15-80e7-66642cb0aa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3ce01535-5d8b-4403-8b45-ad57b3518efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_ProfitLoss_3ce01535-5d8b-4403-8b45-ad57b3518efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_93d547fd-9c01-45d9-9649-2bed704a51c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_93d547fd-9c01-45d9-9649-2bed704a51c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5bf10556-ac90-4650-be5d-562d4e800c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58e69ed9-3455-4b50-b88a-045018af65b8" xlink:to="loc_us-gaap_NetIncomeLoss_5bf10556-ac90-4650-be5d-562d4e800c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20220331.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e1607fe-e23b-494c-bc05-f97ab9ee9d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1bf5ffe2-3382-4e2e-9eff-2e8783c5a957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e1607fe-e23b-494c-bc05-f97ab9ee9d19" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1bf5ffe2-3382-4e2e-9eff-2e8783c5a957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20220331.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b690c614-0cd3-4a15-a245-da41886ba764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_55c1eac3-e094-4046-a8c9-3fce53c8b2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b690c614-0cd3-4a15-a245-da41886ba764" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_55c1eac3-e094-4046-a8c9-3fce53c8b2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_80b08312-6323-49b9-b07d-ae6caba5ff0d" xlink:href="dgx-20220331.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b690c614-0cd3-4a15-a245-da41886ba764" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_80b08312-6323-49b9-b07d-ae6caba5ff0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20220331.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_de403f76-0d32-4b3e-b287-d55c9f019f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_de403f76-0d32-4b3e-b287-d55c9f019f07" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7dca3647-9e2c-4140-b85a-9d77b69833a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7dca3647-9e2c-4140-b85a-9d77b69833a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7dca3647-9e2c-4140-b85a-9d77b69833a0" xlink:to="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_3721b6ae-682e-4fbc-87bb-e0f5a2ebdaa2" xlink:href="dgx-20220331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_3721b6ae-682e-4fbc-87bb-e0f5a2ebdaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_eca43f54-fd64-462e-90bc-c370fef3cdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_69e7732d-b94d-42a0-9973-00a766515409" xlink:to="loc_us-gaap_AllOtherSegmentsMember_eca43f54-fd64-462e-90bc-c370fef3cdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_srt_RangeAxis_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38fed6c8-8345-4476-8b4a-6b3582e10a49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c8c83f1c-e07a-43c9-adb9-cbe8f7f27fc8" xlink:to="loc_srt_RangeMember_38fed6c8-8345-4476-8b4a-6b3582e10a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9b8c8a44-d461-4799-bb28-eae4a1533637" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_38fed6c8-8345-4476-8b4a-6b3582e10a49" xlink:to="loc_srt_MinimumMember_9b8c8a44-d461-4799-bb28-eae4a1533637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_7ba65155-91a9-4758-9c3e-5ac1c378423a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_us-gaap_SubsegmentsAxis_7ba65155-91a9-4758-9c3e-5ac1c378423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_7ba65155-91a9-4758-9c3e-5ac1c378423a" xlink:to="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_5493f1e6-28b8-4858-b4ca-ef4e32ac48b6" xlink:href="dgx-20220331.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_HealthcareInsurersMember_5493f1e6-28b8-4858-b4ca-ef4e32ac48b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_8658beb8-42a2-46f4-93be-cb5cfcb1a615" xlink:href="dgx-20220331.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_GovernmentPayersMember_8658beb8-42a2-46f4-93be-cb5cfcb1a615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_93eb8be6-704c-4a49-b017-fe0935be33b7" xlink:href="dgx-20220331.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_ClientPayersMember_93eb8be6-704c-4a49-b017-fe0935be33b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_fad6e705-3f51-41f6-9979-2dcdafc10115" xlink:href="dgx-20220331.xsd#dgx_PatientsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_PatientsMember_fad6e705-3f51-41f6-9979-2dcdafc10115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_46656931-8321-4889-a78e-156a74ce1a56" xlink:href="dgx-20220331.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7233f41d-9a30-4549-b125-d9804bb94a8a" xlink:to="loc_dgx_DSBusinessesMember_46656931-8321-4889-a78e-156a74ce1a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_92df0d0f-9b3f-48bc-9500-02dd035e5841" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_srt_ProductOrServiceAxis_92df0d0f-9b3f-48bc-9500-02dd035e5841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_92df0d0f-9b3f-48bc-9500-02dd035e5841" xlink:to="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_a95d98bf-4c0a-4f6f-b7ad-4bb13dbb3fec" xlink:href="dgx-20220331.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:to="loc_dgx_FeeforserviceMember_a95d98bf-4c0a-4f6f-b7ad-4bb13dbb3fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_9a7edff9-e5db-4104-b354-451c0551e8d3" xlink:href="dgx-20220331.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_98a7d759-010b-4687-b6d0-ba67f0c8257d" xlink:to="loc_dgx_CapitatedMember_9a7edff9-e5db-4104-b354-451c0551e8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0a42d98-809c-46ff-833b-9c871f5a0ba9" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_dd50affd-5730-4c20-a494-4ba7cf04cbd9" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:to="loc_dgx_PercentageofNetRevenues_dd50affd-5730-4c20-a494-4ba7cf04cbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_f6f61f5c-c547-4513-9bae-922a9603e6cf" xlink:href="dgx-20220331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afc070ae-1afd-438e-939a-6592d884bc69" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_f6f61f5c-c547-4513-9bae-922a9603e6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362177716264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,365,028<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362177381272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 2,611<span></span>
</td>
<td class="nump">$ 2,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">1,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">2,098<span></span>
</td>
<td class="nump">2,060<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating expense, net</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="nump">$ 2.97<span></span>
</td>
<td class="nump">$ 3.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 2.92<span></span>
</td>
<td class="nump">$ 3.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362179766376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 373<span></span>
</td>
<td class="nump">$ 490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in available-for-sale debt securities, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 353<span></span>
</td>
<td class="nump">$ 459<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362176988216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 712<span></span>
</td>
<td class="nump">$ 872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $30 and $31 as of March&#160;31, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">1,371<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,668<span></span>
</td>
<td class="nump">1,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">620<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,197<span></span>
</td>
<td class="nump">7,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,442<span></span>
</td>
<td class="nump">13,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,544<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">3,985<span></span>
</td>
<td class="nump">4,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">742<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2022 and December 31, 2021; 162 shares issued as of both March 31, 2022 and December 31, 2021</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,226<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">7,926<span></span>
</td>
<td class="nump">7,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 45 and 43 shares as of March&#160;31, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="num">(3,761)<span></span>
</td>
<td class="num">(3,453)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">6,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,415<span></span>
</td>
<td class="nump">6,483<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 13,442<span></span>
</td>
<td class="nump">$ 13,611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362177688584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362177345960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 373<span></span>
</td>
<td class="nump">$ 490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Provision for credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(105)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Increase in investments and other assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(169)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(373)<span></span>
</td>
<td class="num">(410)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(471)<span></span>
</td>
<td class="num">(566)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="num">(160)<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">872<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of period</a></td>
<td class="nump">$ 712<span></span>
</td>
<td class="nump">$ 1,230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362174543192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 6,809<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,841<span></span>
</td>
<td class="nump">$ 9,303<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
<td class="num">$ (5,366)<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2021</a></td>
<td class="nump">6,790<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
<td class="nump">9,690<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(5,740)<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2020</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2021</a></td>
<td class="nump">6,483<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
<td class="nump">7,649<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(3,453)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2022</a></td>
<td class="nump">6,415<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,226<span></span>
</td>
<td class="nump">$ 7,926<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">$ (3,761)<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2022</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181346584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DescriptionOfBusinessAbstract', window );"><strong>Description of Business (Abstract)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of Business (Abstract)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181394968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of significant demand for COVID-19 testing.  As a result, operating results for the three months ended March&#160;31, 2022 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181339464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:77.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.187%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.189%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.46&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:77.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.187%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.189%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362179961032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $123&#160;million, net of $4&#160;million cash acquired, which consisted of cash consideration of $105&#160;million and contingent consideration initially estimated at $18&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $96&#160;million of goodwill (of which $78&#160;million is tax-deductible), $30&#160;million of intangible assets,  $5&#160;million of operating lease right-of-use assets, $5&#160;million of operating lease liabilities and $(3)&#160;million of working capital. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 11.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On December 13, 2021, the Company completed the acquisition of assets of Labtech Diagnostics, LLC ("Labtech"), an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, and recorded the assets acquired and liabilities assumed based on a preliminary purchase price allocation. During the three months ended March 31, 2022, the Company revised its purchase price allocation and recorded a $7&#160;million increase to goodwill, a $3&#160;million increase to customer-related intangible assets and a $10&#160;million increase to the estimated contingent consideration liability.  These adjustments did not have a material impact on the Company's consolidated results of operations. </span></div>&#160;&#160;&#160;&#160;For details regarding the Company's 2021 acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362179953832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Such equity investments are classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the acquisitions of Pack Health and Labtech, the Company has contingent consideration obligations, with a potential maximum aggregate payment of $40&#160;million, that are to be paid based on the achievement of certain testing volume or revenue benchmarks.  As of March&#160;31, 2022, the fair value of these contingent consideration liabilities totaled $33 million.  These contingent consideration liabilities are measured at fair value using either an option-pricing method or a Monte Carlo method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume or revenue and other market inputs, including comparable company revenue volatility (7.5%) and a discount rate (ranging from 2.5% to 3.0%).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding the Company's acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 4 to the interim unaudited consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.912%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2022, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of March&#160;31, 2022 and December&#160;31, 2021, the fair value of the Company&#8217;s debt was estimated at $4.1 billion and $4.4 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181385064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in goodwill for the three months ended March&#160;31, 2022 and for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,197&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of March&#160;31, 2022 and December&#160;31, 2021 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, goodwill acquired was principally associated with the acquisition of Pack Health, and adjustments to goodwill primarily related to an adjustment of the purchase price allocation for Labtech (see Note 4), partially offset by foreign currency translation. For the year ended December&#160;31, 2021, goodwill acquired was principally associated with the acquisitions of the assets of the outreach laboratory services business of Mercy Health and the assets of Labtech (see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K), and adjustments to goodwill related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets as of March&#160;31, 2022 and December&#160;31, 2021 consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(930)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(930)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2022 is as follows:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181385912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div>&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181547688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 7); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022 and 2021, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2022, the Company's Board of Directors declared a quarterly cash dividend of $0.66 per common share.  During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2022, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of March&#160;31, 2022, $1.3 billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, the Company repurchased 2.6&#160;million shares of its common stock for $350&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, the Company repurchased 3.4 million shares of its common stock for $410 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022 and 2021, the Company reissued 0.5 million shares and 0.6 million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2022 and December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 5.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181378296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three months ended March&#160;31, 2022 and 2021 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:78.042%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.959%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March 31, 2022, the Company amended a real estate lease and, based on the updated terms, the classification of the lease changed from a finance lease to an operating lease.  As a result, the Company recorded a $31&#160;million operating lease right-of-use asset.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362179968200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2022, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, in 2019 the Company was notified that the Office for Civil Rights of the U.S. Department of Health and Human Services ("OCR") and numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  On April 6, 2022, OCR informed the Company that it closed its review.</span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ReproSource Fertility Diagnostics, Inc.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#8220;ReproSource&#8221;), a subsidiary of the Company, is subject to two putative class action lawsuits: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bickham v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for Massachusetts) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for Nevada). The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#8217; private information. ReproSource has moved to dismiss both complaints and to transfer the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint to the U.S. District Court for Massachusetts.  In addition, the Company has been notified that certain federal and state governmental authorities, including OCR and attorney general offices from three states, are investigating or otherwise seeking information and/or documents related to the incident.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2022, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $3 million and $4 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span>&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $158 million and $159 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181351576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2022, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three months ended March&#160;31, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:77.792%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:77.792%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181534856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over 95% of the Company&#8217;s total net revenues for the three months ended March&#160;31, 2022 and 2021 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue and Net Accounts Receivable by Customer Type</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362177216712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards to be Adopted</a></td>
<td class="text">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181522760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:77.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.187%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.189%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.46&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:77.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.187%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.189%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362182269480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value, Measurement Inputs</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.912%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362177714600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill, Net</a></td>
<td class="text">The changes in goodwill for the three months ended March&#160;31, 2022 and for the year ended December&#160;31, 2021 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,197&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Excluding Goodwill</a></td>
<td class="text">Intangible assets as of March&#160;31, 2022 and December&#160;31, 2021 consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(930)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(930)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense Intangible Assets</a></td>
<td class="text">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2022 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181404872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock', window );">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</a></td>
<td class="text">As of March&#160;31, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181495720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the three months ended March&#160;31, 2022 and 2021 was as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:78.042%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.959%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362182268088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Reporting Information by Segment</a></td>
<td class="text">The following table is a summary of segment information for the three months ended March&#160;31, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:77.792%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock', window );">Schedule of Revenues by Major Service</a></td>
<td class="text">Net revenues by major service were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:77.792%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Revenues by Major Service</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181340744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362177605400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Less: Earnings allocated to participating securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">$ 468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="nump">$ 2.97<span></span>
</td>
<td class="nump">$ 3.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 2.92<span></span>
</td>
<td class="nump">$ 3.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and performance share units</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362174574520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,095<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember', window );">Pack Health, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">$ 123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital', window );">Working capital</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember', window );">Pack Health, LLC | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Labtech Diagnostics, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, purchase adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets', window );">Increase to the estimated contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Labtech Diagnostics, LLC | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments', window );">Intangible assets, purchase adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill and Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for purchase accounting adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362176825320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362179769384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362176998856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Business Acquisition) (Details) - Pack Health, LLC and Labtech Diagnostics, LLC<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Maximum Contingent Consideration Payment</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember', window );">Comparable Company Revenue Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember', window );">Discount rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember', window );">Discount rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=dgx_MeasurementInputComparableCompanyRevenueVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=dgx_MeasurementInputComparableCompanyRevenueVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362182576200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details) - Significant Unobservable Inputs, Level 3 - Contingent Consideration<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2021</a></td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances', window );">Purchases, additions and issuances</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, March 31, 2022</a></td>
<td class="nump">$ 33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362174564232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at beginning of period</a></td>
<td class="nump">$ 7,095<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Adjustments to goodwill</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at end of period</a></td>
<td class="nump">$ 7,197<span></span>
</td>
<td class="nump">$ 7,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362178290808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 2,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(930)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(903)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2022</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Intangible Assets Not Subject to Amortization - Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Intangible Assets Not Subject to Amortization - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer-related intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 1,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember', window );">Total Amortizing Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 1,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(930)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(903)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362181398088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362178471640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase authorization remaining available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362178462968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Mergerconsiderationpaidpayablenet', window );">Merger consideration payable</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: Cash acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Mergerconsiderationpaidpayablenet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger consideration paid (payable), net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Mergerconsiderationpaidpayablenet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362182198216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 620<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TriggeringEventAxis=dgx_AmendedRealEstateLeaseMember', window );">Amended Real Estate Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalCashFlowAndOtherDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Supplemental Cash Flow and Other Data [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalCashFlowAndOtherDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TriggeringEventAxis=dgx_AmendedRealEstateLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TriggeringEventAxis=dgx_AmendedRealEstateLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362178244632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="nump">$ 158,000,000<span></span>
</td>
<td class="nump">$ 159,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember', window );">Excludes general and professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362178337720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,611<span></span>
</td>
<td class="nump">$ 2,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating expense, net</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineClinicalTestingAndOtherServicesMember', window );">Routine clinical testing and other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">1,066<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 Testing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">739<span></span>
</td>
<td class="nump">653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,541<span></span>
</td>
<td class="nump">$ 2,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 562<span></span>
</td>
<td class="nump">$ 712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">$ (56)<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineClinicalTestingAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineClinicalTestingAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140362178157416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients (including coinsurance and deductible responsibilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>dgx-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:dgx="http://questdiagnostics.com/20220331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20220331.xsd" xlink:type="simple"/>
    <context id="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic2dc8d4dcbed40af97db1fac37505ee9_I20220414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-04-14</instant>
        </period>
    </context>
    <context id="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25a67828d80741189c9e71a1926cad84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib939a88f4c11457d8f94ab3011660e90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i387e21b64a5248cc90a14d9bcadffd40_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52d9091e753f4cdfaae8f68bbc2ea33f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a0f83bf88134568bde41c150af0ba41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30bff75e183e4fc391898fd34f86863b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d41353be3a04b738b4f4bc36e5d3820_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia93d7d0509f14b08b2b9728096cbb3e7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idd6c865cfcc5493cb1940ce9b692bd7a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic760c160bf9646bba4102bda5ef94b44_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57bcad1774d541d9ac66fc0077491325_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib1bfa6a5fb1046dca736f71283a88051_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib36d5ba191104fe89f537554035b8907_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iffea91bc8dcb4e06aadf8f63905ab017_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1e3eda6f95ed4a74b1f90e8c5bd28859_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i680491199aa14f2682953e743b93f967_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iea0f667d8e834262a48cda2044511f1a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i481f1360cd724a9f8b74bd582e93a71e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i866848e13a4f4ec1bd85c404788b9111_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie178ff96837c4706a3f4b587cccefe07_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifacdb2eb293b429f930747ce81b4dd81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a484208ca0d41ddb217b0144453f3f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f11b90b6d564754b9b5bd0732625a2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i464858952d21412f9213fc378aaab1ac_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2686a6f90fac460b9d020e72884a3fe2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icddb6cb2943147b2b89e52fe7b46911b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i140c25a605a24f3f911883de7c499016_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id61fd4bfc4644f119456da0f99198313_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2bb36dc1a5204d5a8e9b530e2659be72_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2c0f7fb2e84b44339afb9b2e820d731c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0fd9349805414371ba05699141101f35_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i04a9c2b4a76640dfb7f274a43fe1b5eb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ida954a9978a1447886fc0195a622b9a4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ida1ff8668cba4e6684c42088da1bfa77_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="i884e9caa9b5c413394c2637a54593f5e_I20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-01</instant>
        </period>
    </context>
    <context id="i870e097aa1664c7f8acdc911a05478f0_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="ifdd1512ec1684818af722553ac20625e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5d66988d2a014b72871550db7d08daf0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic936b9e915e24f4d821896ad2218ef1f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i27a72f75399841a68c34e11399b140b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9e3f4eba1f614cb197c151b25af12da1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied8ed8c262d24d46a2c201ca154c4272_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9f9f49fd6c3745b680a20c68977f7aba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2be7687e7ef34f6d9e723bd178e1687e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic598741bcee9497b94ab1430b0c70994_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idcb19055dda64f259d36cb98695b26b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2e2a68bb24914f12aeee3a6a2f421c55_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i47b7a4e4c1d74dffbfc1eda1b01dc524_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dgx:MeasurementInputComparableCompanyRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if5267cce41ca40a1842a5b25f34596c8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4641ff4492b5431787af20a7c361b215_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0c1e1a831dc645f884fd63f68dafc0eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fa858bac8ab409c945714c4cfc92476_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i06ff7b7bc1e443609656c518c6eb5ae7_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="ia5303d7e238e424da44bd18e24d4586b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5ca82d7b06e45028a679da518e76e9b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2a068e932f834d0fbed8af834b0682fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbc15825d3594bf5b2196f75b4ee733a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id71bba1de51f4a99b9449c6f849555cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia8340eece4f647c8a754867732e5a6f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f08c600ea6544d49b1b2a1a8014d75d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4b6174ae321c4e74944b97981d1b2ae3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bc34a35184c4ce7a3e425dbd8fd8062_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2ce3a63acc1249caaa4588f7c259007a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib0a36c4164bf4b33be691b9ef663be7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59659f457ca94d118fef31ba6ba41012_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i97ad39521e69481f9a20580c7230cd21_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icaa2c3e268834b25b750134c958ab08c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81c37e4e3f1a4370a83bb9c770279e61_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8b580343931c4d66b78cda2fd05abe6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09ec31233f0e4dad9da135008aa5f080_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i254bf5959746494883fdd89b5852102b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf58f44b38cb4bb8837626b15f8ab005_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia613c80a290b4a8eb01c818fb05d0800_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9547ae76ad524df1be143291c3dc3dc8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i99220d08c6b942a2b4ba862f3c64bf42_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia42df8753f0440b391d7bee60af61213_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i29b9b62572e64aaeb2ee5d852bb0ac6f_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="i551c518ca51d4c9c9055dcba49fc4c81_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dgx:TriggeringEventAxis">dgx:AmendedRealEstateLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic10d96a9520947408f8b1fbb71092e38_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id00a1c2aa7e8495ab6e23f05811ff14c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic6a79d7e1b5247eca266100ab948eb9f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01801313bd9d425a81cb897b8cba44d0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3b1004fab47841e394d81b95440cd37a_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="iefe7c88a31514a2893220839bc498be1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1e1824dfa71e45bab55dc851db327252_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c68974c9ae14e999016cc1e131cfde0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i67a7e4d1308249418b99f41ff7f71e1c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i406d4d3cc39844eb98b58ddc6a62338d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic37254f6ff664132a27df6fb73d9bc34_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0262431589c64d5988860f60c34228e6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7c63e12f82864bd19c390ad2281a65b9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic4be0056c2d4457d87c5fadf557e6aa3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8822bce97a2b4af293f8ceb8f7512c0c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i06dddf077b184e02aeb6d79159ca7906_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8517e8d9b8ac4e6daf93a2e50dccb9da_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i357b7ece8680488e8499ff07ec4d5141_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib9f3a4d5ffd34af588f97c9b3c569245_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i554bdadf4c5d454fbfe277f057fbf835_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic0122ad278dc483e8e5ca7f6dbcfebaa_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib6e73eb975d144a494494df1d9ae3f91_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i391bf57712c046ac8a065213c2be01ca_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2618e94f78ff4be6a974f3d7437c9209_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4b2b3bb914b24a5fb505052ab070ca0e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic31416e26495484dbfd0cc01ec4b8a6a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i15e3cb2bbf8749a79b1c1e421d2c139e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1c1aad07e73c4da6b04fcd621739200e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i425a3e05cbb94ca5a14e66f99fada19f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i149bfab7a1c24f29b4792c319f8ef948_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3cd4daa713554f92aef54d2f74630a39_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70a9907567b640a289999fae84223794_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i84f9da75efe04d6daab9a677cd6e4633_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia292ad0369a643b9828d88492775c95c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i01cb765ce9e44733bd6b1826d67c2ff7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i170456437f45486e9e310a25b9ca855a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a550c5ebbc248d0b9bce68cfbfe1a1b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if2160658eb534668abfaded3ccde2376_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if2a0ec3fce9b4f089434858787b2e801_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2135620d30a34a64941ea2b56bd5a164_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i951aac53e0e940dcb3d7a633466939f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65b4fed4ceae4b3cab7b60c00ca07f58_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if0c1bc5bdc9442598a7e0cbe2845150b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b80ff0f7b2446d5abc033b9fca38b60_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i933ce909814a47798eadf9de833f81dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e7cf4826791442d82f7d57441fce080_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1679f660fe4a49e7a6124528bc22afb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i28c3b5952b744911ba36a0b36600e646_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib2ad59c542884b95abd5a3ffaad7ec7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV8xLTEtMS0xLTQ1MDg1_c2a64094-cdd6-4587-b003-48c8bfa58a35">0001022079</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV8yLTEtMS0xLTQ1MDg1_36553b5a-8480-4ffd-bc1d-0133c89db2ee">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV8zLTEtMS0xLTQ1MDg1_79fca51c-e367-48d6-8d3b-3c2f6a8e0426">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV80LTEtMS0xLTQ1MDg1_b8871140-27cf-459b-ab0b-09664a2df11b">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80L2ZyYWc6NjJiMmE4ZjlhZjk5NDBmMGExZWFiMzdiM2ZlNDg4ZWYvdGFibGU6YzNhYWM3ODNiYjljNGQ4NmIwYjc2MWY0ZGM5MDJhMjEvdGFibGVyYW5nZTpjM2FhYzc4M2JiOWM0ZDg2YjBiNzYxZjRkYzkwMmEyMV81LTEtMS0xLTQ1MDg1_615cf3be-8b50-42fc-9851-6a8a9661d2d4">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI1_33accfe4-f3f2-44dc-9aad-38e7acaeac47">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI2_6ee5d1ef-4a96-4d69-a657-1a8e4beceaba">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV84MjQ2MzM3MjEwMjcy_7e280708-630b-422e-9e8d-f7a3bf3bb292">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI3_4fce5d5c-3040-4d61-96c4-f6774df1e3aa">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI4_84380149-36ad-451b-a00e-5d6315f59f95">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI5_e0b08b20-6246-4646-87c7-c0f2bc3cf786">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18wLTAtMS0xLTQ1MDg1_3671cfba-ae40-442b-a604-399247a16c35">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18wLTUtMS0xLTQ1MDg1_76891609-047a-4822-9d75-0438f6edc15c">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18yLTAtMS0xLTQ1MDg1_762af191-4889-439d-a0a7-13630416d2ff">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18zLTAtMS0xLTQ1MDg1_6526ed5a-925d-4c30-802c-1ace71fbcd36">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18zLTEtMS0xLTQ1MDg1_1b8c3063-8752-40d1-82b1-ebc261842317">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN18zLTItMS0xLTQ1MDg1_37cc3e3f-ce0d-4ff5-ba69-89c69d980218">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN180LTAtMS0xLTQ1MDg1_660f00a0-6157-4a79-bac7-be2545d871c7">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6MmM5Y2I2YTQ3NTk4NDEzYTgyZDkxMDBmMjE3NDM0MDcvdGFibGVyYW5nZToyYzljYjZhNDc1OTg0MTNhODJkOTEwMGYyMTc0MzQwN180LTEtMS0xLTQ1MDg1_046fb434-4579-4a16-931f-12033e09e5d0">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6YjlkODgzNmUwMzQ3NDNhMGJkZjAwZjdmNDk3NGNjNWUvdGFibGVyYW5nZTpiOWQ4ODM2ZTAzNDc0M2EwYmRmMDBmN2Y0OTc0Y2M1ZV8xLTAtMS0xLTQ1MDg1_e67761f7-e8bc-41df-8725-05179f1b45fb">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6YjlkODgzNmUwMzQ3NDNhMGJkZjAwZjdmNDk3NGNjNWUvdGFibGVyYW5nZTpiOWQ4ODM2ZTAzNDc0M2EwYmRmMDBmN2Y0OTc0Y2M1ZV8xLTEtMS0xLTQ1MDg1_8360a5d2-1180-419d-97f2-65b703d9ac20">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6YjlkODgzNmUwMzQ3NDNhMGJkZjAwZjdmNDk3NGNjNWUvdGFibGVyYW5nZTpiOWQ4ODM2ZTAzNDc0M2EwYmRmMDBmN2Y0OTc0Y2M1ZV8xLTItMS0xLTQ1MDg1_c5b8a023-d83b-4536-8bec-043b6fc7e6c5">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTIy_b9394394-3a7d-4809-a567-534d08066275">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTIz_9803761f-c762-4f3c-ad4e-cc7f8100d7b4">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6Nzk5NzU3MWY4OGNiNDQ2ZGFmYmQxY2Y0N2NkYjM0ZmIvdGFibGVyYW5nZTo3OTk3NTcxZjg4Y2I0NDZkYWZiZDFjZjQ3Y2RiMzRmYl8wLTAtMS0xLTQ1MDg1_383e0983-af43-431a-b231-279d76eb1c05">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6Nzk5NzU3MWY4OGNiNDQ2ZGFmYmQxY2Y0N2NkYjM0ZmIvdGFibGVyYW5nZTo3OTk3NTcxZjg4Y2I0NDZkYWZiZDFjZjQ3Y2RiMzRmYl8xLTMtMS0xLTQ1MDg1_ad02571a-eb0d-442b-957f-93ee29315165">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGFibGU6Nzk5NzU3MWY4OGNiNDQ2ZGFmYmQxY2Y0N2NkYjM0ZmIvdGFibGVyYW5nZTo3OTk3NTcxZjg4Y2I0NDZkYWZiZDFjZjQ3Y2RiMzRmYl8yLTMtMS0xLTQ1MDg1_91910dfd-be9d-44d9-a84b-371babce8aed">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xOTI0_dadad0d7-7b6e-4976-aee9-5dc30f2eab7c">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ic2dc8d4dcbed40af97db1fac37505ee9_I20220414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xL2ZyYWc6OTNlZjU1YTdjZTAyNDNkN2JhYWIzNGZjZGEzZjc0ZTEvdGV4dHJlZ2lvbjo5M2VmNTVhN2NlMDI0M2Q3YmFhYjM0ZmNkYTNmNzRlMV8xODYz_8f8f29ea-5c8f-4575-a6b7-351050083982"
      unitRef="shares">117365028</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMi01LTEtMS00NTA4NQ_4a068ce4-1042-47ff-b864-fa2cdc220c4e"
      unitRef="usd">2611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMi03LTEtMS00NTA4NQ_adb82e78-aa06-4d83-96b0-468ad1ac51d7"
      unitRef="usd">2720000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNS01LTEtMS00NTA4NQ_bf924a53-4d11-4aee-a06a-51390b7971e2"
      unitRef="usd">1646000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNS03LTEtMS00NTA4NQ_ac3694a4-2179-42ba-b95b-88a68486ec74"
      unitRef="usd">1626000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNi01LTEtMS00NTA4NQ_8c7d2f21-1970-4f0e-8ff6-af5ffe3bc9ed"
      unitRef="usd">425000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNi03LTEtMS00NTA4NQ_af89c0ab-531f-490f-866b-5b4073cd2569"
      unitRef="usd">407000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNy01LTEtMS00NTA4NQ_4b2d7487-3170-4b92-89d6-8fd44593db20"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNy03LTEtMS00NTA4NQ_0a386b12-7e06-4877-9f95-569b66fbdd90"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostsAndExpenses
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTAtNS0xLTEtNDUwODU_c19bb904-070f-44d7-929c-62442fc084da"
      unitRef="usd">2098000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTAtNy0xLTEtNDUwODU_7fbb653c-5b0b-44b8-8ee0-4df9962cc67a"
      unitRef="usd">2060000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTItNS0xLTEtNDUwODU_31064a01-9169-46e1-b6b8-0d175d576afa"
      unitRef="usd">513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTItNy0xLTEtNDUwODU_d53ae8f3-cb89-4e56-9aef-f4ea4a3dce8e"
      unitRef="usd">660000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTUtNS0xLTEtNDUwODU_6c0145e2-4c33-4b67-a80b-04fffa68265b"
      unitRef="usd">-37000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTUtNy0xLTEtNDUwODU_290865fb-1f2e-48e3-9d50-41856f720135"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTYtNS0xLTEtNDUwODU_1a273971-dff3-44ea-bbbc-4369e03ef2e3"
      unitRef="usd">-24000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTYtNy0xLTEtNDUwODU_08bb8688-da99-4a18-8e1c-51193a39391a"
      unitRef="usd">4000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTctNS0xLTEtNDUwODU_7c0dc35b-7736-421e-bd1c-e25ea09f363a"
      unitRef="usd">-61000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTctNy0xLTEtNDUwODU_fe3d8ff2-4e3d-4988-acdf-13e93a7481e4"
      unitRef="usd">-34000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTktNS0xLTEtNDUwODU_f7a169a1-d52b-4566-8aa5-ece629c44f7f"
      unitRef="usd">452000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMTktNy0xLTEtNDUwODU_e24a0d1c-d02f-4dbb-88b0-d9552ca074e1"
      unitRef="usd">626000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjAtNS0xLTEtNDUwODU_e2fb4455-2f7c-4708-9da8-f8814813e150"
      unitRef="usd">110000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjAtNy0xLTEtNDUwODU_f3f7b257-d451-4850-a307-f9880cad52e7"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjEtNS0xLTEtNDUwODU_73c943dd-0fd2-449c-a7e1-f320cc5df30e"
      unitRef="usd">31000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjEtNy0xLTEtNDUwODU_13126ed9-f8e8-48df-8001-637de22bf1b5"
      unitRef="usd">17000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjQtNS0xLTEtNDUwODU_df0ba1d5-121a-4f27-a2bc-012df953f6d5"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjQtNy0xLTEtNDUwODU_7c77420e-457f-429d-b4c2-c6f5360588cb"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjUtNS0xLTEtNDUwODU_233006f2-fe72-4ebe-944b-24c5e6a84fc3"
      unitRef="usd">18000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjUtNy0xLTEtNDUwODU_2a0de432-db73-4bc2-86ad-caf0327f2a86"
      unitRef="usd">21000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjYtNS0xLTEtNDUwODU_33d788c6-929c-4290-8f35-513393dba18b"
      unitRef="usd">355000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMjYtNy0xLTEtNDUwODU_64e7effd-baf4-44f1-a795-b36069d54937"
      unitRef="usd">469000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMzYtNS0xLTEtNDUwODU_e7bdd92f-07a2-4766-a48b-de08a0420353"
      unitRef="usdPerShare">2.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfMzYtNy0xLTEtNDUwODU_d7f26672-f4f0-468a-a59d-c0cad197442a"
      unitRef="usdPerShare">3.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDEtNS0xLTEtNDUwODU_ee41b1ff-f4cb-452a-9e59-6a5bbc0a53fc"
      unitRef="usdPerShare">2.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDEtNy0xLTEtNDUwODU_4b799806-8ed0-4128-be56-069490043477"
      unitRef="usdPerShare">3.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDQtNS0xLTEtNDUwODU_4eea8766-5b49-426b-80d5-ea8ad0d48316"
      unitRef="shares">119000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDQtNy0xLTEtNDUwODU_aaa301be-baa9-4030-9604-4905282853ec"
      unitRef="shares">133000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDYtNS0xLTEtNDUwODU_475e5896-ac4a-46ad-8112-f39f1ba8efab"
      unitRef="shares">121000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMy9mcmFnOmYxMDQ5MzA2MGY4OTQ1MWNhZDhiYjk1OTMwZmFiMjhmL3RhYmxlOmJjZjNmM2FiYjNiZTRlMzM4YTJkNjNjMTgwMzdlZTJhL3RhYmxlcmFuZ2U6YmNmM2YzYWJiM2JlNGUzMzhhMmQ2M2MxODAzN2VlMmFfNDYtNy0xLTEtNDUwODU_836b9335-f5e2-4d21-abad-acf0cb9bae92"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMi01LTEtMS00NTA4NQ_df0ba1d5-121a-4f27-a2bc-012df953f6d5"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMi03LTEtMS00NTA4NQ_7c77420e-457f-429d-b4c2-c6f5360588cb"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNS01LTEtMS00NTA4NQ_37f1875d-1509-4b05-ae5b-dd12d611274d"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNS03LTEtMS00NTA4NQ_86846e89-bc86-4cfa-9131-f4841711d493"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNi01LTEtMS00NTA4NQ_ab776ae1-d1a1-4335-85ea-9e532eee81a2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfNi03LTEtMS00NTA4NQ_f9fb019a-1653-488a-8769-53a36cfe49d7"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfOS01LTEtMS00NTA4NQ_20770d43-afdf-4d97-a956-6fd014d4f02a"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfOS03LTEtMS00NTA4NQ_649dbd03-dcf7-4261-8a17-f79033935f64"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTEtNS0xLTEtNDUwODU_1089f3c3-431c-490d-89af-3433f722de6e"
      unitRef="usd">371000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTEtNy0xLTEtNDUwODU_4c8caf16-3b18-4b0f-bbd9-762cf61787ae"
      unitRef="usd">480000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTItNS0xLTEtNDUwODU_5c2bd5da-71bf-4b38-a936-5e6c81b49ae3"
      unitRef="usd">18000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTItNy0xLTEtNDUwODU_887e7721-60bd-49d0-9fab-4bf767e8e4e7"
      unitRef="usd">21000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTMtNS0xLTEtNDUwODU_645762fd-382f-40e6-a219-b8e4c8dcadc4"
      unitRef="usd">353000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xNi9mcmFnOjg0NDRlMDRkNmU2OTQzOGViMmVhNjQxMjFiMWQ3MTU2L3RhYmxlOjUxZmI0ZmY0NmZjNjRiODJiNmI3Y2Y0YmE1OTliZDM1L3RhYmxlcmFuZ2U6NTFmYjRmZjQ2ZmM2NGI4MmI2YjdjZjRiYTU5OWJkMzVfMTMtNy0xLTEtNDUwODU_9e152628-5f84-4d38-9140-c24f237536f3"
      unitRef="usd">459000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMy0xLTEtMS00NTA4NQ_98bec17f-2c80-499e-a944-7ddae25c44d1"
      unitRef="usd">712000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMy0zLTEtMS00NTA4NQ_d6d8c31f-b108-44e6-956d-cfc04698dd61"
      unitRef="usd">872000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0wLTEtMS00NTA4NS90ZXh0cmVnaW9uOjA4Mzk1OTFmMGQxYjRiMWI5MzRjNTVlNGExNTVjNzE1XzYz_f5f78746-5950-4942-9122-d1cf034391b5"
      unitRef="usd">30000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0wLTEtMS00NTA4NS90ZXh0cmVnaW9uOjA4Mzk1OTFmMGQxYjRiMWI5MzRjNTVlNGExNTVjNzE1Xzcw_ee019ee2-fc1e-4b32-b829-b7429e071774"
      unitRef="usd">31000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0xLTEtMS00NTA4NQ_6aad901a-5e16-4c5e-8ac9-6bbe3abef882"
      unitRef="usd">1371000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNC0zLTEtMS00NTA4NQ_839d8c0b-edc3-4f83-ae45-762fdce94d3e"
      unitRef="usd">1438000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNS0xLTEtMS00NTA4NQ_f5fddac9-9be8-4fc2-84ab-04bb819573a7"
      unitRef="usd">197000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNS0zLTEtMS00NTA4NQ_498ff8e4-7388-44ea-8a53-0863ad707493"
      unitRef="usd">208000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNi0xLTEtMS00NTA4NQ_c0f3328d-6d05-42ae-890c-22a2734e2942"
      unitRef="usd">195000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNi0zLTEtMS00NTA4NQ_96b4a779-074b-49a7-89cf-e82bd6a820c2"
      unitRef="usd">223000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOC0xLTEtMS00NTA4NQ_30c7779a-03ba-442c-bdc1-bf942e3bfcfa"
      unitRef="usd">2475000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOC0zLTEtMS00NTA4NQ_a9e0f911-bd19-44d1-91ac-f98a32d8b39a"
      unitRef="usd">2741000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOS0xLTEtMS00NTA4NQ_a6587642-0d83-4268-8924-e4ec2ed5587b"
      unitRef="usd">1668000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfOS0zLTEtMS00NTA4NQ_b79265f4-2560-4c30-8634-5809e9805694"
      unitRef="usd">1707000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTAtMS0xLTEtNDUwODU_e4f1a285-9366-43c7-80be-44887015b967"
      unitRef="usd">620000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTAtMy0xLTEtNDUwODU_a2374933-f104-4f23-8d00-74536b577a46"
      unitRef="usd">597000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTEtMS0xLTEtNDUwODU_95da02f4-feb9-43cb-9cd5-9d9279414770"
      unitRef="usd">7197000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTEtMy0xLTEtNDUwODU_279da6e6-d32e-44d6-9349-309a693276a5"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTItMS0xLTEtNDUwODU_2cd21dbb-d53d-4d81-88ba-cdfc44fac116"
      unitRef="usd">1172000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTItMy0xLTEtNDUwODU_251d5f8d-ab8b-4725-93ae-fa1efb72db9c"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTMtMS0xLTEtNDUwODU_8744dbe3-37d3-476c-a191-0d0137984024"
      unitRef="usd">155000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTMtMy0xLTEtNDUwODU_50b991fa-b948-4e24-9b4b-688dabdde8eb"
      unitRef="usd">141000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTQtMS0xLTEtNDUwODU_09d01510-8272-4702-b691-8066db56d7ac"
      unitRef="usd">155000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTQtMy0xLTEtNDUwODU_88753373-7848-4b2f-bdc9-2902f4e6db01"
      unitRef="usd">163000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTYtMS0xLTEtNDUwODU_4fdee1b3-9963-4198-8871-d424130a27de"
      unitRef="usd">13442000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMTYtMy0xLTEtNDUwODU_f5dfd89a-49aa-42c2-abae-1d416d988a09"
      unitRef="usd">13611000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjAtMS0xLTEtNDUwODU_d1d98f06-aae9-4fca-8bb5-80000602cc0a"
      unitRef="usd">1544000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjAtMy0xLTEtNDUwODU_d3404641-77a7-4587-90ee-94b7c7593516"
      unitRef="usd">1600000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjEtMS0xLTEtNDUwODU_a9972dbe-76f6-416e-b413-1c95a680c71e"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjEtMy0xLTEtNDUwODU_84b46af5-3571-4233-b183-3660575327bd"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjItMS0xLTEtNDUwODU_ae12f260-5aa3-466d-897a-231606ebba9a"
      unitRef="usd">154000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjItMy0xLTEtNDUwODU_92ded2c0-d6ff-4a25-815c-a1928e62ebe0"
      unitRef="usd">151000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjQtMS0xLTEtNDUwODU_655ccd84-10a7-4357-aad2-6f855145012a"
      unitRef="usd">1700000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjQtMy0xLTEtNDUwODU_a029914e-ec3e-4e92-bbb3-0dd17309d015"
      unitRef="usd">1753000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjUtMS0xLTEtNDUwODU_33ec3eb8-05f0-4634-91db-fbe1e908fe60"
      unitRef="usd">3985000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjUtMy0xLTEtNDUwODU_e0061fb4-0e55-479f-bece-e1c81fa434e5"
      unitRef="usd">4010000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjYtMS0xLTEtNDUwODU_591ab7bf-236e-495d-9b6f-de0293c727ce"
      unitRef="usd">522000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjYtMy0xLTEtNDUwODU_7365a477-a572-4b49-b0d8-f9dd166873e7"
      unitRef="usd">494000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjctMS0xLTEtNDUwODU_7d3eadb9-1238-41cf-ba17-7b0ada4b8ea7"
      unitRef="usd">742000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjctMy0xLTEtNDUwODU_73885057-b05c-4dc2-8f5e-ceb48fcc62bf"
      unitRef="usd">792000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjktMS0xLTEtNDUwODU_ca851a6a-2089-4a0b-9df6-aa452f057fc2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMjktMy0xLTEtNDUwODU_5fabb530-e194-4715-858d-28d823b1650b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzAtMS0xLTEtNDUwODU_6386405b-e0d6-4870-b236-499353bdfcb9"
      unitRef="usd">78000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzAtMy0xLTEtNDUwODU_7f6fd3cd-1011-4830-802f-6eee1898f295"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8yOA_98e928b5-a586-42c9-afe5-c3dc7bee05f2"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8yOA_b267389b-75b5-41b0-9937-227eec5418d6"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl80Mg_38c7b8c1-5e38-4a34-87ea-849a8dfed567"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl80Mg_9a35bff7-5c29-4e72-8bcf-339b6a50c9d1"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8xMTY_2656bcd8-bb88-4fe7-bbae-4e5ddab92531"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjoxZjRjNGNlZTljOWQ0ZTVkODZlODNjZGJjMjIxM2VhNl8xMTY_33b599cc-8870-42e3-8566-e902c05917e0"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMS0xLTEtNDUwODU_5ea36b79-84da-4584-934b-c96e2d43eb85"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzMtMy0xLTEtNDUwODU_039b44a7-33aa-43d5-b040-3d43e8ff1b25"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzQtMS0xLTEtNDUwODU_50d768df-f2d2-4c87-af17-7d445639dda0"
      unitRef="usd">2226000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzQtMy0xLTEtNDUwODU_0b90f3c4-7ec5-45cb-afd4-3385b1abf7b3"
      unitRef="usd">2260000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzUtMS0xLTEtNDUwODU_e8cec2e0-69d2-402d-a4c2-38281c15f19e"
      unitRef="usd">7926000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzUtMy0xLTEtNDUwODU_fcd14887-acbb-4a70-849f-7290603205a5"
      unitRef="usd">7649000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzYtMS0xLTEtNDUwODU_b3e27e76-cb72-4a75-a4f6-fbb5262c1855"
      unitRef="usd">-16000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzYtMy0xLTEtNDUwODU_a1d4f71f-46b5-4566-b999-2608b64d3c60"
      unitRef="usd">-14000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjo2YTQ0ZTAyZDYyZWM0YWFmYmYzNTk0YjVjMzU0NDc1M18yOQ_62997032-0fc6-41c4-8f12-1fce3d0b2b8a"
      unitRef="shares">45000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMC0xLTEtNDUwODUvdGV4dHJlZ2lvbjo2YTQ0ZTAyZDYyZWM0YWFmYmYzNTk0YjVjMzU0NDc1M18zNg_f80a0ffc-3a44-4b2e-b4a9-6eacb30df425"
      unitRef="shares">43000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMS0xLTEtNDUwODU_a84df10a-6641-4190-9bab-1173cbf2b3c0"
      unitRef="usd">3761000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzctMy0xLTEtNDUwODU_7e8d016a-e37b-440a-9efa-f52db4e939e8"
      unitRef="usd">3453000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzgtMS0xLTEtNDUwODU_22efadb2-b0f5-4fac-93bf-2da59065e43d"
      unitRef="usd">6377000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzgtMy0xLTEtNDUwODU_cb327d1d-4345-4688-8a18-20fdd88d39b1"
      unitRef="usd">6444000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzktMS0xLTEtNDUwODU_866e2d51-7512-49bc-a910-e0b0b7e1f6ce"
      unitRef="usd">38000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfMzktMy0xLTEtNDUwODU_7225cfd0-5db8-4101-8194-ce7cff375f02"
      unitRef="usd">39000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDAtMS0xLTEtNDUwODU_a00ba80d-9b67-4bf0-a40d-746ff80deeef"
      unitRef="usd">6415000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDAtMy0xLTEtNDUwODU_5bfc60e1-a914-4683-b3ec-006dedd02f58"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDEtMS0xLTEtNDUwODU_f1ffa8f9-7670-416c-bbd6-c68d037327e0"
      unitRef="usd">13442000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xOS9mcmFnOmQ1YmVkNTYxMTg5NzQ1M2NhYWUyYWMzNTMzY2NlMGZhL3RhYmxlOjFlOGE1ZTU2MmYxZjRiNGZiMjYzZmExYTNiZWJmYTMyL3RhYmxlcmFuZ2U6MWU4YTVlNTYyZjFmNGI0ZmIyNjNmYTFhM2JlYmZhMzJfNDEtMy0xLTEtNDUwODU_dde6d203-cedb-4ac7-9295-36e8a09efbd8"
      unitRef="usd">13611000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMy0xLTEtMS00NTA4NQ_df0ba1d5-121a-4f27-a2bc-012df953f6d5"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMy0zLTEtMS00NTA4NQ_7c77420e-457f-429d-b4c2-c6f5360588cb"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNS0xLTEtMS00NTA4NQ_9c02013f-7a68-4b77-a0e8-1601621e7705"
      unitRef="usd">106000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNS0zLTEtMS00NTA4NQ_a0e88d81-eb63-41f5-8442-3fff5c773e4d"
      unitRef="usd">101000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNi0xLTEtMS00NTA4NQ_d031348a-c75a-493e-81b0-66f6bd61b70a"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNi0zLTEtMS00NTA4NQ_58b7b034-c9bd-491d-a8da-20e5525dc8c7"
      unitRef="usd">2000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNy0xLTEtMS00NTA4NQ_46e000ce-875d-4bf2-aa6c-c9077cabdfe5"
      unitRef="usd">-43000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNy0zLTEtMS00NTA4NQ_31c08ada-c6af-476a-8472-3d8b5114a9c2"
      unitRef="usd">-17000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfOC0xLTEtMS00NTA4NQ_0b8a187e-14e2-4b6e-8d48-66ffdfa0b4c4"
      unitRef="usd">18000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfOC0zLTEtMS00NTA4NQ_1f8a835f-abb5-4f28-bee3-099c8c023a7c"
      unitRef="usd">18000000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTEtMS0xLTEtNDUwODU_1f126cda-b5d3-430f-8583-adc0bbfba74c"
      unitRef="usd">-4000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTEtMy0xLTEtNDUwODU_333ca86b-4d9f-499a-858b-5c032f3f8927"
      unitRef="usd">2000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTMtMS0xLTEtNDUwODU_21127bea-c1d1-4442-a598-a3fa090bebca"
      unitRef="usd">-72000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTMtMy0xLTEtNDUwODU_21559f03-4a1f-4547-9e37-f745511c1873"
      unitRef="usd">-138000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTQtMS0xLTEtNDUwODU_496a4d9f-6b07-46db-b29d-4493b9c90d0a"
      unitRef="usd">-165000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTQtMy0xLTEtNDUwODU_5bc6d1c7-ca90-441c-8ef8-b43f53b60f15"
      unitRef="usd">-164000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTUtMS0xLTEtNDUwODU_4fc0fc80-30fa-45fe-adb2-b4fc96faebf9"
      unitRef="usd">95000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTUtMy0xLTEtNDUwODU_5a1a91a3-37a1-4c65-9968-2580069f2b5f"
      unitRef="usd">163000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTctMS0xLTEtNDUwODU_4ba62d2c-db14-476b-bb71-bd69bc91182c"
      unitRef="usd">-20000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTctMy0xLTEtNDUwODU_4b6c5a6a-f3c3-471e-8dbd-777239a19c1b"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTgtMS0xLTEtNDUwODU_aaa42016-bbb7-427f-bd1c-a3a9fe62f277"
      unitRef="usd">480000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMTgtMy0xLTEtNDUwODU_c86a36de-1df3-423c-98dc-451290c22edd"
      unitRef="usd">731000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjEtMS0xLTEtNDUwODU_f26611e9-ea1e-4dad-94b3-18e958d01fde"
      unitRef="usd">105000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjEtMy0xLTEtNDUwODU_22d373fa-406e-4f90-b581-6aa6804e27d5"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjQtMS0xLTEtNDUwODU_ce3e6538-a1e4-44dd-b0ea-937a24500cf3"
      unitRef="usd">63000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjQtMy0xLTEtNDUwODU_4be1d902-b1ba-42fa-a2f3-3945646398dc"
      unitRef="usd">86000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjctMS0xLTEtNDUwODU_a345bf79-6fce-45c3-831c-1f318accc484"
      unitRef="usd">1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjctMy0xLTEtNDUwODU_804ef472-df44-48e7-b205-dd3bfb0230f3"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjgtMS0xLTEtNDUwODU_60f1be2b-fa52-4dab-bceb-9f4efe5d9f10"
      unitRef="usd">-169000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMjgtMy0xLTEtNDUwODU_f751c9bb-91df-41f5-acee-bd658544bd8d"
      unitRef="usd">-93000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzItMS0xLTEtNDUwODU_47af3c62-efd7-4545-8bbc-c23b4b54bac1"
      unitRef="usd">1000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzItMy0xLTEtNDUwODU_0879204d-817b-426a-b069-28331fe15cf3"
      unitRef="usd">1000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzMtMS0xLTEtNDUwODU_00cd785d-33d8-44c3-acf8-b37070bfe99f"
      unitRef="usd">373000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzMtMy0xLTEtNDUwODU_14c2ebe0-0d05-41fb-b44e-4918a4af9bb9"
      unitRef="usd">410000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzQtMS0xLTEtNDUwODU_e3ef6753-669a-4390-a8ff-645917f4df6f"
      unitRef="usd">10000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzQtMy0xLTEtNDUwODU_826834ae-1fed-42c1-96a1-a948e422474e"
      unitRef="usd">17000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzUtMS0xLTEtNDUwODU_075ae360-c3d5-4cbd-b4b2-7212a22e1119"
      unitRef="usd">27000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzUtMy0xLTEtNDUwODU_9b5ef5d5-290c-40b3-83ee-155eb0887c9b"
      unitRef="usd">21000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzYtMS0xLTEtNDUwODU_774c65de-abde-4e2a-b099-fe61ddce6835"
      unitRef="usd">74000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzYtMy0xLTEtNDUwODU_ef54eea7-0f7c-4193-b28e-f7a4eb4ef360"
      unitRef="usd">75000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzctMS0xLTEtNDUwODU_4cd00dad-870e-45cd-bea6-3ea44a69b9b0"
      unitRef="usd">20000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfMzctMy0xLTEtNDUwODU_46903dc4-bf74-451c-b137-4ce9fc82763b"
      unitRef="usd">29000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDAtMS0xLTEtNDUwODU_579017c6-bd00-4ce0-aa0d-b771e6b4d356"
      unitRef="usd">14000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDAtMy0xLTEtNDUwODU_62282c26-741e-4e40-b106-2974a1a27822"
      unitRef="usd">-47000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDEtMS0xLTEtNDUwODU_4e210fe3-6934-4ea1-b637-c15ccb13cda4"
      unitRef="usd">-471000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDEtMy0xLTEtNDUwODU_414274d7-0725-4a85-bc0b-70e24ddf00c8"
      unitRef="usd">-566000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDMtMS0xLTEtNDUwODU_0155645f-816b-468a-b2df-8f43402d40f0"
      unitRef="usd">-160000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDMtMy0xLTEtNDUwODU_9d98fbee-618a-409b-8408-e58328ee6e4d"
      unitRef="usd">72000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDUtMS0xLTEtNDUwODU_3137d606-c9d9-4030-8556-427585f75522"
      unitRef="usd">872000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i25a67828d80741189c9e71a1926cad84_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDUtMy0xLTEtNDUwODU_4bb4445b-6cf1-40f0-893d-b8a248699851"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDYtMS0xLTEtNDUwODU_7dd468cc-b358-4c22-a82c-b29d4616e4f7"
      unitRef="usd">712000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yMi9mcmFnOjk4NjA3Y2MyMzk3YTQxOTFiNGUzMTdjYzVjNjk1ZTkyL3RhYmxlOjI1MzcwMmY2NWRjMjQzZDc5YTQ5OGMwMDQyNGExODEwL3RhYmxlcmFuZ2U6MjUzNzAyZjY1ZGMyNDNkNzlhNDk4YzAwNDI0YTE4MTBfNDYtMy0xLTEtNDUwODU_6222d583-86c4-4362-a407-6524730d215b"
      unitRef="usd">1230000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib939a88f4c11457d8f94ab3011660e90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMS0xLTEtNDUwODU_797d91d4-9b17-49f7-b297-8612c1e6109f"
      unitRef="shares">119000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib939a88f4c11457d8f94ab3011660e90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMy0xLTEtNDUwODU_a6c9cd18-2baf-4074-83bd-88e3c714394d"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i387e21b64a5248cc90a14d9bcadffd40_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctNS0xLTEtNDUwODU_d4f37289-eeef-4bde-875b-d0f72163f7f2"
      unitRef="usd">2260000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52d9091e753f4cdfaae8f68bbc2ea33f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctNy0xLTEtNDUwODU_9ba3aec6-0098-4dfb-87c6-9a552572fb95"
      unitRef="usd">7649000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a0f83bf88134568bde41c150af0ba41_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctOS0xLTEtNDUwODU_965e6ba8-61d4-40af-865e-7c08c55ee6f1"
      unitRef="usd">-14000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i30bff75e183e4fc391898fd34f86863b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTEtMS0xLTQ1MDg1_0c950184-182b-46bc-90cd-1037da63f90c"
      unitRef="usd">-3453000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d41353be3a04b738b4f4bc36e5d3820_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTMtMS0xLTQ1MDg1_c5c298ba-ad21-4b28-8cc9-6344b1fa81ad"
      unitRef="usd">39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTUtMS0xLTQ1MDg1_3e37742c-b64b-4cb7-b50d-ba213ff7323b"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTctMTgtMS0xLTQ1MDg1_64d34a02-155b-4753-8ea3-f75703a9f0d3"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ia93d7d0509f14b08b2b9728096cbb3e7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtNy0xLTEtNDUwODU_40ee5f54-7269-4fb9-afdf-f7065c697b68"
      unitRef="usd">355000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="idd6c865cfcc5493cb1940ce9b692bd7a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtMTMtMS0xLTQ1MDg1_aaac184e-3326-410b-838b-4017e497de58"
      unitRef="usd">16000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtMTUtMS0xLTQ1MDg1_e524c631-aa62-4755-b330-159affe7b379"
      unitRef="usd">371000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTgtMTgtMS0xLTQ1MDg1_07ed1047-56a8-46a5-b0bf-e18560681723"
      unitRef="usd">2000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic760c160bf9646bba4102bda5ef94b44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTktOS0xLTEtNDUwODU_695f2fb3-02c9-4c28-bf66-ab3f8003c5aa"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMTktMTUtMS0xLTQ1MDg1_d8a6b9a7-f107-4979-9af5-5806ae8ff238"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia93d7d0509f14b08b2b9728096cbb3e7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjAtNy0xLTEtNDUwODU_c01fe405-ccbb-4220-9ffa-e03d7cd30a12"
      unitRef="usd">78000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjAtMTUtMS0xLTQ1MDg1_ea5dd237-ae36-4185-bfca-79404744dc76"
      unitRef="usd">78000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="idd6c865cfcc5493cb1940ce9b692bd7a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjEtMTMtMS0xLTQ1MDg1_c043c3b8-eb77-4cbe-ad1e-96d0dc1d192b"
      unitRef="usd">17000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjEtMTUtMS0xLTQ1MDg1_56f14fc7-a216-481c-9a4f-6407983eb5e8"
      unitRef="usd">17000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjEtMTgtMS0xLTQ1MDg1_b001aa21-0827-404a-b0a8-439d4f3ab8a0"
      unitRef="usd">3000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i57bcad1774d541d9ac66fc0077491325_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItMS0xLTEtNDUwODU_d467946e-cc74-4a75-a5f5-2da355eae480"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItNS0xLTEtNDUwODU_ab126913-4923-4d08-823e-fa8625cebbd2"
      unitRef="usd">-41000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItMTEtMS0xLTQ1MDg1_f6251027-1c0e-4dc7-9787-0014f5a13572"
      unitRef="usd">48000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjItMTUtMS0xLTQ1MDg1_832c61a2-a9fb-4c46-abd8-efb097bbdc18"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjMtNS0xLTEtNDUwODU_ab393bc4-30ca-44d7-b162-19594b05e52b"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjMtMTUtMS0xLTQ1MDg1_a330c9a3-c956-4ab1-a4ce-80170b9a263f"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjQtNS0xLTEtNDUwODU_8b9bedd9-c499-4f59-b71f-3fcbdd92391b"
      unitRef="usd">-1000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjQtMTEtMS0xLTQ1MDg1_d5066383-08ae-4f8f-bf64-492ee2b68a4b"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjQtMTUtMS0xLTQ1MDg1_ce68f013-d504-4205-8bdd-c5b8ca2e0f4d"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1c82c5db43604245bb3e517b2be868ab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjUtNS0xLTEtNDUwODU_b4e2bb22-43f4-412c-add2-fdea6e8a255e"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjUtMTEtMS0xLTQ1MDg1_19c44656-8c6d-48c7-9d74-3867ce1e33d5"
      unitRef="usd">17000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjUtMTUtMS0xLTQ1MDg1_d6483263-bf7e-4150-8ac4-1ad3977d55b1"
      unitRef="usd">27000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i57bcad1774d541d9ac66fc0077491325_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjYtMS0xLTEtNDUwODU_3a0fea7b-7b31-43dd-9fc5-d2212a7b518e"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjYtMTEtMS0xLTQ1MDg1_adc52811-8ecf-4be5-bb44-d1fd25051f79"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjYtMTUtMS0xLTQ1MDg1_713c47b2-34a5-4afc-a2b7-120fa32b967b"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib1bfa6a5fb1046dca736f71283a88051_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMS0xLTEtNDUwODU_c9967f70-dc15-40b6-8ad4-6039cf40cf76"
      unitRef="shares">117000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1bfa6a5fb1046dca736f71283a88051_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMy0xLTEtNDUwODU_63eea5a9-c4d4-4eb2-9a97-3be3ac82ccd8"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib36d5ba191104fe89f537554035b8907_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtNS0xLTEtNDUwODU_abc76ea0-e4e4-445a-8060-1c9e62a61b08"
      unitRef="usd">2226000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffea91bc8dcb4e06aadf8f63905ab017_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtNy0xLTEtNDUwODU_ae268977-d4ad-43bc-8707-8e2214d9057d"
      unitRef="usd">7926000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1e3eda6f95ed4a74b1f90e8c5bd28859_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtOS0xLTEtNDUwODU_7bf64cc5-e12f-42c6-a31e-e2343f029780"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i680491199aa14f2682953e743b93f967_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTEtMS0xLTQ1MDg1_a12ced3d-c72f-42b2-aaef-8860fccc2fa1"
      unitRef="usd">-3761000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea0f667d8e834262a48cda2044511f1a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTMtMS0xLTQ1MDg1_d39a28b3-f8b1-4f19-9552-d9c478fa9108"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTUtMS0xLTQ1MDg1_3288286d-771f-47c7-b241-dc40df6d4ba5"
      unitRef="usd">6415000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmQ0YjhiZTUwODRmYjQ0MmJhMDBkZmI2NTRjYjBiMGE0L3RhYmxlcmFuZ2U6ZDRiOGJlNTA4NGZiNDQyYmEwMGRmYjY1NGNiMGIwYTRfMjgtMTgtMS0xLTQ1MDg1_7c82d902-2aa8-4bf2-b08b-376ff6d92d3e"
      unitRef="usd">78000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i481f1360cd724a9f8b74bd582e93a71e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMS0xLTEtNDUwODU_ed654926-360d-457c-9f7a-52cbaad5ecd2"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i481f1360cd724a9f8b74bd582e93a71e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMy0xLTEtNDUwODU_b749ff7b-0d57-45a0-96d2-b1bf71023231"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i866848e13a4f4ec1bd85c404788b9111_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtNS0xLTEtNDUwODU_d4ec6894-be93-40f4-804f-eb39482b385d"
      unitRef="usd">2841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie178ff96837c4706a3f4b587cccefe07_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtNy0xLTEtNDUwODU_8a548145-caea-4af4-8349-62fbc28e2c35"
      unitRef="usd">9303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifacdb2eb293b429f930747ce81b4dd81_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtOS0xLTEtNDUwODU_a7412b0b-1046-43f9-8fad-c00468356815"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a484208ca0d41ddb217b0144453f3f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTEtMS0xLTQ1MDg1_0b7c0a1b-7390-42e8-88d5-9f99ee3d2dcc"
      unitRef="usd">-5366000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f11b90b6d564754b9b5bd0732625a2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTMtMS0xLTQ1MDg1_66ec6383-89de-4f1d-ac72-78c0fc763e3b"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25a67828d80741189c9e71a1926cad84_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTUtMS0xLTQ1MDg1_e6a17255-b197-46f6-a07b-aeb836b686f3"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i25a67828d80741189c9e71a1926cad84_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTYtMTgtMS0xLTQ1MDg1_9eae1637-9da6-4ca4-b0ab-22df8c8a327e"
      unitRef="usd">82000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i464858952d21412f9213fc378aaab1ac_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctNy0xLTEtNDUwODU_7e9fbd51-2b7e-44c0-a85f-ca6b821a6356"
      unitRef="usd">469000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i2686a6f90fac460b9d020e72884a3fe2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctMTMtMS0xLTQ1MDg1_8ff29d1b-45b8-49e7-87b9-02521c28c3e5"
      unitRef="usd">17000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctMTUtMS0xLTQ1MDg1_eb4f2b05-beeb-493c-9cdb-f49f67cab817"
      unitRef="usd">486000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTctMTgtMS0xLTQ1MDg1_ea0dde50-98cd-4ae9-9205-8c1cf334f09b"
      unitRef="usd">4000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icddb6cb2943147b2b89e52fe7b46911b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTgtOS0xLTEtNDUwODU_b225156d-a57c-48ae-a048-284d0575ab02"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTgtMTUtMS0xLTQ1MDg1_1025c509-1f63-4125-b4d5-3c0f620564ba"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i464858952d21412f9213fc378aaab1ac_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTktNy0xLTEtNDUwODU_fe62e50f-9b80-4684-99d6-8911f23076d2"
      unitRef="usd">82000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMTktMTUtMS0xLTQ1MDg1_1357f94c-f683-4810-bb42-6ccca783e94e"
      unitRef="usd">82000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2686a6f90fac460b9d020e72884a3fe2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjAtMTMtMS0xLTQ1MDg1_4e55bc66-3a07-4678-ac20-e352f9a138cb"
      unitRef="usd">22000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjAtMTUtMS0xLTQ1MDg1_e36a5ca4-4513-4ee6-bcd9-a9d7caf635bc"
      unitRef="usd">22000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjAtMTgtMS0xLTQ1MDg1_013d8ea1-972f-42d0-8ebc-b17a479fb613"
      unitRef="usd">7000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjEtNS0xLTEtNDUwODU_5f1a76e1-9d5c-4217-8632-6e58db1cfc3d"
      unitRef="usd">-29000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjEtMTEtMS0xLTQ1MDg1_521db9c4-ef7c-4ed0-9e5d-df7fdb8b7cda"
      unitRef="usd">34000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjEtMTUtMS0xLTQ1MDg1_c17ce449-ff0d-4bad-94fa-ce644d9aee72"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjItNS0xLTEtNDUwODU_3a64e927-28ac-4a02-95bf-1fbf6c1aa83e"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjItMTUtMS0xLTQ1MDg1_dce74170-9e8b-4459-a140-56324c16968e"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id61fd4bfc4644f119456da0f99198313_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtMS0xLTEtNDUwODU_e80e0f97-86c2-4502-bc50-58abe920c00f"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtNS0xLTEtNDUwODU_b0791fed-b026-4ded-b0e4-de93ef783f71"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtMTEtMS0xLTQ1MDg1_c55d9b24-3e8f-42d7-9df7-c6edbf4b8789"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjMtMTUtMS0xLTQ1MDg1_317167bd-2cf5-45b0-b852-559906b8cd0e"
      unitRef="usd">17000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i140c25a605a24f3f911883de7c499016_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjQtNS0xLTEtNDUwODU_0b163910-1867-4e84-8661-760c0be749f0"
      unitRef="usd">9000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjQtMTEtMS0xLTQ3MjU5_bcf48bd8-555a-4560-addf-8bbbd0a11930"
      unitRef="usd">12000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjQtMTUtMS0xLTQ1MDg1_8956564a-19a0-4d57-ae70-c65059f50329"
      unitRef="usd">21000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id61fd4bfc4644f119456da0f99198313_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjUtMS0xLTEtNDUwODU_89b118a7-db06-4752-b4e7-b49d3a05d71e"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjUtMTEtMS0xLTQ1MDg1_52b22775-7cda-404a-b3c7-2a156397bedb"
      unitRef="usd">410000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjUtMTUtMS0xLTQ1MDg1_37adb0f2-a71f-4492-a42e-f667249d8c94"
      unitRef="usd">410000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2bb36dc1a5204d5a8e9b530e2659be72_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMS0xLTEtNDUwODU_bf1a71a4-8c94-42de-a3ca-7842c8241f90"
      unitRef="shares">131000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2bb36dc1a5204d5a8e9b530e2659be72_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMy0xLTEtNDUwODU_c2d3e9f7-a89f-4f00-a3a1-fab17241bb05"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c0f7fb2e84b44339afb9b2e820d731c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtNS0xLTEtNDUwODU_69be6397-f019-485d-b37f-74920ae4bc72"
      unitRef="usd">2824000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fd9349805414371ba05699141101f35_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtNy0xLTEtNDUwODU_666083f5-d31a-4f71-92d4-4ddcf816f510"
      unitRef="usd">9690000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04a9c2b4a76640dfb7f274a43fe1b5eb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtOS0xLTEtNDUwODU_9e3f4caa-d6b4-4194-ac88-1b682f042e50"
      unitRef="usd">-31000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida954a9978a1447886fc0195a622b9a4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTEtMS0xLTQ1MDg1_d817ca7d-269e-4200-8806-72a010ef19ea"
      unitRef="usd">-5740000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida1ff8668cba4e6684c42088da1bfa77_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTMtMS0xLTQ1MDg1_cea8b795-39fb-4ea2-abf5-305ca9d164bc"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTUtMS0xLTQ1MDg1_892a7e0f-b860-48b8-b0d2-e3e1f509ca1b"
      unitRef="usd">6790000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8yNS9mcmFnOjdmZmYyY2QyOThhMzRlNTk4MGYyNzJlOTdmMThiY2ZjL3RhYmxlOmM3MmY3YTAzZjliNzRkNGVhMmE5MDk5ZmFmMTQxODA4L3RhYmxlcmFuZ2U6YzcyZjdhMDNmOWI3NGQ0ZWEyYTkwOTlmYWYxNDE4MDhfMjYtMTgtMS0xLTQ1MDg1_6fa9d363-6c91-4d5e-9dc4-d3ec99635baf"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zMS9mcmFnOmNkMzVhZWZkOGVjNTRhNjc5OTdmNmNmZmUwOTQ0OTRjL3RleHRyZWdpb246Y2QzNWFlZmQ4ZWM1NGE2Nzk5N2Y2Y2ZmZTA5NDQ5NGNfMTcwMw_50aa7bea-d22f-4692-985b-67a9ef092583">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM0MQ_61557ea7-e07d-4ec6-b864-dc4d1ebb3b59">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of significant demand for COVID-19 testing.  As a result, operating results for the three months ended March&#160;31, 2022 may not be indicative of the results that may be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM1NA_c75b708f-ec08-4e9f-9091-a4aaa5f11a15">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM1NQ_a897e138-92d1-4291-b0d9-72dc3dcb6e1d">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDM0Ng_028c0eeb-5d7c-4053-ac98-d17ae1affbab">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNC9mcmFnOjdmOWQ0M2QyMjIyMzQwYmFhNGVkMjg2YTkyZDlhNTNkL3RleHRyZWdpb246N2Y5ZDQzZDIyMjIzNDBiYWE0ZWQyODZhOTJkOWE1M2RfNDMzNg_c5ef46b6-56b8-4dd8-9865-916867b1903b">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RleHRyZWdpb246OTI3YTA4OWZkODY0NGNjYWIxNTRjNGFiNDg4ZTNmNWNfODc5_f6fee789-1eb8-4b72-a44c-361580773319">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RleHRyZWdpb246OTI3YTA4OWZkODY0NGNjYWIxNTRjNGFiNDg4ZTNmNWNfODgz_fc4e3520-a54b-4c84-b7f7-9371adbafdd4">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfNy01LTEtMS00NTA4NQ_1cd8faaa-92b3-4088-8152-c6dc9aa8d255"
      unitRef="usd">355000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfNy03LTEtMS00NTA4NQ_5e28949f-4b1b-468d-b310-9d90336caf16"
      unitRef="usd">469000000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOC01LTEtMS00NTA4NQ_db818d3c-264a-40e7-adb6-c935d239465a"
      unitRef="usd">1000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOC03LTEtMS00NTA4NQ_834cad5b-d650-4457-b233-c0a95f49fb95"
      unitRef="usd">1000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOS01LTEtMS00NTA4NQ_83191a5d-b512-4e0e-bd23-2036239b292c"
      unitRef="usd">354000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfOS03LTEtMS00NTA4NQ_5423752d-f37b-4de3-8aec-8a6ec802d71c"
      unitRef="usd">468000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTEtNS0xLTEtNDUwODU_4eea8766-5b49-426b-80d5-ea8ad0d48316"
      unitRef="shares">119000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTEtNy0xLTEtNDUwODU_aaa301be-baa9-4030-9604-4905282853ec"
      unitRef="shares">133000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTMtNS0xLTEtNDUwODU_2cba3c9b-e5ed-4516-868d-ff7db3187664"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTMtNy0xLTEtNDUwODU_5090a94f-61bd-4faf-af4c-70d7dba82f90"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTQtNS0xLTEtNDUwODU_475e5896-ac4a-46ad-8112-f39f1ba8efab"
      unitRef="shares">121000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTQtNy0xLTEtNDUwODU_836b9335-f5e2-4d21-abad-acf0cb9bae92"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTctNS0xLTEtNDUwODU_e2b10e1f-e2c1-4b41-848c-b67a7fea4cf5"
      unitRef="usdPerShare">2.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMTctNy0xLTEtNDUwODU_1d866f94-bb0c-44a2-af6a-87b8314edfdf"
      unitRef="usdPerShare">3.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMjItNS0xLTEtNDUwODU_298ea881-3450-4699-bc39-8438bd6300ce"
      unitRef="usdPerShare">2.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjZmYjAxZjI2YTJkNjQ1MTE5ZDBhMjc1ZDE0NWY2YWFjL3RhYmxlcmFuZ2U6NmZiMDFmMjZhMmQ2NDUxMTlkMGEyNzVkMTQ1ZjZhYWNfMjItNy0xLTEtNDUwODU_ece92274-e260-4672-b0cc-86a08436c22b"
      unitRef="usdPerShare">3.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RleHRyZWdpb246OTI3YTA4OWZkODY0NGNjYWIxNTRjNGFiNDg4ZTNmNWNfODg2_39611a6e-2eef-4dc6-b898-149568d683bc">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjkwNDQwMTFkNTg1YjQxN2FhMjk5MmZhMmRiNWMxMGQzL3RhYmxlcmFuZ2U6OTA0NDAxMWQ1ODViNDE3YWEyOTkyZmEyZGI1YzEwZDNfMi01LTEtMS00NTA4NQ_4c0d7b6a-9bba-418d-b9ed-63d432593406"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8zNy9mcmFnOjkyN2EwODlmZDg2NDRjY2FiMTU0YzRhYjQ4OGUzZjVjL3RhYmxlOjkwNDQwMTFkNTg1YjQxN2FhMjk5MmZhMmRiNWMxMGQzL3RhYmxlcmFuZ2U6OTA0NDAxMWQ1ODViNDE3YWEyOTkyZmEyZGI1YzEwZDNfMi03LTEtMS00NTA4NQ_a04f259a-3f67-4b35-89fe-2b3f822cd70c"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfMTYyMQ_ef3caf0f-45f2-4175-aa7e-87a381777371">BUSINESS ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $123&#160;million, net of $4&#160;million cash acquired, which consisted of cash consideration of $105&#160;million and contingent consideration initially estimated at $18&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $96&#160;million of goodwill (of which $78&#160;million is tax-deductible), $30&#160;million of intangible assets,  $5&#160;million of operating lease right-of-use assets, $5&#160;million of operating lease liabilities and $(3)&#160;million of working capital. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 11.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On December 13, 2021, the Company completed the acquisition of assets of Labtech Diagnostics, LLC ("Labtech"), an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, and recorded the assets acquired and liabilities assumed based on a preliminary purchase price allocation. During the three months ended March 31, 2022, the Company revised its purchase price allocation and recorded a $7&#160;million increase to goodwill, a $3&#160;million increase to customer-related intangible assets and a $10&#160;million increase to the estimated contingent consideration liability.  These adjustments did not have a material impact on the Company's consolidated results of operations. &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;For details regarding the Company's 2021 acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1ODkyMw_31142bed-50bd-4432-a154-7f529099abbc"
      unitRef="usd">123000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNTQ5NzU1ODE0NTQ5MA_45d3771e-b0cb-4bde-a994-f921860f3265"
      unitRef="usd">4000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTExNQ_3d79d5e0-4dba-4fb9-a51d-23e8549da135"
      unitRef="usd">105000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1ODkzNw_92f3199e-d245-4c10-a2d3-4e7f13779624"
      unitRef="usd">18000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:Goodwill
      contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNzE0NjgyNTU4NzI4Mw_c20bc7bc-3031-4e33-b3c5-468a3802b10b"
      unitRef="usd">96000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNTQ5NzU1ODE0NTgxNg_7f7530f4-59bb-4f79-9714-e8c6c456ad01"
      unitRef="usd">78000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1ODk3Mw_37e28cff-d055-4a79-84cd-11f576871810"
      unitRef="usd">30000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTAwOQ_d21f1a15-0d94-459e-afed-7d6fb936aa82"
      unitRef="usd">5000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTAyMQ_412d42c6-586d-4188-8f31-d8549ca00094"
      unitRef="usd">5000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital
      contextRef="i884e9caa9b5c413394c2637a54593f5e_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNTQ5NzU1ODE0NTcwOQ_69cac492-0d68-4841-af73-1b7bb29a90f9"
      unitRef="usd">-3000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i870e097aa1664c7f8acdc911a05478f0_D20220201-20220201"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk1OTA0OA_8c95cea8-4ee8-4db3-b2a2-68fa2c43d4ba">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ifdd1512ec1684818af722553ac20625e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk2MjYzOA_4d3242c0-17c1-4938-a0cc-4b17fb1295dd"
      unitRef="usd">7000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
      contextRef="i5d66988d2a014b72871550db7d08daf0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk2MjY2Mw_67b04256-30df-431e-9bc0-654c34d192a3"
      unitRef="usd">3000000</us-gaap:FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments>
    <dgx:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets
      contextRef="ifdd1512ec1684818af722553ac20625e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80MC9mcmFnOjY0YzU0NDdmNzA1ZDRjYWY5OGUxMjFjMmYyMWM2YWJiL3RleHRyZWdpb246NjRjNTQ0N2Y3MDVkNGNhZjk4ZTEyMWMyZjIxYzZhYmJfNjA0NzMxMzk2MjY4OQ_4b1cba9d-01c8-4577-b1be-2f4905bdf489"
      unitRef="usd">10000000</dgx:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjE2Ng_eb80e6a8-f09a-4bef-818d-1cd740da00f8">FAIR VALUE MEASUREMENTS  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Such equity investments are classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the acquisitions of Pack Health and Labtech, the Company has contingent consideration obligations, with a potential maximum aggregate payment of $40&#160;million, that are to be paid based on the achievement of certain testing volume or revenue benchmarks.  As of March&#160;31, 2022, the fair value of these contingent consideration liabilities totaled $33 million.  These contingent consideration liabilities are measured at fair value using either an option-pricing method or a Monte Carlo method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#x2019;s estimate of volume or revenue and other market inputs, including comparable company revenue volatility (7.5%) and a discount rate (ranging from 2.5% to 3.0%).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding the Company's acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 4 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2022, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of March&#160;31, 2022 and December&#160;31, 2021, the fair value of the Company&#x2019;s debt was estimated at $4.1 billion and $4.4 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjE1Ng_b5b5d4ce-c91a-4b97-98da-1820dc0c6524">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:TradingSecurities
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi0xLTEtMS00NTA4NQ_01570880-d6d5-45ac-8e30-2bbf61af3f0d"
      unitRef="usd">75000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi0zLTEtMS00NTA4NQ_39fb3430-6a80-4a71-a34e-3f29ff05affe"
      unitRef="usd">75000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi01LTEtMS00NTA4NQ_fcb0cb7f-ec46-433d-9c0d-e1777b77ce44"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNi03LTEtMS00NTA4NQ_8c22a391-1975-452e-92de-46dba2c869e6"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy0xLTEtMS00NTA4NQ_b92401ca-3420-43f1-a49a-0875d0ceefae"
      unitRef="usd">54000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy0zLTEtMS00NTA4NQ_ac2d3e0e-68d8-4a1b-b0d6-a1ececc854bd"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy01LTEtMS00NTA4NQ_45d55a1e-47e7-41d7-b3cb-69e2ab802a5a"
      unitRef="usd">54000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfNy03LTEtMS00NTA4NQ_5248bda9-812e-40dd-9735-0a7dffb40dc5"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC0xLTEtMS00NTA4NQ_a320462f-ef95-4be7-a95a-d8d3d29cefb6"
      unitRef="usd">28000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC0zLTEtMS00NTA4NQ_2eb990eb-f383-48ec-8074-db9bbccacd13"
      unitRef="usd">28000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC01LTEtMS00NTA4NQ_7226001d-3d75-43e9-b537-14eeb73dd4d9"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOC03LTEtMS00NTA4NQ_0ddb6829-17f4-4e9a-9b1d-59ab39d20bc6"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS0xLTEtMS00NTA4NQ_93dfcd01-1985-4b42-8441-722a3f8332bc"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS0zLTEtMS00NTA4NQ_5673896e-e6f8-4889-9e41-77668504bf77"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS01LTEtMS00NTA4NQ_2f0dfe03-2735-4fda-bf9c-ffabbbf39635"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfOS03LTEtMS00NTA4NQ_dd9fb3d4-9989-43c9-9098-efba7eaa758c"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItMS0xLTEtNDUwODU_f5f29bad-c93a-451a-90f9-c5d760bb61bc"
      unitRef="usd">158000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItMy0xLTEtNDUwODU_029ebb44-9fe7-476e-b35d-b59b19d8cfe3"
      unitRef="usd">103000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItNS0xLTEtNDUwODU_9a0f8377-87e1-448a-96c8-6976c6a865e6"
      unitRef="usd">54000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTItNy0xLTEtNDUwODU_eb2a3c2c-bd0f-4bd3-9731-812f9994870d"
      unitRef="usd">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtMS0xLTEtNDUwODU_b88859cf-23f8-408d-8209-ea7b2a11898c"
      unitRef="usd">136000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtMy0xLTEtNDUwODU_6c712446-39fb-4c0f-81d1-22debead4c42"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtNS0xLTEtNDUwODU_8c329f14-3d95-4077-b4ed-0b03275b4ad2"
      unitRef="usd">136000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTUtNy0xLTEtNDUwODU_5cd4e3aa-7982-4567-b05c-6ba657c4be59"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtMS0xLTEtNDUwODU_59876ccb-b04a-402c-b2f1-f75e169ce024"
      unitRef="usd">33000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtMy0xLTEtNDUwODU_bde1c08d-d575-45ed-9c7a-29c1463bd505"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtNS0xLTEtNDUwODU_036b114e-dfc7-4b2f-b4a0-6e214acd44b6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMTgtNy0xLTEtNDUwODU_65fd694c-f3b0-44c4-afd4-d90748d29705"
      unitRef="usd">33000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtMS0xLTEtNDUwODU_1a61392e-ed86-4040-b653-1bf9182ea08d"
      unitRef="usd">169000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtMy0xLTEtNDUwODU_f6ebbce1-a5f6-48aa-aadc-f7b4e724e3c7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9e3f4eba1f614cb197c151b25af12da1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtNS0xLTEtNDUwODU_f4b8cf6c-68b3-4429-8ef8-38d10cdf2f55"
      unitRef="usd">136000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjAtNy0xLTEtNDUwODU_922fe093-dcd2-4dfd-b4fd-5b61b70dd7c1"
      unitRef="usd">33000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ic936b9e915e24f4d821896ad2218ef1f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjItMS0xLTEtNDUwODU_0e34e08b-8f2a-46b9-bb14-ad3bd12cde9e"
      unitRef="usd">78000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i27a72f75399841a68c34e11399b140b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjItMy0xLTEtNDUwODU_1b86b7e3-fb2b-4164-8f48-d6262b9f5c4e"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ied8ed8c262d24d46a2c201ca154c4272_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjE4NDFhZTE0YmI3ZDRkZTI5ZmZhMTEyOThmY2FhNTQyL3RhYmxlcmFuZ2U6MTg0MWFlMTRiYjdkNGRlMjlmZmExMTI5OGZjYWE1NDJfMjItNy0xLTEtNDUwODU_b4ca20c9-799e-4762-b1ba-05ca7fb66cf4"
      unitRef="usd">78000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy0xLTEtMS00NTA4NQ_9f8f9a56-431b-445c-9a9e-edbc43822875"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy0zLTEtMS00NTA4NQ_036d1694-9676-4727-998b-2c52b40c3890"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy01LTEtMS00NTA4NQ_448305d6-4cd1-4955-b67e-a68fe38cb45f"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMy03LTEtMS00NTA4NQ_d039cfd8-0887-4217-b9d5-40fe3b7e39df"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC0xLTEtMS00NTA4NQ_5e7b1c87-6671-4e79-90d9-b4a3f6e32751"
      unitRef="usd">57000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC0zLTEtMS00NTA4NQ_d84c4a44-7e93-4a6a-9c2f-aba70e3232f1"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC01LTEtMS00NTA4NQ_03c13fde-eca7-4bf9-a338-6918a1c989de"
      unitRef="usd">57000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNC03LTEtMS00NTA4NQ_f5680246-5da1-47f6-8302-b7cea2bb00a4"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0xLTEtMS00NzQyMg_24c22667-3e71-431f-af2e-754e3ec23036"
      unitRef="usd">44000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0zLTEtMS00NzQyMg_1de74ecc-1aac-4d25-b21b-4763169adb2f"
      unitRef="usd">44000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS01LTEtMS00NzQyMg_7b41cf1a-12f8-435a-b555-d27ee41d9062"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS03LTEtMS00NzQyMg_83791045-7e97-4c83-8943-cfba9cd8d99c"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0xLTEtMS00NTA4NQ_37c19246-312c-43c1-8a55-9f1a659f9e26"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS0zLTEtMS00NTA4NQ_79723b55-d0fd-4fa0-b766-02aad474fb8e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS01LTEtMS00NTA4NQ_178a386d-652a-4f29-822b-c2b8f4383ab3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfNS03LTEtMS00NTA4NQ_3013cbc0-54f3-4f37-810f-e304bb217a51"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtMS0xLTEtNDUwODU_b646f376-6f00-464b-970f-7b7df022c553"
      unitRef="usd">179000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtMy0xLTEtNDUwODU_1c044ad6-dd32-4be9-81b6-af5aa0b46908"
      unitRef="usd">121000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtNS0xLTEtNDUwODU_632ccb0f-92a6-4eca-8d05-f63c5728e3b6"
      unitRef="usd">57000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTAtNy0xLTEtNDUwODU_6851ad08-4640-42c0-8186-89f775684bac"
      unitRef="usd">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtMS0xLTEtNDUwODU_1f872c47-768b-4046-a495-00dcbc16c21d"
      unitRef="usd">143000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtMy0xLTEtNDUwODU_49ceccf0-8136-4ac4-ae70-c93dca9fe53b"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtNS0xLTEtNDUwODU_c0eb0140-51cf-4fb6-b059-8d3ba49f4e47"
      unitRef="usd">143000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTMtNy0xLTEtNDUwODU_2c275517-837d-44f3-96c8-e0041344c63b"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtMS0xLTEtNDUwODU_5b87e09c-4113-4b44-8ecd-9a9cfeb19604"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtMy0xLTEtNDUwODU_b2d0ce96-ae52-4645-8e28-a68cab332ab3"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtNS0xLTEtNDUwODU_4d07b470-ae96-4956-9ac6-9aa006ee6dad"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTUtNy0xLTEtNDUwODU_d06bbe34-6fc4-466b-9418-64bd99bb7bcb"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktMS0xLTEtNDUwODU_3c267f4a-8cf3-4357-a567-58d221fefec9"
      unitRef="usd">148000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktMy0xLTEtNDUwODU_9140c4e2-f799-4acd-9ec9-960f0c6d856b"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2be7687e7ef34f6d9e723bd178e1687e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktNS0xLTEtNDUwODU_dfe3ed35-3f5c-4009-865e-c8f0aa3f1722"
      unitRef="usd">143000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMTktNy0xLTEtNDUwODU_feb196ba-52ca-486a-8553-bbfb08d0b77d"
      unitRef="usd">5000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i9f9f49fd6c3745b680a20c68977f7aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMjEtMS0xLTEtNDUwODU_303a6705-0bb9-4e12-9834-b0cce218fbdc"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="iacb3797b5d2f4dcbbc27b0e3807aa546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMjEtMy0xLTEtNDUwODU_37f83399-e534-427b-b159-0b391d850d96"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ic598741bcee9497b94ab1430b0c70994_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjIwZTYyMTQ2MjdhMjRjZGY4ZjJhYTQ2ZDRkMDA3NzYzL3RhYmxlcmFuZ2U6MjBlNjIxNDYyN2EyNGNkZjhmMmFhNDZkNGQwMDc3NjNfMjEtNy0xLTEtNDUwODU_a4fa9a26-2aa2-4c94-9dc2-380fd7c1d466"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="idcb19055dda64f259d36cb98695b26b1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDU4NQ_ecf6b0be-d24c-4008-901e-b327d415ef83"
      unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2e2a68bb24914f12aeee3a6a2f421c55_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfMTY0OTI2NzQ1NTYzMw_e08b76d9-879c-417b-a4d2-68a90d32d9ae"
      unitRef="usd">33000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i47b7a4e4c1d74dffbfc1eda1b01dc524_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDM4MA_06356c83-fa57-496f-8929-f4022512dff2"
      unitRef="number">0.075</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="if5267cce41ca40a1842a5b25f34596c8_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDQxNA_07c6ed90-e04b-4d8d-bbad-f4566e879e11"
      unitRef="number">0.025</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4641ff4492b5431787af20a7c361b215_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNjA0NzMxMzk3MDQyMA_ef656efb-5bc6-4c24-86f0-878e99a53b72"
      unitRef="number">0.030</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfODI0NjMzNzIyNTc4Mg_fe3d55ea-5a6e-48a2-aafb-bdba63bb27ce">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0c1e1a831dc645f884fd63f68dafc0eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjkyY2Y4M2ZhNjU2ZTQ3OWVhY2ZiNDhiYzk0NGZhYTZlL3RhYmxlcmFuZ2U6OTJjZjgzZmE2NTZlNDc5ZWFjZmI0OGJjOTQ0ZmFhNmVfMi0xLTEtMS00NzYwMA_d1773486-29fb-4b5b-92a0-cb06c0420699"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances
      contextRef="i4fa858bac8ab409c945714c4cfc92476_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjkyY2Y4M2ZhNjU2ZTQ3OWVhY2ZiNDhiYzk0NGZhYTZlL3RhYmxlcmFuZ2U6OTJjZjgzZmE2NTZlNDc5ZWFjZmI0OGJjOTQ0ZmFhNmVfMy0xLTEtMS00NzYwMA_b9775d4e-233a-413e-959d-f87ccdcf3cda"
      unitRef="usd">28000000</dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2e2a68bb24914f12aeee3a6a2f421c55_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RhYmxlOjkyY2Y4M2ZhNjU2ZTQ3OWVhY2ZiNDhiYzk0NGZhYTZlL3RhYmxlcmFuZ2U6OTJjZjgzZmE2NTZlNDc5ZWFjZmI0OGJjOTQ0ZmFhNmVfOS0xLTEtMS00NzYwMA_e08b76d9-879c-417b-a4d2-68a90d32d9ae"
      unitRef="usd">33000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i06ff7b7bc1e443609656c518c6eb5ae7_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNDI4OQ_3a9adaba-de71-4a21-9f22-4338f46f640c"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfMTA5OTUxMTYzNjk1NQ_8f359804-d838-434f-814d-5cd4fbb33374"
      unitRef="usd">4100000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80Ni9mcmFnOjljZDUyNWNmZWM1YjRkMGU5ODgyZDYyNzU4NzUxMzIzL3RleHRyZWdpb246OWNkNTI1Y2ZlYzViNGQwZTk4ODJkNjI3NTg3NTEzMjNfNTc5Ng_9ada7f2a-c6ac-440e-ba22-bc958dc51fb5"
      unitRef="usd">4400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTI0NQ_4ab76518-1d18-4c73-a9a4-8154ae93a2ed">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in goodwill for the three months ended March&#160;31, 2022 and for the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Principally all of the Company&#x2019;s goodwill as of March&#160;31, 2022 and December&#160;31, 2021 was associated with its DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, goodwill acquired was principally associated with the acquisition of Pack Health, and adjustments to goodwill primarily related to an adjustment of the purchase price allocation for Labtech (see Note 4), partially offset by foreign currency translation. For the year ended December&#160;31, 2021, goodwill acquired was principally associated with the acquisitions of the assets of the outreach laboratory services business of Mercy Health and the assets of Labtech (see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K), and adjustments to goodwill related to foreign currency translation.  &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets as of March&#160;31, 2022 and December&#160;31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(930)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(930)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTI1MA_fd9b7f4a-5d95-40dd-a924-dc16b5b838bf">The changes in goodwill for the three months ended March&#160;31, 2022 and for the year ended December&#160;31, 2021 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMS0xLTEtMS00NTA4NQ_896be123-7a60-4d1d-8786-1c8c518680a7"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i25a67828d80741189c9e71a1926cad84_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMS0zLTEtMS00NTA4NQ_e4249cd5-f5dc-4063-9c4d-6b4882f7d8b1"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMi0xLTEtMS00NTA4NQ_eccf06d2-f9db-413f-8c85-fc671842250b"
      unitRef="usd">96000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia5303d7e238e424da44bd18e24d4586b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMi0zLTEtMS00NTA4NQ_bc142af9-3543-4424-93cc-b32f4b913e7f"
      unitRef="usd">228000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMy0xLTEtMS00NTA4NQ_809b1f87-ccdd-4d66-8c7d-784a4e158ad9"
      unitRef="usd">6000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="ia5303d7e238e424da44bd18e24d4586b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfMy0zLTEtMS00NTA4NQ_e075df2a-f3e5-4e22-911a-9689f86ab58f"
      unitRef="usd">-6000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfNy0xLTEtMS00NTA4NQ_1b497a72-357e-4cda-ad75-0b036764a616"
      unitRef="usd">7197000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmIzMjJkMTgwY2ZkMzQ2MGRhNWJiODFjMjBmZTdjNzFmL3RhYmxlcmFuZ2U6YjMyMmQxODBjZmQzNDYwZGE1YmI4MWMyMGZlN2M3MWZfNy0zLTEtMS00NTA4NQ_6b8898f3-2856-4f15-8efb-65d94d6980d5"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTIzMw_b8e34e6d-b50b-4ed5-86c0-d4f14107fd13">Intangible assets as of March&#160;31, 2022 and December&#160;31, 2021 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(930)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(930)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic5ca82d7b06e45028a679da518e76e9b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0xLTEtMS00NTA4NQ_4706d592-58f6-4bdf-ab74-cb142c2f7e3f">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0zLTEtMS00NTA4NQ_1e712245-272f-4618-bfee-01e9f9d63b9c"
      unitRef="usd">1609000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy01LTEtMS00NTA4NQ_c52925cc-30ca-4256-8c85-21e7c15ee46c"
      unitRef="usd">749000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ieb76b50fbdda42d7a6dd1ecbff18bb60_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy03LTEtMS00NTA4NQ_2e3a38dc-ac03-47f5-b328-202f1a9b8220"
      unitRef="usd">860000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i2a068e932f834d0fbed8af834b0682fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy05LTEtMS00NTA4NQ_02dba096-6104-4138-99f0-d0876703d8a9"
      unitRef="usd">1581000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2a068e932f834d0fbed8af834b0682fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0xMS0xLTEtNDUwODU_ba3528af-6d23-450d-871b-398bdd4f5b10"
      unitRef="usd">726000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2a068e932f834d0fbed8af834b0682fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMy0xMy0xLTEtNDUwODU_e26b222e-3a28-44ec-b1c2-259b4ba04086"
      unitRef="usd">855000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icbc15825d3594bf5b2196f75b4ee733a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0xLTEtMS00NTA4NQ_c3a789e5-84c9-4ec4-82bd-65b75c916085">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="id71bba1de51f4a99b9449c6f849555cd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0zLTEtMS00NTA4NQ_b4afdd10-87fd-4b24-bf07-e4f8e285e156"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id71bba1de51f4a99b9449c6f849555cd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC01LTEtMS00NTA4NQ_85155d37-247a-4c70-a8ad-f90621695e9c"
      unitRef="usd">3000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id71bba1de51f4a99b9449c6f849555cd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC03LTEtMS00NTA4NQ_bbc34e2a-510f-4f9d-b2bc-0a13fbe300ca"
      unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia8340eece4f647c8a754867732e5a6f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC05LTEtMS00NTA4NQ_4cc25eb6-6601-43df-8589-467c0e64ede1"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia8340eece4f647c8a754867732e5a6f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0xMS0xLTEtNDUwODU_3d6b6239-e9d8-491c-8f35-083db328fde9"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia8340eece4f647c8a754867732e5a6f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNC0xMy0xLTEtNDUwODU_1ae8c944-78ef-4fbb-acec-d033b9f9a8ff"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3f08c600ea6544d49b1b2a1a8014d75d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0xLTEtMS00NTA4NQ_d1134445-12b5-408a-b961-886002090035">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0zLTEtMS00NTA4NQ_9cbd50b9-8b11-40cc-9623-f001f54612e7"
      unitRef="usd">140000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS01LTEtMS00NTA4NQ_11178b2b-da1f-44c4-b755-e72158273cc8"
      unitRef="usd">76000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4ebda91eda344b3abc3bcd4f6d7b3b1b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS03LTEtMS00NTA4NQ_8cceab98-2e01-476d-a1e4-f045d4222135"
      unitRef="usd">64000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4b6174ae321c4e74944b97981d1b2ae3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS05LTEtMS00NTA4NQ_bb1c8e0b-f107-4bba-b840-8bed5f0ab64f"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4b6174ae321c4e74944b97981d1b2ae3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0xMS0xLTEtNDUwODU_417b3cd8-c3d1-4f2f-a5e1-63c0dc657c51"
      unitRef="usd">74000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4b6174ae321c4e74944b97981d1b2ae3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNS0xMy0xLTEtNDUwODU_8d7a4ace-d525-45db-8847-94334fc4f6d1"
      unitRef="usd">67000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4bc34a35184c4ce7a3e425dbd8fd8062_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0xLTEtMS00NTA4NQ_0457bb20-5e55-4692-a0c5-69d6272e608e">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i2ce3a63acc1249caaa4588f7c259007a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0zLTEtMS00NTA4NQ_f347d44e-dfcc-4c06-a74b-40638c70dbec"
      unitRef="usd">114000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2ce3a63acc1249caaa4588f7c259007a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi01LTEtMS00NTA4NQ_842abe28-4173-4516-bb89-1b3b44b111ad"
      unitRef="usd">102000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2ce3a63acc1249caaa4588f7c259007a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi03LTEtMS00NTA4NQ_5c58c7d2-26d3-44ad-9256-b17afcb29253"
      unitRef="usd">12000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib0a36c4164bf4b33be691b9ef663be7b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi05LTEtMS00NTA4NQ_2d3ac538-0928-40ca-8f60-1086e1e0a143"
      unitRef="usd">109000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib0a36c4164bf4b33be691b9ef663be7b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0xMS0xLTEtNDUwODU_45c43cd0-3d2b-475a-b9bf-da69c648a808"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib0a36c4164bf4b33be691b9ef663be7b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNi0xMy0xLTEtNDUwODU_556ebbe1-6b4d-4f34-bbfd-905f52dee48b"
      unitRef="usd">8000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i59659f457ca94d118fef31ba6ba41012_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0xLTEtMS00NTA4NQ_6406cfd1-2c6e-4833-981b-08f70fb822be">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i97ad39521e69481f9a20580c7230cd21_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0zLTEtMS00NTA4NQ_8c587ad0-f066-457f-bee0-f1cbe3abad8c"
      unitRef="usd">1866000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i97ad39521e69481f9a20580c7230cd21_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy01LTEtMS00NTA4NQ_42053c39-2d6a-4cd0-8c5f-b6dc57d041be"
      unitRef="usd">930000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i97ad39521e69481f9a20580c7230cd21_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy03LTEtMS00NTA4NQ_5a2a8763-0bfe-462f-bb80-8210dabbcb3a"
      unitRef="usd">936000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="icaa2c3e268834b25b750134c958ab08c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy05LTEtMS00NTA4NQ_9bd6cf35-c030-454b-a467-6e30caa7404a"
      unitRef="usd">1834000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icaa2c3e268834b25b750134c958ab08c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0xMS0xLTEtNDUwODU_abdc14e8-d79f-4e44-a4b7-28e0107630d9"
      unitRef="usd">903000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icaa2c3e268834b25b750134c958ab08c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfNy0xMy0xLTEtNDUwODU_53020913-2899-49fb-abc3-f61377502208"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i81c37e4e3f1a4370a83bb9c770279e61_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtMy0xLTEtNDUwODU_81b608f8-eddb-4404-860e-8ed7307d451a"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i81c37e4e3f1a4370a83bb9c770279e61_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtNy0xLTEtNDUwODU_a6e75eca-2319-40ef-8e49-e7731734a07e"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8b580343931c4d66b78cda2fd05abe6a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtOS0xLTEtNDUwODU_2a12a261-0ab5-4332-8779-732016592f54"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8b580343931c4d66b78cda2fd05abe6a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTAtMTMtMS0xLTQ1MDg1_5a6670fa-3b0a-4ae5-94da-3bc254ee182e"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i09ec31233f0e4dad9da135008aa5f080_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItMy0xLTEtNDUwODU_23dab266-cd35-4492-b4cd-8b5a28aca0df"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i09ec31233f0e4dad9da135008aa5f080_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItNy0xLTEtNDUwODU_97c2be32-2641-4799-abe3-e0e1fcb96e22"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i254bf5959746494883fdd89b5852102b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItOS0xLTEtNDUwODU_dfd9d6a8-8c12-4be9-8b48-eee89d08cc75"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i254bf5959746494883fdd89b5852102b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTItMTMtMS0xLTQ1MDg1_b090e95b-e097-4a3d-8644-7419d90ee9c7"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtMy0xLTEtNDUwODU_15647984-dab9-4567-bb04-509722194013"
      unitRef="usd">2102000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtNS0xLTEtNDUwODU_d1241d13-ef68-4b24-8500-bb7abf9122c8"
      unitRef="usd">930000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtNy0xLTEtNDUwODU_a3c09c89-4e2b-4db3-b5a0-336bfeee4435"
      unitRef="usd">1172000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtOS0xLTEtNDUwODU_0afd1551-7681-4d66-bf4e-b275c6145f90"
      unitRef="usd">2070000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtMTEtMS0xLTQ1MDg1_e0cbf0c8-619d-49cb-87af-dab0b1e1d5a7"
      unitRef="usd">903000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOmExMDExY2I0NGM4MTRhZmNhMDcxZmIzYjhkZTgzNzc0L3RhYmxlcmFuZ2U6YTEwMTFjYjQ0YzgxNGFmY2EwNzFmYjNiOGRlODM3NzRfMTMtMTMtMS0xLTQ1MDg1_19cd2ac0-8251-4925-8bf0-a837a121348c"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RleHRyZWdpb246MjZmYzEyNzFmMGMyNDM2ODhjNTkxYjEwNDljYjI5NDVfMTI0MQ_d8e13822-f820-490d-a7f7-0227ce9b4453">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2022 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfMS0xLTEtMS00NTA4NQ_8cd804e7-0f98-420c-8c6a-3f10ab5618e3"
      unitRef="usd">80000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfMi0xLTEtMS00NTA4NQ_d11aa008-1781-4ef1-89bf-ea2ff621b4d8"
      unitRef="usd">106000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfMy0xLTEtMS00NTA4NQ_38e7f68f-3786-433e-86d6-230fe1514f57"
      unitRef="usd">102000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNC0xLTEtMS00NTA4NQ_be24022d-606a-441a-bac9-e2cf1afdadc8"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNS0xLTEtMS00NTA4NQ_232c81de-e2af-430a-b1cf-11592dfa90da"
      unitRef="usd">95000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNi0xLTEtMS00NTA4NQ_328d5fd7-bf09-4dc0-b249-6b10fda8bb43"
      unitRef="usd">85000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfNy0xLTEtMS00NTA4NQ_f9640a0b-d4ba-40b7-b8e6-335cde699deb"
      unitRef="usd">367000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV80OS9mcmFnOjI2ZmMxMjcxZjBjMjQzNjg4YzU5MWIxMDQ5Y2IyOTQ1L3RhYmxlOjVjZTkwZGQ2YjAyZTQ0MTFhNjlkNTQ5MGZjNGQ1ODc5L3RhYmxlcmFuZ2U6NWNlOTBkZDZiMDJlNDQxMWE2OWQ1NDkwZmM0ZDU4NzlfOC0xLTEtMS00NTA4NQ_e24a54a7-77dc-405a-ac54-c6ff515574b5"
      unitRef="usd">936000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RleHRyZWdpb246YWJlOGY1OTY1YzIyNDJkMjlkMWFmYjlkZGFiYzc1N2FfMzQ1Mw_cd1378f2-a0ab-48e0-9075-710eff6acfba">FINANCIAL INSTRUMENTS &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of March&#160;31, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both March&#160;31, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RleHRyZWdpb246YWJlOGY1OTY1YzIyNDJkMjlkMWFmYjlkZGFiYzc1N2FfMzQ4MQ_c18a065e-37ae-4637-9129-321136eafe97">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RleHRyZWdpb246YWJlOGY1OTY1YzIyNDJkMjlkMWFmYjlkZGFiYzc1N2FfMzQ2Mw_09ec8385-2c19-47e4-a28b-0c08215194ca">As of March&#160;31, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both March&#160;31, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ibf58f44b38cb4bb8837626b15f8ab005_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RhYmxlOmI4OTEzZDg3YTRiMTRkNTNhZmU4NmM4NTU2MDgxNmVjL3RhYmxlcmFuZ2U6Yjg5MTNkODdhNGIxNGQ1M2FmZTg2Yzg1NTYwODE2ZWNfMi01LTEtMS00NTA4NQ_240b9a79-8d28-4ba1-960a-975f96cd92fc"
      unitRef="usd">35000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ia613c80a290b4a8eb01c818fb05d0800_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81Mi9mcmFnOmFiZThmNTk2NWMyMjQyZDI5ZDFhZmI5ZGRhYmM3NTdhL3RhYmxlOmI4OTEzZDg3YTRiMTRkNTNhZmU4NmM4NTU2MDgxNmVjL3RhYmxlcmFuZ2U6Yjg5MTNkODdhNGIxNGQ1M2FmZTg2Yzg1NTYwODE2ZWNfMi05LTEtMS00NTA4NQ_0de2448a-69d6-49cf-83c4-b13bcc3c401d"
      unitRef="usd">38000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNTU5MA_ce22414f-49df-4e32-8ccb-3c1f2d438968">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 7); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022 and 2021, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the first quarter of 2022, the Company's Board of Directors declared a quarterly cash dividend of $0.66 per common share.  During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In February 2022, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of March&#160;31, 2022, $1.3 billion remained available under the Company&#x2019;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, the Company repurchased 2.6&#160;million shares of its common stock for $350&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, the Company repurchased 3.4 million shares of its common stock for $410 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022 and 2021, the Company reissued 0.5 million shares and 0.6 million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2022 and December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 5.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTQ5OA_2b2b1368-c054-423e-bc4a-d4a48d59ca4e"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9547ae76ad524df1be143291c3dc3dc8_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_1ec5918c-8672-415c-b1db-a23b969c7800"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i99220d08c6b942a2b4ba862f3c64bf42_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_42687315-fde3-417d-921f-ad18a5afac3b"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia42df8753f0440b391d7bee60af61213_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_56211d06-7d26-4461-8303-8d014e3c3763"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTYzMQ_988f51c3-f6cf-4a16-87f2-0924f5cd1842"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i29b9b62572e64aaeb2ee5d852bb0ac6f_D20220201-20220201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTgxMg_0eabb765-1a4e-4609-9600-0b893ee275b4"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMTA5OTUxMTYzNjIwMA_ac2b1385-a632-4353-b2ad-f36b85011ba5"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMjA1NQ_a6efa34e-b352-4c2c-ac16-b83840918d3d"
      unitRef="shares">2600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic660b7ee65fc4568944bc8292c4e5f89_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMjEwMA_3fc34292-1476-49b3-89dc-1e1c0ec694a5"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMzYxMw_b78781de-f235-43bd-81e4-0a30edfcfd42"
      unitRef="shares">3400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iaa45517fca4341b4aff5d50019463fa8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfMzY0Nw_548f7fc0-f79a-49d7-8f5b-07dcf09ca0b6"
      unitRef="usd">410000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNDEzNw_5e69aa4e-bf5d-42e6-93cf-e8e048cece48"
      unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNDE1MQ_72c9d4a0-a697-478e-9c74-1e89ea98f8c5"
      unitRef="shares">600000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i06ff7b7bc1e443609656c518c6eb5ae7_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81NS9mcmFnOmY5ZGUyNmU0YjQyMDQyODM5YWJmYmUxMDVjZmNhZmYxL3RleHRyZWdpb246ZjlkZTI2ZTRiNDIwNDI4MzlhYmZiZTEwNWNmY2FmZjFfNDg2MA_3a9adaba-de71-4a21-9f22-4338f46f640c"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RleHRyZWdpb246ZmU5OGIzZjNjNjM2NDE3Njg5NjE1NzljNTYwZGQwOGNfMTM2Nw_922fce88-048b-4e4d-9ed1-242df5fa01c1">SUPPLEMENTAL CASH FLOW AND OTHER DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three months ended March&#160;31, 2022 and 2021 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended March 31, 2022, the Company amended a real estate lease and, based on the updated terms, the classification of the lease changed from a finance lease to an operating lease.  As a result, the Company recorded a $31&#160;million operating lease right-of-use asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RleHRyZWdpb246ZmU5OGIzZjNjNjM2NDE3Njg5NjE1NzljNTYwZGQwOGNfMTM3MA_1be55af2-d1cd-4826-a85d-7f7f3e1d7ca5">Supplemental cash flow and other data for the three months ended March&#160;31, 2022 and 2021 was as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMi01LTEtMS00NTA4NQ_244d2770-20ec-4434-af4c-ad86455997d6"
      unitRef="usd">79000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMi03LTEtMS00NTA4NQ_6083e47d-455a-49e4-a09f-c2394076d95c"
      unitRef="usd">74000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMy01LTEtMS00NTA4NQ_4b2d7487-3170-4b92-89d6-8fd44593db20"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMy03LTEtMS00NTA4NQ_c3c060e7-fbd9-44a7-bf8b-16ffec71ac25"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNC01LTEtMS00NTA4NQ_f912700c-50ce-4d80-8279-787277afc0d0"
      unitRef="usd">106000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNC03LTEtMS00NTA4NQ_ca771cd1-449b-424b-b8c9-ae13fe099464"
      unitRef="usd">101000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNi01LTEtMS00NTA4NQ_aec9d36e-5a8e-4381-a191-66cee90d6a1f"
      unitRef="usd">37000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNi03LTEtMS00NTA4NQ_a62449f2-041e-4440-b17e-5a3ecad18b17"
      unitRef="usd">38000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNy01LTEtMS00NTA4NQ_23418b9d-ec58-4fe0-812e-37199bfa6d96"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfNy03LTEtMS00NTA4NQ_961b0e46-6e97-4627-9098-3a36b27bbd9e"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfOC01LTEtMS00NTA4NQ_8ab5fc5d-b647-4b2d-bd90-61ce48f7fd0e"
      unitRef="usd">-37000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfOC03LTEtMS00NTA4NQ_77debe91-42e1-48eb-b183-107bd1b4ab99"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestPaidNet
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTAtNS0xLTEtNDUwODU_292c8dd7-f8a6-42a6-a1b6-a11f1ba059c4"
      unitRef="usd">32000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTAtNy0xLTEtNDUwODU_d276a40d-f308-4270-9395-54365325d141"
      unitRef="usd">32000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTEtNS0xLTEtNDUwODU_227ce3a6-6196-4187-aa3d-4097f9a9b1e6"
      unitRef="usd">23000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTEtNy0xLTEtNDUwODU_e6deaa59-281e-4b9c-bf90-2e4431831e93"
      unitRef="usd">7000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTMtNS0xLTEtNDUwODU_604acf5c-c1ad-4297-973e-4097eaa3b27a"
      unitRef="usd">22000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTMtNy0xLTEtNDUwODU_0bc37e3d-6d5c-4416-b7bd-5243b354b834"
      unitRef="usd">30000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTUtNS0xLTEtNDUwODU_f4a6c272-c308-4c38-8355-10fa0b2b2a56"
      unitRef="usd">78000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="icedb4e4651ac4dc09e1a18ee75b9e30a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTUtNy0xLTEtNDUwODU_9ee8e8ed-2b61-4e8f-b8c1-64f30ea83235"
      unitRef="usd">82000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTgtNS0xLTEtNDUwODU_74ccb7c1-9303-4c1d-a141-487772b16851"
      unitRef="usd">142000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTktNS0xLTEtNDUwODU_21d7eda2-0c43-4afd-866e-1bcbb769914d"
      unitRef="usd">15000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMTktNy0xLTEtNDUwODU_56f633f3-79c5-4e49-b160-6b290f9eaadd"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjAtNS0xLTEtNDUwODU_7030e63c-6f01-42bb-9a4f-3e432484d8da"
      unitRef="usd">127000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjEtNS0xLTEtNDUwODU_ed5fdd0d-2a2e-4e83-897d-c37c4ce26bd7"
      unitRef="usd">-18000000</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjEtNy0xLTEtNDUwODU_ee6006ac-bf81-40ec-b80c-37fba1dc848c"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjItNS0xLTEtNDUwODU_0e09eaa2-68b3-4b99-a8d5-888eda903db7"
      unitRef="usd">109000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjItNy0xLTEtNDUwODU_be7db6cf-748b-40cc-9608-c6b0d82428c3"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjMtNS0xLTEtNDUwODU_d5b915e5-2ffb-4031-9773-d4f39f3ce826"
      unitRef="usd">4000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjMtNy0xLTEtNDUwODU_d2cedb18-6823-41ae-be7b-9e87b5b102b0"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMjQtNS0xLTEtNDUwODU_4b5ca169-b3a4-4ecd-bc29-f091bae4b3ef"
      unitRef="usd">105000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMzEtNS0xLTEtNDUwODU_54300f80-8640-4f20-9efe-ca7a937be664"
      unitRef="usd">63000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RhYmxlOmMzMTc5MmJlMWY0MjQwNzhiZTk3MDFhMjY3Nzc5Yzg4L3RhYmxlcmFuZ2U6YzMxNzkyYmUxZjQyNDA3OGJlOTcwMWEyNjc3NzljODhfMzEtNy0xLTEtNDUwODU_e0edf689-f116-463d-aa0b-6c7e8b91fb59"
      unitRef="usd">36000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i551c518ca51d4c9c9055dcba49fc4c81_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV81OC9mcmFnOmZlOThiM2YzYzYzNjQxNzY4OTYxNTc5YzU2MGRkMDhjL3RleHRyZWdpb246ZmU5OGIzZjNjNjM2NDE3Njg5NjE1NzljNTYwZGQwOGNfNjA0NzMxMzk1NTc3NA_4493e809-41f2-42b9-b7d9-e24108f7f24b"
      unitRef="usd">31000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODQ1Nw_9c5a1e2f-346d-4dc8-a334-e9d69ae6a733">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2022, providing collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#x2019;s 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, in 2019 the Company was notified that the Office for Civil Rights of the U.S. Department of Health and Human Services ("OCR") and numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  On April 6, 2022, OCR informed the Company that it closed its review.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ReproSource Fertility Diagnostics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#x201c;ReproSource&#x201d;), a subsidiary of the Company, is subject to two putative class action lawsuits: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bickham v. ReproSource Fertility Diagnostics, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (U.S. District Court for Massachusetts) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gordon v. ReproSource Fertility Diagnostics, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (U.S. District Court for Nevada). The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#x2019; private information. ReproSource has moved to dismiss both complaints and to transfer the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gordon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint to the U.S. District Court for Massachusetts.  In addition, the Company has been notified that certain federal and state governmental authorities, including OCR and attorney general offices from three states, are investigating or otherwise seeking information and/or documents related to the incident.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2022, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $3 million and $4 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $158 million and $159 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic10d96a9520947408f8b1fbb71092e38_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTEx_ebb74ba2-0f7d-490e-b302-e82b5c9eb27f"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id00a1c2aa7e8495ab6e23f05811ff14c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTI0_be46b273-9379-451e-b2d1-809c60598105"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic6a79d7e1b5247eca266100ab948eb9f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTY3_b760ed80-e042-4d36-bfb7-21861e53fbc8"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i01801313bd9d425a81cb897b8cba44d0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTgw_c77097d7-213e-4a84-922c-1ee46d117cb0"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="id00a1c2aa7e8495ab6e23f05811ff14c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMzgz_3d8866d2-58cf-40fb-be8f-e599a5d44f9a"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i25a67828d80741189c9e71a1926cad84_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMTcyNw_0f98aa3b-07de-4b33-ac9f-f9f24c43fb19"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3b1004fab47841e394d81b95440cd37a_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfMjI3NQ_1314bedf-5679-4a12-9d15-b858c9fe3117"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODI0NjMzNzIyNjkyMQ_a8a29f7a-cedb-41e8-b665-523158e23b16"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationReserve
      contextRef="iefe7c88a31514a2893220839bc498be1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfNzE2OA_58c89698-c8b9-4a92-a852-63be972ada65"
      unitRef="usd">3000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i1e1824dfa71e45bab55dc851db327252_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfNzE3NQ_b07eaf16-e1c9-4717-9ab1-8b2383e9e050"
      unitRef="usd">4000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODI4Mw_0f4d65cb-d56e-40a8-be67-677739771748"
      unitRef="usd">158000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82MS9mcmFnOmQyZGQyZWYwYTNmMjQzOGVhZjE3MmQwMDU1MzdmYjYwL3RleHRyZWdpb246ZDJkZDJlZjBhM2YyNDM4ZWFmMTcyZDAwNTUzN2ZiNjBfODI5MA_c43a26dd-49de-495a-9cc5-91adc25dd01a"
      unitRef="usd">159000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfMjQxNw_071d0bd5-8798-4106-be3d-e743ffe3cb59">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of March&#160;31, 2022, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three months ended March&#160;31, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i7c68974c9ae14e999016cc1e131cfde0_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfODA2_1240f7e0-b29f-474c-abed-21497cbaf769"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i67a7e4d1308249418b99f41ff7f71e1c_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfODA2_6879de7e-4c6d-4058-b10d-0a4713ae94d6"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfMjQwNw_89aa431f-b7fb-4a25-b496-d81e011857c1">The following table is a summary of segment information for the three months ended March&#160;31, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMy01LTEtMS00NTA4NQ_cc08e4f6-94e0-46cf-8157-1c6762e8dbf7"
      unitRef="usd">2541000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMy03LTEtMS00NTA4NQ_7642847b-e533-403f-8a57-ac75316dc72f"
      unitRef="usd">2643000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i406d4d3cc39844eb98b58ddc6a62338d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNC01LTEtMS00NTA4NQ_82fcde73-5e80-4c32-800b-d53a54c4e8af"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic37254f6ff664132a27df6fb73d9bc34_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNC03LTEtMS00NTA4NQ_76f23564-89d1-4d5a-bbf0-54c96bf18889"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNS01LTEtMS00NTA4NQ_cbd9bcc5-ba40-4192-a353-16b4e8ea578e"
      unitRef="usd">2611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfNS03LTEtMS00NTA4NQ_a8e3935e-3672-467f-bf4e-c3703a6d1897"
      unitRef="usd">2720000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOC01LTEtMS00NTA4NQ_9c532beb-8c1a-4575-a0a4-dcf189bb24f9"
      unitRef="usd">562000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOC03LTEtMS00NTA4NQ_79007064-293a-4b8d-882a-7191e91188bd"
      unitRef="usd">712000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i406d4d3cc39844eb98b58ddc6a62338d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOS01LTEtMS00NTA4NQ_1ddbd216-5e43-49d4-957b-767ba8b85786"
      unitRef="usd">7000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic37254f6ff664132a27df6fb73d9bc34_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfOS03LTEtMS00NTA4NQ_96811512-c6e8-4d27-9ff2-a79c4a6b6791"
      unitRef="usd">9000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0262431589c64d5988860f60c34228e6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTAtNS0xLTEtNDUwODU_2e95848f-3eac-40b9-9fc6-c975491aeeb2"
      unitRef="usd">-56000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7c63e12f82864bd19c390ad2281a65b9_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTAtNy0xLTEtNDUwODU_1830ad3c-20ef-4ff7-ace1-0cdd4376eec1"
      unitRef="usd">-61000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTEtNS0xLTEtNDUwODU_8509a5b8-7bde-4277-83bb-0aa5fbddeb06"
      unitRef="usd">513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTEtNy0xLTEtNDUwODU_d6ef4b19-ccc7-4171-bdac-476e4fb1e08e"
      unitRef="usd">660000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTItNS0xLTEtNDUwODU_7c0dc35b-7736-421e-bd1c-e25ea09f363a"
      unitRef="usd">-61000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTItNy0xLTEtNDUwODU_fe3d8ff2-4e3d-4988-acdf-13e93a7481e4"
      unitRef="usd">-34000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTMtNS0xLTEtNDUwODU_f7a169a1-d52b-4566-8aa5-ece629c44f7f"
      unitRef="usd">452000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTMtNy0xLTEtNDUwODU_e24a0d1c-d02f-4dbb-88b0-d9552ca074e1"
      unitRef="usd">626000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTQtNS0xLTEtNDUwODU_e2fb4455-2f7c-4708-9da8-f8814813e150"
      unitRef="usd">110000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTQtNy0xLTEtNDUwODU_f3f7b257-d451-4850-a307-f9880cad52e7"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTUtNS0xLTEtNDUwODU_73c943dd-0fd2-449c-a7e1-f320cc5df30e"
      unitRef="usd">31000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTUtNy0xLTEtNDUwODU_13126ed9-f8e8-48df-8001-637de22bf1b5"
      unitRef="usd">17000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTgtNS0xLTEtNDUwODU_df0ba1d5-121a-4f27-a2bc-012df953f6d5"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTgtNy0xLTEtNDUwODU_7c77420e-457f-429d-b4c2-c6f5360588cb"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTktNS0xLTEtNDUwODU_233006f2-fe72-4ebe-944b-24c5e6a84fc3"
      unitRef="usd">18000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMTktNy0xLTEtNDUwODU_2a0de432-db73-4bc2-86ad-caf0327f2a86"
      unitRef="usd">21000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMjAtNS0xLTEtNDUwODU_33d788c6-929c-4290-8f35-513393dba18b"
      unitRef="usd">355000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOjgyZWU2ZGU4MDc5ZTQ1OThhMjJlOTY2MzA5YWM0ZmJlL3RhYmxlcmFuZ2U6ODJlZTZkZTgwNzllNDU5OGEyMmU5NjYzMDlhYzRmYmVfMjAtNy0xLTEtNDUwODU_64e7effd-baf4-44f1-a795-b36069d54937"
      unitRef="usd">469000000</us-gaap:NetIncomeLoss>
    <dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RleHRyZWdpb246YzNiYzA5NjZmNWNhNDk1YTg1ODI2ZmY3MzlhNDk3NzlfMjQwOQ_c81c6c80-ed9c-4037-8144-3959d958b48d">Net revenues by major service were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4be0056c2d4457d87c5fadf557e6aa3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfMy01LTEtMS00NTA4NQ_f8e7b679-d113-41db-942f-a8e63c470e3e"
      unitRef="usd">1066000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8822bce97a2b4af293f8ceb8f7512c0c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfMy03LTEtMS00NTA4NQ_ebaa9bef-77d4-426e-9d15-9aa77482dfe9"
      unitRef="usd">1032000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06dddf077b184e02aeb6d79159ca7906_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNC01LTEtMS00NTA4NQ_00612ea8-a5bc-4091-a0a9-a6869699a897"
      unitRef="usd">599000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8517e8d9b8ac4e6daf93a2e50dccb9da_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNC03LTEtMS00NTA4NQ_9874f6b9-95cf-4b43-870d-6bb2a9d2b277"
      unitRef="usd">828000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i357b7ece8680488e8499ff07ec4d5141_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNS01LTEtMS00NTA4NQ_ef472941-6f23-4457-b2e7-ec54d194ff90"
      unitRef="usd">739000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9f3a4d5ffd34af588f97c9b3c569245_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNS03LTEtMS00NTA4NQ_e798b542-dd17-4177-b672-1e2e1deb0589"
      unitRef="usd">653000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i554bdadf4c5d454fbfe277f057fbf835_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNi01LTEtMS00NTA4NQ_7707b27f-869d-4592-b587-e46eb83ee93a"
      unitRef="usd">137000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0122ad278dc483e8e5ca7f6dbcfebaa_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNi03LTEtMS00NTA4NQ_56488527-fda1-45c0-b1eb-9192f5f01b86"
      unitRef="usd">130000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6e73eb975d144a494494df1d9ae3f91_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNy01LTEtMS00NTA4NQ_b800aa9e-3116-4d2e-9a8b-0af179cc7572"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i391bf57712c046ac8a065213c2be01ca_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfNy03LTEtMS00NTA4NQ_9d4a66b0-5d33-4e23-8252-9dd156b56e5c"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfOC01LTEtMS00NTA4NQ_43870c99-da30-4f32-b26b-367ffe1991d1"
      unitRef="usd">2611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82NC9mcmFnOmMzYmMwOTY2ZjVjYTQ5NWE4NTgyNmZmNzM5YTQ5Nzc5L3RhYmxlOmIyY2IxNGFlZWIyMzRkNDI4N2JhMTBhY2RiZWY1OGIxL3RhYmxlcmFuZ2U6YjJjYjE0YWVlYjIzNGQ0Mjg3YmExMGFjZGJlZjU4YjFfOC03LTEtMS00NTA4NQ_59291475-2edd-4fca-a1b7-7f7648628590"
      unitRef="usd">2720000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfMTU1Mg_5c5cb636-2ee8-4c5c-84c1-3ad9f007f8b0">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for over 95% of the Company&#x2019;s total net revenues for the three months ended March&#160;31, 2022 and 2021 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Revenue and Net Accounts Receivable by Customer Type&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i67a7e4d1308249418b99f41ff7f71e1c_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfOTk_40ef7773-7642-4275-8175-16d3a1105f2c"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i7c68974c9ae14e999016cc1e131cfde0_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfOTk_a6216764-4e6e-4784-9eec-13d3d526a9c3"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfMTU1MA_f874e123-acf8-44d7-bc5a-c82b3fc248df">The approximate percentage of net revenue by type of customer was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i2618e94f78ff4be6a974f3d7437c9209_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMy01LTEtMS00NTA4NQ_a4ad1af7-909a-4927-8a18-3363c524748f"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i4b2b3bb914b24a5fb505052ab070ca0e_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMy03LTEtMS00NTA4NQ_2567b853-40b7-455f-99b2-734d54532aa7"
      unitRef="number">0.38</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ic31416e26495484dbfd0cc01ec4b8a6a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNC01LTEtMS00NTA4NQ_5960ac6a-5974-4965-ad8e-38e5b1a9f98a"
      unitRef="number">0.02</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i15e3cb2bbf8749a79b1c1e421d2c139e_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNC03LTEtMS00NTA4NQ_bc32215c-e54b-46a6-8257-d71d6bbb25b6"
      unitRef="number">0.02</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i1c1aad07e73c4da6b04fcd621739200e_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNS01LTEtMS00NTA4NQ_9b492891-54f0-4415-85cf-a4248d100ff8"
      unitRef="number">0.41</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i425a3e05cbb94ca5a14e66f99fada19f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNS03LTEtMS00NTA4NQ_3875c47d-7a14-47ba-9115-386c32d1d921"
      unitRef="number">0.40</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i149bfab7a1c24f29b4792c319f8ef948_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNi01LTEtMS00NTA4NQ_4b9c9638-5b58-476d-b226-baa8250c9330"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3cd4daa713554f92aef54d2f74630a39_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNi03LTEtMS00NTA4NQ_9f3d7516-bc12-4800-bf33-07d71a285586"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i70a9907567b640a289999fae84223794_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNy01LTEtMS00NTA4NQ_62c79379-0bbc-45cf-907b-f2043eaf6d2f"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i84f9da75efe04d6daab9a677cd6e4633_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfNy03LTEtMS00NTA4NQ_0c9b4af1-7179-464e-a77f-b8f3360f86ba"
      unitRef="number">0.35</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia292ad0369a643b9828d88492775c95c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOC01LTEtMS00NTA4NQ_1b3bd4ef-6e7a-43ab-8a18-34999cfac5b8"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i01cb765ce9e44733bd6b1826d67c2ff7_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOC03LTEtMS00NTA4NQ_73d61929-f4f6-4cd4-ab04-dcee97a24c15"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib77e12927bca4786b2fbdff356c147ee_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOS01LTEtMS00NTA4NQ_62fe90a6-c611-4128-aecd-0db735edf63f"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i815f45de0dca4dfeb3a149d99c93e582_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfOS03LTEtMS00NTA4NQ_6aafcc7a-3970-4c90-be1c-43825866a483"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i170456437f45486e9e310a25b9ca855a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTAtNS0xLTEtNDUwODU_0f4036c2-4c5e-4559-a90a-ac1ac86b084a"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i2a550c5ebbc248d0b9bce68cfbfe1a1b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTAtNy0xLTEtNDUwODU_eac9d235-908b-4569-96ae-5c91b0ff7bad"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTEtNS0xLTEtNDUwODU_3d3abf3d-0611-4b4e-9689-624f384ea5b8"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i21b29910bc3a4912a15b0b5974751891_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOjRmMWQyMTYzMjQ1ZjRlNzFhNzQ0ZGE5MzU0NzYyZWE4L3RhYmxlcmFuZ2U6NGYxZDIxNjMyNDVmNGU3MWE3NDRkYTkzNTQ3NjJlYThfMTEtNy0xLTEtNDUwODU_e0c3bfd7-5ba6-40b9-acb3-038fabfb2017"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RleHRyZWdpb246MDQ5MWQ0MTUzZmIyNGYyMzk3MDc3MjJiZWE3ZGY4NmFfMTU1Mw_1ce8d51a-374b-4dfe-a0da-356c57379b8a">The approximate percentage of net accounts receivable by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if2160658eb534668abfaded3ccde2376_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMi0xLTEtMS00NTA4NQ_b7970ef4-61cd-4037-ae83-ffdd470388df"
      unitRef="number">0.29</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if2a0ec3fce9b4f089434858787b2e801_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMi0zLTEtMS00NTA4NQ_eeb1d142-b2f7-4dea-94b2-46cc11dddba6"
      unitRef="number">0.32</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i2135620d30a34a64941ea2b56bd5a164_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMy0xLTEtMS00NTA4NQ_9b4d9376-ece0-4727-8b15-9117f9ea0554"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i951aac53e0e940dcb3d7a633466939f8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfMy0zLTEtMS00NTA4NQ_fabfdc74-ed01-4c10-b4eb-59904896f264"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i65b4fed4ceae4b3cab7b60c00ca07f58_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNC0xLTEtMS00NTA4NQ_35e8b93f-6c1d-4f83-bc4a-170fc190e990"
      unitRef="number">0.41</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if0c1bc5bdc9442598a7e0cbe2845150b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNC0zLTEtMS00NTA4NQ_7588ca9e-0eae-44fd-8848-c20c254fb624"
      unitRef="number">0.38</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i4b80ff0f7b2446d5abc033b9fca38b60_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNS0xLTEtMS00NTA4NQ_05075c3f-9c88-4dff-bbf2-912ea2c09626"
      unitRef="number">0.20</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i933ce909814a47798eadf9de833f81dd_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNS0zLTEtMS00NTA4NQ_fe7fd68a-510c-49b1-a4dc-333975c7ad7c"
      unitRef="number">0.21</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i6e7cf4826791442d82f7d57441fce080_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNi0xLTEtMS00NTA4NQ_d3cba155-bf93-49cc-8afd-b6a9bb07fd3f"
      unitRef="number">0.96</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i1679f660fe4a49e7a6124528bc22afb7_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNi0zLTEtMS00NTA4NQ_d2fd6944-6e54-4573-a1cc-a5d333e0b0fd"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i28c3b5952b744911ba36a0b36600e646_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNy0xLTEtMS00NTA4NQ_68fc696e-c5aa-408d-a4f5-9110ddde6324"
      unitRef="number">0.04</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ib2ad59c542884b95abd5a3ffaad7ec7d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfNy0zLTEtMS00NTA4NQ_b3cffa0c-1057-44b3-b162-49257e003eb0"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ic8a628e1577e44afb2b5fc5220acb6dd_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfOC0xLTEtMS00NTA4NQ_6f7b5c79-fa0e-4f2b-9ad9-15e4442eda0b"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ib599976dc0dd4ee59f6bc1e033b46e43_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV82Ny9mcmFnOjA0OTFkNDE1M2ZiMjRmMjM5NzA3NzIyYmVhN2RmODZhL3RhYmxlOmQxNjdjODU2ODk2YTQyYTJhNTJkMDY3ZGYzYTM5MjM2L3RhYmxlcmFuZ2U6ZDE2N2M4NTY4OTZhNDJhMmE1MmQwNjdkZjNhMzkyMzZfOC0zLTEtMS00NTA4NQ_69132eea-ff7d-4790-b16e-e108ab298949"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i29b9b62572e64aaeb2ee5d852bb0ac6f_D20220201-20220201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM0NTUyN2Y1NzQ4ODQ4Y2VhNjQxZWI5YzQwOGJmNmJlL3NlYzozNDU1MjdmNTc0ODg0OGNlYTY0MWViOWM0MDhiZjZiZV8xMDYvZnJhZzo0MDYxYTQ0OWVhN2Q0OTRmYjI1ZjJkZWNjMTc1OTlmZi90ZXh0cmVnaW9uOjQwNjFhNDQ5ZWE3ZDQ5NGZiMjVmMmRlY2MxNzU5OWZmXzE2NDkyNjc0NDM3MjQ_0eabb765-1a4e-4609-9600-0b893ee275b4"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>55
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M]P4(@4R02V*,E>6S5I8_CWD4D<M4PVU=/YJX3M-ZR*N<WFOE]->Q4"M;8)]
MP:S!6N,-3VK3UR#8B%89O8?[]#Y9:P')PH!PF4:@RNX]W*GWL_*-,\ZS'2+R
M-370(A-K:'6[,X5R/U.V&XDO8TJ'WJ#OLK.1\W*(Y1QL7=E1R7;T-/'MRC3?
MQ2JOEKN&DVROS*D>S[<<X8,?!E632"PAU#T=PN^K?!<O/S%RDVV$+:0Q,LX.
MUX('0MD'X/Y22K,_L3]0[J6._P-02P,$%     @ X8&65(BOWS$R!0  -A,
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M5*T0S18H-A?L1\'7-&%9UW<5HLI56+HRBVL]CS $8[T=A[[--&IM=C0&C<;
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M15I>KA@%T<8 WC\)H5]NS \%S0]#\[\!4$L#!!0    ( .&!EE34#,AZO@(
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MC0'N+X70[Q-SR-9WZO ?4$L#!!0    ( .&!EE3Y-LES"P8  #88   8
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MVD,IV] RT]_%X0L['FALUDM$INQ?=#C*#GLH*946^7$R(,AY4?W2QZ,B3B;
M.OX)Y#B!M">, A.BXP2KN4&%S![KBFJZF$MQ0-)(PVKFP>K&SH;3\,*8<:4E
M?.4P3R^6=[>KNV]?KRY^7%^AU0_XN;F^_;%"=Y_1\F+U!7W^=O=KA?KHY^H*
M_?7A;_0!\0+=\"P#&ZCY0 ,$L] @.6YW66U' MM%Z$84>JO0=9&R].7\ 4"O
M\9-G_)>D<\$;*C^A"']$9$B(!\_R[=-Q!YRH5F=DUXM"ZJ1JBS80&PIMI,@1
MA)NDFA</E;]RS9DZZ]AG5.\SLON, OO<0H#S(A$Y\]F@FCNQ<TT<[Q=1',T'
M^U.]N#*CV;"6>0%J7(,:=Q[^(OT7'!9B7"ND!01Y(HJ$9PP5-5HS;MX2HZ>=
M%'L.;H#63^]6U*3&-.E4U!6#[)9P6N6,(D4T%U+S_^R 3W?5<N,3O>#AI*4[
MGPSVZRZN<<:=..^-+FQNA-2,$LE2KE$FE&+>*(L=!,,61E>"^!%.:X335S2Y
M81)PU9:DCVC-"K;AVH=PZNS?'[5]T".#8S_*68URUHERI47RNV\2>XH )K"=
MJFS/'LVS-UQFKCFG+:2=(B^ XF&3>8>=4._TELF/)AR\>73H;#EJ@?*(] -&
MQB=\@+LSV)86#TR9-'\2D^"'$-0F?C).USQ[-3XQ:38DG6JX2!)1FI0!<<KX
MGJXSKY&.JYP>-B9MA;@R. K9J4GI.'H;P!U],NBJ-)(DL@0?.[J5GPHCCW]/
MQFW07JE1 '5#$+B;(;[64<IJY%Z0(V?[F0/1E<&3*("P80L\?MW_ ZX5#HNQ
MF]?:J<\G$P#;T CNYI';MY*6%[1+&*.I@]H5BJ, J^"&5G#\KH*$%WNFWL&S
MN*$'W,T/EZ6"$06F3/Z40&4FZU9V1&)3Z<Y^D>VZ[Z@C'QD,'4]TI0)%"VX8
M W=3QI+NN*99%<I NZ4,6-$E@?ZD36D^H>G$#Y$T5$&ZJ0*"&7HTQ4Q6KBQ8
M55DF:L1)&/E@$P]+X!9JGTR B$G#) 2_+61*9:L&K^]Y$6-?1IRU,7ND9H&D
M1!HV(N1=\;+A!84B]LWQ0AI:(=VT\IU!5J[,"/&1LK4WWQ$?.[0UT2GS$E[#
M'Z2;/^Y+F6S!Y2PZ;;ROE$](F?+*B].EB+[;=/BD1C@0P:1A$M+-)->/3"8<
MP@.@6H20F76H024N.^!V+O;)A.*AH1#232'7^2X33XP9-I8BRVP%?>!ZNQ59
M"AX&FBZ.\+E2IK@HH4F6U9"OI-UE-'!$ETKZ)&Z?T2<4<IN&;TAW'W/%#3L6
MJ:DYN#?1$[<SZ<?MTM8K- Z :RB*O-+"<*4E7Y?6-VPK"@VJ*+2QA@EQ7F@&
MR5\#=JD+)OW*]1"54X)XA68!_ U3D6ZFJBHF7TH*UDO$T[DXRO9PUBC@[E'#
M65$W9SGIWX?;!SGRD-$H;B<]G]1X$F#:J"&MZ VD95L@ [FJ6H!D[0.#ZF5/
MLYIYC:M(GFA6??>>Q4ME;6_Q2,6!BC5JF"SJ[JN6[\'^$5KY!UX4QCJ01*&N
MY<(;O9';8DV=/LPCA/$XT(A%)W=KW8SYSA,Q4QQUGB5R[L!B[)S%%<(D:E/6
MX.0&-F?RP5Y,*V0;Q^HRLQZM+[\O[)5O:_P2GRVK*^QFF>I&_89*L)!"&=O
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M%^!Y+?_R-$;\068R2U<)?V9,'L+G\F"6)4ZVR6)9JD799:%-ZL?R3,BDJ4]
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M+W-H965T."YX;6RE5,&.FS 0_17+IU:J0@+9;14!4LAFU1QV-PK=]NS  %;
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M+!+5'J&\2UW"!*DTQ6!6JPUJAVHC6_# N^I7^J<%?)=(?[4DWU'.H5HVT._
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M_N2V]%.&"T_OU"HR^OI.JXUU:(0B]%.X>Y4FL R@P\@H<#'0!:JL'+0('.T
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MTSNPL*4%J/.DJ4C<?E)XUJ6)PW-O.AB)62S]3!\/IO6#/LTQY"UTOF8UH*\
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M,=%04.<F9-:%QI/Z:SB".<3S]Q,H#I8H#@3%P?]E^S^X49\+4F>NK'4U5TW
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MA8GYCWO<"FAMO)/L?8J2-3J?$;<%'3>3X1Q<++8B*M^@BGN)N<1;')2SPBP
M+<*]7!9((71P$!*;OVV/ UO@A.=-S(@ZP6,8,NF1J]SEIBB:IO.L:BFZ-G.-
MRL_5+%C?M :?@+^<8]UG35L75:9\<*Z=*506NNAJK#J/A64#W?3*E%)?ZPIR
M2%IC/0\#/NM3M[/])L%B)E%M7&)#@X:JO37@$_#/FA&++H%U75\QYLKGL?9Y
M/O"(UM1]GOSX+;?N=?WEB.;)LFKG"][5N[<8YHSDYPJ-+.1 =V\S]&!6\SZC
M*'^Q?/E@;2MQ +-R0QS+J^(NBB:'UT$$T"L8PM-$*$LWHJAD2'9,+P:^PM3K
MU.UCI87NRK=$M&0EIMHXKU+8CA?'D(72WJBTGJ<4IASW2HQEA?ZY"/0U6#AN
ML1<ZAR%1H?_@\DDC]-BX.71\6<YB,XH#Y%Z.P6;E 5(VDJL<J!6V0$CH=&,I
M.7?#T0;8UO3<QC%7QF,N>&)[4]10/3U#<Q#6+AA"/*%QL^3E%:-W-_J0]J<R
ME>48MC:[DUVEXGW;G /^"CF0?>J3*W%2V7 $7P_+9E6NQ;UFZ\N^URIS+[GK
M'M1>NZ"6TD[#-9S9!SWQKKI<7=[T^_&"NQ*/?R8 9U,^P!5R M5.\FRO%;._
M>?%F%JZ[8^-Q>0Z/N10(&PO@^\0 9_W"#I9__SCZ&U!+ P04    " #A@994
M_<;4Y ($  !6"0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6RM5O]/
MVSH0_U=.>6C:)$::I$#7E4HI!8$$6P5L^^'I_> F3F/-B3/;H;"__MW936@1
MH*?I26T<^^[SN2\^^S)9*_W3E)Q;>*AD;4Z"TMIF'(8F*WG%S(%J>(V20NF*
M69SJ56@:S5GN0)4,X\'@**R8J(/IQ*TM]'2B6BM%S1<:3%M53#_.N%3KDR *
MNH4;L2HM+8332<-6_);;;\U"XRSL67)1\=H(58/FQ4F01N/9D/2=PG?!UV;K
M'2B2I5(_:7*9GP0#<HA+GEEB8#C<\U,N)1&A&[\VG$%ODH#;[QW[N8L=8UDR
MPT^5_"%R6YX$HP!R7K!6VANUON";> Z)+U/2N">LO>XP"2!KC575!HP>5*+V
M(WO8Y&$+,!J\ H@W@-CY[0TY+^?,LNE$JS5HTD8V>G&A.C0Z)VK:E%NK42H0
M9Z>WWQ:+J[/KLR]WZ16<IK<7<'[U]0>\8U7S&;[>79S=P#R]2R>A16,$";,-
M\<P3QZ\0)W"M:EL:.*MSGN_B0W2R]S3N/)W%;Q)>,WT 2;0/\2".W^!+^L@3
MQY>\%GG;-))C?5DFX929$LZQ0N',KQGX.UT:J[%J_GG#V+ W-G3&AO]_FO^(
M./TRWZ*%G5@SBK6@6%F=@[(EUY!C[0 ><< 9_C7G4/GMX[1]@,G/RC[[#H@O
M$:R9 ?P52B*?&<.=@V[O_'.H@\TYWB"98.Y@\@>\80R'/3C^1(\AI)725OS>
M%<?']-M!DAOL)=T]B 9'[AG!96VYYL9N"=\GQQ_<,/KP)!9UIBH.[_X:Q5'\
MN1^?P_>AQJOR%8Z&B1P7D]@_+CVE90_<=+(XH1@AS3+54IDU[)$M)<<L&D5Q
M8<;6PI:X2XV@W7)F<V%;-$!P1SV N;@7.0J>")!UA(]1#+/68)48@P"6_6J%
MYOD8SIG0<,]DRT$59(W;)S&E:DC,7=2[VE*PI9#""F(T>'\C(CI\19G2\YP^
MPIWKM*^Y7F'%90HO]IQKOW%=$.\C3&>GZ0ZE2QM5YG(3E6<U@G &=_A3KW^%
MTK%']9:'O73V$M[O)GJ=[:"H<@ZWTG'%\>)';C?F77AJ:;'KX5Q0Y64EJU?<
MN5IC,\*V2;'5*Y $VLGA'AQ1%21',&\UJ?RG4[?OU$Y5U;#Z$>O>ZS!LC50F
MQF+M;&SAN=AWO0J/=^U0;9.[TL(ZK8PGRB2&(0J1^1W '-"J)_"Q8-ZUJM!"
M(6I69YW0*C3P/+X#2(WSQ6 [W/44SZO2WM6]),(F)J4S^"Q!FOKG1U5\; WW
M&3YXZ>(-MWI=1:5$'=V .TV^[?6K_4=#ZGOED[K_XL#TK@36D.0%0@<'QX>!
M]Z*;6-6XSKE4%ONP>RWQPX=K4D!YH93M)F2@_Y2:_@M02P,$%     @ X8&6
M5!)0D.(U#@  ?28  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULK5K;
M<MLX$OT5E#>UFU1IY&LRV=RJ'"<SXVQL9^/,[L/6/H D*&%, AP E,;[]7NZ
M 9"4(GL\EQ=;HHA&HR^G3S?Y:FW=C5\J%<0O;6/\Z[UE"-V+_7U?+E4K_=QV
MRN"7VKI6!GQUBWW?.24K7M0V^T<'!\_V6ZG-WIM7?.V3>_/*]J'11GURPO=M
M*]WM6]78]>N]P[U\X;->+ -=V'_SJI,+=:W"C]TGAV_[@Y1*M\IX;8UPJGZ]
M=WKXXNT)W<\W_$NKM9]\%G22PMH;^G)>O=X[((54H\I $B3^K=29:AH2!#5^
M3C+WABUIX?1SEOX=GQUG*:179[;YMZ["\O7>\SU1J5KV3?ALUS^H=)ZG)*^T
MC>>_8AWO?7JT)\K>!]NFQ="@U2;^E[\D.TP6/#^X8\%16G#$>L>-6,MW,L@W
MKYQ="T=W0QI]X*/R:BBG#3GE.CC\JK$NO#F[NK@X_W+Q_O++M3B]?"?.KBZ_
MG%]^__[R[/S]]:O]@"WHQOTRB7L;Q1W=(>Y87%@3EEZ\-Y6J-M?O0[5!OZ.L
MW]NC>P5>2#<7QX<S<71P='2/O./AO,<L[_BN\]JVU0%1%;R0IA)G4%>;A3*E
M5EZ\T[YLK.^=$O\Y+7QP")K_WK/KR;#K">]Z\F=9^0^($Q]5",IY86MQYE2E
M@_BR5#AHVTES*TIIA/:^5Z(9[ROC?<$&B;T6XM'AP0&BK6DH<7JXT@D-@SUZ
M-KGL50D[5<C,4NF5+!K8+\FI9:D;'6[9PH\.G^Z4]>W3J2RCK<.OH]"5;5:D
MRI;(N4 RBKIW80E!%?S5^P00"^DJ6A'&T_[-/UC-AZLPP[U*7-J@Q.$Q;,8;
MRAZW8%5IC;>-KB1]J;61""S9"!]P(4:=-EL:(K(/Q:DQ/>[[K#KK@L!Y"'/$
MX<$W_YB+<QBH[^(/-1O/:7\#%#" 31(J.F<73K8S6'4T*C;ZVL71 :3 0PRS
M5L@$0#G4-VQ;R;*0E.5RR,H9;;_2_#O@J,%)'8Z"@@$ <X[T(P/7?:"\DCT@
MS1:Z00!J68P.(/2&KG_]R_.CPV]?0E*+PN,E8S=RTHM.WK(%YV/2!@0[(%E<
M%8U>\*U^(]B=HKJ$(.B+GU &R%GEN-9.5D6[E,H%+, Z'$"QTV!#[.#Y..NE
MQKF-G6B^A$4*I6A):1TP;RM %>0U?AHRS_]HR"0+/2!PSM)Q/B(W&G@M!L/4
M0*V\A72XB4V,8TKO+;8G5=8Z+&E?V!<.+I4B#T?4U&8%ZV3CS431!\0E< 7&
M031"E$8\T4'IMI;,R"=N;6\XB-FAL).3<$6^,!.ZAG@D6%C*@#A&085=/0JL
MJ)UMA:Q6.( 2/_75@BU#=@VA4>D+C*?P#W$CFZ#I([:P[ B(L4W/P83='G(J
M+O85692S)<BHZ,,,PJ<M@"DE+_*=*G6M2R&;1F7YB!P8B*]@GTJVV"$M[4V*
M1,H-GP.&KI$4F8\A1=G(:$C^H*(RK*_^'^_,D!_74:C17=',7== $KPTHS7[
M-H)"(\L;6K9I+J\7AC<VC V! HXV:CBNN)H@*Z=Q16F!Q.OA7UB@M/ ;V<^1
M2SF>.^RDQ.-&MYP#N!*#X^4T5Y%./5@;E'P2X23%<X=$0A9C[]+Z5,AS2E(9
M=ZKA"(YV^U5WS<7)P>'CFR?B4X/B^%&N?8]@!NHBP0[@D+4578]L!'U,!I>1
M4C;Q5A]QL@:F53E7?YQ?SXE.!*=QEC,+/. C7(*G?J @AF,7A$UAFMJLG$W(
M42M324I_3D1XI$MFV84%Z00PJXF>(/QL*()2A,'ML# @.HH/2S)&RC026&O8
M6DM']HMA/I4I"D B&@(.+@WM>C9T<8MXT$P9R%V1/<5<5[\0?*>(I'K%8EE6
MM#X7+MNEA(&2=DUR>H.=O#44FDAX4%XR8@SY028V*W#$I72+Z&:6VTG$>:D[
MR6 0BSJS?RI<I 6!L:%O2\0AQPY?[RP<TRE'+0[].NKGN?A>E<$6L%D*!S8N
M^7,#N.DR1<H0$V.E+26?DD0Y]4+\$]D2$!MR8:"!+D&6/Y]?GXJ/.D=DU(J]
MI^O:I\B2FQM**%AQ^4B.9ETO .A4%Z9Z5J V2<.1=;26=XIN:Y'#:<$@[/3B
M[%103R&NB2E0L3M'9:K(;5=&?.B-$L?$  [_/MN(8<>EB#=$;'U62 &UDLTW
M%])S_8FDU.+36Q "V<]([GS_M%6.($9<X.<2N8U&*_=NIT30;\5C"O>C@Y>D
M&G\\?/D$4$-)1[[;/",;\:H+?7O\[$!\_'@6]9%$0D%"EM8!(BO1>WB)9,BR
M5)Y#*XOGQ/*WT+I%N(4UE?G3?H&F3##U02FG/1(;.HBV$(])AXFB=]@PZS\?
M=8PTBO%KI0P8^H3A0<N5+I7?RO\8YKQ-6HU*HHK 1"P9;[HT[Y7<6VN'P^RT
M7L* ^Z+ QG [/(DGGV\:3M8U%(#49$'0C*:O-BA.W#B&_&,U7\QGF8&6X/+"
M]&U! 4-'+*2Y(1<Q@9BL>S(3;8J7J;011Y'7A"8[-V.JTT0F3"=+&\(G7RA%
M(_5(Z$[$)A]A#AC7+#W;<SBU285T&Y^C$;A4(WUEP9R2!0-MT&>,E4,G\R87
MR<;;W1[B<)Z>JHOE,:%Q/'XC"POTM(3K [7FL0)9=HTRS1MD9Q%[S4@LC;%$
M1")0_VHXS.*/WO9$VQ"-(<7?"(1<%,F3KN\"\IFP,E:KR<6Q5H_D.D$46[Z'
MYK;WOZ$D[RJTFQ3AOG-%!5GU#V#L'#&?I%$-QS\"!)U/*O,3!$?),KY6SB6G
ME>QP=AEKAFO(S(!6C>AJ[%MMS.;MLM(R<>B<^@:[8/,IF=%F]D"ZP=7A$D2L
MC:4LH_:DS*0 ;#?.-'''SC*TVPT3]G$'RQE0CVUB)$6WK)#[.F5KI0%G8)I,
ME"=:1H9+2(Z X#HCQ8IX2V#0PLYMC(/( * =.DYW2_KIE@\)_4V*S=SCW!\
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MXP/8GQKV8'Q@ ?57FLO_ E!+ P04    " #A@994.8]DEU8%  "J#   &0
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M"I[RAQ)!R+(4,O\.8,7O%X7."D@4 8)MK0VE"JRLI$%.TAHAG1)&9<I[9*T
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M4 2"&(24AVCD'.)%S-\33Z2#VH'Z01L)3()+2878L""NU=H_,)=0@]Z&E%X
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MME*Y[4';^W"Z#R:9$*N)S=H.[-ZOOQDGA'"E;+7:DZ+$CN?UF3</MDH_FP3
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M8\-D:V%:6X@/6.C"G2Y<9F%6I)CNXT/RMG4Y;ER>QA\2W@ES"MWH,\2=./Z
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M3+AWAP^G5_ZN.]..W/2O2_JI@H8%:'^N.8+A@PTT/W[&_P!02P,$%     @
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MTNN-@$<6G5LQT"*SS<].:&BE[&,"W2Z1Q@#6]T+HEX%Y0=4_S_\!4$L#!!0
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M/XJ@G3)G)JQ?/T6_RA\>'F9)-9M*\8VO3'C>&730BJUI*LRMW'YBQ0/Y6;Q
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MQ])SK]2I]YLGTSOQ\QR7/,=[3)[4KG@^UF.7@W9KK)Y,3/VL)R7K27C>R,S
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M_971J@^)E+(7;B$")&Y1(T&%H*0/51_,,H 5K[VQO1"D?GQM[V9#(T"JHO#
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M[0:SOA9"OPYL6RB[>O<O4$L#!!0    ( .&!EE3+?[5ZV (  &0&   9
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;(U546_:,!#^*Z>H#U1B#22%514@
M0:$:4JD0C.YAVH-)#F+5L9GM0/OO=W8@8RV@O<#9OOONN^_L2V>G]*O)$"V\
MY4*:;I!9N[D/0Y-DF#-SHS8HZ62E=,XL+?4Z-!N-+/5!N0BC1J,=YHS+H-?Q
M>U/=ZZC""BYQJL$4><[T^P"%VG6#9G#8F/%U9MU&V.MLV!KG:!>;J:956*&D
M/$=IN)*@<=4-^LW[0=OY>X<7CCMS9(.K9*G4JUN,TV[0<(108&(= J._+3Z@
M$ Z(:/S>8P952A=X;!_0'WWM5,N2&7Q0X@=/;=8-[@)(<<4*86=J]PWW];0<
M7J*$\;^PV_LV D@*8U6^#R8&.9?E/WO;ZW 4$#7/!$3[@,CS+A-YED-F6:^C
MU0ZT\R8T9_A2?321X](U96XUG7**L[W'_G@&+_VGQ0@FH_Y\,1M-1L_?YU";
M8:)DP@5G7CVU@@&NN91<KH')%$8R=>: "283-,ZA;PQ:XT^?.%M2K.5TLI!J
M:5!OV5(@C.6FL.8::D.TC NROL"<KR5?\81)>\JY#D^X10$QN3XH:2DMDB>9
MAJ>H2WY7P"5,N!"T,)W0DC2NP##9RS H98C.R!##A) SX\K"]-_XD"2M=(T.
MN@ZBBX 3IF\@;M8A:D318CZ$VM7U!=BX:E?L8>-S[6)<PPL3!=;AF9[L$#7?
M,G>Q2_6A=E#^_1HFR$RA,072A]I9:%UVS'#2]+/0\*'E/Y\H.8PMYN;7!>JW
M%?5;3_WV#/7]3:D3YP3S)>J#/,U3[2JQVA[+#99MK]4)MR?2MZKTK8OIIX5.
M,GJ^5#I+4^XJ+*\J-Z;P5_@4C1*S=40CNCO-HUWQ:/^?#'1#DJRZ(J>2MS]I
M$,<?DH='+S]'O?;SS4"B"FG+(5#M5B.T7TZ.O^[E_"4^]+X-"%Q1:./F*U6M
MRYE6+JS:^#FR5):FDC<S^@R@=@YTOE+*'A8N0?5AZ?T!4$L#!!0    ( .&!
MEE1JXZT(NP(  $\'   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;)55
MVU+;,!#]E1T/#S!#<6(3&Y@D,[E0FAEN0Z \=/J@V)M8Q9:"I&#Z]Y5DQW43
MX[8OMBY[SI[=E5;]G(L7F2 J>,]2)@=.HM3ZPG5EE&!&Y E?(],[2RXRHO14
MK%RY%DAB"\I2U^MT C<CE#G#OEV[%\,^WZB4,KP7(#=91L3/,:8\'SA=9[OP
M0%>),@ONL+\F*YRC>EK?"SUS*Y:89L@DY0P$+@?.J'LQ"8V]-?A*,9>U,9A(
M%IR_F,DL'C@=(PA3C)1A(/KWAA-,4T.D9;R6G$[ET@#KXRW[9QN[CF5!)$YX
M^DQCE0R<,P=B7))-JAYX_@7+>'J&+^*IM%_("]LP<"#:2,6S$JP59)05?_)>
MYJ$&T#S- *\$>+N CSSX)<"W@1;*;%A3HLBP+W@.PEAK-C.PN;%H'0UEIHIS
M)?0NU3@UO+J[FS[/KJ]A=#N%V>WCZ/9J-KZ^A-%\?ODXA\,KSN.<IND1'$Y1
M$9K*(_@$3_,I'!X<P0%0!C=Z6U=$]EVE!1E:-RJ=CPOGW@?.?;CA3"42+EF,
M<0-^TH[O>BT$KLY$E0YOFXZQU\IX0\0)^-UC\#J>UR2H'3[%J()W6^3X575\
MR^=_5)TR^_#M@>NO/K@Y$?'W%N;3BOG4,I_^A?D8QB0E+$(@"A:XHHQ1M@*^
MA#4*RIN*,BZ8 \MLNL3;,.R<]_KN6SU1^T;!6>A71G^([E6B>_\D6E_^UPT5
M&$.\$4:N2K!%;T':JTDY#W;4[IMXWEFSV* 2&[2*'<4_]/75#4])4!Q6I?8F
M@<&>]UU]^Q:?@F9Y824O_/\#@"QN+WVX7_KN>;@CML&H?CX*N6ZM9V4H5K:5
M2XCXAJFB?56KU6LQLDW2_6U>/#7ZTNIS*R'%I89V3D*=)U&T[V*B^-IVP 57
MNI_:8:)?/!3&0.\O.5?;B7%0O:'#7U!+ P04    " #A@994;#3U5$8&   D
M(@  &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6S%FEUOVS84AO\*8>RB
M!>):_)!L%XD!QTX[ TD:U.F*H=B%8M&V5DG,*#II]NM'28XIBQ^V@@RY2229
M/.<E=<Y#ZDBGCXS_S->4"O K3;+\K+,6XOYCKY<OUC0-\P_LGF;RER7C:2CD
M*5_U\GM.PZCLE"8]Y'E!+PWCK#,Z+:_=\-$IVX@DSN@-!_DF34/^=$X3]GC6
M@9WG"U_CU5H4%WJCT_MP1>=4?+N_X?*LM[,2Q2G-\IAE@-/E66<,/TY]4G0H
M6_P1T\>\=@R*H=PQ]K,XF45G':]01!.Z$(6)4/Y[H!.:)(4EJ>.?K='.SF?1
ML7[\;/U3.7@YF+LPIQ.6?(\CL3[K##H@HLMPDXBO[/%WNAV07]A;L"0O_X+'
M;5NO Q:;7+!TVUDJ2..L^A_^VDY$K8.T8^Z MAU0LP.Q=,#;#OC8#F3;H9SJ
M7C64<AZFH0A'IYP] EZTEM:*@W(RR]YR^'%6W/>YX/+76/83H\]?ODR_SRXO
MP?AZ"F;7M^/KS[/SRPLPGL\O;N?@W5P&6K1):/X>O)M2$<:)/.J";_,I>/?;
M>_ ;B#-P%2>)O(?Y:4](187=WF+K_;SRCBS>,;ABF5CGX"*+:+3?OR='LAL.
M>A[..7(:O KY!X#A"4 >0@8]D^.[0T/WJ;O[E"YLW?=&@W<W!Y?VL,7>ISB+
M!>U>RLR(0)A%8":G:5E=3,J+LTR$V2J^2R@8YSD5.?AQ*8V F:!I_I=# ME)
M(*4$8I%0<Q"6#D[ A.7"=*LK0T%IJ,#-PPA!3]Z$A_H$&AIY?6_7:$^CO]/H
MM]4X7BPVZ28)A9RC<<JXB/\-"\Z8=%?&_9JD[A![#=VF1AXVZPYVN@.G[ELF
MPD0FD*;^FAHG.- T0-AO3K"I4= W"^WOA/:=0NLS".@ON>;DU"2PK_E&_7UY
MD[Y^_RWB!CMQ@^.31,N'<C)/]F( 7%0C. &?XGPA[\"?-.3@*A0;'HLG\&-\
MEPLNUR-7^@QWXH;.F?M*B[4WHARPI8U)YT-MV@:6C(">PKKG="Q]82.//3T^
MO,#BK;:(P$/>B-$;-'A#%F](>4.'O/E&;\C@#5J\*09#?,A;8/2&-6]#W^),
MT1:Z<2N=]8W.B!XC-F<*F]#-S=LUE5O%I:#<Z%)''K:!!"KDP2.89W2G@VN(
M;8&IP 7=Y-+7QVLFP'QS][?<=P+!]L'0!;<\C&@6IC1W)#]4:((MV/2Z"SA4
M"()N!K58PJ&.(H3]Q@ISH-'^ODT!"[F!U78Q1#K(=*D'&NU+5;1#;MJU#:HO
M8MU,L7W/BGP(O54\(05$Y 9BBWA".B-A\Q:YFNPK5!1%;HJVCB5]5ZK)U %L
MDZGXB]S\G92/=Y1W.:UVJDJQ"S](P18%;Q8N"L'(C>#OY:-WL0]_H#Q<T?WL
MN*$\9I'QIKC-PCYXDOLVYT0I3J/!JX7T0(^5P!LVPV6@AXL_L$6,0CEJC?(V
M3SI()W>W3S3MIE;(LA1C!7C\NH#?FJM/]"!H/I9A'? #WP)XK "/W8"_9EEW
MP=)[*J3*%:<TI9EP11I6!,=O1G!<*RNX"?[2E#Q@=G@P([%".'ZUN@/6Z8V;
M8:+3V_+LCA6]\?]:=<"&BH(FV]#&\O2$U:* 7[?JL#57GUXM"PU%!XM,M6Q@
M-]]OZ6*=L82MGESQI B/WVPGCA6^L1O?+\X[MUE(#B8>49@F;DRW*?CIA(:D
M&1O$4' @EN@@BM#DZ"WX2Y*/Z'6);C]H*C<U(A;E:@$@[N)%V_3;FJM/<D":
M2O7"A^U)G:A%@KAI?NBIA=1*R.3-RM@*U\2-ZY?FW@&SP>'44V0F;C*W23T=
MRA!J86' <FVGNJ]2@9D<75)Y4>KI1>*NX36!L94-&VH5(.Y]?NOD,VSV-:GZ
M5G]@T:D6"N(F>J5S.Y5QMM(3Q!%POF*][[U58OH*Y;X;Y2]-S -FCW@^]!6T
M?3>T6V2FK_,:#H+FVN(;2M4#;%E<?,5LOW5IIM6;,+T68WH59FIE>Q?FJU7"
M?]VBC:]O^^L%XZU64Z,F1GJUU^<IY:OR,X0<+-@F$]6KY]W5W:<.X_(%?^/Z
M.?PXJ3Y84&:J[R>N0KZ*LQPD="E->A_Z<O9X]4E"=2+8??F2_HX)P=+R<$W#
MB/*B@?Q]R9AX/BD<[#X,&?T'4$L#!!0    ( .&!EE1*< 470 (  -\$   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;(U4WV_:,!#^5TY1'UII;2"!
MMJI")'ZL*E)!"$KW,.W!) =X=6QF&^BD_?$[.R%B$J"])'?V?=]]=SX[V2O]
M8=:(%CX+(4TG6%N[>0I#DZVQ8.9.;5#2SE+I@EER]2HT&XTL]Z!"A%&C<1\6
MC,L@3?S:1*>)VEK!)4XTF&U1,/V[AT+M.T$S."Q,^6IMW4*8)ANVPAG:^6:B
MR0MKEIP7* U7$C0N.T&W^=1ON7@?\,YQ;XYL<)4LE/IPSC#O! TG" 5FUC$P
M^NVPCT(X(I+QJ^(,ZI0.>&P?V)]][53+@AGL*_&-YW;="1X#R'')ML).U?X%
MJWK:CB]3PO@O[,O8ASB ;&NL*BHP*2BX+/_LL^K#$:#9.@.(*D#TOX"X L2^
MT%*9+VO +$L3K?:@732Q.</WQJ.I&B[=*<ZLIEU..)L^#\?=<7_8?87A>/8V
MG8^^CM]F<-UC@LD,8>:(S0U<#] R+LBZA?EL -=7-W %7,*("T''89+0DAK'
M&695YEZ9.3J3><3T'<3-+Q UHN@$O'\9/L"LAC?_A8?4@[H14=V(R/.USO"]
M*KFZM:@+&.#"PA]X9ES#.Q-;A!?,5URN+F2)ZRRQSQ*?5:WYCKG)A>^OM =#
MBX7Y<8&Y53.W+NIW&A&Z6::VTI)8Z#'##73SGS1$=.WLJ1,J*>\]I;OONS1N
M)^'N^!1.A#S6(:72\&C\W-6GDZ5V&1"X)%#C[J$=@"ZO4^E8M?$3N5"6YMN;
M:WJ!4+L VE\J90^.&_+Z34O_ E!+ P04    " #A@994I=A/)18$   @#@
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MJ#CMXYI1."J, 7Q?"J'?&Z:#\M\,D_\ 4$L#!!0    ( .&!EE2H=E39;P(
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MU\"V&^#S$]C0!C9V)W9+&[K):%/AQCY@WU<XVS+PY?\OW)BMN6;:^22';>/
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M^Z\YRR]6'%W\*\GU?Y5#P5Z-S3'VVD6>OP61\5L0^3I[,FR.G=[9MG>R==8
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MR>J"Z_,.%_*/:]@_X"KR-.F0@ES#"GI]XG&2>,A$KO%=M==0)SHJ9"/7L(W
M!2^ZTG?,(1M-?M=&V]FI7*!C0C::&+;1V:G<F0G(!'+19'#1Z/@-;,TW2F3K
M6-V@5>T%*XM4HOYPV,*;7/>KZ<V^+'W5EM1AP];'3VK'SX&?_@902P,$%
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M) <?HP1!(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M (:M
M(:M (:M (:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$
M(6N"0M8$A:S)?Y+U7>O57_]+:->X5F5S]&?=#YOY)U!+ 0(4 Q0    ( .&!
MEE0'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N
M>&UL4$L! A0#%     @ X8&65%R8=<?N    *P(  !$              ( !
MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ X8&65)E<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " #A@994<?HS%2T%  !7%0  &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ X8&65(BOWS$R!0
M-A,  !@              ("!< T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( .&!EE1ILDFS9 ,  ,X)   8              " @=@2
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #A@994 W*_
MQ'$&   D&@  &               @(%R%@  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ X8&65-0,R'J^ @  7P<  !@
M ("!&1T  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .&!
MEE3Y-LES"P8  #88   8              " @0T@  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " #A@994# &%7E\'   C)   &
M        @(%.)@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ X8&65.X!R_T$ @  B00  !@              ("!XRT  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( .&!EE2M=\]I-0@  #05   8
M              " @1TP  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " #A@9944SP9LWH#  !E"   &0              @(&(.   >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( .&!EE1Y@Y #308
M ,H.   9              " @3D\  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ X8&65*'JB H&"P  KR(  !D              ("!
MO4(  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #A@994
MMIN'9E %  "9#   &0              @('Z30  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( .&!EE1'P7)$GP8  !\1   9
M      " @8%3  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ X8&65'>E 769!@  "Q$  !D              ("!5UH  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #A@994_<;4Y ($  !6"0
M&0              @($G80  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( .&!EE024)#B-0X  'TF   9              " @6!E  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ X8&65&CN.<$9
M!P  L1$  !D              ("!S',  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " #A@994.8]DEU8%  "J#   &0
M@($<>P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( .&!
MEE1)7-PREPH   \<   9              " @:F   !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ X8&65(>@Y=RA P  4 D  !D
M         ("!=XL  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " #A@994G__M E0$  #J"P  &0              @(%/CP  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( .&!EE0]CNJ_?@0  +4*
M   9              " @=J3  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ X8&65!QFX.\8 P  N08  !D              ("!CY@
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #A@994J1G>
M)J #   N"   &0              @('>FP  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( .&!EE1"F@Z2<P4   @-   9
M  " @;6?  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
MX8&65%>Q6F@U P  LP<  !D              ("!7Z4  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " #A@994(<%;#98#  !+"P  &0
M            @('+J   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( .&!EE2B(LGH?@0  !T3   9              " @9BL  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ X8&65!32!2NH!0
M#QX  !D              ("!3;$  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " #A@994K+35E T#  "1"   &0              @($L
MMP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( .&!EE1Y
M3SCON0(  .$'   9              " @7"Z  !X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ X8&65,M_M7K8 @  9 8  !D
M     ("!8+T  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .&!EE03!\,I> 0  '(0   9              "
M@:+0  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ X8&6
M5*AV5-EO @  _P4  !D              ("!4=4  'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " #A@9944E)H2:T#   .#@  &0
M        @('WUP  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( .&!EE37)I_]K04  ,P:   9              " @=O;  !X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ X8&65'P]2+23!   ,1H
M !D              ("!O^$  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " #A@994XO0=#!H#  !*$0  #0              @ &)Y@
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .&!EE27BKL<P    !,"   +
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4!08     ,@ R )4-  "&\@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>142</ContextCount>
  <ElementCount>225</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>48</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107104 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109105 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115106 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119107 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2122108 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124109 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2128110 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2130111 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2133112 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2334307 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2412404 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2421409 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2427412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2429413 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2432414 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2435415 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="dgx-20220331.htm">dgx-20220331.htm</File>
    <File>dgx-20220331.xsd</File>
    <File>dgx-20220331_cal.xml</File>
    <File>dgx-20220331_def.xml</File>
    <File>dgx-20220331_lab.xml</File>
    <File>dgx-20220331_pre.xml</File>
    <File>dgx03312022ex22.htm</File>
    <File>dgx03312022ex311.htm</File>
    <File>dgx03312022ex312.htm</File>
    <File>dgx03312022ex321.htm</File>
    <File>dgx03312022ex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="544">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20220331.htm": {
   "axisCustom": 1,
   "axisStandard": 17,
   "contextCount": 142,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 368,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 5
   },
   "keyCustom": 16,
   "keyStandard": 209,
   "memberCustom": 23,
   "memberStandard": 25,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - EARNINGS PER SHARE",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107104 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109105 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115106 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119107 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122108 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124109 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128110 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130111 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133112 - Disclosure - REVENUE RECOGNITION",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334307 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAcquiredFromAcquisition",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i76bf93c88af8464a9a58729f38c9d757_D20220201-20220201",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic936b9e915e24f4d821896ad2218ef1f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411403 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic936b9e915e24f4d821896ad2218ef1f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412404 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "idcb19055dda64f259d36cb98695b26b1_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "idcb19055dda64f259d36cb98695b26b1_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i0c1e1a831dc645f884fd63f68dafc0eb_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i4fa858bac8ab409c945714c4cfc92476_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ib599976dc0dd4ee59f6bc1e033b46e43_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ibf58f44b38cb4bb8837626b15f8ab005_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421409 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ibf58f44b38cb4bb8837626b15f8ab005_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427412 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i551c518ca51d4c9c9055dcba49fc4c81_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429413 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432414 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic4be0056c2d4457d87c5fadf557e6aa3_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435415 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dgx:PercentageofNetAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "ic8a628e1577e44afb2b5fc5220acb6dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i481f1360cd724a9f8b74bd582e93a71e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i481f1360cd724a9f8b74bd582e93a71e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220331.htm",
      "contextRef": "i93ed172ac7b04060ba7dbde228dcaa45_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 48,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AmendedRealEstateLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Real Estate Lease",
        "label": "Amended Real Estate Lease [Member]",
        "terseLabel": "Amended Real Estate Lease"
       }
      }
     },
     "localname": "AmendedRealEstateLeaseMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill and Intangible Assets",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill and Intangible Assets",
        "terseLabel": "Increase to the estimated contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "terseLabel": "Working capital"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 Testing Services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client Payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS Businesses"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DescriptionOfBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business (Abstract)",
        "label": "Description of Business (Abstract)",
        "terseLabel": "Description of Business (Abstract)"
       }
      }
     },
     "localname": "DescriptionOfBusinessAbstract",
     "nsuri": "http://questdiagnostics.com/20220331",
     "xbrltype": "stringItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "label": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ExcludesgeneralandprofessionalliabilityclaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excludes general and professional liability claims [Member]",
        "label": "Excludes general and professional liability claims [Member]",
        "terseLabel": "Excludes general and professional liability claims"
       }
      }
     },
     "localname": "ExcludesgeneralandprofessionalliabilityclaimsMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances",
        "terseLabel": "Purchases, additions and issuances"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government Payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare Insurers"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LabtechDiagnosticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Labtech Diagnostics, LLC",
        "label": "Labtech Diagnostics, LLC [Member]",
        "terseLabel": "Labtech Diagnostics, LLC"
       }
      }
     },
     "localname": "LabtechDiagnosticsLLCMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MeasurementInputComparableCompanyRevenueVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Comparable Company Revenue Volatility [Member]",
        "label": "Measurement Input, Comparable Company Revenue Volatility [Member]",
        "terseLabel": "Comparable Company Revenue Volatility"
       }
      }
     },
     "localname": "MeasurementInputComparableCompanyRevenueVolatilityMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_Mergerconsiderationpaidpayablenet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger consideration paid (payable), net",
        "label": "Merger consideration paid (payable), net",
        "terseLabel": "Merger consideration payable"
       }
      }
     },
     "localname": "Mergerconsiderationpaidpayablenet",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pack Health, LLC and Labtech Diagnostics, LLC",
        "label": "Pack Health, LLC and Labtech Diagnostics, LLC [Member]",
        "terseLabel": "Pack Health, LLC and Labtech Diagnostics, LLC"
       }
      }
     },
     "localname": "PackHealthLLCAndLabtechDiagnosticsLLCMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PackHealthLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pack Health, LLC",
        "label": "Pack Health, LLC [Member]",
        "terseLabel": "Pack Health, LLC"
       }
      }
     },
     "localname": "PackHealthLLCMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PatientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients [Member]",
        "label": "Patients [Member]",
        "terseLabel": "Patients (including coinsurance and deductible responsibilities)"
       }
      }
     },
     "localname": "PatientsMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_RoutineClinicalTestingAndOtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing and other services",
        "label": "Routine clinical testing and other services [Member]",
        "terseLabel": "Routine clinical testing and other services"
       }
      }
     },
     "localname": "RoutineClinicalTestingAndOtherServicesMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Revenues by Major Service",
        "label": "Schedule of Revenues by Major Service [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Major Service"
       }
      }
     },
     "localname": "ScheduleOfRevenuesByMajorServiceTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "label": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt"
       }
      }
     },
     "localname": "ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior Unsecured Revolving Credit Facility"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAmountAuthorized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized",
        "label": "Stock Repurchase Program, Additional Amount Authorized",
        "terseLabel": "Additional amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorized",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Line Items]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Line Items]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataLineItems",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Table]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Table]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataTable",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TotalAmortizingIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Amortizing Intangible Assets [Member]",
        "label": "Total Amortizing Intangible Assets [Member]",
        "terseLabel": "Total Amortizing Intangible Assets"
       }
      }
     },
     "localname": "TotalAmortizingIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TriggeringEventAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Triggering Event",
        "label": "Triggering Event [Axis]",
        "terseLabel": "Triggering Event [Axis]"
       }
      }
     },
     "localname": "TriggeringEventAxis",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_TriggeringEventDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Triggering Event",
        "label": "Triggering Event [Domain]",
        "terseLabel": "Triggering Event [Domain]"
       }
      }
     },
     "localname": "TriggeringEventDomain",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20220331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r250",
      "r274",
      "r320",
      "r322",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r487",
      "r489",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r250",
      "r274",
      "r320",
      "r322",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r487",
      "r489",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r180",
      "r306",
      "r308",
      "r446",
      "r486",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r180",
      "r306",
      "r308",
      "r446",
      "r486",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r250",
      "r274",
      "r310",
      "r320",
      "r322",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r487",
      "r489",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r250",
      "r274",
      "r310",
      "r320",
      "r322",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r487",
      "r489",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r16",
      "r185",
      "r186"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $30 and $31 as of March\u00a031, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r19",
      "r45",
      "r46",
      "r47",
      "r472",
      "r494",
      "r495"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r44",
      "r47",
      "r54",
      "r55",
      "r56",
      "r106",
      "r107",
      "r108",
      "r373",
      "r490",
      "r491",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r329",
      "r330",
      "r331",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r323",
      "r324",
      "r333",
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r150",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r23",
      "r187",
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r88",
      "r204",
      "r211"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r100",
      "r162",
      "r169",
      "r176",
      "r192",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r368",
      "r374",
      "r414",
      "r433",
      "r435",
      "r450",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r40",
      "r100",
      "r192",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r368",
      "r374",
      "r414",
      "r433",
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r189",
      "r190",
      "r196",
      "r454"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r385",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r319",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r319",
      "r321",
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r354",
      "r355",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Maximum Contingent Consideration Payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r353",
      "r356",
      "r359"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired from acquisition",
        "verboseLabel": "Less: Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r26",
      "r90"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r83",
      "r90",
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r83",
      "r415"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW &amp; OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r34",
      "r224",
      "r455",
      "r477"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r232",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r106",
      "r107",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15",
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2022 and December 31, 2021; 162 shares issued as of both March 31, 2022 and December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r50",
      "r52",
      "r53",
      "r64",
      "r462",
      "r483"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r50",
      "r52",
      "r63",
      "r366",
      "r367",
      "r378",
      "r461",
      "r482"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r50",
      "r52",
      "r62",
      "r365",
      "r378",
      "r460",
      "r481"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r195",
      "r295",
      "r305"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate activities"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r67",
      "r100",
      "r192",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r414"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating income:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer-related intangibles"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r256",
      "r265",
      "r266",
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r32",
      "r99",
      "r104",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r287",
      "r288",
      "r289",
      "r290",
      "r424",
      "r425",
      "r427",
      "r428",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r88",
      "r101",
      "r336",
      "r340",
      "r341",
      "r342"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r88",
      "r216"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r88",
      "r157"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r395",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r383",
      "r386",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r388",
      "r389",
      "r391",
      "r393",
      "r394",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r379",
      "r380",
      "r383",
      "r384",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r11",
      "r13",
      "r451",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r65",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r119",
      "r121",
      "r131",
      "r132",
      "r133",
      "r137",
      "r138",
      "r397",
      "r398",
      "r463",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic(in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r65",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r121",
      "r131",
      "r132",
      "r133",
      "r137",
      "r138",
      "r397",
      "r398",
      "r463",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r54",
      "r55",
      "r56",
      "r106",
      "r107",
      "r108",
      "r110",
      "r116",
      "r118",
      "r140",
      "r193",
      "r286",
      "r291",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r396",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r490",
      "r491",
      "r492",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r27",
      "r163",
      "r191"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r400",
      "r412",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r256",
      "r265",
      "r266",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r401",
      "r436",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r406",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r400",
      "r401",
      "r403",
      "r404",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r256",
      "r311",
      "r312",
      "r317",
      "r318",
      "r401",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r256",
      "r265",
      "r266",
      "r311",
      "r312",
      "r317",
      "r318",
      "r401",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r256",
      "r265",
      "r266",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r401",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3",
        "verboseLabel": "Significant Unobservable Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r405",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value, Measurement Inputs"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, March 31, 2022",
        "periodStartLabel": "Balance, December 31, 2021",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r256",
      "r265",
      "r266",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r436",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r406",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r405",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful life",
        "verboseLabel": "Weighted Average Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Intangible assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r205",
      "r207",
      "r210",
      "r214",
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r205",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r210",
      "r447"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for purchase accounting adjustments.",
        "label": "Finite-Lived Intangible Assets, Purchase Accounting Adjustments",
        "terseLabel": "Intangible assets, purchase adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r197",
      "r198",
      "r435",
      "r449"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Balance at end of period",
        "periodStartLabel": "Goodwill, Balance at beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r200",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, purchase adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r162",
      "r168",
      "r172",
      "r175",
      "r178"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r59",
      "r88",
      "r159",
      "r191",
      "r457",
      "r478"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r117",
      "r118",
      "r160",
      "r335",
      "r339",
      "r343",
      "r485"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r85",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Non-controlling Interest [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r133"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r206",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r206",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets Excluding Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible assets, Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r203",
      "r208"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total intangible assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r464"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r58",
      "r156",
      "r423",
      "r426",
      "r466"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r81",
      "r84",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r39",
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "verboseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r22",
      "r100",
      "r192",
      "r414",
      "r435",
      "r453",
      "r475"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r100",
      "r192",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r369",
      "r374",
      "r375",
      "r414",
      "r433",
      "r434",
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r34",
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r32",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r38",
      "r100",
      "r192",
      "r236",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r414",
      "r452",
      "r474"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r141",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r83",
      "r86",
      "r89"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r48",
      "r51",
      "r56",
      "r60",
      "r89",
      "r100",
      "r109",
      "r111",
      "r112",
      "r113",
      "r114",
      "r117",
      "r118",
      "r129",
      "r162",
      "r168",
      "r172",
      "r175",
      "r178",
      "r192",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r398",
      "r414",
      "r458",
      "r479"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Quest Diagnostics",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r48",
      "r51",
      "r56",
      "r117",
      "r118",
      "r371",
      "r377"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r120",
      "r125",
      "r126",
      "r127",
      "r128",
      "r130",
      "r133"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards to be Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r291",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating expense, net",
        "totalLabel": "Total non-operating expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r162",
      "r168",
      "r172",
      "r175",
      "r178"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Total operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r42",
      "r43",
      "r45"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in available-for-sale debt securities, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r49",
      "r52",
      "r54",
      "r55",
      "r57",
      "r61",
      "r286",
      "r416",
      "r421",
      "r422",
      "r459",
      "r480"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive loss",
        "verboseLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r72",
      "r75"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Increase in investments and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r73",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for business acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "terseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r24",
      "r25"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r77",
      "r80"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r76",
      "r328"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r48",
      "r51",
      "r56",
      "r82",
      "r100",
      "r109",
      "r117",
      "r118",
      "r162",
      "r168",
      "r172",
      "r175",
      "r178",
      "r192",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r365",
      "r370",
      "r372",
      "r377",
      "r378",
      "r398",
      "r414",
      "r467"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r9",
      "r10",
      "r217",
      "r435",
      "r468",
      "r476"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r291",
      "r332",
      "r435",
      "r473",
      "r493",
      "r495"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r106",
      "r107",
      "r108",
      "r110",
      "r116",
      "r118",
      "r193",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r396",
      "r490",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r153",
      "r154",
      "r167",
      "r173",
      "r174",
      "r180",
      "r181",
      "r183",
      "r304",
      "r306",
      "r446"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r307",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill, Net"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r162",
      "r165",
      "r171",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r162",
      "r165",
      "r171",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Reporting Information by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r150",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r183",
      "r219",
      "r220",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r162",
      "r166",
      "r172",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r97",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r150",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r183",
      "r201",
      "r218",
      "r219",
      "r220",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r37",
      "r54",
      "r55",
      "r56",
      "r106",
      "r107",
      "r108",
      "r110",
      "r116",
      "r118",
      "r140",
      "r193",
      "r286",
      "r291",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r396",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r490",
      "r491",
      "r492",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r140",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r286",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r14",
      "r15",
      "r286",
      "r291",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r15",
      "r286",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r291",
      "r325",
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r286",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase authorization remaining available"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r20",
      "r21",
      "r100",
      "r188",
      "r192",
      "r414",
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r55",
      "r100",
      "r106",
      "r107",
      "r108",
      "r110",
      "r116",
      "r192",
      "r193",
      "r291",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r363",
      "r364",
      "r376",
      "r396",
      "r414",
      "r416",
      "r417",
      "r422",
      "r491",
      "r492",
      "r505"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r98",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r291",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r35",
      "r100",
      "r192",
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, Value",
        "periodStartLabel": "Balance, Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Intangible Assets Not Subject to Amortization - Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Deferred compensation trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r36",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r36",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r15",
      "r286",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "terseLabel": "Purchases of treasury stock- shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r36",
      "r292",
      "r293"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 45 and 43 shares as of March\u00a031, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r286",
      "r291",
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock, value"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Intangible Assets Not Subject to Amortization - Other"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpatentedTechnologyMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based innovations or scientific advances that have not been patented.",
        "label": "Unpatented Technology [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "UnpatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r120",
      "r133"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in Shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r119",
      "r133"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in Shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r499": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r500": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r501": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r502": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r503": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r504": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0001022079-22-000074-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-22-000074-xbrl.zip
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MR[WS^N'>QQK;WJ@W]XY:1_77[WB]O?5E[\C3VL<]O/^Z)FH;?Q_6H"_#[WR
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M,G)6C@ A=-9&@"!")S,"5%BI-'@]C14G@!'>1$4L,51Z&S0O1P#/W@C@B8V
MC\'QR*4@UH-?PR9"]W6,2C@3&;9#'9@]*R"3LP+#C-4Z<0]47ZB@D^'6,4R(
ME#@:_'Q6,$*]>)#Y_?#7 "\[/6XU?7-0BVT'KPA-N#I<.QC-?*[L#@#X\W<V
M_W.2I^^Z[>-N!W[MKYTVP5V/;X//V]W.[J#K/PV?]?O+6U]Q,6H7+9F6>3*M
M(CAUB+4$Y=I[@RWAP3BPS92 @"V,:-9":.9Y;XC8;3-L==;M<7-@6W,B)D&#
MP88 9C"PHI"LC3I)[9RGT3*6%D9,.W%@FYT8-FVOT^P<].=$/L3BI)E+6A/&
M!0@F1$X\$1# 0.3'R<+(9\W[D_9)*Z^;;@\.8R_?UXN'^6F?XU;'=]MQ3D3&
ML$M)B4@TBSQY9H";Z!083UIJR=S"B*S1*VG]V3RY)1PX88*YR"SF3C'M>.(0
M=,HH M-T<=Q2O=O)'>]U6RV NRT8 HC'!G,B)6M84 $+;!+A#FN([XRB&AOI
MG6-136&.:^[=T_1GX$*07DOAD_>"&^8=,1S[:)PTU 5E%T^JSV6$TY>M5Q)[
M(L'U&<FER]0$@U"MB!"2.<X73[93(2S3%[10.80C2O$@. G&>BF3QQ@^,(31
M:2P_/+&@GS3VGKY B=?4B^ XDYA3+K*#%42!RXW 5ZU;/($^6\0^?>&"<6*G
M8I0B^1P^&@YD5U-#/8\B:;-XPGWBH&3Z(G7$)2NM2(Y@+H.WBLFD"-7,:HT%
M>;ZUCWG&W:=9E&$R"&>)(2":%+5)@BDA.&;":8/5PHAF&G.>DQ-32M$: C@8
MO.,12VM#TDDR@X5UF"R.F)YUSG-R\B&1Q6!E,B(&;A5W)!D<M1<N4*V%61CY
M3'O.<W(BDQH#_2?&6$MXHA(HAF!1<>8,@XAP<4SJ^>8\)R><:'&24@4=->-4
M4LNU#Y9BS@4AB=B%$<X4YCPG)R6N0180@_F@*+<F:0?(%X2FT3"K2'R^?(8%
MX7632[304FJN(V&6)QX]<4$+SS%76CM /;(PHID&KYN<F")1.H&WT4QYKH#7
ML<2=T,I['U,<T>]%$-.S\KK)R2=9GW?..&J8X]0DP[#BRD=-' ]!+Y 939G7
M31#Y@"MPBK6W>>$T@/B(@A") W5@B26Z,")[/EXW0>'D/2P&.QF$Y$IP9QR$
M2%@QX'C"4K<PPID"KYN<E+CD6F@C:*"$$YH,)2QYIK2UUA'KIY#9/O?N:2IY
M]U>SCZ66>8H"@U/C$CL30&>BHEISH!V1+IY4I[*6/179>O!ST@--X8SPO!"F
M310T1>6X!+KO%D^VTU_+GHJ@"<<^;R/ X"TYT!D0KM8L1 @?C,%$+J"@I[+T
M.17AYKV0@JCD+6<<(@R;D@@"!M]PR9+5BR?<YUSZG(I(@R0I<)? XW(.Y-=P
M(8/%R1AB-"-L\43Z?+DGTV%1+B^9>F(%Q3P(JR.$, Q'*H5QP*:>;P?3/,OQ
M2;9648^32HY&G=/W&#,V07P)OU(<%"-^840SG?T[DQ(33L$P;C06G'"FB+-8
M2,!#3@ %$Q,+(Z9GWK\S,?EP:SP%]J&DY#@DIQ)5'"A)BL2)Z!9&/M.>\YR<
MR((U J1FE+:$YS6>G-]*#,0)E#IC^<*([#GW[TQ.."2EO![GG>4QK\OY/#^M
MX7.7K%(+(YRI[-^9E)24=,DPK[5-&KBZ-59H14UBVIN@Q'C_#AVGG<(/LRJN
M/T_ZX';Z_34/XNJ73&$HJ'!PNO+6^D]_1=L:'+YYL_[TR:;T_LFF7]_Z P1=
M:QZ-MQ9HN><$6"#W5#)E!1>&)1%'J2.5_+YG6]=$\B.K/@I';)2U!!B%5TE;
M'[PA!(@?.*N$Y\BV7C4[S4%\ P0!>#>,QT'3M>):OQ\'_3_/:O:HVUMOV?[U
M4.JD/P RT=N)K;+>;/^P>?P]-C@7VC)]:T\A$$%H]"3GNQ! ;T6I$,QZBB4%
M:Y^?W0+?%.0;ZP;1'VY<UI%^%H%.8;-6D-( .:(6$^X4U8H(@8-3 0-CNL"*
MGU*@LX=2<ZEBWC#I3#1$1,H3#YH2;:0-%/Z.B:393RY]99N]#[9U$D&:PSIE
M^0&O>O$_)['CSZ[*]>+FKV[M[T1_TNL!39^35%.JK*))"6:,YL1",,5X) 1^
M=81C-P<)]L\GL\<TZ>+'OZ"3MN</S][$S[%U1ZNV.L<G@WYY!YD3!3*1)1X=
MQ.*2\+R/7WD@#HX*FPB%4'RN%.C1TJ)/H#H_"0+%H.$_B"5IH#QP:2E03.(M
M$7D^9[3PL_ *Q"H%>C0")9.X24%ZIKAP4F-+L9?:*)64=7;VZ_C,B\PF6-7'
M.Z:,<B+0E.LP.T^5PY%IK*P57%8R6TC:,<&2KRXJJ554,3&>9#!14>8"43J2
M_/E<*5!%.YY?@;PP6G'B?(R& Q+E:K&$,^RP5]@8_G,HT$]'.R:G0"$'.UB(
M$*SDB0H3F/3.:&F$H]+-0>!S_QGNM4YXIHG2IYGDB-3F0K:4&\(A++4Q1F8A
MTDB<$B_$[(MJ5FW]3=.Z9BNO75_.>V;MR4?K@2E#)^&G/HQ KYSZG!-]X<HI
MRR/W)"@>4G+)DYC3"C )7E ^^_KRY*9][Y9\!?&E+N;#%B^;<OUJ3H&P/>M:
ML?RI<[8#FMLYB1^Z>>X\*]KLJM#%81R=D]R6.PY8.88?QP^X]Y$H25"IO,_U
MGBW'EFA.+7@9 =Q7&.GU["ODW6IPUQT;S;[OGG0&.W;PO72Q[[:BWQNL[%C
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M7LS[W$9E;Q.RMVM<@S!"90P&N'O4P#5"0AJ#C"13&2Q=(DX UZB*WRW.G=7
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M5CN)D1-'4C[[VN=2KM0B$X5!T@KG/+:")5^&Q3-?R[4"B+D"B*<.BRN >"1
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M7<0-:96*/,2YO>KVX-=.X4]ZO=CQ9\6@!T]KE4L]A0U')_U!7NN<>SV9Z]3
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M\4@Y,HX[)+4.UH40=<S9'@_-**O<\-7EYG(/6K6N/-EUY<M=,/D0\6HCS",
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MTE&&0R218''"P@Q1+/G&\^)+:I%M*"^INUU2LVEQ@S:&$0@\4A10@1B03#J
MI9.8&,09-#<NJ4?$MT?>>=^KKX_'?J;56PVZW>0X+>-"KOPPGX@NRU+[-M2M
M*R.]/QGH)H?*CJZJ\_C7[5ZZ=9G5S$5P_G7^WC4GDE/(#/#0<4"E@,!@$G]2
MBC!B7+!&134S5SI?-=0MRX3+J+L/U,T:=X$'1ZP#""(449>JG$,< /?>(ZED
MP"H5<U,K9]NMT]9]71ZNIOY+SF.4\QBMXCJ^OG=OQI&&B]U2G_8'P]BJ86Q
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M4L]2( /"  7KB8-QIJ7>V*+S.73K6(N'B1++RVBEEM'7UNG[(*&&(5A -*6
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M:#C2_=2?Y:ZL13+CK/8(-F-6CU8S;C\>IV75%GD\@[@=VYIR >AN/9"O=>G
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M5RFM$0U1#\"*$2^B$J!(4/P[>MX=LUQ6^);H[IN+54+8>D<<L*+F0(.!UCX
M*3D,UEH<--K8(IN"WSX32:;!3(,KU?$%6-!K&#@73GI)*.984VF=QI!2AE!
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M/Z4F^TSK"]'Z_IPQ1S2G7F$!L-114=,0 \5, "B8P"W26I+(B4BN(:UGT<R
M#Z^J9@9<,0:<4VR=]8(BD2Q4:0"E3 $=-T+ .,'4(JZX7%<*7$W-]@$88.^+
MKVPYK,\7FH.%P5E]S+; C82U9KIKZY ZCH*C)E@:3;B D**,.PU#)$ E"2++
MLLN;XJ3UAX?-L$_GPV7Z6HB^#N;+E$KHXXPE'[S%@+*HP!G+(GM);:)B!RV$
M(;+7&F5_>B*:QM)MK>\ZQ3+VEH"]6>/)0*%0\ X8B#F@KO[)4^"\(CX(28)
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M;BXY<[]8KA_X/ 6ZE_8*NL6UZ/Y-=U,JD,WB0$?+JB!HLTC(O#%@\1N330H
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M<3,-9AI<J8XOQ((H!,FYM$93'_]+;02%E/'O)F@A\G'&BO/;3&4VZ[4T0C%
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MEP;%B@%1++/ENK,>V'_6>^MKUQV=_D@GNMZYBWK[09<O^@#SBW,XUV&JQDF
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MQ'@"X[1S"CKAFAE[9!H[&#_B,5GLX*!^Y"U 6-\Q$X]]/N)LO]IV)Z]"! *
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MP/R8%WH4\^/1'9+C*L[0MV_;&Q\_.\L$A<E",E @&@+G$L[$(68T\$2>A"-
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M;*)GH$U9PA& .YA@"1,8:VM%PAH7_^(3*MRM*?\B9<$Z*B7R@8'-P U%CON
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M+AVX4MN)'9:V#+K>3T9;V-M727$&$ F/ RR(:+<=,70!A0", >4'$0>K'5"
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M-MDE=A7P[6-#%;%ZU1_#]E42B2'.9OD@@&PW(%YY:3PA*TADN+LZ.7KF\G"
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MK==\<;%V+L_BGE+^-*?7U1#SPB'F1]/T:HAY0(BA<Q"3IX(ZQBT"/ D;HQQ
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M26+_JRE+PL/!XX)+P[M4)R!N>#/H9 %CT:\L_B">L6X&86[A>3!S@]:@#7,
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M/06 9E'V2K=[ND7*YQJ^MI\3NY@FL,TQ?/E.V4Y.U%/&[6A--..K( -YXVX
MU=. 745Q"LJ,<A;Y<3(6%58N>7(=N'PSI#'Z^\:8[4[@XY2GF5+N/%7X>!+?
M\"15)CR> -_,8B5CW[DBK0WX9S">)/$U5T94C4")IYD;PU)[BO(75Z8IL%I
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M=]'2\>$TA4^Q7).@_56EGNY243 /O203.F.J[XEEZ  T,>AU*7YW87;@&U<
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MM%$\<P67WY8!VI%6E)\#*\]A(L^AZFS&F(PP3DL'$H9&*"=DU2F?..EA0&C
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M1-DV*<16[ZCV>A_29MNL1QAWBUWUVAQ@5_^!>0(M=K78=<_FC.8PKB4NCQ]
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ME0'R2,'<'W?"=/H;5:=88N]CB?^N06_/U](&+!&FH*[LTWRZ1"\#7OHT#W"
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M!+;\.@.=]?<"Y;BHB469S=2]8B;4$. BXPS)NI3=<&2[&Q_1\SK7N@FM7B[
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MFZ.C"/XP@UUR'Q<,"CVK:5FW)HP)G6ZGT>T,>MTVT'(-8X75L_J#7+LD=JI
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M=*^(8XTKH\%B025TM\DY</)U;%UV+XY*G.]I:8=QDG&8DW_:DCH)CNPG'*)
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MOE2?U.>AQD>2#)O5XBIB:UA[GU!25Z.K:?2.SY%3(TE.6N&Z A:W%AQ;-$8
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M9G!)B[:H=HR -VB@"%TB'U,F8))BGH-A:IE^8X^]XZ7KN3'Y-3R_?X4N!#_
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M0Z'3UFF+G/%Q0UG-;YM=T=5#:</5CA \H-4S(70!JF,WH588>N@3="CK%3H
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MR[7B)4,>MIOKG2"[ >>5$AU5&)0$N\&S3WL=1_&:WUUZMBU9PW&$LB22!(J
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M"3NV\(7N4$5P*FV-FWBW$/F,:O=DH_A567BA@?+: G\$XP"75\JQD3LH"3D
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MKD N4 P@QD);>0R#E!0X5QS"/+4R]8Y&'AM?U<+9L=,Q3MVL<Y'V/;-)+5?
MNA6MVG;M??W0SK[7_W6XYX]''60OMRK3[-'V#[C?>'^LRSM^:5(H/M*UG,!"
M*,EC A#)]'&+0 QPEF@#HR )0QG*"V1]U7URAK'MQ4;(^JT6:3'-K:UE^$\[
MD.=OM2^&IV]/O2LR3O?8G=I[7V"?'G6PF^M.I7:OK+L_&,I/7]::>7B12VJN
M<F[HRW1-9_=R/6%YSF ,">"2*J#?JX5)SS O7BQ@6B"(F72+N[2?W.H;/FCT
M956KJKJ.+G/@9[NY[W-IZ>CR6 =?Q_Q%V+ZK6[[">B-Z?0%=HKY7<>"^ _4
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MMD$I]ZS2A]Q[_@'W6ZIK?0(34GR5=':[,BWO2XNRCECC,:%IDB+ L) FN:\
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M)@%5.004,T5HIDDE<[I^LYMV;-Q22FUNQ;[H49M7LAN;6.)MQROA4>S;3=8
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M[*[PA>G88^$]DN]%FGRATR;EX7I>-7NZ7JWD>M5T]]"GR801O3(0(Z'_X"G
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M]Q6L6NYP[P07E(*^$ZPF'O2=X +%X3O!Z=D+?:T[A:!6FVON^GX/0B82GL6
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M>_6U:E6]HXE5^S-^1'*_F"]>RL(+\V][#5HV7_(DC9-""0$@R90)_J0 IZP
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M#V'QA!^I?Y1*+I>FBK-IP/E$?];=,3[(N533]:1029X2!4V!+5-0@U" ,9$
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MP([31#!IR@0LXRE*FE+LRCZL)& ];#2_';F[<)O R-DEC$:WU)L,D2L.1%E
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MA=Z"/_.SRV*4\:]RX^6K'Y5;+@?S]WXZ_8Y^^J]^= V#D#G/,B=TTF4$H[&
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M@KY^CX@Z0\VS&W+=*^>MV:+M2RQ>>UI5RU2SU.)5J-G ?4Z^[.FY$L2A.PK
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MDI)!9HF"B23:4EOLG22^5)4P,-KK "[[RN%"S91L499SO_NQ>%>"_/)^R+)
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M'$]&DXO;D1.!<^^,,<1'\$2*(JIL*<8E3E'J@H^NCD-]F::>Z\WWB+".]-(
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M">A^BL_1&#%TO;A8>S!.?X%T,1Q?'$3\U6((ZHKN+LPK@:DYXHP+062B@K@
MFE /T4ME,I-U-L]W('I7B[;%J^\[)#M#!3"3B$F+$1XY$6^M*U/OF),I&AKK
M=#O;A>I^CQGVA<^GQG!O>FZY$_8J*[3UX)17'E;5;%8<E;(+.+W(H+VQ) J$
MI#26H2?U4.8W*XB*1_ITL./;-9[E,/R^U?P'"//[5]_/=2^#UP[2?UW/YN7G
M!_/Y=!BNYT5[\TDA#E+YET^:SD=CK,Z2$0;E7HV+F@3+,V&<.HR'A>!/FQZO
M+.2O0]W;-9V;H/-AU7\#6GYK!O6='Y5IG6>74'KH;=W'<NU'5S6V/V:F =.K
M7/#9)$N8$IE(YBD)-**WMDQ P-" 5IK8UT3<NKS6@X%1H!PYIZP4&2DN29"X
MP'/P*B;(E-(Z)ZA/"'F[)G(3%+T<76ZNC0:V=1ZN\N/RZ:*N<CO;\>@A)T&X
M7E3?HCA<LH;00!/EDF?+ZZRLERAJ!5Y;J'E20>:-8N?FDBL%F4/"5,TJ7VX1
M*$$\4ZAN7$G>)A6%3GM#3PO-$;K1^1I VD(!#4#I>#*^.(?I50D8;WO!T>2S
M1GNL*2@4C,&XU054N+->4.M VSH0>DY+>]#91LN33D7> &A6NOQ?4"['D]GL
MW?<;S_^PE^5BQ=G$DU&)$N:X)=(+14*6D5BME7%HR1.M<Q-C.WK[K9WLTN_M
M05\-H'(%&S>KE0?,=+4L9]BY3+<2*#L+DL32*-@**2RM$U*]2%(K,54]/$QJ
M**<!E-WMPMQP=-NDU\9RJQ@= E>EQ8/,*!9CB?'"RQP5E97:CJZFIU]\=:3L
MIV>KNTN^ ?S<K[WCN]M*05J;&7B""6^9/*31_0MDQ@3)@J59&56GJ\ *8OHM
MM*[C];:3= -@66[F'@]]&(Z&\^^/5@"\7]X@7UCQ)Z.LG..&A7*74I9YMCE@
M>!JU(X;QE+6-ULLZ;:2V)+@5=[@E4%;XNMI::WF'_NS\Y/V__^7D^,/AZ=GA
M?_QV=/Z?!Y\^G!Y^.#S\]>#=\>&GDT_O3SZ=GYX<'Q]]^N7HT_GAZ>'9^1;;
M]=N]I[.]^P[8[&@C_VP^B7^_G(QPF<P.__L:,7=?S,0!N*:19*'1X4)"1,>(
M@1L3P4@56-9U7,O+-.T\:OW9DS]-YK"JAB!"]DH9489"NM*%B!*?T(\DR;G7
MS H5ZM3&K4UBOX:O(]P\FXA>14%_.(NW_3GE3J_KU_[5/,]\!<[::6XXS00T
M9"*MRZ3<XB12*ZFS-#I4&K_7O1E\7"+P_/E^G$XA 5R5 'HQ\F,\1WV-ELW.
M 56^K P82&VXI)X3L!R7>(P8;I@R1C<)K:A.U&;S R!V14NS9G 3W*RNX=B3
M@AI(5LY08XNA,DLVWT^NODS&B\/@LGDD)!>)ZDQ*LQ<BA8O$1JZ(5B'GE%-@
MIL[DGU?)ZJ]SX_X1\LQ+=Z6N!K#WA(>;W2:M59F<)<NH+""2E0HLQS@BQ4>P
MAAJJZQ17KR2G;R/7F;HG7<N^ 0"=EQ3\>OI]L1AOI\FPZ&S*AL2 6;@4"DA0
M2I)H>%+4695YG?OE*XCI%SP=J/A9<_?=Y-T 9 Y2&A8%^-%G/TQ'X_?^RW#N
M1[?,V  \H"TVE"4B:98D"*I)9EZE"%2#JY-XOTI6OV>:W<.H.QWT"*C9=#XX
M^7V,S[D]:0,A=50L$N^!8=B9/0DF S':*TZ5 !/7*L' )S\ #G[W%#3/7MU?
M!^'> J+=Q-\*;FX6D\A9<YTIT4[B8E))$&L%@A]D<%1S":P"<OH,<'94WRH0
M;"'+GD<X_/:KG\W^UV0XGO\5174]A1L+*'B0@8$AV2Z*W!RN!ZTX<90R844I
MMGU2^; RQW_A\0TH?!M53;J56\^JW]%NWA]YT1R#$E(1Y50@,N=R7\5I EP:
M&0 L>WJ3O,9^T''_$SYZ\T2]J;.!:!JCPJO)>,'SA^'788)QFGV&Z=DEJNL#
MQ!'^E09@G(,D.,D2+&8(R1%,"QP1:-Z=X)X)6:?3S#K4O=F]I"TQ\W2$>=<*
M[-NN%DY.X<OU-%[Z&7R>3BZF_NH^X3BXFER/YP?7\\O)=/@/Y$T[EKU-FIAD
M2A=KY]%=V)+1)&D"YV#%6OOI&[[WS4;LN\&NNHH:L(FK^5NVXRU7J^X8N__,
MDF4V,,!-B,H0%10ELG2Z"5HX0O/_7]ZU];:1[.CW_2\$ZGYY62 7SQP#23Q(
M,N=@GXRZL#Q:.%)6DK.3?[\L6;)C^=:2NM2MLP.<@WB<Z6:17[%(-NMC=,$4
M3X=3FW[$_64^V0._'_]Y)&./ -8/:G^K\V'Q)I&RZP'!I2@)%0.O5WP3R4-P
M7$"]!,')5:)D;4KV+P@UW(2040"S+W.-#7FKGKS-2M[-%LN/2%N,UD29GE*D
M*T7[IC+>D:[JMY!42]!*,HNJS;7>+M(--S9D?%CLPX C .5J+>>+Q0WF]S=S
M4AE%S9-9OMUI#Q;\&2>KOW;IHXLI\@B:8D=0IGZN$[I6T+-W/@MG99O^WMUE
M'6YTR"@ V]BX(X#OQ\F4XI+ESXW>[DISM-)4;7V%;W\^5/'M7[G,S!J&AO0J
M-:_]S@D\MP4<3]I%HY+ -J-P]A9Y&+;-T8#Y.*8>=:/GGW_\\>&LTK2\^?#N
MS9=__/;AXE\77_]Q]OG]FZ]O]NGD?/%Y_;5J=A>[KU[,F^^T^MIO$J[?A<5?
MOUW/_O?L]E\L[KKK<N*9<Y0@''I0E2LI%G)\J%1T'+W2H4TYKXMT!Q<TU\_]
M]5WW/="+^R;H(@HWY/&A\+(:I!,@!MJ;(J)%7UR*P3310E<)!VY<ZAM)CPJ7
M+0QULDYL;V["+D\]CD-KR%;8"8S".I4<LR!49?E%%<!YJ<'*HCV7G.OMQNH3
M<FN;0.2BO+9O'M+/%<6-D73N"Q4I LB4F05,"+7SD'OTZ$R;.1=["GP"3F\7
MG#W*2XY@QI/U@1OE''!#9Y?''\<KOKBH8[I'RWETVCAPM35/,<LA9,IO67 E
M"VZX]VU*O,=PC^^13)@F*P->FI*\=L) 5JIR&"<.,14$DZ616F>*5=HT$/\J
MQ0DXLET0\?B6_YX*'T'IY)6QR"YXD;BSD NK?"L8R;_3GV+(N3;FQQS;')D]
M3*YNUD/<'% ]&F4$$/MU>]"?KW%EIVG^=967I01T4EN0:.N:@H,@#(>:U&0M
M40K?BD?[=>F&)20YJO_JQ4"]S0W9'W2;^N!ZLLJEL=(&G3S(4L7'DL'5N#49
MIQ-Y:8/8AE%P2Y!A!S VA](A:M\=-?X6-5.\"DO,7WOS6)M5T![8])&=3RG$
MQ8OO."=C3:\NG1$Z12T@2TH]5-8!(M,,0BB)B^CISVT^'+PNV[#S$8\&L9Z,
M,X(#<K.BVV7<381>TNY!#%)08EWGG5!V+2"D(D!2(&DM8\*6-A>6GY-HV+F%
M1X/60888T>%7+Z15\2-&(S)/$$NJ%Q)H9\1"X@L19%$F,R/;)(%;@@P[*?!H
M\-E'[:-P0Q7U7\/?N*@KN R%!1'KI0')ZUU8SNH'4PM.>J5*#L;G-A^%M@09
M=H[?$5"SO]I'@)KU==>5L\R3>G]I02NZJ9*\O5E^FBW_"U<;XI*KF#2EKH Q
M6%"K3^_,T;Z(Y$EYR18;$0)VE; 3SOS)XJR)H48 P/N;'N%G_5#PKBYI6L/#
MV@9R^\.E,%I3BAHA!?+'2N<,T=+VTF@*N6)3*<7:E!<Z2->M/,I.%GF]6V@$
MJ+MCU+PHZYF_FW[D;+W4@E<D5+[80GLH9O2UQ8DKE303L<VQ^:Q(W?!UNO7W
M?FPQ E!M^%HGN*"%W'S#S"]]Y1FV(4/6=2X#([_LE)? 7?'1N"2]:%.!?T*8
M;D ZW;K[H?H?^+K@+_N TH^MK:!=2MY'!*%=_2ZE+.T"KD#7 1^>&<[2UFVL
M)Z\&OO2.;O XO3IYK[H=L#Q0U_$1YU<X3[/I@H[D^<HXWRGH^WY[,D]KUJI3
M#)Y+*%&Y>FO<0 SD.'UV0@J&26*7._BOOJ@;6DZO%-Z_ED=P,E'DMM+,U]D:
M]&]O%I,ITC98_#Z?+1:7,;B0G8_@BT%007O2E*(?LS)118'T[YL<4Z])U@UF
MIUL.[]4R(T!:5=+&L?Y&ZES]>;&Z37V94D)?6758K 6U2,[660Q0=!9)2:]\
MHTGU+PC5#5^G6Q/ORQY[0^L'SN.LO1NC4_VV$?'N5(\F"B<S$A@"17Y",XK\
MK 154]%ZI]F[-I<P=Y&R&_Q.MZ;>S&(C<'4?ZLB->FGT?ABM#L$;6D#)-M0%
M"'"9%.>CSHEC%MFU*5,]$J4;KDZWZGZ8[D?AS#Y/KOZB'?#GXK8O["(N ^V,
M?#X]^SO]%:97^-ML?O=-?+7>NWDPE\$9*VKXJ5"0Z@R+$&5QE.1ZE:6)7#:Z
M8'Z T,-VD1X(F-DPMCO9_O=/83Y?C2AJU #_Z/G'Z8!_>5G';('W&9/GR0-C
M]>:&-W7.5$R 3%KZ)Y2"C2[#-&R!7UU3?N+Y;Z;Y8OD7SM^'9;CEQM,9&3K#
M@#+O.M4M9G"".RC,U3LDS/C0A96RT\M.H/U]%S0\H+_J7=D#UU"_SB=75UA9
M$LY^U&]4*V9Z'K53*H#5E9F>TF;P0B<@K2AE"X^,=ZF(/?'H ?GZ^C?<K#\M
MC@L$:X)793.CI%:#9)[.W53;>4AN$%'JG)5T>7LH>1<8#,E;W(NIGC?['GH;
MV/!OOJW.W\\8KL\6=5K%*O1:$_(*B2SIA,!7@V.+\1"3H.!+>V.2T3IO,]X\
M:?^7WC$:&.QCNED#/0Y-P/F*E_QPQVDB6 E8&.V6@@Q(,Y0,"&/ .*%DB<GF
M;2*9O>*)#SM1$[>AW&QZ<K31^ B*/0^SN:W\[Q*+5 J3!I_JGLA.@F-"0HC!
M6\V2BZK-=8(7Q1IO>+(G#&:M;#+F//O=Q<>/YU]K0OKES:?W=2#B^:??SSZ]
M.S_[LD=6_=+3>LNA.XO<4\9<B:,GR]N4:)K?S:85%#A-$US<\Q#<)4O!QFP<
M!C I8IV4C! D94PE9N]$LBR61I^A=A&S#S;T5U]VS\J@/"O<(6V\E.KX+N-(
M*10Y)"NBS]PXVVBXWFYR#IN+M\/94U3HC:QWHKYN_T)BAX<>P_.U+!GN!DQ>
M?)*Z#I8PV=;\D(%+@=/Q6##Y4KPN;9B]C^H /\P6BP>ON(UL'5.9>>?!,%:
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M<(<P2W<'LT&S?8!Q@/TQ[%]@^EP2_#2VZIB?(UJ8[:M@HAQSLNC)IUY5:&@
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MPE9IL] '[@4TF:;"6LX?2!EC!0H$RYD _UPCSP'=P- &,P#\1T%>+4G^9R'
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MVS82_GZ_ I7GTF1&;]1+[,B.9Q19;G23VJFC-M=/-R !2AB#! N DG6_OKL
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ML-9$!NG]NP5T=#B +C,UGU&9NW2&T\WC&$BFF,%$F1UD<<D^]DC/_G$W?W0
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MGDR'T]%D>(*OD.K/L6[GB[?#:0#!#-PNO+46ULB"IWON0:</F&*G_MW[.ES
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M=KFWO<]1\I,'T/L<3J]=S.2BNIGJ2<J)J;H;5S57([W$X%R)D"7.]4+?+?*
MX_-'S^H6JKP/._H+4$L! A0#%     @ X8&65/2;PO3GBP$ C9,3 !
M         ( !     &1G>"TR,#(R,#,S,2YH=&U02P$"% ,4    " #A@994
MG53RD^L-  !W@@  $               @ $5C $ 9&=X+3(P,C(P,S,Q+GAS
M9%!+ 0(4 Q0    ( .&!EE1Z':E:FQL  +\$ 0 4              "  2Z:
M 0!D9W@M,C R,C S,S%?8V%L+GAM;%!+ 0(4 Q0    ( .&!EE2R:\&-C3@
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M,S,Q,C R,F5X,C(N:'1M4$L! A0#%     @ X8&65#FVBP-$"   KRD  !0
M             ( !7@@# &1G># S,S$R,#(R97@S,3$N:'1M4$L! A0#%
M  @ X8&65%; 6GM#"   :2D  !0              ( !U! # &1G># S,S$R
M,#(R97@S,3(N:'1M4$L! A0#%     @ X8&65-=?"<ZO!   <Q,  !0
M         ( !21D# &1G># S,S$R,#(R97@S,C$N:'1M4$L! A0#%     @
MX8&65/E-G;JH!   :A,  !0              ( !*AX# &1G># S,S$R,#(R
?97@S,C(N:'1M4$L%!@     +  L S0(   0C P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
